UniProtAccession	GeneName	Mutation	WT	Position	MUT	AlignmentPosition	MutationType	Description	Source
Q13131	PRKAA1	V307G	V	307	G	-	activating	Q: Activates the kinase activity."";/evidence=""ECO:0000269|PubMed:17088252""	UniProt
P00519	ABL1	A337T	A	337	T	323	increase	in CHDSKM; increases kinase activity; no;effect on protein levels; dbSNP:rs1060499548)"";/evidence=""ECO:0000269|PubMed:28288113"";/id=""VAR_079483""	UniProt
P00519	ABL1	Y226C	Y	226	C	-	increase	in CHDSKM; increases kinase activity; no;effect on protein levels; dbSNP:rs1060499547)"";/evidence=""ECO:0000269|PubMed:28288113"";/id=""VAR_079482""	UniProt
Q07912	TNK2	L487F	L	487	F	-	activating	Constantly active kinase."";/evidence=""ECO:0000269|PubMed:16288044""	UniProt
Q07912	TNK2	V365R	V	365	R	761	increase	Increased autophosphorylation at Y-284."";/evidence=""ECO:0000269|PubMed:20110370""	UniProt
P36896	ACVR1B	T206V	T	206	V	-	activating	Leads to constitutive activation."";/evidence=""ECO:0000269|PubMed:8622651""	UniProt
P31749	AKT1	E17K	E	17	K	-	increase	(in PROTEUSS and breast cancer; also detected;in colorectal and ovarian cancer; somatic mutation; results;in increased phosphorylation at T-308 and higher basal;ubiquitination; the mutant protein is more efficiently;recruited to the plasma membrane; alters;phosphatidylinositiol phosphates lipid specificity of the;AKT1 PH domain; dbSNP:rs121434592)"";/evidence=""ECO:0000269|PubMed:17611497,;ECO:0000269|PubMed:18954143, ECO:0000269|PubMed:19713527,;ECO:0000269|PubMed:21793738"";/id=""VAR_055422""	UniProt
Q9Y243	AKT3	E17K	E	17	K	-	activating	(in MPPH2 and melanoma; results in activation;of AKT; dbSNP:rs397514606)"";/evidence=""ECO:0000269|PubMed:18813315,;ECO:0000269|PubMed:22500628, ECO:0000269|PubMed:22729223"";/id=""VAR_065830""	UniProt
Q9UM73	ALK	F1174L	F	1174	L	184	activating	(in NBLST3; somatic mutation; constitutively;activated; retained in the endoplasmic reticulum and Golgi;compartments; dbSNP:rs863225281)"";/evidence=""ECO:0000269|PubMed:18923523,;ECO:0000269|PubMed:18923525, ECO:0000269|PubMed:21242967"";/id=""VAR_063857""	UniProt
Q9UM73	ALK	F1174V	F	1174	V	184	activating	(in NBLST3; somatic mutation; constitutively;activated; retained in the endoplasmic reticulum and Golgi;compartments; dbSNP:rs281864719)"";/evidence=""ECO:0000269|PubMed:18923523,;ECO:0000269|PubMed:21242967"";/id=""VAR_063858""	UniProt
Q9UM73	ALK	R1275Q	R	1275	Q	448	activating	(in NBLST3; constitutively activated;;retained in the endoplasmic reticulum and Golgi;compartments; dbSNP:rs113994087)"";/evidence=""ECO:0000269|PubMed:18724359,;ECO:0000269|PubMed:18923523, ECO:0000269|PubMed:18923525,;ECO:0000269|PubMed:21242967, ECO:0000269|PubMed:22932897"";/id=""VAR_063865""	UniProt
O14965	AURKA	I57V	I	57	V	-	increase	(increased kinase activity; dbSNP:rs1047972)"";/evidence=""ECO:0000269|PubMed:15489334,;ECO:0000269|PubMed:15867347, ECO:0000269|PubMed:16011022,;ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9153231,;ECO:0000269|PubMed:9514916, ECO:0000269|PubMed:9771714"";/id=""VAR_030842""	UniProt
O14965	AURKA	T288D	T	288	D	512	increase	Mimics phosphorylation state and increases;kinase activity."";/evidence=""ECO:0000269|PubMed:11039908""	UniProt
O14965	AURKA	V174M	V	174	M	144	activating	(in a metastatic melanoma sample; somatic;mutation; constitutively enhanced kinase activity)"";/evidence=""ECO:0000269|PubMed:17344846,;ECO:0000269|PubMed:19801554"";/id=""VAR_041129""	UniProt
Q13873	BMPR2	R899P	R	899	P	-	activating	(in PPH1; leads to constitutive activation of;the MAPK14 pathway; dbSNP:rs137852752)"";/evidence=""ECO:0000269|PubMed:15965979"";/id=""VAR_033111""	UniProt
P15056	BRAF	G464V	G	464	V	37	increase	(in a colorectal cancer cell line; elevated;kinase activity; efficiently induces cell transformation;;dbSNP:rs121913348)"";/evidence=""ECO:0000269|PubMed:12068308"";/id=""VAR_018616""	UniProt
P15056	BRAF	G469A	G	469	A	42	increase	(in NHL; also in a lung adenocarcinoma;sample; somatic mutation; elevated kinase activity;;efficiently induces cell transformation;;dbSNP:rs121913355)"";/evidence=""ECO:0000269|PubMed:12068308,;ECO:0000269|PubMed:14612909, ECO:0000269|PubMed:17344846"";/id=""VAR_018620""	UniProt
P15056	BRAF	L597V	L	597	V	445	increase	(in NS7; also in a lung adenocarcinoma;sample; somatic mutation; elevated kinase activity;;efficiently induces cell transformation;;dbSNP:rs121913369)"";/evidence=""ECO:0000269|PubMed:12068308,;ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19206169"";/id=""VAR_018627""	UniProt
P15056	BRAF	R671K	R	671	K	639	increase	Increased kinase activity and stability in;response to EGF treatment."";/evidence=""ECO:0000269|PubMed:21917714""	UniProt
Q8IWQ3	BRSK2	T174E	T	174	E	512	activating	Constitutively activated."";/evidence=""ECO:0000269|PubMed:14976552,;ECO:0000269|PubMed:18339622, ECO:0000269|PubMed:22798068""	UniProt
Q8IWQ3	BRSK2	T443A	T	443	A	-	activating	Constitutively activated. Promotes formation;of actin stress fibers."";/evidence=""ECO:0000269|PubMed:22669945""	UniProt
Q9BWU1	CDK19	Y32H	Y	32	H	41	increase	(in DEE87; fails to rescue neurologic;phenotypes in a Drosophila model system; increased protein;kinase activity; dbSNP:rs1236246272)"";/evidence=""ECO:0000269|PubMed:32330417,;ECO:0000269|PubMed:33134521, ECO:0000269|PubMed:33495529"";/id=""VAR_084395""	UniProt
P24941	CDK2	T14A	T	14	A	40	increase	2-fold increase in activity."";/evidence=""ECO:0000269|PubMed:1396589""	UniProt
P24941	CDK2	Y15F	Y	15	F	41	increase	2-fold increase in activity."";/evidence=""ECO:0000269|PubMed:1396589""	UniProt
P50750	CDK9	S175A	S	175	A	456	activating	Constitutive kinase activity."";/evidence=""ECO:0000269|PubMed:21533037""	UniProt
P50750	CDK9	T186D	T	186	D	511	activating	Mimics autophosphorylation; constitutive;kinase activity, independently of calcium signaling."";/evidence=""ECO:0000269|PubMed:11145967,;ECO:0000269|PubMed:18566585, ECO:0000269|PubMed:21448926""	UniProt
P07333	CSF1R	L301S	L	301	S	-	activating	Constitutive kinase activity."";/evidence=""ECO:0000269|PubMed:15117969""	UniProt
Q08345	DDR1	N211A	N	211	A	-	activating	Phosphorylates regardless of collagen;presence, collagen addition does not alter significantly;the levels of constitutive phosphorylation."";/evidence=""ECO:0000269|PubMed:24509848""	UniProt
Q08345	DDR1	S213A	S	213	A	-	activating	Phosphorylates regardless of collagen;presence, collagen addition does not alter significantly;the levels of constitutive phosphorylation."";/evidence=""ECO:0000269|PubMed:24509848""	UniProt
Q16832	DDR2	L610P	L	610	P	129	increase	(in WRCN; increased autophosphorylation in;patient fibroblasts)"";/evidence=""ECO:0000269|PubMed:30449416"";/id=""VAR_081931""	UniProt
Q16832	DDR2	Y740C	Y	740	C	461	increase	(in WRCN; increased autophosphorylation in;patient fibroblasts)"";/evidence=""ECO:0000269|PubMed:30449416"";/id=""VAR_081932""	UniProt
Q9Y463	DYRK1B	H90P	H	90	P	-	increase	(in AOMS3; expression of glucose-6-;phosphatase is significantly higher than wild-type;;dbSNP:rs587777380)"";/evidence=""ECO:0000269|PubMed:24827035"";/id=""VAR_071773""	UniProt
O43781	DYRK3	S350E	S	350	E	437	increase	D: Phosphomimetic mutant; increased stability;of the protein."";/evidence=""ECO:0000269|PubMed:29634919""	UniProt
P19525	EIF2AK2	G130R	G	130	R	-	increase	(in DYT33; gain-of-function variant resulting;in increased levels of phosphorylated EIF2AK2 and EIF2A in;patient cells compared to controls)"";/evidence=""ECO:0000269|PubMed:33236446,;ECO:0000269|PubMed:33866603, ECO:0000269|PubMed:35146068"";/id=""VAR_086716""	UniProt
P19525	EIF2AK2	N32T	N	32	T	-	increase	(in DYT33; unknown pathological significance;;gain-of-function variant resulting in increased levels of;phosphorylated EIF2AK2 and EIF2A in patient cells compared;to controls)"";/evidence=""ECO:0000269|PubMed:33236446"";/id=""VAR_086715""	UniProt
P00533	EGFR	E709G	E	709	G	-	activating	(found in a lung cancer sample;;constitutively activated kinase with higher levels of basal;autophosphorylation; more sensitive to gefitinib than wild-;type; dbSNP:rs397517085)"";/evidence=""ECO:0000269|PubMed:15623594,;ECO:0000269|PubMed:16205628"";/id=""VAR_069498""	UniProt
P00533	EGFR	G719S	G	719	S	37	activating	(found in a lung cancer sample; somatic;mutation; strongly increased kinase activity;;constitutively activated kinase with higher levels of basal;autophosphorylation; more sensitive to gefitinib than wild-;type; dbSNP:rs28929495)"";/evidence=""ECO:0000269|PubMed:15118125,;ECO:0000269|PubMed:15623594, ECO:0000269|PubMed:16205628,;ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:17349580"";/id=""VAR_019297""	UniProt
P00533	EGFR	L858R	L	858	R	445	activating	(found in a lung cancer sample; somatic;mutation; constitutively activated enzyme with strongly;increased kinase activity; more sensitive to gefitinib than;wild-type; dbSNP:rs121434568)"";/evidence=""ECO:0000269|PubMed:15118125,;ECO:0000269|PubMed:15623594, ECO:0000269|PubMed:16205628,;ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:17349580"";/id=""VAR_019298""	UniProt
P00533	EGFR	L861Q	L	861	Q	452	activating	(found in a lung cancer sample;;constitutively activated kinase with higher levels of basal;autophosphorylation; more sensitive to gefitinib than wild-;type; dbSNP:rs121913444)"";/evidence=""ECO:0000269|PubMed:15623594,;ECO:0000269|PubMed:16205628, ECO:0000269|PubMed:16533793"";/id=""VAR_026102""	UniProt
P00533	EGFR	S768I	S	768	I	181	activating	(found in a lung cancer sample;;constitutively activated kinase with higher levels of basal;autophosphorylation; more sensitive to gefitinib than wild-;type; dbSNP:rs121913465)"";/evidence=""ECO:0000269|PubMed:15623594,;ECO:0000269|PubMed:16205628"";/id=""VAR_069502""	UniProt
P00533	EGFR	T790M	T	790	M	266	increase	(found in a lung cancer sample; increased;kinase activity; dbSNP:rs121434569)"";/evidence=""ECO:0000269|PubMed:16533793,;ECO:0000269|PubMed:18227510"";/id=""VAR_026098""	UniProt
P00533	EGFR	V689M	V	689	M	-	activating	Constitutively activated kinase."";/evidence=""ECO:0000269|PubMed:19560417""	UniProt
P29317	EPHA2	R721Q	R	721	Q	353	activating	(in CTRCT6; retained in the cytoplasm and;constitutively active it alters EPHA2 signaling;;dbSNP:rs116506614)"";/evidence=""ECO:0000269|PubMed:19649315"";/id=""VAR_062532""	UniProt
P21860	ERBB3	A1337T	A	1337	T	-	increase	(in FERLK; risk factor for erythroleukemia;;results in increased ERBB-mediated signaling; results in a;block of erythroid differentiation and increased cell;proliferation; dbSNP:rs755855285)"";/evidence=""ECO:0000269|PubMed:27416908"";/id=""VAR_081641""	UniProt
Q15303	ERBB4	I947R	I	947	R	752	activating	Constitutively autophosphorylated."";/evidence=""ECO:0000269|PubMed:18287036""	UniProt
Q15303	ERBB4	Q646C	Q	646	C	-	activating	Constitutively activated kinase."";/evidence=""ECO:0000269|PubMed:17120616""	UniProt
P07332	FES	L145P	L	145	P	-	activating	Constitutively activated kinase that can act;as oncogene. Promotes myeloid cell survival and;proliferation."";/evidence=""ECO:0000269|PubMed:11509660,;ECO:0000269|PubMed:15485904""	UniProt
P21802	FGFR2	C278F	C	278	F	-	activating	(in CS, JWS and PS; forms disulfide-linked;dimers with constitutive kinase activity, is retained in an;intracellular compartment and not detected at the cell;surface; dbSNP:rs776587763)"";/evidence=""ECO:0000269|PubMed:11173845,;ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:16844695,;ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:9677057"";/id=""VAR_004121""	UniProt
P21802	FGFR2	E565A	E	565	A	267	activating	Constitutive kinase activity."";/evidence=""ECO:0000269|PubMed:17803937""	UniProt
P21802	FGFR2	E565G	E	565	G	267	activating	(in PS; constitutive kinase activity;;dbSNP:rs121918506)"";/evidence=""ECO:0000269|PubMed:11781872,;ECO:0000269|PubMed:17803937"";/id=""VAR_017277""	UniProt
P21802	FGFR2	K526E	K	526	E	141	activating	(in FSPC; constitutive kinase activity;;dbSNP:rs121918507)"";/evidence=""ECO:0000269|PubMed:16061565,;ECO:0000269|PubMed:17803937"";/id=""VAR_023788""	UniProt
P21802	FGFR2	K641R	K	641	R	439	activating	(in PS; constitutive kinase activity;;dbSNP:rs1057519047)"";/evidence=""ECO:0000269|PubMed:11781872,;ECO:0000269|PubMed:17803937"";/id=""VAR_017278""	UniProt
P21802	FGFR2	K659N	K	659	N	509	activating	(in craniosynostosis; constitutive kinase;activity; dbSNP:rs1589722765)"";/evidence=""ECO:0000269|PubMed:11781872,;ECO:0000269|PubMed:17803937"";/id=""VAR_017279""	UniProt
P21802	FGFR2	N549H	N	549	H	203	activating	(in CS; constitutive kinase activity;;dbSNP:rs1057519045)"";/evidence=""ECO:0000269|PubMed:11781872,;ECO:0000269|PubMed:17803937"";/id=""VAR_017276""	UniProt
P21802	FGFR2	N549T	N	549	T	203	activating	Constitutive kinase activity."";/evidence=""ECO:0000269|PubMed:17803937""	UniProt
P22607	FGFR3	G380R	G	380	R	-	activating	in keratinocytic non-epidermolytic nevus and;ACH; very common mutation; constitutively activated kinase;with impaired internalization and degradation, resulting in;prolonged FGFR3 signaling; dbSNP:rs28931614)"";/evidence=""ECO:0000269|PubMed:10611230,;ECO:0000269|PubMed:12297284, ECO:0000269|PubMed:16841094,;ECO:0000269|PubMed:17561467, ECO:0000269|PubMed:7847369,;ECO:0000269|PubMed:8078586, ECO:0000269|PubMed:8599935"";/id=""VAR_004155""	UniProt
P22607	FGFR3	K650D	K	650	D	509	activating	Constitutively activated kinase.""	UniProt
P22607	FGFR3	K650E	K	650	E	509	activating	in KERSEB, TD2, TGCT and BLC; bladder;transitional cell carcinoma; somatic mutation;;constitutively activated kinase with impaired;internalization and degradation, resulting in prolonged;FGFR3 signaling; dbSNP:rs78311289)"";/evidence=""ECO:0000269|PubMed:10471491,;ECO:0000269|PubMed:11294897, ECO:0000269|PubMed:12297284,;ECO:0000269|PubMed:14534538, ECO:0000269|PubMed:15772091,;ECO:0000269|PubMed:17145761, ECO:0000269|PubMed:17344846,;ECO:0000269|PubMed:17561467, ECO:0000269|PubMed:19855393,;ECO:0000269|PubMed:7773297, ECO:0000269|PubMed:8754806,;ECO:0000269|PubMed:9207791"";/id=""VAR_004160""	UniProt
P22607	FGFR3	K650L	K	650	L	509	activating	Constitutively activated kinase.""	UniProt
Q04759	PRKCQ	A148E	A	148	E	-	activating	Constitutively active form."";/evidence=""ECO:0000269|PubMed:10652356""	UniProt
P22607	FGFR3	R248C	R	248	C	-	activating	(in KERSEB, BLC, keratinocytic non-;epidermolytic nevus and TD1; severe and lethal; also found;as somatic mutation in one patient with multiple myeloma;;constitutive dimerization and kinase activation;;dbSNP:rs121913482)"";/evidence=""ECO:0000269|PubMed:10360402,;ECO:0000269|PubMed:10471491, ECO:0000269|PubMed:11529856,;ECO:0000269|PubMed:15772091, ECO:0000269|PubMed:16841094,;ECO:0000269|PubMed:17509076, ECO:0000269|PubMed:7773297,;ECO:0000269|PubMed:8845844"";/id=""VAR_004148""	UniProt
P22607	FGFR3	Y373C	Y	373	C	-	activating	(in KERSEB and TD1; disulfide-linked dimer;with constitutive kinase activation; dbSNP:rs121913485)"";/evidence=""ECO:0000269|PubMed:10360402,;ECO:0000269|PubMed:15772091, ECO:0000269|PubMed:17509076,;ECO:0000269|PubMed:8845844, ECO:0000269|PubMed:9207791"";/id=""VAR_004153""	UniProt
P09769	FGR	Y523F	Y	523	F	-	increase	Strongly increased catalytic activity.;Functions as oncogene."";/evidence=""ECO:0000269|PubMed:1737799""	UniProt
P36888	FLT3	D835E	D	835	E	452	activating	(in acute lymphoblastic leukemia patients and;acute myelogenous leukemia patients; somatic mutation;;constitutively activated; dbSNP:rs121913487)"";/evidence=""ECO:0000269|PubMed:11290608,;ECO:0000269|PubMed:14504097"";/id=""VAR_065679""	UniProt
P36888	FLT3	D835H	D	835	H	452	activating	(in acute lymphoblastic leukemia patients and;in acute myelogenous leukemia patients; somatic mutation;;constitutively activated; dbSNP:rs121913488)"";/evidence=""ECO:0000269|PubMed:11290608,;ECO:0000269|PubMed:11442493, ECO:0000269|PubMed:14504097"";/id=""VAR_065680""	UniProt
P36888	FLT3	D835N	D	835	N	452	activating	(in acute lymphoblastic leukemia patients and;in acute myelogenous leukemia patients; somatic mutation;;constitutively activated; dbSNP:rs121913488)"";/evidence=""ECO:0000269|PubMed:11290608"";/id=""VAR_065681""	UniProt
P36888	FLT3	D835V	D	835	V	452	activating	(in acute lymphoblastic leukemia patients and;in acute myelogenous leukemia patients; somatic mutation;;constitutively activated; dbSNP:rs121909646)"";/evidence=""ECO:0000269|PubMed:11290608"";/id=""VAR_065682""	UniProt
P36888	FLT3	D835Y	D	835	Y	452	activating	(in acute lymphoblastic leukemia patients and;in acute myelogenous leukemia patients; somatic mutation;;constitutively activated; dbSNP:rs121913488)"";/evidence=""ECO:0000269|PubMed:11290608,;ECO:0000269|PubMed:11442493, ECO:0000269|PubMed:14504097"";/id=""VAR_065683""	UniProt
P49841	GSK3B	S9A	S	9	A	-	activating	oss of phosphorylation; abolished inhibition;of activity, leading to constitutively active."";/evidence=""ECO:0000269|PubMed:17050006,;ECO:0000269|PubMed:28992046, ECO:0000269|PubMed:7980435""	UniProt
P25092	GUCY2C	S840I	S	840	I	-	increase	(in DIAR6; activating mutation; exposure of;the mutant receptor to its ligands results in markedly;increased production of cyclic guanosine monophosphate;;dbSNP:rs587776871)"";/evidence=""ECO:0000269|PubMed:22436048"";/id=""VAR_067724""	UniProt
Q96GX5	MASTL	K72M	K	72	M	142	activating	Hyperactive form."";/evidence=""ECO:0000269|PubMed:21164014""	UniProt
P08631	HCK	Y522F	Y	522	F	-	activating	Constitutively activated kinase, leading to;cellular transformation."";/evidence=""ECO:0000269|PubMed:10092522,;ECO:0000269|PubMed:11896602""	UniProt
O15111	CHUK	S176E	S	176	E	460	activating	Full activation."";/evidence=""ECO:0000269|PubMed:9346484,;ECO:0000269|PubMed:9520446""	UniProt
O14920	IKBKB	K171E	K	171	E	448	increase	Increased activation of NF-kappa-B signaling."";/evidence=""ECO:0000269|PubMed:30337470""	UniProt
O14920	IKBKB	V203I	V	203	I	580	increase	(in IMD15A; gain-of-function mutation;resulting in increased activation of NF-kappa-B signaling;pathway; dbSNP:rs1563340753)"";/evidence=""ECO:0000269|PubMed:30337470"";/id=""VAR_081275""	UniProt
P06213	INSR	Y1011A	Y	1011	A	-	increase	Increases kinase activity."";/evidence=""ECO:0000269|PubMed:12707268""	UniProt
P23458	JAK1	A634D	A	634	D	170	activating	in AIIDE; constitutive gain of function;resulting in increased receptor signaling pathway via JAK-;STAT; no effect on protein abundance)"";/evidence=""ECO:0000269|PubMed:28111307"";/id=""VAR_084991""	UniProt
P23458	JAK1	V658F	V	658	F	211	activating	Constitutively active. Increased receptor;signaling pathway via JAK-STAT."";/evidence=""ECO:0000269|PubMed:16239216""	UniProt
P52333	JAK3	C759R	C	759	R	763	activating	(in T(-)B(+)NK(-) SCID; constitutive;phosphorylation)"";/evidence=""ECO:0000269|PubMed:9354668"";/id=""VAR_010497""	UniProt
P17612	PRKACA	L206R	L	206	R	531	activating	(in PPNAD4; somatic mutation; the mutation;results in cAMP-independent basal protein kinase activity;and constitutive activation of protein kinase A;;dbSNP:rs386352352)"";/evidence=""ECO:0000269|PubMed:24571724,;ECO:0000269|PubMed:24700472, ECO:0000269|PubMed:24747643,;ECO:0000269|PubMed:24855271"";/id=""VAR_071707""	UniProt
Q9UQM7	CAMK2A	P212Q	P	212	Q	616	increase	(in MRD53; increased basal;autophosphorylation)"";/evidence=""ECO:0000269|PubMed:29560374"";/id=""VAR_081160""	UniProt
Q13555	CAMK2G	R292P	R	292	P	-	activating	(in MRD59; gain-of-function variant affecting;regulation of neurite formation and arborization; results;in constitutive autophosphorylation; dbSNP:rs397514627)"";/evidence=""ECO:0000269|PubMed:23033978,;ECO:0000269|PubMed:30184290"";/id=""VAR_069390""	UniProt
Q13976	PRKG1	R177Q	R	177	Q	-	activating	in AAT8; impairs cGMP binding; the mutant;protein is constitutively active; dbSNP:rs397515330)"";/evidence=""ECO:0000269|PubMed:23910461"";/id=""VAR_070434""	UniProt
P10721	KIT	D816F	D	816	F	452	activating	(in MASTC; sporadic case; somatic mutation;;requires 2 nucleotide substitutions; constitutively;activated and is much more rapidly autophosphorylated than;wild type)"";/evidence=""ECO:0000269|PubMed:9990072"";/id=""VAR_033133""	UniProt
P10721	KIT	D816H	D	816	H	452	activating	(in a testicular tumor; seminoma; somatic;mutation; constitutively activated; dbSNP:rs121913506)"";/evidence=""ECO:0000269|PubMed:10362788,;ECO:0000269|PubMed:19164557, ECO:0000269|PubMed:20147452"";/id=""VAR_033134""	UniProt
P10721	KIT	D816I	D	816	I	452	activating	(in MASTC; somatic mutation; constitutively;activated; requires 2 nucleotide substitutions;;dbSNP:rs1057519709)"";/evidence=""ECO:0000269|PubMed:19865100"";/id=""VAR_081064""	UniProt
P10721	KIT	D816Y	D	816	Y	452	activating	(in MASTSYS and MASTC; also found in acute;myeloid leukemia and a germ cell tumor of the testis;;somatic mutation; constitutively activated;;dbSNP:rs121913506)"";/evidence=""ECO:0000269|PubMed:16175573,;ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19865100,;ECO:0000269|PubMed:9657776, ECO:0000269|PubMed:9990072"";/id=""VAR_023828""	UniProt
P10721	KIT	N822I	N	822	I	461	activating	(in MASTC; constitutively activated;;dbSNP:rs993022333)"";/evidence=""ECO:0000269|PubMed:21689725"";/id=""VAR_081065""	UniProt
Q15139	PRKD1	Y463E	Y	463	E	-	activating	Constitutive activation and constitutive;phosphorylation of S-738 and S-742."";/evidence=""ECO:0000269|PubMed:12637538""	UniProt
O75676	RPS6KA4	F709A	F	709	A	-	increase	Strongly elevates basal activity."";/evidence=""ECO:0000269|PubMed:11035004""	UniProt
P43405	SYK	A353T	A	353	T	-	activating	(in IMD82; constitutively active protein;tyrosine kinase activity)"";/evidence=""ECO:0000269|PubMed:33782605"";/id=""VAR_085996""	UniProt
P43405	SYK	M450I	M	450	I	268	activating	(in IMD82; constitutively active protein;tyrosine kinase activity)"";/evidence=""ECO:0000269|PubMed:33782605"";/id=""VAR_085997""	UniProt
P43405	SYK	P342T	P	342	T	-	activating	(in IMD82; constitutively active protein;tyrosine kinase activity)"";/evidence=""ECO:0000269|PubMed:33782605"";/id=""VAR_085995""	UniProt
P43405	SYK	S550F	S	550	F	577	activating	(in IMD82; constitutively active protein;tyrosine kinase activity)"";/evidence=""ECO:0000269|PubMed:33782605"";/id=""VAR_085998""	UniProt
P43405	SYK	S550Y	S	550	Y	577	activating	(in IMD82; constitutively active protein;tyrosine kinase activity)"";/evidence=""ECO:0000269|PubMed:33782605"";/id=""VAR_085999""	UniProt
P53667	LIMK1	T508E	T	508	E	512	increase	Phosphomimetic mutant; enhances kinase;activity."";/evidence=""ECO:0000269|PubMed:22328514""	UniProt
P53671	LIMK2	T505E	T	505	E	512	increase	Phosphomimetic mutant; enhances kinase;activity."";/evidence=""ECO:0000269|PubMed:11018042,;ECO:0000269|PubMed:22328514""	UniProt
Q5S007	LRRK2	H2391D	H	2391	D	-	increase	Increases kinase activity."";/evidence=""ECO:0000269|PubMed:30635421""	UniProt
Q5S007	LRRK2	I2020T	I	2020	T	445	increase	in PARK8; significant increase in;autophosphorylation of about 40% in comparison to wild-type;protein in vitro; shows a progressive reduction in neurite;length and branching; shows an increase in activity in;phosphorylation of RAB8A and RAB10; dbSNP:rs35870237)"";/evidence=""ECO:0000269|PubMed:15541309,;ECO:0000269|PubMed:15880653, ECO:0000269|PubMed:16172858,;ECO:0000269|PubMed:16251215, ECO:0000269|PubMed:16321986,;ECO:0000269|PubMed:17114044, ECO:0000269|PubMed:26824392,;ECO:0000269|PubMed:29212815"";/id=""VAR_024959""	UniProt
Q5S007	LRRK2	R1441G	R	1441	G	-	increase	in PARK8; shows a progressive reduction in;neurite length and branching; shows an increase in activity;in phosphorylation of RAB8A and RAB10; decreases;phosphorylation-dependent binding to YWHAG;;dbSNP:rs33939927)"";/evidence=""ECO:0000269|PubMed:15541308,;ECO:0000269|PubMed:15925109, ECO:0000269|PubMed:16172858,;ECO:0000269|PubMed:16533964, ECO:0000269|PubMed:17114044,;ECO:0000269|PubMed:26824392, ECO:0000269|PubMed:28720718,;ECO:0000269|PubMed:29125462, ECO:0000269|PubMed:29212815,;ECO:0000269|PubMed:30398148, ECO:0000269|PubMed:30635421"";/id=""VAR_024946""	UniProt
Q5S007	LRRK2	R1728H	R	1728	H	-	increase	(in PARK8; shows an increase in activity in;phosphorylation of RAB8A and RAB10; dbSNP:rs145364431)"";/evidence=""ECO:0000269|PubMed:18213618,;ECO:0000269|PubMed:26824392, ECO:0000269|PubMed:29212815"";/id=""VAR_054744""	UniProt
Q5S007	LRRK2	T2031S	T	2031	S	512	increase	(in PARK8; shows an increase in activity in;phosphorylation of RAB8A and RAB10; dbSNP:rs78029637)"";/evidence=""ECO:0000269|PubMed:26824392,;ECO:0000269|PubMed:29212815"";/id=""VAR_082047""	UniProt
P29376	LTK	E763K	E	763	K	767	increase	(may possibly contribute to susceptibility to;systemic lupus erythematosus; increases autophosphorylation;and interaction with PI3-kinase subunit p85;;dbSNP:rs76282169)"";/evidence=""ECO:0000269|PubMed:14695357"";/id=""VAR_065465""	UniProt
P29376	LTK	G750E	G	750	E	752	increase	Increases autophosphorylation and interaction;with PI3-kinase subunit p85 (demonstrated with chimeric;EGFR-LTK)."";/evidence=""ECO:0000269|PubMed:14695357""	UniProt
P07948	LYN	Y508F	Y	508	F	-	increase	bolishes autoinhibition and thereby increases;kinase activity."";/evidence=""ECO:0000269|PubMed:16920712""	UniProt
Q13233	MAP3K1	L189P	L	189	P	-	increase	(in SRXY6; increases phosphorylation of the;downstream target MAPK3/MAPK1 compared to wild-type and;enhances binding of RHOA to the mutant MAP3K1 complex;;dbSNP:rs387906788)"";/evidence=""ECO:0000269|PubMed:21129722"";/id=""VAR_065504""	UniProt
Q13233	MAP3K1	L189R	L	189	R	-	increase	(in SRXY6; increases phosphorylation of the;downstream targets MAPK14 and MAPK3/MAPK1 compared to wild-;type and enhances binding of RHOA to the mutant MAP3K1;complex; dbSNP:rs387906788)"";/evidence=""ECO:0000269|PubMed:21129722"";/id=""VAR_065505""	UniProt
Q99683	MAP3K5	S1033A	S	1033	A	-	increase	Enhanced induction of apoptosis and increased;kinase activity."";/evidence=""ECO:0000269|PubMed:15094778""	UniProt
O43318	MAP3K7	P512L	P	512	L	-	increase	(in FMD2; does not affect interaction with;TAB2; does not affect homodimerization; increases;autophosphorylation; increases MAPK signaling; increases;NF-kappa-B signaling; dbSNP:rs886039230)"";/evidence=""ECO:0000269|PubMed:27426733"";/id=""VAR_077347""	UniProt
Q92918	MAP4K1	T355A	T	355	A	-	activating	Retains kinase activity. Not degraded by the;Cul7-RING ubiquitin-protein ligase complex containing;FBXW8."";/evidence=""ECO:0000269|PubMed:24362026""	UniProt
P49137	MAPKAPK2	K353R	K	353	R	-	increase	nduces decreased sumoylation and increase in;protein kinase activity."";/evidence=""ECO:0000269|PubMed:21131586""	UniProt
P49137	MAPKAPK2	S272D	S	272	D	638	increase	Mimicks phosphorylation state, leading to;slight increase of basal kinase activity."";/evidence=""ECO:0000269|PubMed:8846784""	UniProt
P49137	MAPKAPK2	T222D	T	222	D	512	increase	Mimicks phosphorylation state, leading to;slight increase of basal kinase activity."";/evidence=""ECO:0000269|PubMed:14517288,;ECO:0000269|PubMed:15014438, ECO:0000269|PubMed:8846784""	UniProt
P49137	MAPKAPK2	T334D	T	334	D	-	increase	E: Mimicks phosphorylation state, leading to;elevated basal kinase activity."";/evidence=""ECO:0000269|PubMed:14517288,;ECO:0000269|PubMed:15014438, ECO:0000269|PubMed:8846784""	UniProt
Q16644	MAPKAPK3	K73M	K	73	M	127	loss	Higher affinity toward PCH2."";/evidence=""ECO:0000269|PubMed:15563468""	UniProt
Q8IW41	MAPKAPK5	L337G	L	337	G	-	activating	Induces constitutive protein kinase activity."";/evidence=""ECO:0000269|PubMed:21329882""	UniProt
Q8IW41	MAPKAPK5	S212D	S	212	D	563	increase	Mimicks phosphorylation state and displays a;slightly higher protein kinase activity."";/evidence=""ECO:0000269|PubMed:12808055""	UniProt
Q8IW41	MAPKAPK5	T182D	T	182	D	512	activating	Mimicks phosphorylation state and induces;constitutive protein kinase activity."";/evidence=""ECO:0000269|PubMed:12808055,;ECO:0000269|PubMed:21329882, ECO:0000269|PubMed:9628874""	UniProt
Q9P0L2	MARK1	T215E	T	215	E	512	activating	Constitutively active."";/evidence=""ECO:0000269|PubMed:14976552""	UniProt
Q96L34	MARK4	T214E	T	214	E	512	increase	imicks phosphorylation state, leading to;increased activity. Decreases mTORC1 activity."";/evidence=""ECO:0000269|PubMed:14976552,;ECO:0000269|PubMed:23184942""	UniProt
P00533	EGFR	L792H	L	792	H	268	resistance	-	COSMIC
P08581	MET	H1094L	H	1094	L	52	activating	(in RCCP; constitutive autophosphorylation;;causes malignant transformation in cell lines)"";/evidence=""ECO:0000269|PubMed:10327054"";/id=""VAR_032486""	UniProt
P08581	MET	H1094Y	H	1094	Y	52	activating	(in RCCP; constitutive autophosphorylation;;causes malignant transformation in cell lines;;dbSNP:rs121913244)"";/evidence=""ECO:0000269|PubMed:10327054"";/id=""VAR_032488""	UniProt
P08581	MET	H1106D	H	1106	D	121	activating	(in RCCP; constitutive autophosphorylation;;causes malignant transformation in cell lines)"";/evidence=""ECO:0000269|PubMed:10327054,;ECO:0000269|PubMed:10433944"";/id=""VAR_032489""	UniProt
P08581	MET	V1092I	V	1092	I	45	activating	(in RCCP; constitutive autophosphorylation;;dbSNP:rs786202724)"";/evidence=""ECO:0000269|PubMed:10327054,;ECO:0000269|PubMed:10417759, ECO:0000269|PubMed:10433944"";/id=""VAR_032485""	UniProt
P08581	MET	Y1230D	Y	1230	D	456	activating	(in RCCP; constitutive autophosphorylation;;causes malignant transformation in cell lines)"";/evidence=""ECO:0000269|PubMed:10327054,;ECO:0000269|PubMed:10433944"";/id=""VAR_032491""	UniProt
P53778	MAPK12	D179A	D	179	A	456	activating	Emulation of the active state."";/evidence=""ECO:0000269|PubMed:15284239""	UniProt
Q9BUB5	MKNK1	T385D	T	385	D	-	activating	Constitutively active."";/evidence=""ECO:0000269|PubMed:11463832""	UniProt
Q9HBH9	MKNK2	T379D	T	379	D	-	activating	Constitutively active."";/evidence=""ECO:0000269|PubMed:11463832""	UniProt
Q02750	MAP2K1	K57N	K	57	N	-	increase	(in MEL; somatic mutation; results in;increased MAPK signal transduction; dbSNP:rs869025608)"";/evidence=""ECO:0000269|PubMed:29643386"";/id=""VAR_084454""	UniProt
Q02750	MAP2K1	M219V	M	219	V	460	increase	Increases interaction with KSR1 and BRAF."";/evidence=""ECO:0000269|PubMed:29433126""	UniProt
Q02750	MAP2K1	N221Y	N	221	Y	511	increase	Increases interaction with KSR1 and BRAF."";/evidence=""ECO:0000269|PubMed:29433126""	UniProt
P36507	MAP2K2	P128Q	P	128	Q	195	increase	(in CFC4; results in increased kinase;activity; dbSNP:rs267607230)"";/evidence=""ECO:0000269|PubMed:20358587"";/id=""VAR_069782""	UniProt
P46734	MAP2K3	S218E	S	218	E	459	activating	Constitutive activation."";/evidence=""ECO:0000269|PubMed:8622669""	UniProt
P46734	MAP2K3	T222E	T	222	E	511	activating	Constitutive activation."";/evidence=""ECO:0000269|PubMed:8622669""	UniProt
P52564	MAP2K6	S207E	S	207	E	459	activating	Constitutive activation according to;PubMed:8622669, but not to PubMed:8621675.""	UniProt
P52564	MAP2K6	T211E	T	211	E	511	activating	Constitutive activation according to;PubMed:8622669, but not to PubMed:8621675.""	UniProt
Q5VT25	CDC42BPA	D478A	D	478	A	-	loss	revents cleavage by CASP3, impairs the;increase of its kinase activity and impairs extrusion;apical actin ring assembly."";/evidence=""ECO:0000269|PubMed:29162624""	UniProt
P42345	MTOR	A1459D	A	1459	D	-	increase	(in FCORD2; somatic mutation; increased TOR;signaling)"";/evidence=""ECO:0000269|PubMed:26018084"";/id=""VAR_078828""	UniProt
P42345	MTOR	C1483R	C	1483	R	-	increase	(in FCORD2; somatic mutation; increased TOR;signaling; increased kinase activity; dbSNP:rs1057519914)"";/evidence=""ECO:0000269|PubMed:25799227"";/id=""VAR_078831""	UniProt
P42345	MTOR	E1799K	E	1799	K	-	increase	(in SKS; results in increased mTOR signaling;;dbSNP:rs863225264)"";/evidence=""ECO:0000269|PubMed:25851998,;ECO:0000269|PubMed:26542245"";/id=""VAR_075072""	UniProt
P42345	MTOR	L1460P	L	1460	P	-	increase	(in FCORD2; somatic mutation; increased TOR;signaling; dbSNP:rs1057519779)"";/evidence=""ECO:0000269|PubMed:26018084,;ECO:0000269|PubMed:27830187"";/id=""VAR_078830""	UniProt
P42345	MTOR	L2427P	L	2427	P	-	increase	(in FCORD2; somatic mutation; increased TOR;signaling; increased kinase activity; dbSNP:rs1085307113)"";/evidence=""ECO:0000269|PubMed:25799227"";/id=""VAR_078841""	UniProt
P42345	MTOR	L2427Q	L	2427	Q	-	increase	(in FCORD2; somatic mutation; increased TOR;signaling; increased kinase activity; dbSNP:rs1085307113)"";/evidence=""ECO:0000269|PubMed:25799227"";/id=""VAR_078842""	UniProt
P42345	MTOR	S2215F	S	2215	F	-	increase	(in FCORD2; somatic mutation; increased TOR;signaling; dbSNP:rs587777894)"";/evidence=""ECO:0000269|PubMed:25799227,;ECO:0000269|PubMed:26018084, ECO:0000269|PubMed:27830187"";/id=""VAR_078839""	UniProt
P42345	MTOR	S2215Y	S	2215	Y	-	increase	(in FCORD2; also found in a colorectal;adenocarcinoma sample; somatic mutation; increased TOR;signaling; dbSNP:rs587777894)"";/evidence=""ECO:0000269|PubMed:17344846,;ECO:0000269|PubMed:26018084, ECO:0000269|PubMed:27830187"";/id=""VAR_041543""	UniProt
P42345	MTOR	T2173A	T	2173	A	-	increase	Increased mTOR kinase activity."";/evidence=""ECO:0000269|PubMed:24247430""	UniProt
P51955	NEK2	S171D	S	171	D	461	increase	Kinase activity increased by two fold."";/evidence=""ECO:0000269|PubMed:17197699""	UniProt
P51955	NEK2	T170E	T	170	E	460	increase	Kinase activity increased by two fold."";/evidence=""ECO:0000269|PubMed:17197699""	UniProt
P51955	NEK2	T175E	T	175	E	512	increase	Kinase activity increased by two fold."";/evidence=""ECO:0000269|PubMed:17197699""	UniProt
Q9HC98	NEK6	Y108A	Y	108	A	205	increase	Increase in catalytic activity."";/evidence=""ECO:0000269|PubMed:19941817""	UniProt
Q8TDX7	NEK7	Y97A	Y	97	A	205	increase	5-fold increase in catalytic activity."";/evidence=""ECO:0000269|PubMed:19941817""	UniProt
Q8TDX7	NEK7	Y97F	Y	97	F	205	increase	L: Moderate increase in catalytic activity."";/evidence=""ECO:0000269|PubMed:19941817""	UniProt
Q8TD19	NEK9	I167T	I	167	T	365	increase	(in NC; increased autophosphorylation at T-;210; dbSNP:rs879253775)"";/evidence=""ECO:0000269|PubMed:27153399"";/id=""VAR_077801""	UniProt
Q8TD19	NEK9	I573T	I	573	T	-	increase	(in NC; increased autophosphorylation at T-;210; dbSNP:rs1555352529)"";/evidence=""ECO:0000269|PubMed:27153399"";/id=""VAR_077802""	UniProt
Q13153	PAK1	L107F	L	107	F	-	activating	bolishes autoinhibition, leading to;constitutive kinase activity."";/evidence=""ECO:0000269|PubMed:10551809""	UniProt
Q13153	PAK1	T423E	T	423	E	512	activating	Constitutive kinase activity."";/evidence=""ECO:0000269|PubMed:10551809""	UniProt
O96013	PAK4	S445N	S	445	N	394	activating	Approximately 30-fold increased;autophosphorylation (constitutively active mutant)."";/evidence=""ECO:0000269|PubMed:11313478""	UniProt
O96013	PAK4	S474E	S	474	E	512	increase	Approximately 3-fold increased;autophosphorylation."";/evidence=""ECO:0000269|PubMed:11313478""	UniProt
O15530	PDPK1	A277V	A	277	V	600	increase	3-fold increase in kinase activity."";/evidence=""ECO:0000269|PubMed:10364160""	UniProt
O15530	PDPK1	T513E	T	513	E	-	increase	Enhanced kinase activity towards PKB."";/evidence=""ECO:0000269|PubMed:20978239""	UniProt
P16234	PDGFRA	D842V	D	842	V	452	activating	(in a GIST sample; imatinib resistant,;constitutively activated kinase; dbSNP:rs121908585)"";/evidence=""ECO:0000269|PubMed:12522257,;ECO:0000269|PubMed:15928335, ECO:0000269|PubMed:20972453"";/id=""VAR_066471""	UniProt
P16234	PDGFRA	D842Y	D	842	Y	452	activating	(in a GIST sample; imatinib sensitive,;constitutively activated kinase; dbSNP:rs121913265)"";/evidence=""ECO:0000269|PubMed:15928335"";/id=""VAR_066472""	UniProt
P16234	PDGFRA	H650Q	H	650	Q	181	activating	(in a hypereosinophilic syndrome sample;;constitutively activated kinase)"";/evidence=""ECO:0000269|PubMed:21224473"";/id=""VAR_066465""	UniProt
P16234	PDGFRA	N659K	N	659	K	203	activating	(in GIST sample; constitutively activated;kinase; dbSNP:rs1057519700)"";/evidence=""ECO:0000269|PubMed:15928335"";/id=""VAR_066466""	UniProt
P16234	PDGFRA	N659S	N	659	S	203	activating	(in a hypereosinophilic syndrome sample;;constitutively activated kinase)"";/evidence=""ECO:0000269|PubMed:21224473"";/id=""VAR_066467""	UniProt
P16234	PDGFRA	R748G	R	748	G	-	activating	(in a hypereosinophilic syndrome sample;;constitutively activated kinase)"";/evidence=""ECO:0000269|PubMed:21224473"";/id=""VAR_066469""	UniProt
P16234	PDGFRA	V561D	V	561	D	-	activating	(in a GIST sample; constitutively activated;kinase; dbSNP:rs121908586)"";/evidence=""ECO:0000269|PubMed:12522257,;ECO:0000269|PubMed:15928335"";/id=""VAR_066462""	UniProt
P16234	PDGFRA	Y555C	Y	555	C	-	activating	(in GISTPS; increased platelet-derived growth;factor alpha-receptor activity; constitutively activated;kinase; dbSNP:rs121908589)"";/evidence=""ECO:0000269|PubMed:17087943"";/id=""VAR_083158""	UniProt
P16234	PDGFRA	Y849S	Y	849	S	462	activating	(in a hypereosinophilic syndrome sample;;constitutively activated kinase)"";/evidence=""ECO:0000269|PubMed:21224473"";/id=""VAR_066475""	UniProt
P09619	PDGFRB	V665A	V	665	A	202	activating	(in PENTT; gain of function in protein;tyrosine kinase activity; shows ligand-independent;constitutive signaling; dbSNP:rs1554108211)"";/evidence=""ECO:0000269|PubMed:26279204"";/id=""VAR_075866""	UniProt
P11309	PIM1	H68Y	H	68	Y	128	increase	Increased kinase activity."";/evidence=""ECO:0000269|PubMed:15808862""	UniProt
P53350	PLK1	S137D	S	137	D	274	increase	Increases activity. Results in a block in;G1/S."";/evidence=""ECO:0000269|PubMed:12207013,;ECO:0000269|PubMed:18615013""	UniProt
P53350	PLK1	T210D	T	210	D	512	increase	Increases activity and restores recovery after;DNA damage checkpoint."";/evidence=""ECO:0000269|PubMed:12207013,;ECO:0000269|PubMed:12447691, ECO:0000269|PubMed:17461553,;ECO:0000269|PubMed:18615013, ECO:0000269|PubMed:19160488""	UniProt
O00444	PLK4	T170D	T	170	D	512	activating	Activating mutant."";/evidence=""ECO:0000269|PubMed:18239451,;ECO:0000269|PubMed:19164942""	UniProt
Q13882	PTK6	W184A	W	184	A	-	loss	Abrogates interaction between PTK6-domain;kinase and PTK6-linker. Abrogates autophosphorylation and;phosphorylation of KHDRBS1."";/evidence=""ECO:0000269|PubMed:15961400""	UniProt
P04049	RAF1	A237T	A	237	T	-	increase	(in CMD1NN; shows a mild increase in kinase;activity; dbSNP:rs587777588)"";/evidence=""ECO:0000269|PubMed:24777450"";/id=""VAR_071844""	UniProt
P04049	RAF1	H626R	H	626	R	-	increase	(in CMD1NN; shows a mild increase in kinase;activity; dbSNP:rs1553609795)"";/evidence=""ECO:0000269|PubMed:24777450"";/id=""VAR_071848""	UniProt
P04049	RAF1	L613V	L	613	V	-	increase	(in NS5 and LPRD2; shows in vitro greater;kinase activity and enhanced MAPK1 activation than wild-;type; dbSNP:rs80338797)"";/evidence=""ECO:0000269|PubMed:17603482,;ECO:0000269|PubMed:17603483"";/id=""VAR_037821""	UniProt
P04049	RAF1	P261A	P	261	A	-	increase	(in NS5; shows in vitro greater kinase;activity and enhanced MAPK1 activation than wild-type;;dbSNP:rs121434594)"";/evidence=""ECO:0000269|PubMed:17603482"";/id=""VAR_037812""	UniProt
P04049	RAF1	P261L	P	261	L	-	increase	(in NS5; shows greater kinase activity and;enhanced MAPK1 activation than wild-type;;dbSNP:rs397516828)"";/evidence=""ECO:0000269|PubMed:17603483"";/id=""VAR_037813""	UniProt
P04049	RAF1	P261S	P	261	S	-	increase	(in NS5; shows in vitro greater kinase;activity and enhanced MAPK1 activation than wild-type;;dbSNP:rs121434594)"";/evidence=""ECO:0000269|PubMed:17603482,;ECO:0000269|PubMed:17603483, ECO:0000269|PubMed:20683980"";/id=""VAR_037814""	UniProt
P04049	RAF1	P332A	P	332	A	-	increase	(in CMD1NN; shows a mild increase in kinase;activity; dbSNP:rs1057403865)"";/evidence=""ECO:0000269|PubMed:24777450"";/id=""VAR_071846""	UniProt
P04049	RAF1	R563K	R	563	K	639	increase	oss of methylation. Increased stability and;catalytic activity in response to EGF treatment."";/evidence=""ECO:0000269|PubMed:21917714""	UniProt
P04049	RAF1	S257L	S	257	L	-	increase	(in NS5 and LPRD2; shows in vitro greater;kinase activity and enhanced ERK activation than wild-type;;dbSNP:rs80338796)"";/evidence=""ECO:0000269|PubMed:17603482,;ECO:0000269|PubMed:17603483"";/id=""VAR_037808""	UniProt
P04049	RAF1	S259A	S	259	A	-	increase	(in an ovarian serous carcinoma sample;;somatic mutation; increased ERK activation;;dbSNP:rs3730271)"";/evidence=""ECO:0000269|PubMed:16630891,;ECO:0000269|PubMed:17344846"";/id=""VAR_041037""	UniProt
P04049	RAF1	T310A	T	310	A	-	increase	(in CMD1NN; shows a mild increase in kinase;activity; dbSNP:rs778155315)"";/evidence=""ECO:0000269|PubMed:24777450"";/id=""VAR_071845""	UniProt
P04049	RAF1	T641M	T	641	M	-	increase	(in CMD1NN; shows a mild increase in kinase;activity; dbSNP:rs587777587)"";/evidence=""ECO:0000269|PubMed:24777450"";/id=""VAR_071849""	UniProt
P04049	RAF1	V263A	V	263	A	-	increase	(in NS5; shows in vitro greater kinase;activity and enhanced MAPK1 activation than wild-type;;dbSNP:rs397516830)"";/evidence=""ECO:0000269|PubMed:17603482"";/id=""VAR_037815""	UniProt
P07949	RET	G894S	G	894	S	444	activating	(in a patient with renal agenesis; unknown;pathological significance; constitutively phosphorylated;;expressed only the immature intracellular form)"";/evidence=""ECO:0000269|PubMed:18252215"";/id=""VAR_044396""	UniProt
P07949	RET	V376A	V	376	A	-	activating	(in a patient with renal agenesis; unknown;pathological significance; constitutively phosphorylated;;expressed only the immature intracellular form)"";/evidence=""ECO:0000269|PubMed:18252215"";/id=""VAR_044393""	UniProt
P07949	RET	V778I	V	778	I	177	activating	(in a patient with renal agenesis; unknown;pathological significance; constitutively phosphorylated;;dbSNP:rs75686697)"";/evidence=""ECO:0000269|PubMed:18252215"";/id=""VAR_044395""	UniProt
P20594	NPR2	W115G	W	115	G	-	decrease	(in AMD1; markedly deficient activity;;dbSNP:rs28931582)"";/evidence=""ECO:0000269|PubMed:15146390"";/id=""VAR_022584""	UniProt
Q13546	RIPK1	D324H	D	324	H	-	increase	(in AIEFL; prevents cleavage by CASP8;;increased kinase activity; increased inflammatory;response)"";/evidence=""ECO:0000269|PubMed:31827280,;ECO:0000269|PubMed:31827281"";/id=""VAR_083518""	UniProt
Q13546	RIPK1	D324V	D	324	V	-	increase	(in AIEFL; prevents cleavage by CASP8;;increased kinase activity; increased inflammatory;response)"";/evidence=""ECO:0000269|PubMed:31827280"";/id=""VAR_084135""	UniProt
Q01974	ROR2	D482G	D	482	G	39	increase	Slight increase in kinase activity."";/evidence=""ECO:0000269|PubMed:25029443""	UniProt
O00141	SGK1	S422D	S	422	D	-	increase	10-fold activation."";/evidence=""ECO:0000269|PubMed:10191262,;ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12911626,;ECO:0000269|PubMed:15040001""	UniProt
Q9HBY8	SGK2	S356D	S	356	D	-	increase	Increased activation."";/evidence=""ECO:0000269|PubMed:10548550""	UniProt
Q96BR1	SGK3	S486D	S	486	D	-	increase	Increased activation."";/evidence=""ECO:0000269|PubMed:10548550""	UniProt
Q9H0K1	SIK2	T175E	T	175	E	512	activating	Constitutively active."";/evidence=""ECO:0000269|PubMed:14976552""	UniProt
P12931	SRC	E527K	E	527	K	-	increase	in THC6; increased protein tyrosine kinase;activity; increased autophosphorylation at Y-419; causes;defective megakaryopoiesis associated with increased;overall tyrosine phosphorylation in megakaryocytes;;dbSNP:rs879255268)"";/evidence=""ECO:0000269|PubMed:26936507"";/id=""VAR_076919""	UniProt
Q15831	STK11	K48R	K	48	R	-	increase	Enhanced phosphorylation at Thr-336 and Ser-;428, enhanced cytoplasmic localization and increased kinase;activity."";/evidence=""ECO:0000269|PubMed:18687677""	UniProt
P49842	STK19	D89N	D	89	N	-	increase	(recurrent gain-of-function variant found in;metastatic melanoma; promotes NRAS signaling; somatic;mutation; dbSNP:rs267600971)"";/evidence=""ECO:0000269|PubMed:17344846,;ECO:0000269|PubMed:30712867"";/id=""VAR_042361""	UniProt
P36897	TGFBR1	T204D	T	204	D	-	activating	Constitutive activation."";/evidence=""ECO:0000269|PubMed:7774578""	UniProt
Q02763	TEK	A925S	A	925	S	326	increase	(in VMCM; increased ligand-independent;autophosphorylation and kinase activation)"";/evidence=""ECO:0000269|PubMed:19888299"";/id=""VAR_066610""	UniProt
Q02763	TEK	K1100N	K	1100	N	-	increase	(in VMCM; strongly increased ligand-;independent autophosphorylation and kinase activation)"";/evidence=""ECO:0000269|PubMed:19888299"";/id=""VAR_066611""	UniProt
Q02763	TEK	L914F	L	914	F	286	increase	(found in patients with solitary and multiple;sporadic venous malformations; increased ligand-independent;autophosphorylation; novel location at endoplasmic;reticulum and Golgi apparatus; partially retained at;endoplasmic reticulum and Golgi apparatus;;dbSNP:rs1825682849)"";/evidence=""ECO:0000269|PubMed:19079259"";/id=""VAR_078051""	UniProt
Q02763	TEK	R849W	R	849	W	117	increase	in VMCM; increased ligand-independent;autophosphorylation and kinase activation; no effect on;location at membrane; dbSNP:rs80338908)"";/evidence=""ECO:0000269|PubMed:10369874,;ECO:0000269|PubMed:19079259, ECO:0000269|PubMed:19888299,;ECO:0000269|PubMed:8980225"";/id=""VAR_006352""	UniProt
Q02763	TEK	R915C	R	915	C	287	increase	(found in a patient with solitary sporadic;venous malformations; increased ligand-independent;autophosphorylation; dbSNP:rs1825682922)"";/evidence=""ECO:0000269|PubMed:19079259"";/id=""VAR_078052""	UniProt
Q02763	TEK	R915H	R	915	H	287	increase	(in VMCM; strongly increased ligand-;independent autophosphorylation and kinase activation;;dbSNP:rs387906745)"";/evidence=""ECO:0000269|PubMed:19888299"";/id=""VAR_066607""	UniProt
Q02763	TEK	R918C	R	918	C	314	increase	(in VMCM; strongly increased ligand-;independent autophosphorylation and kinase activation;;dbSNP:rs1825683100)"";/evidence=""ECO:0000269|PubMed:19888299"";/id=""VAR_066608""	UniProt
Q02763	TEK	S917I	S	917	I	313	increase	(found in a patient with solitary sporadic;venous malformations; increased ligand-independent;autophosphorylation)"";/evidence=""ECO:0000269|PubMed:19079259"";/id=""VAR_078054""	UniProt
Q02763	TEK	V919L	V	919	L	315	increase	(in VMCM; increased ligand-independent;autophosphorylation and kinase activation)"";/evidence=""ECO:0000269|PubMed:19888299"";/id=""VAR_066609""	UniProt
Q02763	TEK	Y897C	Y	897	C	258	increase	(in VMCM; increased ligand-independent;autophosphorylation and kinase activation;;dbSNP:rs80338909)"";/evidence=""ECO:0000269|PubMed:19888299"";/id=""VAR_066606""	UniProt
Q02763	TEK	Y897H	Y	897	H	258	increase	(found in a patient with solitary sporadic;venous malformations; increased ligand-independent;autophosphorylation)"";/evidence=""ECO:0000269|PubMed:19079259"";/id=""VAR_078050""	UniProt
Q02763	TEK	Y897S	Y	897	S	258	increase	(in VMCM; also found in a patient with;solitary sporadic venous malformations; increased ligand-;independent autophosphorylation and kinase activation;;dbSNP:rs80338909)"";/evidence=""ECO:0000269|PubMed:10369874,;ECO:0000269|PubMed:19079259, ECO:0000269|PubMed:19888299"";/id=""VAR_008716""	UniProt
Q86UE8	TLK2	S617A	S	617	A	447	increase	Increase in autophosphorylation."";/evidence=""ECO:0000269|PubMed:29955062""	UniProt
O75962	TRIO	P1461L	P	1461	L	-	increase	(in MRD63; slightly increased occipitofrontal;circumference; slightly increased RAC1-mediated signaling;;slightly increased neurite outgrowth)"";/evidence=""ECO:0000269|PubMed:32109419"";/id=""VAR_083921""	UniProt
O75962	TRIO	R1078G	R	1078	G	-	increase	(in MRD63; increased activation of RAC1-;mediated signaling; increased neurite outgrowth)"";/evidence=""ECO:0000269|PubMed:32109419"";/id=""VAR_083917""	UniProt
O75962	TRIO	R1078Q	R	1078	Q	-	increase	(in MRD63; increased activation of RAC1-;mediated signaling; increased neurite outgrowth)"";/evidence=""ECO:0000269|PubMed:32109419"";/id=""VAR_083918""	UniProt
O75962	TRIO	R1078W	R	1078	W	-	increase	(in MRD63; increased activation of RAC1-;mediated signaling; increased neurite outgrowth;;dbSNP:rs1554065887)"";/evidence=""ECO:0000269|PubMed:32109419"";/id=""VAR_083919""	UniProt
Q9BXA7	TSSK1B	T174E	T	174	E	512	activating	Constitutively active."";/evidence=""ECO:0000269|PubMed:15733851""	UniProt
P17948	FLT1	N1050D	N	1050	D	459	increase	Strongly increases kinase activity. Increases;activity in promoting proliferation of endothelial cells."";/evidence=""ECO:0000269|PubMed:16286478""	UniProt
P35968	KDR	C1045A	C	1045	A	441	increase	Significantly higher kinase activity."";/evidence=""ECO:0000269|PubMed:23199280""	UniProt
P43403	ZAP70	A141E	A	141	E	-	increase	Increased constitutive kinase activity."";/evidence=""ECO:0000269|PubMed:17512407""	UniProt
P43403	ZAP70	D327P	D	327	P	-	increase	ncreases constitutive kinase activity on LAT;phosphorylation, strongly increases subcellular;localization of CD69 at the cell surface and decreases;autoinhibition conformation."";/evidence=""ECO:0000269|PubMed:26783323""	UniProt
P43403	ZAP70	K362E	K	362	E	109	increase	ncreases constitutive kinase activity on LAT;phosphorylation, strongly increases subcellular;localization of CD69 at the cell surface and decreases;autoinhibition conformation."";/evidence=""ECO:0000269|PubMed:26783323""	UniProt
P43403	ZAP70	L133A	L	133	A	-	increase	Increased constitutive kinase activity."";/evidence=""ECO:0000269|PubMed:17512407""	UniProt
P43403	ZAP70	P147A	P	147	A	-	increase	Increased kinase activity after activation by;LCK."";/evidence=""ECO:0000269|PubMed:17512407""	UniProt
P43403	ZAP70	Q145A	Q	145	A	-	increase	Increased kinase activity after activation by;LCK."";/evidence=""ECO:0000269|PubMed:17512407""	UniProt
P43403	ZAP70	S144A	S	144	A	-	increase	Increased kinase activity after activation by;LCK."";/evidence=""ECO:0000269|PubMed:17512407""	UniProt
P43403	ZAP70	V314A	V	314	A	-	increase	Increased constitutive kinase activity.""	UniProt
P43403	ZAP70	W131A	W	131	A	-	increase	Increased constitutive kinase activity."";/evidence=""ECO:0000269|PubMed:17512407""	UniProt
P43403	ZAP70	Y292F	Y	292	F	-	increase	Induces constitutive TCR stimulation-;independent NFAT induction."";/evidence=""ECO:0000269|PubMed:8943331""	UniProt
P43403	ZAP70	Y492F	Y	492	F	462	increase	Increases kinase activity."";/evidence=""ECO:0000269|PubMed:7781602""	UniProt
P43403	ZAP70	Y597A	Y	597	A	-	increase	Increased kinase activity after activation by;LCK."";/evidence=""ECO:0000269|PubMed:17512407""	UniProt
P43403	ZAP70	Y598A	Y	598	A	-	increase	Increased kinase activity after activation by;LCK."";/evidence=""ECO:0000269|PubMed:17512407""	UniProt
Q07912	TNK2	K158R	K	158	R	127	loss	Loss of autophosphorylation at Y-284."";/evidence=""ECO:0000269|PubMed:16288044,;ECO:0000269|PubMed:20110370""	UniProt
Q8NER5	ACVR1C	K222R	K	222	R	127	loss	Loss of response to NODAL and SMAD2;phosphorylation."";/evidence=""ECO:0000269|PubMed:12063393,;ECO:0000269|PubMed:15531507""	UniProt
P37023	ACVRL1	C41G	C	41	G	-	loss	(in HHT2; loss of receptor activity in;response to BMP9; predominantly retained in the endoplasmic;reticulum)"";/evidence=""ECO:0000269|PubMed:26176610"";/id=""VAR_075231""	UniProt
P37023	ACVRL1	C41Y	C	41	Y	-	loss	(in HHT2; loss of receptor activity in;response to BMP9; predominantly retained in the endoplasmic;reticulum; dbSNP:rs1184716348)"";/evidence=""ECO:0000269|PubMed:26176610"";/id=""VAR_075232""	UniProt
P37023	ACVRL1	C46G	C	46	G	-	loss	(in HHT2; loss of receptor activity in;response to BMP9; retained in the endoplasmic reticulum)"";/evidence=""ECO:0000269|PubMed:26176610"";/id=""VAR_075233""	UniProt
P37023	ACVRL1	R47P	R	47	P	-	loss	(in HHT2; loss of receptor activity in;response to BMP9; retained in the endoplasmic reticulum;;dbSNP:rs774389618)"";/evidence=""ECO:0000269|PubMed:26176610"";/id=""VAR_075234""	UniProt
P37023	ACVRL1	H66Y	H	66	Y	-	loss	(in HHT2; loss of receptor activity in;response to BMP9; retained in the endoplasmic reticulum;;dbSNP:rs1480110873)"";/evidence=""ECO:0000269|PubMed:26176610"";/id=""VAR_075235""	UniProt
P37023	ACVRL1	C77F	C	77	F	-	loss	(in HHT2; loss of receptor activity in;response to BMP9; retained in the endoplasmic reticulum;;dbSNP:rs1330837892)"";/evidence=""ECO:0000269|PubMed:26176610"";/id=""VAR_075236""	UniProt
P37023	ACVRL1	G211D	G	211	D	39	loss	(in HHT2; loss of receptor activity in;response to BMP9; retained in the endoplasmic reticulum;;dbSNP:rs28936687)"";/evidence=""ECO:0000269|PubMed:14684682,;ECO:0000269|PubMed:26176610"";/id=""VAR_026788""	UniProt
P37023	ACVRL1	G211S	G	211	S	39	loss	(in HHT2; loss of receptor activity in;response to BMP9; retained in the endoplasmic reticulum)"";/evidence=""ECO:0000269|PubMed:26176610"";/id=""VAR_075238""	UniProt
P37023	ACVRL1	A306P	A	306	P	355	loss	(in HHT2; loss of receptor activity in;response to BMP9; retained in the endoplasmic reticulum)"";/evidence=""ECO:0000269|PubMed:15024723,;ECO:0000269|PubMed:26176610"";/id=""VAR_026795""	UniProt
P37023	ACVRL1	L313V	L	313	V	365	loss	(in HHT2; loss of receptor activity in;response to BMP9; predominantly retained in the endoplasmic;reticulum)"";/evidence=""ECO:0000269|PubMed:26176610"";/id=""VAR_075240""	UniProt
P37023	ACVRL1	H314Y	H	314	Y	367	loss	(in HHT2; loss of receptor activity in;response to BMP9; retained in the endoplasmic reticulum;;dbSNP:rs1565594311)"";/evidence=""ECO:0000269|PubMed:15024723,;ECO:0000269|PubMed:26176610"";/id=""VAR_026796""	UniProt
P37023	ACVRL1	P378S	P	378	S	533	loss	(in HHT2; loss of receptor activity in;response to BMP9; retained in the endoplasmic reticulum;;dbSNP:rs959973779)"";/evidence=""ECO:0000269|PubMed:20414677,;ECO:0000269|PubMed:26176610"";/id=""VAR_070335""	UniProt
P37023	ACVRL1	E379D	E	379	D	534	loss	(in HHT2; loss of receptor activity in;response to BMP9; retained in the endoplasmic reticulum)"";/evidence=""ECO:0000269|PubMed:26176610"";/id=""VAR_075241""	UniProt
P37023	ACVRL1	E379K	E	379	K	534	loss	(in HHT2; loss of receptor activity in;response to BMP9; retained in the endoplasmic reticulum;;dbSNP:rs1131691686)"";/evidence=""ECO:0000269|PubMed:15024723,;ECO:0000269|PubMed:15712270, ECO:0000269|PubMed:26176610"";/id=""VAR_026803""	UniProt
P37023	ACVRL1	V404G	V	404	G	589	loss	(in HHT2; loss of receptor activity in;response to BMP9; predominantly retained in the endoplasmic;reticulum)"";/evidence=""ECO:0000269|PubMed:26176610"";/id=""VAR_075242""	UniProt
P37023	ACVRL1	R411W	R	411	W	602	loss	(in HHT2; loss of receptor activity in;response to BMP9; predominantly retained in the endoplasmic;reticulum; dbSNP:rs121909287)"";/evidence=""ECO:0000269|PubMed:11484689,;ECO:0000269|PubMed:15024723, ECO:0000269|PubMed:15712270,;ECO:0000269|PubMed:26176610"";/id=""VAR_026809""	UniProt
P31749	AKT1	K14Q	K	14	Q	-	decrease	Substantial reduction of phosphorylation at T-;308 and S-473, loss of AKT activation, and loss of binding;to PIP3 as well as IGF1-induced membrane recruitment."";/evidence=""ECO:0000269|PubMed:12176338,;ECO:0000269|PubMed:19713527, ECO:0000269|PubMed:21775285""	UniProt
P31749	AKT1	K179M	K	179	M	127	loss	Abolished serine/threonine-protein kinase;activity."";/evidence=""ECO:0000269|PubMed:33594058""	UniProt
P31749	AKT1	T305Y	T	305	Y	509	loss	Abolishes phosphorylation at Thr-308."";/evidence=""ECO:0000269|PubMed:22629392""	UniProt
P31749	AKT1	T312Y	T	312	Y	521	loss	Abolishes phosphorylation at Thr-308."";/evidence=""ECO:0000269|PubMed:22629392""	UniProt
Q9Y243	AKT3	S472A	S	472	A	-	decrease	67% decrease of activity after pervanadate;treatment."";/evidence=""ECO:0000269|PubMed:10092583""	UniProt
Q96QP1	ALPK1	K1067M	K	1067	M	-	loss	Abolishes the serine/threonine-protein kinase;and ability to initiate the innate immune response."";/evidence=""ECO:0000269|PubMed:30111836""	UniProt
P36888	FLT3	D835V	D	835	V	452	resistance	-	COSMIC
P20594	NPR2	T297M	T	297	M	-	decrease	(in AMD1; markedly deficient activity;;dbSNP:rs1313765432)"";/evidence=""ECO:0000269|PubMed:15146390"";/id=""VAR_022586""	UniProt
P20594	NPR2	G413E	G	413	E	-	decrease	(in AMD1; markedly deficient activity)"";/evidence=""ECO:0000269|PubMed:15146390"";/id=""VAR_022589""	UniProt
P25098	GRK2	K220R	K	220	R	127	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:9892019""	UniProt
P25098	GRK2	D3A	D	3	A	-	decrease	85% reduction in phosphorylation of G-protein;coupled receptor rhodopsin."";/evidence=""ECO:0000269|PubMed:19715378""	UniProt
P25098	GRK2	D3N	D	3	N	-	decrease	60% reduction in phosphorylation of G-protein;coupled receptor rhodopsin."";/evidence=""ECO:0000269|PubMed:19715378""	UniProt
P25098	GRK2	L4K	L	4	K	-	decrease	95% reduction in phosphorylation of G-protein;coupled receptor rhodopsin."";/evidence=""ECO:0000269|PubMed:19715378""	UniProt
P25098	GRK2	E5A	E	5	A	-	decrease	50% reduction in phosphorylation of G-protein;coupled receptor rhodopsin."";/evidence=""ECO:0000269|PubMed:19715378""	UniProt
Q13315	ATM	L1465P	L	1465	P	-	decrease	(in AT; decreased phosphorylation of target;proteins; dbSNP:rs730881391)"";/evidence=""ECO:0000269|PubMed:10234507,;ECO:0000269|PubMed:19431188"";/id=""VAR_010826""	UniProt
Q13315	ATM	L2068S	L	2068	S	-	decrease	(in AT; decreased protein abundance; loss of;DNA damage induced protein autophosphorylation;;dbSNP:rs1555114558)"";/evidence=""ECO:0000269|PubMed:27664052"";/id=""VAR_077239""	UniProt
Q13315	ATM	Y2080D	Y	2080	D	-	loss	(in AT; loss of DNA damage induced protein;autophosphorylation; dbSNP:rs1064795467)"";/evidence=""ECO:0000269|PubMed:27664052"";/id=""VAR_077240""	UniProt
Q13315	ATM	F2827C	F	2827	C	-	decrease	(in AT; mild; decreased phosphorylation of;target proteins; dbSNP:rs121434216)"";/evidence=""ECO:0000269|PubMed:19431188,;ECO:0000269|PubMed:8755918, ECO:0000269|PubMed:9463314"";/id=""VAR_010879""	UniProt
Q13315	ATM	K1807E	K	1807	E	-	decrease	Decreased phosphorylation of target proteins."";/evidence=""ECO:0000269|PubMed:19431188""	UniProt
Q13315	ATM	V1941L	V	1941	L	-	decrease	Decreased phosphorylation of target proteins."";/evidence=""ECO:0000269|PubMed:19431188""	UniProt
Q13315	ATM	Y2019C	Y	2019	C	-	loss	Loss of phosphorylation of target proteins."";/evidence=""ECO:0000269|PubMed:19431188""	UniProt
Q13315	ATM	E2039K	E	2039	K	-	decrease	Decreased phosphorylation of target proteins."";/evidence=""ECO:0000269|PubMed:19431188""	UniProt
Q13315	ATM	L2338P	L	2338	P	-	loss	Loss of phosphorylation of target proteins."";/evidence=""ECO:0000269|PubMed:19431188""	UniProt
Q13315	ATM	S2394L	S	2394	L	-	loss	Loss of phosphorylation of target proteins."";/evidence=""ECO:0000269|PubMed:19431188""	UniProt
Q13315	ATM	L2452P	L	2452	P	-	loss	Loss of phosphorylation of target proteins."";/evidence=""ECO:0000269|PubMed:19431188""	UniProt
Q13315	ATM	P2699L	P	2699	L	-	loss	Loss of phosphorylation of target proteins."";/evidence=""ECO:0000269|PubMed:19431188""	UniProt
Q13315	ATM	D2708N	D	2708	N	-	decrease	Decreased phosphorylation of target proteins."";/evidence=""ECO:0000269|PubMed:19431188""	UniProt
Q13315	ATM	Q2730P	Q	2730	P	-	loss	Loss of phosphorylation of target proteins."";/evidence=""ECO:0000269|PubMed:19431188""	UniProt
Q13315	ATM	D2870A	D	2870	A	-	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:9733515""	UniProt
Q13315	ATM	N2875K	N	2875	K	-	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:9733515""	UniProt
Q13315	ATM	K3016R	K	3016	R	-	loss	Loss of DNA damage-inducible acetylation.;Retains constitutive kinase activity, but blocks DNA;damage-induced kinase activation. Disrupts dimer and;abolishes S-1981 autophosphorylation."";/evidence=""ECO:0000269|PubMed:17923702""	UniProt
Q13315	ATM	R3047Q	R	3047	Q	-	loss	Abolished interaction with PEX5 and;translocation to peroxisomes in response to reactive oxygen;species (ROS)."";/evidence=""ECO:0000269|PubMed:26344566""	UniProt
Q13535	ATR	K2327R	K	2327	R	-	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:11114888,;ECO:0000269|PubMed:12011431, ECO:0000269|PubMed:9925639""	UniProt
Q13535	ATR	D2475A	D	2475	A	-	loss	Abolishes kinase activity; increases;sensitivity to IR and impairs translocation to nuclear foci;upon DNA damage."";/evidence=""ECO:0000269|PubMed:12814551,;ECO:0000269|PubMed:9427750, ECO:0000269|PubMed:9925639""	UniProt
Q13535	ATR	D2494E	D	2494	E	-	loss	Abolishes kinase activity; reduces cell;viability, augments sensitivity to IR and UV."";/evidence=""ECO:0000269|PubMed:10597277,;ECO:0000269|PubMed:9636169""	UniProt
O14965	AURKA	K162R	K	162	R	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:14702041""	UniProt
O14965	AURKA	D274N	D	274	N	442	loss	Abolishes cilia disassembly and kinase;activity."";/evidence=""ECO:0000269|PubMed:14580337,;ECO:0000269|PubMed:17604723""	UniProt
O14965	AURKA	T288A	T	288	A	512	decrease	Reduces cilia disassembly and kinase;activity."";/evidence=""ECO:0000269|PubMed:17604723""	UniProt
Q96GD4	AURKB	K106R	K	106	R	127	loss	Leads to loss of kinase activity and severely;impairs mitotic progression."";/evidence=""ECO:0000269|PubMed:12686604,;ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:14722118,;ECO:0000269|PubMed:16179162""	UniProt
Q9UQB9	AURKC	K72R	K	72	R	127	decrease	Impairs kinase activity."";/evidence=""ECO:0000269|PubMed:15316025,;ECO:0000269|PubMed:15499654""	UniProt
Q9UQB9	AURKC	D166Y	D	166	Y	389	decrease	Impairs kinase activity, and keeps AURKC with;the chromosomes until the end of mitosis."";/evidence=""ECO:0000269|PubMed:15938719""	UniProt
Q9UQB9	AURKC	T198A	T	198	A	512	decrease	Impairs kinase activity."";/evidence=""ECO:0000269|PubMed:15316025,;ECO:0000269|PubMed:15670791""	UniProt
Q9UIG0	BAZ1B	C338A	C	338	A	-	loss	Loss of tyrosine-protein kinase activity."";/evidence=""ECO:0000269|PubMed:19092802""	UniProt
O14874	BCKDK	R174G	R	174	G	-	decrease	(in BCKDKD; partial loss of kinase activity)"";/evidence=""ECO:0000269|PubMed:24449431"";/id=""VAR_072184""	UniProt
O14874	BCKDK	L389P	L	389	P	-	loss	(in BCKDKD; complete loss of kinase;activity)"";/evidence=""ECO:0000269|PubMed:24449431"";/id=""VAR_072185""	UniProt
Q13873	BMPR2	D485G	D	485	G	765	loss	(in PPH1; complete loss of function;;dbSNP:rs137852745)"";/evidence=""ECO:0000269|PubMed:10973254,;ECO:0000269|PubMed:11115378"";/id=""VAR_013679""	UniProt
P51813	BMX	Y566F	Y	566	F	461	loss	Abolishes almost completely the SRC-induced;phosphorylation of BMX."";/evidence=""ECO:0000269|PubMed:10688651""	UniProt
P15056	BRAF	K483S	K	483	S	127	decrease	Reduces kinase activity with MAP2K1."";/evidence=""ECO:0000269|PubMed:21441910""	UniProt
O60885	BRD4	S503A	S	503	A	-	decrease	Impaired phosphorylation by CK2 and binding to;acetylated histones."";/evidence=""ECO:0000269|PubMed:23317504""	UniProt
Q8TDC3	BRSK1	K59A	K	59	A	117	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:15150265""	UniProt
Q8TDC3	BRSK1	G327A	G	327	A	-	loss	Abolishes activation of kinase activity."";/evidence=""ECO:0000269|PubMed:18339622""	UniProt
Q8IWQ3	BRSK2	K48M	K	48	M	127	loss	Loss of catalytic activity. Causes;disintegration of actin stress fibers."";/evidence=""ECO:0000269|PubMed:22669945,;ECO:0000269|PubMed:22798068""	UniProt
Q8IWQ3	BRSK2	T260A	T	260	A	775	decrease	Decreased phosphorylation. Nearly abolishes;stimulation of insulin secretion."";/evidence=""ECO:0000269|PubMed:16870137,;ECO:0000269|PubMed:22669945""	UniProt
Q8IWQ3	BRSK2	G310A	G	310	A	-	decrease	Decreased activation of kinase activity."";/evidence=""ECO:0000269|PubMed:18339622""	UniProt
Q06187	BTK	R307G	R	307	G	-	loss	(in XLA; loss of activity;;dbSNP:rs128621195)"";/evidence=""ECO:0000269|PubMed:8162056"";/id=""VAR_006231""	UniProt
Q06187	BTK	K430E	K	430	E	127	loss	(in XLA; loss of phosphorylation of GTF2I;;dbSNP:rs128620184)"";/evidence=""ECO:0000269|PubMed:7809124"";/id=""VAR_006242""	UniProt
Q06187	BTK	Y223F	Y	223	F	-	loss	Loss of phosphorylation of GTF2I."";/evidence=""ECO:0000269|PubMed:8630736,;ECO:0000269|PubMed:9012831""	UniProt
Q06187	BTK	R307K	R	307	K	-	loss	Loss of phosphorylation of GTF2I."";/evidence=""ECO:0000269|PubMed:9012831""	UniProt
Q06187	BTK	Y551F	Y	551	F	510	loss	Loss of phosphorylation of GTF2I."";/evidence=""ECO:0000269|PubMed:9012831""	UniProt
O43683	BUB1	K821A	K	821	A	127	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:10198256""	UniProt
Q9NYV4	CDK12	D877N	D	877	N	442	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:24662513""	UniProt
O94921	CDK14	K164R	K	164	R	127	loss	Abolishes protein kinase activity."";/evidence=""ECO:0000269|PubMed:17517622,;ECO:0000269|PubMed:19524571""	UniProt
Q00536	CDK16	S12A	S	12	A	-	loss	Abolishes phosphorylation by BRSK2. Abolishes;effect on insulin secretion."";/evidence=""ECO:0000269|PubMed:22798068""	UniProt
Q00536	CDK16	K194A	K	194	A	127	loss	Loss of kinase activity. Abolishes effect on;insulin secretion."";/evidence=""ECO:0000269|PubMed:22184064,;ECO:0000269|PubMed:22798068""	UniProt
Q00536	CDK16	K194R	K	194	R	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:22184064,;ECO:0000269|PubMed:22798068""	UniProt
Q9BWU1	CDK19	G28R	G	28	R	37	decrease	(in DEE87; decreased protein kinase;activity)"";/evidence=""ECO:0000269|PubMed:33495529"";/id=""VAR_084393""	UniProt
Q8IZL9	CDK20	T161A	T	161	A	511	decrease	Impairs CDK2 T-160 phosphorylation and;activity."";/evidence=""ECO:0000269|PubMed:14597612""	UniProt
P24941	CDK2	K9F	K	9	F	35	decrease	Reduced phosphorylation by CAK."";/evidence=""ECO:0000269|PubMed:17373709""	UniProt
P24941	CDK2	T160A	T	160	A	511	loss	Abolishes activity."";/evidence=""ECO:0000269|PubMed:1396589""	UniProt
P24941	CDK2	L166R	L	166	R	525	decrease	Reduced phosphorylation by CAK and reduced;kinase activity."";/evidence=""ECO:0000269|PubMed:17373709""	UniProt
P50613	CDK7	K41A	K	41	A	127	loss	Total loss of activity.""	UniProt
P50613	CDK7	T170A	T	170	A	511	loss	Total loss of activity. Total loss of;transcriptional activity of the reconstituted TFIIH;complex."";/evidence=""ECO:0000269|PubMed:8069918,;ECO:0000269|PubMed:9832506""	UniProt
P49336	CDK8	V27L	V	27	L	36	decrease	(in IDDHBA; decreased protein kinase;activity)"";/evidence=""ECO:0000269|PubMed:30905399"";/id=""VAR_083786""	UniProt
P49336	CDK8	R29G	R	29	G	38	decrease	(in IDDHBA; decreased protein kinase;activity; dbSNP:rs1593218885)"";/evidence=""ECO:0000269|PubMed:30905399"";/id=""VAR_083787""	UniProt
P49336	CDK8	G30S	G	30	S	39	decrease	(in IDDHBA; decreased protein kinase;activity; dbSNP:rs1593218890)"";/evidence=""ECO:0000269|PubMed:30905399"";/id=""VAR_083788""	UniProt
P49336	CDK8	S62L	S	62	L	170	decrease	(in IDDHBA; decreased protein kinase;activity; dbSNP:rs1565977796)"";/evidence=""ECO:0000269|PubMed:30905399"";/id=""VAR_083789""	UniProt
P49336	CDK8	R178Q	R	178	Q	448	decrease	(in IDDHBA; decreased protein kinase;activity; dbSNP:rs1418353379)"";/evidence=""ECO:0000269|PubMed:30905399"";/id=""VAR_083791""	UniProt
P49336	CDK8	V193G	V	193	G	516	decrease	(in IDDHBA; decreased protein kinase;activity)"";/evidence=""ECO:0000269|PubMed:30905399"";/id=""VAR_083792""	UniProt
P49336	CDK8	I223M	I	223	M	589	decrease	(in IDDHBA; decreased protein kinase;activity; dbSNP:rs1593310364)"";/evidence=""ECO:0000269|PubMed:30905399"";/id=""VAR_083793""	UniProt
P50750	CDK9	K44R	K	44	R	117	decrease	Impaired kinase and transcriptional elongation;activities, but normal cyclin T1 and HEXIM1 binding."";/evidence=""ECO:0000269|PubMed:17452463""	UniProt
P50750	CDK9	K48Q	K	48	Q	127	decrease	Mimics acetylation; leading to impaired;protein kinase activity."";/evidence=""ECO:0000269|PubMed:28426094""	UniProt
P50750	CDK9	K48R	K	48	R	127	activating	Decreased acetylation; leading to enhanced;protein kinase activity."";/evidence=""ECO:0000269|PubMed:28426094""	UniProt
P50750	CDK9	S175D	S	175	D	456	loss	Mimics phosphorylation, constitutive loss of;kinase activity."";/evidence=""ECO:0000269|PubMed:21533037""	UniProt
Q9Y5P4	CERT1	S132A	S	132	A	-	loss	Abolishes the phosphorylation. Strongly;reduces the interaction with phosphatidylinositol 4-;phosphate. Increases the ceramide transfer activity."";/evidence=""ECO:0000269|PubMed:17591919""	UniProt
O14757	CHEK1	K38R	K	38	R	127	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:12446774,;ECO:0000269|PubMed:14681223""	UniProt
O14757	CHEK1	D130A	D	130	A	389	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:10673501,;ECO:0000269|PubMed:11390642, ECO:0000269|PubMed:11535615,;ECO:0000269|PubMed:11821419, ECO:0000269|PubMed:12588868,;ECO:0000269|PubMed:14681206, ECO:0000269|PubMed:15311285,;ECO:0000269|PubMed:9278511""	UniProt
O96017	CHEK2	H371Y	H	371	Y	445	decrease	(confers a moderate risk of breast cancer;;partially reduces kinase activity; dbSNP:rs531398630)"";/evidence=""ECO:0000269|PubMed:21618645"";/id=""VAR_066012""	UniProt
O96017	CHEK2	T68A	T	68	A	-	loss	Loss of activation and phosphorylation."";/evidence=""ECO:0000269|PubMed:11901158,;ECO:0000269|PubMed:15342622""	UniProt
O96017	CHEK2	S73A	S	73	A	-	decrease	Impaired activation, phosphorylation by ATM;and G2/M transition checkpoint."";/evidence=""ECO:0000269|PubMed:16481012""	UniProt
P35968	KDR	L840F	L	840	F	36	resistance	-	COSMIC
O96017	CHEK2	D347A	D	347	A	389	loss	Loss of kinase activity and of the ability to;phosphorylate CDC25A."";/evidence=""ECO:0000269|PubMed:11298456,;ECO:0000269|PubMed:9836640""	UniProt
O96017	CHEK2	D368N	D	368	N	442	loss	Loss of autophosphorylation activity."";/evidence=""ECO:0000269|PubMed:15342622""	UniProt
O96017	CHEK2	T383A	T	383	A	512	loss	Loss of phosphorylation in response to;ionizing radiation."";/evidence=""ECO:0000269|PubMed:11390408""	UniProt
O96017	CHEK2	T387A	T	387	A	521	loss	Loss of phosphorylation in response to;ionizing radiation."";/evidence=""ECO:0000269|PubMed:11390408""	UniProt
Q9UPZ9	CILK1	R272Q	R	272	Q	773	decrease	(in ECO; significantly impairs kinase;activity; decreased localization at the ciliary tips;;impaired ciliogenesis; results in abnormally elongated;cilia; impairs mitosis, cell-cycle exit and radial;neuroblast migration, while promoting apoptosis, when;tested in a heterologous system; loss of nuclear;localization; dbSNP:rs118203918)"";/evidence=""ECO:0000269|PubMed:19185282,;ECO:0000269|PubMed:24797473, ECO:0000269|PubMed:24853502,;ECO:0000269|PubMed:29539279"";/id=""VAR_057994""	UniProt
Q9HAZ1	CLK4	K189R	K	189	R	127	loss	Loss of function."";/evidence=""ECO:0000269|PubMed:11170754""	UniProt
P07333	CSF1R	P132L	P	132	L	-	decrease	(in BANDDOS; impairs phosphorylation of JNK;kinases upon stimulation with CSF1; dbSNP:rs1351319114)"";/evidence=""ECO:0000269|PubMed:30982609"";/id=""VAR_083140""	UniProt
P07333	CSF1R	E633K	E	633	K	174	decrease	(in HDLS1; impairs autophosphorylation upon;stimulation with CSF1; dbSNP:rs281860269)"";/evidence=""ECO:0000269|PubMed:22197934"";/id=""VAR_067398""	UniProt
P07333	CSF1R	G765D	G	765	D	358	decrease	(in HDLS1; impairs autophosphorylation upon;stimulation with CSF1; dbSNP:rs690016566)"";/evidence=""ECO:0000269|PubMed:24336230"";/id=""VAR_083144""	UniProt
P07333	CSF1R	M766T	M	766	T	359	decrease	(in HDLS1; impairs autophosphorylation upon;stimulation with CSF1; dbSNP:rs281860270)"";/evidence=""ECO:0000269|PubMed:22197934,;ECO:0000269|PubMed:23408870"";/id=""VAR_067401""	UniProt
P07333	CSF1R	I775N	I	775	N	386	decrease	(in HDLS1; impairs autophosphorylation upon;stimulation with CSF1; dbSNP:rs281860273)"";/evidence=""ECO:0000269|PubMed:22197934"";/id=""VAR_067404""	UniProt
P07333	CSF1R	A781E	A	781	E	392	decrease	(in HDLS1; impairs autophosphorylation upon;stimulation with CSF1; dbSNP:rs587777247)"";/evidence=""ECO:0000269|PubMed:24336230"";/id=""VAR_083145""	UniProt
P07333	CSF1R	R782H	R	782	H	393	decrease	(in HDLS1; impairs autophosphorylation upon;stimulation with CSF1; dbSNP:rs281860281)"";/evidence=""ECO:0000269|PubMed:23408870"";/id=""VAR_083146""	UniProt
P07333	CSF1R	I794T	I	794	T	440	decrease	(in HDLS1; impairs autophosphorylation upon;stimulation with CSF1; dbSNP:rs281860274)"";/evidence=""ECO:0000269|PubMed:22197934,;ECO:0000269|PubMed:24336230"";/id=""VAR_067405""	UniProt
P07333	CSF1R	P824S	P	824	S	533	decrease	(in HDLS1; impairs autophosphorylation upon;stimulation with CSF1)"";/evidence=""ECO:0000269|PubMed:24336230"";/id=""VAR_083147""	UniProt
P07333	CSF1R	M875T	M	875	T	670	decrease	(in HDLS1; impairs autophosphorylation upon;stimulation with CSF1; dbSNP:rs281860279)"";/evidence=""ECO:0000269|PubMed:22197934,;ECO:0000269|PubMed:23408870"";/id=""VAR_067410""	UniProt
P07333	CSF1R	Y809F	Y	809	F	462	decrease	Reduced kinase activity. Reduced interaction;with SRC, FYN and YES1."";/evidence=""ECO:0000269|PubMed:7681396""	UniProt
P07333	CSF1R	Y969F	Y	969	F	-	loss	Abolishes down-regulation of activated CSF1R."";/evidence=""ECO:0000269|PubMed:15117969""	UniProt
P41240	CSK	Y184F	Y	184	F	-	loss	Abolishes phosphorylation."";/evidence=""ECO:0000269|PubMed:9148770""	UniProt
P41240	CSK	Y304F	Y	304	F	364	decrease	Decreases activity by two-thirds and alters;conformation."";/evidence=""ECO:0000269|PubMed:9148770""	UniProt
P41240	CSK	S364A	S	364	A	577	decrease	Strong decrease of phosphorylation by PRKACA;(catalytic subunit of PKA)."";/evidence=""ECO:0000269|PubMed:11181701""	UniProt
O14578	CIT	G106V	G	106	V	39	decrease	(in MCPH17; impairs kinase activity; exhibits;abnormal mitotic cytokinesis; exhibits multipolar spindles;;increases the neurons apoptotic process;;dbSNP:rs886037892)"";/evidence=""ECO:0000269|PubMed:27453578"";/id=""VAR_077442""	UniProt
O14578	CIT	K126Q	K	126	Q	127	decrease	(in MCPH17; impairs kinase activity; exhibits;abnormal mitotic cytokinesis; exhibits multipolar spindles;;increases the neurons apoptotic process;;dbSNP:rs886037893)"";/evidence=""ECO:0000269|PubMed:27453578"";/id=""VAR_077443""	UniProt
O14578	CIT	D230V	D	230	V	398	decrease	(in MCPH17; impairs kinase activity; exhibits;abnormal mitotic cytokinesis; exhibits multipolar spindles;;increases the neurons apoptotic process;;dbSNP:rs886037894)"";/evidence=""ECO:0000269|PubMed:27453578"";/id=""VAR_077444""	UniProt
P53355	DAPK1	K42A	K	42	A	127	loss	Loss of activity, apoptotic function and of;autophosphorylation."";/evidence=""ECO:0000269|PubMed:11579085,;ECO:0000269|PubMed:7828849""	UniProt
P53355	DAPK1	S289A	S	289	A	-	activating	Loss of phosphorylation and significant;increase in proapoptotic activity.""	UniProt
P53355	DAPK1	S308D	S	308	D	-	decrease	Reduced Ca(2+)-calmodulin binding and Ca(2+)-;calmodulin-independent kinase activity. Decreases apoptotic;activity."";/evidence=""ECO:0000269|PubMed:11579085""	UniProt
Q9UIK4	DAPK2	K52A	K	52	A	127	loss	Loss of activity, apoptotic function and of;autophosphorylation."";/evidence=""ECO:0000269|PubMed:10376525,;ECO:0000269|PubMed:10629061, ECO:0000269|PubMed:11230133""	UniProt
Q9UIK4	DAPK2	S318A	S	318	A	-	activating	Loss of Ca(2+)-calmodulin independent;phosphorylation, increase in apoptotic activity."";/evidence=""ECO:0000269|PubMed:11230133""	UniProt
O43293	DAPK3	T112M	T	112	M	322	decrease	(in a colorectal adenocarcinoma sample;;somatic mutation; greatly reduces kinase activity,;increases cell proliferation and cell survival)"";/evidence=""ECO:0000269|PubMed:17344846,;ECO:0000269|PubMed:21487036"";/id=""VAR_040438""	UniProt
O43293	DAPK3	D161N	D	161	N	442	decrease	(in an ovarian mucinous carcinoma sample;;somatic mutation; greatly reduces kinase activity,;increases cell proliferation and cell survival)"";/evidence=""ECO:0000269|PubMed:17344846,;ECO:0000269|PubMed:21487036"";/id=""VAR_040439""	UniProt
O43293	DAPK3	P216S	P	216	S	616	decrease	(in a lung neuroendocrine carcinoma sample;;somatic mutation; greatly reduces kinase activity,;increases cell proliferation, cell adhesion and cell;survival)"";/evidence=""ECO:0000269|PubMed:17344846,;ECO:0000269|PubMed:21487036"";/id=""VAR_040440""	UniProt
O43293	DAPK3	K42A	K	42	A	127	loss	Loss of kinase activity at low concentrations;of ATP."";/evidence=""ECO:0000269|PubMed:17158456""	UniProt
O43293	DAPK3	D161A	D	161	A	442	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:17158456""	UniProt
O43293	DAPK3	T180A	T	180	A	521	decrease	Greatly reduced kinase activity."";/evidence=""ECO:0000269|PubMed:21487036""	UniProt
O43293	DAPK3	T225A	T	225	A	630	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:17158456""	UniProt
O43293	DAPK3	T265A	T	265	A	775	loss	Loss of phosphorylation by ROCK1,;catalytically inactive."";/evidence=""ECO:0000269|PubMed:17158456""	UniProt
O43293	DAPK3	T299A	T	299	A	-	loss	Loss of phosphorylation by ROCK1."";/evidence=""ECO:0000269|PubMed:17158456""	UniProt
Q16832	DDR2	K608A	K	608	A	127	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:16186108""	UniProt
Q09013	DMPK	K100A	K	100	A	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:15598648""	UniProt
Q13627	DYRK1A	K188R	K	188	R	127	loss	Abolished protein kinase activity."";/evidence=""ECO:0000269|PubMed:23665168,;ECO:0000269|PubMed:25620562""	UniProt
Q13627	DYRK1A	Y321F	Y	321	F	516	decrease	Mildly reduces kinase activity. Does not;abolish autophosphorylation on tyrosine residues."";/evidence=""ECO:0000269|PubMed:23665168""	UniProt
Q9Y463	DYRK1B	D239A	D	239	A	389	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:32611815""	UniProt
Q92630	DYRK2	K251R	K	251	R	127	loss	Abolishes protein serine/threonine kinase;activity."";/evidence=""ECO:0000269|PubMed:23362280""	UniProt
Q9NR20	DYRK4	K133R	K	133	R	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:17292540""	UniProt
Q9NR20	DYRK4	Y264F	Y	264	F	516	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:21127067""	UniProt
P19525	EIF2AK2	A67E	A	67	E	-	loss	Significant loss of activity; loss of dsRNA;binding and dimerization."";/evidence=""ECO:0000269|PubMed:11337501""	UniProt
P19525	EIF2AK2	T258A	T	258	A	-	decrease	Moderate loss of activity."";/evidence=""ECO:0000269|PubMed:11152499""	UniProt
P19525	EIF2AK2	K296R	K	296	R	127	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:11152499""	UniProt
P19525	EIF2AK2	T446A	T	446	A	511	decrease	Significant loss of activity and impairs;autophosphorylation of T-451."";/evidence=""ECO:0000269|PubMed:11337501""	UniProt
P19525	EIF2AK2	T451A	T	451	A	521	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:11337501""	UniProt
Q9P2K8	EIF2AK4	K614A	K	614	A	109	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:10026192""	UniProt
O00418	EEF2K	S78A	S	78	A	-	decrease	Decreased kinase activity."";/evidence=""ECO:0000269|PubMed:22216903""	UniProt
O00418	EEF2K	T348A	T	348	A	-	decrease	Decreased kinase activity."";/evidence=""ECO:0000269|PubMed:22216903""	UniProt
O00418	EEF2K	S366A	S	366	A	-	decrease	Decreased kinase activity."";/evidence=""ECO:0000269|PubMed:11500364,;ECO:0000269|PubMed:22216903""	UniProt
P00533	EGFR	G428D	G	428	D	-	loss	(in NISBD2; loss of function; the mutant does;not localize to the cell membrane; has diffuse cytoplasmic;localization; dbSNP:rs606231253)"";/evidence=""ECO:0000269|PubMed:24691054"";/id=""VAR_072435""	UniProt
P00533	EGFR	R429E	R	429	E	-	loss	Abolishes autophosphorylation and activation;of downstream kinases."";/evidence=""ECO:0000269|PubMed:12297050""	UniProt
P00533	EGFR	L688A	L	688	A	-	decrease	Strongly reduced phosphorylation."";/evidence=""ECO:0000269|PubMed:19560417,;ECO:0000269|PubMed:19563760""	UniProt
P00533	EGFR	V689A	V	689	A	-	decrease	Reduced autophosphorylation."";/evidence=""ECO:0000269|PubMed:19560417""	UniProt
P00533	EGFR	E690A	E	690	A	-	decrease	Reduced phosphorylation."";/evidence=""ECO:0000269|PubMed:19560417,;ECO:0000269|PubMed:19563760""	UniProt
P00533	EGFR	L692A	L	692	A	-	decrease	P: Strongly reduced phosphorylation."";/evidence=""ECO:0000269|PubMed:19560417,;ECO:0000269|PubMed:19563760""	UniProt
P00533	EGFR	T693D	T	693	D	-	decrease	Strongly reduced phosphorylation."";/evidence=""ECO:0000269|PubMed:19560417""	UniProt
P00533	EGFR	P694A	P	694	A	-	decrease	Strongly reduced phosphorylation."";/evidence=""ECO:0000269|PubMed:19560417""	UniProt
P00533	EGFR	P699A	P	699	A	-	decrease	Reduced phosphorylation."";/evidence=""ECO:0000269|PubMed:19560417""	UniProt
P00533	EGFR	N700A	N	700	A	-	loss	Abolishes phosphorylation."";/evidence=""ECO:0000269|PubMed:19560417""	UniProt
P00533	EGFR	L704A	L	704	A	-	loss	Abolishes phosphorylation."";/evidence=""ECO:0000269|PubMed:19560417""	UniProt
P00533	EGFR	R705A	R	705	A	-	loss	Abolishes phosphorylation."";/evidence=""ECO:0000269|PubMed:19560417""	UniProt
P00533	EGFR	I706A	I	706	A	-	loss	Abolishes phosphorylation."";/evidence=""ECO:0000269|PubMed:19560417""	UniProt
P00533	EGFR	K745A	K	745	A	127	loss	M: Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:19560417""	UniProt
P00533	EGFR	D974A	D	974	A	-	decrease	Strongly reduced phosphorylation.""	UniProt
P00533	EGFR	R977A	R	977	A	-	decrease	Reduced phosphorylation."";/evidence=""ECO:0000269|PubMed:19563760""	UniProt
P29317	EPHA2	K646M	K	646	M	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:16236711""	UniProt
P29320	EPHA3	V133E	V	133	E	-	loss	Loss of EFNA5-binding ability and function."";/evidence=""ECO:0000269|PubMed:14660665""	UniProt
P29320	EPHA3	F152L	F	152	L	-	loss	Loss of EFNA5-binding ability and function."";/evidence=""ECO:0000269|PubMed:14660665""	UniProt
P54762	EPHB1	K651R	K	651	R	127	loss	Kinase-dead mutant. Unable to;autophosphorylate, to interact with SH2 domain-containing;interactors, to activate the MAPK/ERK and JUN signaling;cascades. Not ubiquitinated by CBL."";/evidence=""ECO:0000269|PubMed:18034775,;ECO:0000269|PubMed:9430661""	UniProt
P54753	EPHB3	K665R	K	665	R	127	loss	Kinase-dead. Loss of autophosphorylation."";/evidence=""ECO:0000269|PubMed:9674711""	UniProt
P54760	EPHB4	K650N	K	650	N	130	decrease	(in CMAVM2; highly decreased tyrosine;phosphorylation; highly decreased interaction with RASA1;;dbSNP:rs1584658113)"";/evidence=""ECO:0000269|PubMed:30578106"";/id=""VAR_081706""	UniProt
P54760	EPHB4	E664K	E	664	K	174	loss	(in CMAVM2; the mutant protein is not;detected by Western blot; loss of localization to cell;membrane; dbSNP:rs1562969219)"";/evidence=""ECO:0000269|PubMed:28687708"";/id=""VAR_081708""	UniProt
P54760	EPHB4	R739Q	R	739	Q	388	loss	(in LMPHM7; loss of kinase activity;;dbSNP:rs1057519263)"";/evidence=""ECO:0000269|PubMed:27400125"";/id=""VAR_078063""	UniProt
P54760	EPHB4	I782S	I	782	S	526	loss	(in LMPHM7; loss of kinase activity;;dbSNP:rs1057519264)"";/evidence=""ECO:0000269|PubMed:27400125"";/id=""VAR_078064""	UniProt
P51617	IRAK1	K239S	K	239	S	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:15084582""	UniProt
P54760	EPHB4	R838W	R	838	W	669	loss	(in CMAVM2; the mutant protein is not;detected by Western blot; loss of localization to cell;membrane; dbSNP:rs764827256)"";/evidence=""ECO:0000269|PubMed:28687708"";/id=""VAR_081719""	UniProt
P54760	EPHB4	C845R	C	845	R	681	loss	(in CMAVM2; the mutant protein is not;detected by Western blot; loss of localization to cell;membrane; dbSNP:rs1584653054)"";/evidence=""ECO:0000269|PubMed:28687708"";/id=""VAR_081720""	UniProt
P54760	EPHB4	R864W	R	864	W	773	loss	(in CMAVM2; the mutant protein is not;detected by Western blot; loss of localization to cell;membrane; dbSNP:rs769965440)"";/evidence=""ECO:0000269|PubMed:28687708"";/id=""VAR_081722""	UniProt
P04626	ERBB2	A710V	A	710	V	-	loss	(in VSCN2; almost complete loss of ERBB2 and;ERBB3 phosphorylation in the presence or in the absence of;NRG1 stimulation, suggesting alteration of downstream;signaling; does not affect the subcellular localization at;the cell membrane)"";/evidence=""ECO:0000269|PubMed:33497358"";/id=""VAR_086107""	UniProt
P21860	ERBB3	T787P	T	787	P	266	loss	(in VSCN1; almost complete loss of ERBB2 and;ERBB3 phosphorylation in the presence or in the absence of;NRG1 stimulation, suggesting alteration of downstream;signaling; does not affect the subcellular localization at;the cell membrane)"";/evidence=""ECO:0000269|PubMed:33497358"";/id=""VAR_086108""	UniProt
P21860	ERBB3	V899M	V	899	M	588	loss	(in VSCN1; almost complete loss of ERBB2 and;ERBB3 phosphorylation in the presence or in the absence of;NRG1 stimulation, suggesting alteration of downstream;signaling; does not affect the subcellular localization at;the cell membrane)"";/evidence=""ECO:0000269|PubMed:33497358"";/id=""VAR_086110""	UniProt
P21860	ERBB3	K742M	K	742	M	127	decrease	Strongly reduced autophosphorylation."";/evidence=""ECO:0000269|PubMed:20351256""	UniProt
P21860	ERBB3	Y868E	Y	868	E	511	decrease	Strongly reduced tyrosine phosphorylation."";/evidence=""ECO:0000269|PubMed:20351256""	UniProt
Q15303	ERBB4	R927Q	R	927	Q	624	decrease	(in ALS19; reduces autophosphorylation upon;NRG1 stimulation; dbSNP:rs397514262)"";/evidence=""ECO:0000269|PubMed:24119685"";/id=""VAR_070810""	UniProt
Q15303	ERBB4	R1275W	R	1275	W	-	decrease	(in ALS19; reduces autophosphorylation upon;NRG1 stimulation; dbSNP:rs397514263)"";/evidence=""ECO:0000269|PubMed:24119685"";/id=""VAR_070811""	UniProt
Q15303	ERBB4	L710N	L	710	N	-	decrease	Strongly reduced autophosphorylation."";/evidence=""ECO:0000269|PubMed:18287036""	UniProt
Q15303	ERBB4	K751R	K	751	R	127	loss	Abolishes kinase activity. Abolishes;phosphorylation, proteolytic processing and nuclear;localization."";/evidence=""ECO:0000269|PubMed:11390655,;ECO:0000269|PubMed:17486069, ECO:0000269|PubMed:17638867""	UniProt
Q15303	ERBB4	M766R	M	766	R	172	decrease	Strongly reduced autophosphorylation."";/evidence=""ECO:0000269|PubMed:18287036""	UniProt
Q15303	ERBB4	D843N	D	843	N	389	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:16978839""	UniProt
Q15303	ERBB4	D861Y	D	861	Y	442	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:19098003""	UniProt
Q15303	ERBB4	L864R	L	864	R	445	decrease	Strongly reduced autophosphorylation."";/evidence=""ECO:0000269|PubMed:18287036""	UniProt
O75460	ERN1	K599A	K	599	A	127	loss	Loss of autophosphorylation and of;endoribonuclease activity. Inhibition of growth arrest."";/evidence=""ECO:0000269|PubMed:11175748,;ECO:0000269|PubMed:9637683""	UniProt
Q76MJ5	ERN2	K548A	K	548	A	127	loss	Loss of autophosphorylation, of induction of;apoptosis and of 28S rRNA cleavage, attenuation of;repression of protein synthesis."";/evidence=""ECO:0000269|PubMed:11175748""	UniProt
Q14289	PTK2B	K457A	K	457	A	127	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:15166227""	UniProt
Q14289	PTK2B	Y881F	Y	881	F	-	decrease	Loss of phosphorylation site. Strongly reduced;interaction with GRB2."";/evidence=""ECO:0000269|PubMed:20521079""	UniProt
P16591	FER	R483Q	R	483	Q	-	loss	Abolishes kinase activity. Abolishes location;at microtubules."";/evidence=""ECO:0000269|PubMed:12972546""	UniProt
P16591	FER	K591R	K	591	R	127	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:9722593""	UniProt
P07332	FES	L334P	L	334	P	-	loss	Abolishes autophosphorylation."";/evidence=""ECO:0000269|PubMed:11509660""	UniProt
P07332	FES	G463V	G	463	V	-	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:18775312""	UniProt
P07332	FES	K590E	K	590	E	127	loss	Abolishes kinase activity. Fails to inhibit;proliferation of melanoma cells."";/evidence=""ECO:0000269|PubMed:15485904,;ECO:0000269|PubMed:28463229""	UniProt
P07332	FES	M704V	M	704	V	445	decrease	Reduced autophosphorylation and strongly;reduced kinase activity."";/evidence=""ECO:0000269|PubMed:15867340,;ECO:0000269|PubMed:16455651""	UniProt
P07332	FES	Y713F	Y	713	F	461	decrease	Reduces kinase activity by over 90%."";/evidence=""ECO:0000269|PubMed:7687763""	UniProt
P07332	FES	V743M	V	743	M	583	decrease	Strongly reduced autophosphorylation and;kinase activity."";/evidence=""ECO:0000269|PubMed:15867340,;ECO:0000269|PubMed:16455651""	UniProt
P07332	FES	S759F	S	759	F	614	decrease	Reduced autophosphorylation and strongly;reduced kinase activity."";/evidence=""ECO:0000269|PubMed:15867340,;ECO:0000269|PubMed:16455651""	UniProt
P11362	FGFR1	K618N	K	618	N	372	decrease	(in HH2; some patients also carry GNRHR;mutations; impairs tyrosine kinase activity)"";/evidence=""ECO:0000269|PubMed:19820032,;ECO:0000269|PubMed:23643382"";/id=""VAR_069293""	UniProt
P11362	FGFR1	K514A	K	514	A	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:15117958""	UniProt
P11362	FGFR1	D623A	D	623	A	389	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:19224897""	UniProt
P21802	FGFR2	M391R	M	391	R	-	decrease	(in BBDS; the mutation selectively reduces;plasma-membrane levels of the protein and markedly;diminishes the receptor's responsiveness to extracellular;FGF; dbSNP:rs387906677)"";/evidence=""ECO:0000269|PubMed:22387015"";/id=""VAR_067978""	UniProt
P21802	FGFR2	A628T	A	628	T	391	decrease	(in LADDS; strongly reduced kinase activity;;dbSNP:rs121918509)"";/evidence=""ECO:0000269|PubMed:16501574"";/id=""VAR_029884""	UniProt
P21802	FGFR2	Y769F	Y	769	F	-	decrease	Increases fibroblast proliferation. Decreases;phosphorylation of PLCG1 and FRS2. Decreases activation of;MAP kinases."";/evidence=""ECO:0000269|PubMed:15629145,;ECO:0000269|PubMed:19103595""	UniProt
P22607	FGFR3	K508A	K	508	A	127	loss	Loss of kinase activity. Abolishes;ubiquitination."";/evidence=""ECO:0000269|PubMed:12297284,;ECO:0000269|PubMed:16410555""	UniProt
P22607	FGFR3	Y724F	Y	724	F	756	decrease	Strongly reduced kinase activity. Strongly;reduced mitogen activity."";/evidence=""ECO:0000269|PubMed:11294897""	UniProt
P22455	FGFR4	K503R	K	503	R	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:11433297,;ECO:0000269|PubMed:17311277""	UniProt
P36888	FLT3	K644A	K	644	A	127	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:15831474""	UniProt
P42685	FRK	K262R	K	262	R	127	loss	Loss of ability to phosphorylate PTEN."";/evidence=""ECO:0000269|PubMed:19345329""	UniProt
Q15835	GRK1	K219A	K	219	A	127	loss	Loss of autophosphorylation and RHO;phosphorylation."";/evidence=""ECO:0000269|PubMed:15946941""	UniProt
P49841	GSK3B	L128A	L	128	A	262	loss	Abolishes activity toward AXIN1."";/evidence=""ECO:0000269|PubMed:11430833""	UniProt
Q02846	GUCY2D	F565S	F	565	S	-	loss	(in LCA1; loss of activity;;dbSNP:rs61749755)"";/evidence=""ECO:0000269|PubMed:9888789"";/id=""VAR_009131""	UniProt
Q8TF76	HASPIN	K282M	K	282	M	-	decrease	Loss of catalytic activity. Reduced nuclear;size in larval salivary glands."";/evidence=""ECO:0000269|PubMed:32750047""	UniProt
Q8TF76	HASPIN	E492A	E	492	A	38	decrease	Markedly reduced affinity for histone H3 and;reduced histone H3 phosphorylation."";/evidence=""ECO:0000269|PubMed:19918049""	UniProt
Q8TF76	HASPIN	K511A	K	511	A	127	decrease	Strongly reduced enzyme activity."";/evidence=""ECO:0000269|PubMed:19918057""	UniProt
Q8TF76	HASPIN	H651A	H	651	A	391	decrease	Strongly reduced enzyme activity, markedly;reduced affinity for histone H3."";/evidence=""ECO:0000269|PubMed:19918049,;ECO:0000269|PubMed:19918057""	UniProt
Q8TF76	HASPIN	D707L	D	707	L	-	decrease	Markedly reduced affinity for histone H3 and;reduced histone H3 phosphorylation."";/evidence=""ECO:0000269|PubMed:19918049""	UniProt
Q8TF76	HASPIN	D709N	D	709	N	-	decrease	Markedly reduced affinity for histone H3 and;reduced histone H3 phosphorylation."";/evidence=""ECO:0000269|PubMed:19918049""	UniProt
Q8TF76	HASPIN	G713F	G	713	F	-	decrease	Markedly reduced affinity for histone H3 and;reduced histone H3 phosphorylation."";/evidence=""ECO:0000269|PubMed:19918049""	UniProt
Q8TF76	HASPIN	D716L	D	716	L	-	decrease	Markedly reduced histone H3 phosphorylation."";/evidence=""ECO:0000269|PubMed:19918049""	UniProt
P08631	HCK	K290E	K	290	E	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:11896602""	UniProt
P08631	HCK	E305A	E	305	A	174	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:10644735""	UniProt
P08631	HCK	D381E	D	381	E	389	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:15998323""	UniProt
P08631	HCK	Y411A	Y	411	A	461	decrease	Reduced catalytic activity and higher affinity;for target peptides."";/evidence=""ECO:0000269|PubMed:10644735""	UniProt
Q86Z02	HIPK1	K219A	K	219	A	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:19646965""	UniProt
Q86Z02	HIPK1	D315N	D	315	N	389	loss	Loss of kinase activity and impaired MAP3K5-;JNK inactivation."";/evidence=""ECO:0000269|PubMed:15701637""	UniProt
Q9H422	HIPK3	K226R	K	226	R	127	loss	Loss of kinase activity and impaired;activation of SF1."";/evidence=""ECO:0000269|PubMed:17210646""	UniProt
P08069	IGF1R	R138Q	R	138	Q	-	decrease	(in IGF1RES; has decreased IGF1R function;;dbSNP:rs121912426)"";/evidence=""ECO:0000269|PubMed:14657428"";/id=""VAR_034891""	UniProt
P08069	IGF1R	K145N	K	145	N	-	decrease	(in IGF1RES; has decreased IGF1R function;;dbSNP:rs121912427)"";/evidence=""ECO:0000269|PubMed:14657428"";/id=""VAR_034892""	UniProt
P08069	IGF1R	N359Y	N	359	Y	-	decrease	(in IGF1RES; significant decrease in IGF1-;induced DNA synthesis and AKT1 phosphorylation in patient;fibroblasts)"";/evidence=""ECO:0000269|PubMed:25040157"";/id=""VAR_076247""	UniProt
P08069	IGF1R	Y865C	Y	865	C	-	decrease	(in IGF1RES; significant decrease in IGF1-;induced DNA synthesis and AKT1 phosphorylation in patient;fibroblasts)"";/evidence=""ECO:0000269|PubMed:25040157"";/id=""VAR_076248""	UniProt
P08069	IGF1R	R1256S	R	1256	S	773	decrease	(in IGF1RES; significant decrease in IGF1-;induced DNA synthesis and AKT1 phosphorylation in patient;fibroblasts)"";/evidence=""ECO:0000269|PubMed:25040157"";/id=""VAR_076249""	UniProt
O15111	CHUK	T23A	T	23	A	38	decrease	Loss of phosphorylation and decrease of kinase;activity."";/evidence=""ECO:0000269|PubMed:10485710""	UniProt
O15111	CHUK	K44A	K	44	A	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:9244310,;ECO:0000269|PubMed:9346484""	UniProt
O15111	CHUK	K44M	K	44	M	127	loss	Loss of autophosphorylation."";/evidence=""ECO:0000269|PubMed:9244310,;ECO:0000269|PubMed:9346484""	UniProt
O15111	CHUK	S176A	S	176	A	460	loss	Loss of phosphorylation and of activity."";/evidence=""ECO:0000269|PubMed:9346484,;ECO:0000269|PubMed:9520446""	UniProt
O14920	IKBKB	D166A	D	166	A	442	loss	Loss of protein kinase activity."";/evidence=""ECO:0000269|PubMed:25326418""	UniProt
O14920	IKBKB	S177A	S	177	A	460	decrease	Decrease of activity."";/evidence=""ECO:0000269|PubMed:19675099,;ECO:0000269|PubMed:9346484""	UniProt
O14920	IKBKB	S181A	S	181	A	512	decrease	Decrease of activity."";/evidence=""ECO:0000269|PubMed:19675099,;ECO:0000269|PubMed:9346484""	UniProt
Q14164	IKBKE	K38A	K	38	A	127	loss	Loss of kinase activity and loss of nuclear;import."";/evidence=""ECO:0000269|PubMed:10421793""	UniProt
Q14164	IKBKE	E168A	E	168	A	460	decrease	Slight decrease of kinase activity."";/evidence=""ECO:0000269|PubMed:10421793""	UniProt
Q14164	IKBKE	S172A	S	172	A	512	loss	Loss of autophosphorylation and of kinase;activity."";/evidence=""ECO:0000269|PubMed:10421793""	UniProt
Q14164	IKBKE	S172E	S	172	E	512	decrease	Decrease in kinase activity."";/evidence=""ECO:0000269|PubMed:10421793""	UniProt
P06213	INSR	E1206D	E	1206	D	534	decrease	(in IRAN type A; accelerates degradation of;the protein and impairs kinase activity)"";/evidence=""ECO:0000269|PubMed:7983039"";/id=""VAR_015931""	UniProt
P06213	INSR	W1220L	W	1220	L	584	decrease	(in IRAN type A; accelerates degradation of;the protein and impairs kinase activity; dbSNP:rs52800171)"";/evidence=""ECO:0000269|PubMed:7983039,;ECO:0000269|PubMed:8390949"";/id=""VAR_004100""	UniProt
P06213	INSR	K1057M	K	1057	M	127	loss	R: Abolishes the kinase activity."";/evidence=""ECO:0000269|PubMed:10803466,;ECO:0000269|PubMed:3101064, ECO:0000269|PubMed:7537849""	UniProt
P06213	INSR	D1159N	D	1159	N	389	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:11598120""	UniProt
P06213	INSR	R1163Q	R	1163	Q	393	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:11598120""	UniProt
P51617	IRAK1	T209A	T	209	A	-	loss	Completely abolishes auto-phosphorylation in;the kinase domain."";/evidence=""ECO:0000269|PubMed:14625308""	UniProt
P51617	IRAK1	D340N	D	340	N	389	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:18691762""	UniProt
P51617	IRAK1	T387A	T	387	A	521	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:14625308""	UniProt
Q9NWZ3	IRAK4	K213A	K	213	A	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:15084582""	UniProt
P23458	JAK1	K908A	K	908	A	127	loss	Loss of protein tyrosine kinase activity."";/evidence=""ECO:0000269|PubMed:32750333""	UniProt
P52333	JAK3	Y785F	Y	785	F	-	decrease	Strong decrease of JAK3 phosphorylation."";/evidence=""ECO:0000269|PubMed:15121872""	UniProt
P52333	JAK3	K855A	K	855	A	127	loss	More than 90% loss of STAT5a activation."";/evidence=""ECO:0000269|PubMed:18250158""	UniProt
P52333	JAK3	Y904F	Y	904	F	268	decrease	About 40% loss of STAT5a activation."";/evidence=""ECO:0000269|PubMed:18250158""	UniProt
P52333	JAK3	Y939F	Y	939	F	364	loss	About 80% loss of STAT5a activation."";/evidence=""ECO:0000269|PubMed:18250158""	UniProt
O60229	KALRN	K2713A	K	2713	A	-	loss	Loss of autophosphorylation."";/evidence=""ECO:0000269|PubMed:10023074""	UniProt
P22612	PRKACG	I74M	I	74	M	128	decrease	(in BDPLT19; patient platelets show impaired;activation; dbSNP:rs724159972)"";/evidence=""ECO:0000269|PubMed:25061177"";/id=""VAR_072672""	UniProt
P48730	CSNK1D	T44A	T	44	A	136	decrease	(in FASPS2; strongly reduces kinase activity;;dbSNP:rs104894561)"";/evidence=""ECO:0000269|PubMed:15800623,;ECO:0000269|PubMed:23636092"";/id=""VAR_029075""	UniProt
P48730	CSNK1D	H46R	H	46	R	140	decrease	(in FASPS2; strongly reduces kinase activity;;dbSNP:rs397514693)"";/evidence=""ECO:0000269|PubMed:23636092"";/id=""VAR_069801""	UniProt
P48730	CSNK1D	K38M	K	38	M	127	decrease	Impaired kinase activity and abnormal;subcellular localization with exclusive accumulation to the;nucleus."";/evidence=""ECO:0000269|PubMed:11161704""	UniProt
P48730	CSNK1D	T176I	T	176	I	521	decrease	Impaired kinase activity and abnormal;subcellular localization with exclusive accumulation to the;nucleus."";/evidence=""ECO:0000269|PubMed:11161704""	UniProt
P49674	CSNK1E	K38R	K	38	R	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:29222110""	UniProt
Q9HCP0	CSNK1G1	N169A	N	169	A	394	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:21680713""	UniProt
Q14012	CAMK1	T177A	T	177	A	512	loss	Loss of activation by CaMKK1."";/evidence=""ECO:0000269|PubMed:7641687""	UniProt
Q6P2M8	PNCK	T179A	T	179	A	531	loss	Loss of activation by cmkC."";/evidence=""ECO:0000269|PubMed:10988293""	UniProt
Q8IU85	CAMK1D	T180A	T	180	A	512	loss	Loss of ionomycin-induced activation."";/evidence=""ECO:0000269|PubMed:12935886,;ECO:0000269|PubMed:16324104""	UniProt
Q16566	CAMK4	S12A	S	12	A	-	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:8702940""	UniProt
Q16566	CAMK4	S13A	S	13	A	-	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:8702940""	UniProt
Q16566	CAMK4	K75E	K	75	E	127	loss	Loss of activity; dominant negative form."";/evidence=""ECO:0000269|PubMed:10617605""	UniProt
Q16566	CAMK4	T200A	T	200	A	512	loss	Loss of activation by CaMKK1 or CaMKK2."";/evidence=""ECO:0000269|PubMed:8855261""	UniProt
P10721	KIT	E839K	E	839	K	534	loss	(in MASTC; sporadic case; somatic mutation;;dominant negative mutation; loss of autophosphorylation;;dbSNP:rs121913509)"";/evidence=""ECO:0000269|PubMed:9990072"";/id=""VAR_033136""	UniProt
P10721	KIT	R381A	R	381	A	-	decrease	Reduces autophosphorylation in response to;KITLG/SCF."";/evidence=""ECO:0000269|PubMed:17662946""	UniProt
P10721	KIT	E386A	E	386	A	-	decrease	Reduces autophosphorylation in response to;KITLG/SCF."";/evidence=""ECO:0000269|PubMed:17662946""	UniProt
Q15139	PRKD1	Y502E	Y	502	E	-	loss	Loss of activation."";/evidence=""ECO:0000269|PubMed:12637538""	UniProt
Q15139	PRKD1	K612W	K	612	W	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:12637538""	UniProt
Q9BZL6	PRKD2	D695A	D	695	A	442	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:23503467""	UniProt
Q9BZL6	PRKD2	Y717F	Y	717	F	530	loss	Abolishes phosphorylation. Decreases substrate;affinity and increases catalytic efficiency. Increases Ser-;706 or/and Ser-710 phosphorylation. Increases NF-kappa-B;activation in response to oxidative stress."";/evidence=""ECO:0000269|PubMed:28428613""	UniProt
Q05655	PRKCD	S299A	S	299	A	-	loss	Loss of phosphorylation."";/evidence=""ECO:0000269|PubMed:17603046""	UniProt
Q02156	PRKCE	K437W	K	437	W	127	loss	Abolishes activity and S-729 phosphorylation."";/evidence=""ECO:0000269|PubMed:11964154""	UniProt
Q02156	PRKCE	T566A	T	566	A	512	loss	Abolishes phosphorylation by PDK1, and S-729;phosphorylation."";/evidence=""ECO:0000269|PubMed:11964154""	UniProt
P41743	PRKCI	K274W	K	274	W	86	loss	Abolishes activity."";/evidence=""ECO:0000269|PubMed:10906326""	UniProt
Q04759	PRKCQ	K409A	K	409	A	127	loss	E: Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:10652356""	UniProt
Q04759	PRKCQ	T538A	T	538	A	512	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:11772397,;ECO:0000269|PubMed:16252004""	UniProt
Q04759	PRKCQ	S676A	S	676	A	-	decrease	Reduction in kinase activity."";/evidence=""ECO:0000269|PubMed:16252004""	UniProt
Q04759	PRKCQ	S695A	S	695	A	-	decrease	Reduction in kinase activity."";/evidence=""ECO:0000269|PubMed:11772397,;ECO:0000269|PubMed:16252004""	UniProt
P51812	RPS6KA3	R383W	R	383	W	-	decrease	(in XLID19; kinase activity is decreased but;not abolished; dbSNP:rs122454129)"";/evidence=""ECO:0000269|PubMed:10319851"";/id=""VAR_065897""	UniProt
O75582	RPS6KA5	D195A	D	195	A	442	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:9687510""	UniProt
O75582	RPS6KA5	S360A	S	360	A	-	decrease	Decreases kinase activity by 60% in response;to PMA and UV-C."";/evidence=""ECO:0000269|PubMed:15568999""	UniProt
O75582	RPS6KA5	S376A	S	376	A	-	loss	Loss of kinase activity, and decreases the;phosphorylation of S-360 and T-581."";/evidence=""ECO:0000269|PubMed:15568999""	UniProt
O75582	RPS6KA5	D565A	D	565	A	442	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:9687510""	UniProt
O75582	RPS6KA5	T581A	T	581	A	512	loss	Loss of kinase activity, and blocks;phosphorylation of S-212; S-376 and S-381 in response to;PMA and UV-C."";/evidence=""ECO:0000269|PubMed:15568999""	UniProt
O75582	RPS6KA5	T700A	T	700	A	-	decrease	D: Strongly reduces phosphorylation of T-581 in;response to PMA and UV-C."";/evidence=""ECO:0000269|PubMed:17117922""	UniProt
P04626	ERBB2	L869R	L	869	R	452	resistance	-	COSMIC
Q9UK32	RPS6KA6	S389A	S	389	A	-	decrease	Strongly decreases activity."";/evidence=""ECO:0000269|PubMed:15632195""	UniProt
P23443	RPS6KB1	K167N	K	167	N	258	decrease	Greatly reduces activity. Greatly reduces;phosphorylation at T-412 and moderately reduces;phosphorylation at T-252."";/evidence=""ECO:0000269|PubMed:17446865""	UniProt
P23443	RPS6KB1	S394A	S	394	A	-	loss	Loss of activity. Loss of phosphorylation at;T-412."";/evidence=""ECO:0000269|PubMed:17446865""	UniProt
Q8IVT5	KSR1	E72K	E	72	K	-	decrease	Loss of interaction with BRAF and MAP2K1 and;severe decrease in MAP2K1 phosphorylation levels."";/evidence=""ECO:0000269|PubMed:29433126""	UniProt
Q6VAB6	KSR2	D786A	D	786	A	389	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:21441910""	UniProt
O95835	LATS1	S464A	S	464	A	-	loss	Abolishes phosphorylation by NUAK1 and NUAK2."";/evidence=""ECO:0000269|PubMed:19927127""	UniProt
O95835	LATS1	K734A	K	734	A	127	loss	Loss of kinase activity, autophosphorylation,;increased ploidy, prolonged duration of mitosis and lack of;p53 expression."";/evidence=""ECO:0000269|PubMed:15122335""	UniProt
Q9NRM7	LATS2	K697A	K	697	A	127	loss	Loss of kinase activity, autophosphorylation;and tumor suppressor activity."";/evidence=""ECO:0000269|PubMed:10871863,;ECO:0000269|PubMed:12853976""	UniProt
Q9NRM7	LATS2	S872A	S	872	A	512	loss	Loss of tumor suppressor activity."";/evidence=""ECO:0000269|PubMed:12853976""	UniProt
P53667	LIMK1	T508A	T	508	A	512	loss	Abolishes activation by ROCK1."";/evidence=""ECO:0000269|PubMed:10196227,;ECO:0000269|PubMed:10652353""	UniProt
P53667	LIMK1	T508V	T	508	V	512	decrease	Reduces kinase activity."";/evidence=""ECO:0000269|PubMed:10196227,;ECO:0000269|PubMed:10652353""	UniProt
P53671	LIMK2	T505V	T	505	V	512	loss	Abolishes cofilin phosphorylation and;enhancement of stress fiber formation."";/evidence=""ECO:0000269|PubMed:11018042""	UniProt
Q38SD2	LRRK1	K1270W	K	1270	W	127	loss	Loss of autophosphorylation."";/evidence=""ECO:0000269|PubMed:16243488""	UniProt
Q5S007	LRRK2	L760D	L	760	D	-	decrease	Decreased kinase activity and loss of RAB29-;mediated activation."";/evidence=""ECO:0000269|PubMed:29212815""	UniProt
Q5S007	LRRK2	L761D	L	761	D	-	decrease	Decreased kinase activity and loss of RAB29-;mediated activation."";/evidence=""ECO:0000269|PubMed:29212815""	UniProt
Q5S007	LRRK2	L762D	L	762	D	-	decrease	Decreased kinase activity and loss of RAB29-;mediated activation."";/evidence=""ECO:0000269|PubMed:29212815""	UniProt
Q5S007	LRRK2	D1994A	D	1994	A	389	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:28720718""	UniProt
P29376	LTK	K544M	K	544	M	127	loss	Loss of interaction with PLCG1, PI3-kinase;subunit p85, Ras GTPase-activating protein and RAF1."";/evidence=""ECO:0000269|PubMed:8084603""	UniProt
P29376	LTK	Y862F	Y	862	F	-	decrease	Impairs phosphorylation of CBLC (demonstrated;with chimeric EGFR-LTK)."";/evidence=""ECO:0000269|PubMed:9223670""	UniProt
P07948	LYN	K275L	K	275	L	127	loss	R: Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:11435302,;ECO:0000269|PubMed:11517336, ECO:0000269|PubMed:15173188,;ECO:0000269|PubMed:18817770""	UniProt
P07948	LYN	Y397F	Y	397	F	461	decrease	Strongly reduced kinase activity."";/evidence=""ECO:0000269|PubMed:16920712""	UniProt
Q16584	MAP3K11	K144A	K	144	A	127	decrease	Greatly reduced autophosphorylation activity."";/evidence=""ECO:0000269|PubMed:11053428,;ECO:0000269|PubMed:8195146""	UniProt
Q16584	MAP3K11	K144R	K	144	R	127	loss	Loss of kinase activity. Prevents activation;of SAPK and MAPK14."";/evidence=""ECO:0000269|PubMed:11053428,;ECO:0000269|PubMed:8195146""	UniProt
Q16584	MAP3K11	E164A	E	164	A	174	decrease	Greatly reduced autophosphorylation activity."";/evidence=""ECO:0000269|PubMed:8195146""	UniProt
Q16584	MAP3K11	T277A	T	277	A	459	decrease	Severely reduced autophosphorylation activity.;Prevents phosphorylation of SAPK and MAPK14."";/evidence=""ECO:0000269|PubMed:11053428""	UniProt
Q16584	MAP3K11	S281A	S	281	A	512	decrease	Reduced autophosphorylation activity. Reduced;activation of SAPK and MAPK14."";/evidence=""ECO:0000269|PubMed:11053428""	UniProt
Q9NYL2	MAP3K20	K45M	K	45	M	127	loss	Loss of kinase activity. Does not affect;ability to activate EIF2AK4/GCN2 in response to mild;ribosome collision."";/evidence=""ECO:0000269|PubMed:11836244,;ECO:0000269|PubMed:32610081, ECO:0000269|PubMed:35857590""	UniProt
Q9NYL2	MAP3K20	T161A	T	161	A	460	loss	Loss of autophosphorylation activity."";/evidence=""ECO:0000269|PubMed:15342622""	UniProt
Q9NYL2	MAP3K20	T162A	T	162	A	509	decrease	Slight loss of autophosphorylation activity."";/evidence=""ECO:0000269|PubMed:15342622""	UniProt
Q9NYL2	MAP3K20	S165A	S	165	A	512	loss	Loss of autophosphorylation activity."";/evidence=""ECO:0000269|PubMed:15342622""	UniProt
Q9Y6R4	MAP3K4	K1372R	K	1372	R	127	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:12052864,;ECO:0000269|PubMed:9305639""	UniProt
Q99683	MAP3K5	K709M	K	709	M	127	loss	Loss of kinase activity. Inhibits activation;of JNK and apoptosis mediated by TNFRSF6 and DAXX. Does not;affect interaction with TRIM48."";/evidence=""ECO:0000269|PubMed:17210579,;ECO:0000269|PubMed:29186683, ECO:0000269|PubMed:9743501""	UniProt
Q99683	MAP3K5	K709R	K	709	R	127	loss	Loss of kinase activity. Abolishes DAXX-;mediated apoptosis. Loss of RC3H2-mediated ubiquitination."";/evidence=""ECO:0000269|PubMed:17210579,;ECO:0000269|PubMed:24448648, ECO:0000269|PubMed:9743501""	UniProt
O43318	MAP3K7	K63W	K	63	W	127	loss	Loss of kinase activity. Loss of;autophosphorylation."";/evidence=""ECO:0000269|PubMed:12589052,;ECO:0000269|PubMed:22802624""	UniProt
P80192	MAP3K9	K171A	K	171	A	127	loss	Loss of kinase activity and threonine;phosphorylation."";/evidence=""ECO:0000269|PubMed:15610029""	UniProt
P80192	MAP3K9	T304A	T	304	A	459	decrease	Reduces threonine phosphorylation. Impairs JNK;activation."";/evidence=""ECO:0000269|PubMed:15610029""	UniProt
P80192	MAP3K9	S308A	S	308	A	512	decrease	Impairs JNK activation."";/evidence=""ECO:0000269|PubMed:15610029""	UniProt
P80192	MAP3K9	T312A	T	312	A	521	loss	Loss of threonine phosphorylation. Strongly;impairs JNK activation."";/evidence=""ECO:0000269|PubMed:15610029""	UniProt
Q8IVH8	MAP4K3	K48E	K	48	E	130	loss	Loss of kinase activity and ability to;activate JNK family."";/evidence=""ECO:0000269|PubMed:9275185""	UniProt
Q9Y4K4	MAP4K5	K49R	K	49	R	127	loss	Loss of kinase activity and ability to;activate JNK family."";/evidence=""ECO:0000269|PubMed:9038372""	UniProt
P20794	MAK	G13S	G	13	S	39	loss	(in RP62; results in a complete loss of;kinase activity compared to wild-type; dbSNP:rs387906647)"";/evidence=""ECO:0000269|PubMed:21835304"";/id=""VAR_066988""	UniProt
P20794	MAK	N130H	N	130	H	394	loss	(in RP62; results in a complete loss of;kinase activity compared to wild-type; dbSNP:rs387906646)"";/evidence=""ECO:0000269|PubMed:21835304"";/id=""VAR_066990""	UniProt
P20794	MAK	K33R	K	33	R	127	loss	Abolishes autophosphorylation."";/evidence=""ECO:0000269|PubMed:12084720""	UniProt
P20794	MAK	T157A	T	157	A	511	loss	Abolishes autophosphorylation and impairs;kinase activity."";/evidence=""ECO:0000269|PubMed:21986944""	UniProt
P49137	MAPKAPK2	K93R	K	93	R	127	loss	Kinase defective mutant, abolishes activity."";/evidence=""ECO:0000269|PubMed:14517288""	UniProt
P49137	MAPKAPK2	D207A	D	207	A	442	loss	Kinase defective mutant, abolishes activity."";/evidence=""ECO:0000269|PubMed:8846784""	UniProt
P49137	MAPKAPK2	T222A	T	222	A	512	decrease	Strong decrease in kinase activity."";/evidence=""ECO:0000269|PubMed:14517288,;ECO:0000269|PubMed:15014438, ECO:0000269|PubMed:8846784""	UniProt
P49137	MAPKAPK2	S272A	S	272	A	638	decrease	Strong decrease in kinase activity."";/evidence=""ECO:0000269|PubMed:8846784""	UniProt
P49137	MAPKAPK2	T334A	T	334	A	-	decrease	Slight decrease in kinase activity."";/evidence=""ECO:0000269|PubMed:14517288,;ECO:0000269|PubMed:15014438, ECO:0000269|PubMed:8846784""	UniProt
Q8IW41	MAPKAPK5	K51M	K	51	M	127	loss	Kinase defective mutant, abolishes activity."";/evidence=""ECO:0000269|PubMed:12808055""	UniProt
Q7KZI7	MARK2	S219A	S	219	A	534	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:14517247,;ECO:0000269|PubMed:9108484""	UniProt
Q14680	MELK	D150A	D	150	A	442	loss	Abolishes enzymatic activity."";/evidence=""ECO:0000269|PubMed:14699119,;ECO:0000269|PubMed:16216881, ECO:0000269|PubMed:17280616""	UniProt
Q14680	MELK	T167A	T	167	A	512	loss	Abolishes activation of serine/threonine-;protein kinase activity and has only weak activity."";/evidence=""ECO:0000269|PubMed:14976552""	UniProt
Q14680	MELK	S171A	S	171	A	521	loss	Abolishes activation of serine/threonine-;protein kinase activity and has only weak activity."";/evidence=""ECO:0000269|PubMed:16216881""	UniProt
P45983	MAPK8	K55D	K	55	D	127	loss	Abolished protein kinase activity."";/evidence=""ECO:0000269|PubMed:22966201""	UniProt
P53778	MAPK12	Y185F	Y	185	F	516	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:8633070""	UniProt
O15264	MAPK13	T180A	T	180	A	511	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:9374491""	UniProt
O15264	MAPK13	Y182A	Y	182	A	516	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:9374491""	UniProt
Q16539	MAPK14	A34V	A	34	V	40	decrease	Lowered kinase activity."";/evidence=""ECO:0000269|PubMed:7493921""	UniProt
Q16539	MAPK14	K53R	K	53	R	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:7493921""	UniProt
Q16539	MAPK14	K54R	K	54	R	128	decrease	Impairs MAP2K6/MKK6-dependent;autophosphorylation."";/evidence=""ECO:0000269|PubMed:11010976""	UniProt
Q16539	MAPK14	Y69H	Y	69	H	172	decrease	Lowered kinase activity."";/evidence=""ECO:0000269|PubMed:15284239""	UniProt
Q16539	MAPK14	D168A	D	168	A	442	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:7493921""	UniProt
Q16539	MAPK14	D177A	D	177	A	458	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:15284239""	UniProt
Q16539	MAPK14	T180E	T	180	E	511	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:7493921""	UniProt
Q16539	MAPK14	Y182F	Y	182	F	516	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:7493921""	UniProt
Q16539	MAPK14	A320T	A	320	T	-	decrease	Lowered kinase activity."";/evidence=""ECO:0000269|PubMed:15284239""	UniProt
Q16539	MAPK14	W337R	W	337	R	-	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:15284239""	UniProt
Q8TD08	MAPK15	K42R	K	42	R	127	loss	Loss of autophosphorylation and activity. Does;not increase dopamine transporter activity. Impairs kinase;activity. Does not rescue cilium assembly in MAPK15-;depleted cells."";/evidence=""ECO:0000269|PubMed:11875070,;ECO:0000269|PubMed:28842414, ECO:0000269|PubMed:29021280""	UniProt
Q8TD08	MAPK15	R59Q	R	59	Q	173	loss	Does not increase dopamine transporter;activity. Impairs kinase activity."";/evidence=""ECO:0000269|PubMed:28842414""	UniProt
Q8TD08	MAPK15	Y177A	Y	177	A	516	loss	Loss of autophosphorylation and activity.;Heavily phosphorylated at Thr-175."";/evidence=""ECO:0000269|PubMed:11875070,;ECO:0000269|PubMed:16336213""	UniProt
Q9HBH9	MKNK2	D228G	D	228	G	444	decrease	Reduced phosphorylation."";/evidence=""ECO:0000269|PubMed:16917500""	UniProt
Q02750	MAP2K1	K97A	K	97	A	127	loss	Loss of catalytic activity. Strongly reduces;phosphorylation upon UV irradiation."";/evidence=""ECO:0000269|PubMed:20956560""	UniProt
Q5VT25	CDC42BPA	K106A	K	106	A	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:11283256""	UniProt
Q5VT25	CDC42BPA	S234A	S	234	A	510	loss	Loss of autophosphorylation and kinase;activity."";/evidence=""ECO:0000269|PubMed:11283256""	UniProt
Q5VT25	CDC42BPA	T240A	T	240	A	521	loss	Loss of autophosphorylation and kinase;activity."";/evidence=""ECO:0000269|PubMed:11283256""	UniProt
Q5VT25	CDC42BPA	T403A	T	403	A	-	loss	Loss of autophosphorylation and kinase;activity."";/evidence=""ECO:0000269|PubMed:11283256""	UniProt
P42345	MTOR	H2340A	H	2340	A	-	loss	Barely detectable kinase activity."";/evidence=""ECO:0000269|PubMed:23636326""	UniProt
O15146	MUSK	I575T	I	575	T	-	decrease	(in FADS1; reduces agrin-dependent AChR;aggregation and tyrosine kinase activity in developing;neuromuscular junction; dbSNP:rs751889864)"";/evidence=""ECO:0000269|PubMed:25537362"";/id=""VAR_072787""	UniProt
O15146	MUSK	M605I	M	605	I	117	decrease	(in CMS9; affects interaction with DOK7 and;impairs MUSK phosphorylation; altered AChR clustering;;dbSNP:rs766640370)"";/evidence=""ECO:0000269|PubMed:20371544"";/id=""VAR_066604""	UniProt
O15146	MUSK	A727V	A	727	V	391	decrease	(in CMS9; affects interaction with DOK7 and;impairs MUSK phosphorylation; altered AChR clustering;;dbSNP:rs397515450)"";/evidence=""ECO:0000269|PubMed:20371544"";/id=""VAR_066605""	UniProt
O15146	MUSK	V790M	V	790	M	588	decrease	(in CMS9; does not affect catalytic kinase;activity; reduces protein expression and stability;;dbSNP:rs199476083)"";/evidence=""ECO:0000269|PubMed:15496425"";/id=""VAR_023046""	UniProt
O15146	MUSK	G584C	G	584	C	39	decrease	D: Mild decrease in kinase activity."";/evidence=""ECO:0000269|PubMed:25029443""	UniProt
O15146	MUSK	K609R	K	609	R	127	loss	Severe loss of kinase activity."";/evidence=""ECO:0000269|PubMed:25029443""	UniProt
P10721	KIT	D816E	D	816	E	452	resistance	-	COSMIC
Q15746	MYLK	A1491S	A	1491	S	125	decrease	(in AAT7; decreases kinase activity;;dbSNP:rs1576422965)"";/evidence=""ECO:0000269|PubMed:29544503"";/id=""VAR_083425""	UniProt
Q15746	MYLK	A1754T	A	1754	T	-	decrease	(in AAT7; 4-fold reduced affinity for;calmodulin; decreased kinase activity compared to wild-type;protein)"";/evidence=""ECO:0000269|PubMed:21055718"";/id=""VAR_065576""	UniProt
Q15746	MYLK	K608A	K	608	A	-	loss	Loss of acetylation and no kinase activity;repression by NAA10/ARD1."";/evidence=""ECO:0000269|PubMed:19826488""	UniProt
Q6ZWH5	NEK10	K548R	K	548	R	127	decrease	Catalytically inactive. Impaired mucociliary;transport."";/evidence=""ECO:0000269|PubMed:20956560,;ECO:0000269|PubMed:31959991""	UniProt
P51955	NEK2	K37R	K	37	R	127	loss	Loss of kinase activity and of ability to;activate NEK11. Loss of phosphorylation of CCDC102B."";/evidence=""ECO:0000269|PubMed:15161910,;ECO:0000269|PubMed:17197699, ECO:0000269|PubMed:30404835""	UniProt
P51955	NEK2	D141A	D	141	A	389	loss	Loss of autophosphorylation."";/evidence=""ECO:0000269|PubMed:17197699""	UniProt
P51955	NEK2	T175A	T	175	A	512	decrease	Kinase activity decreased by two fold."";/evidence=""ECO:0000269|PubMed:17197699""	UniProt
P51955	NEK2	T179A	T	179	A	521	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:17197699""	UniProt
P51955	NEK2	T179E	T	179	E	521	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:17197699""	UniProt
P51955	NEK2	S241A	S	241	A	751	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:17197699""	UniProt
P51955	NEK2	S241D	S	241	D	751	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:17197699""	UniProt
Q8TDX7	NEK7	N33D	N	33	D	-	decrease	Significant decrease in catalytic activity."";/evidence=""ECO:0000269|PubMed:19941817""	UniProt
Q8TD19	NEK9	K81M	K	81	M	127	loss	Loss of activity and autophosphorylation."";/evidence=""ECO:0000269|PubMed:12101123""	UniProt
Q8TD19	NEK9	T210A	T	210	A	512	decrease	Significant reduction of autophosphorylation."";/evidence=""ECO:0000269|PubMed:11864968""	UniProt
Q8IY84	NIM1K	T229A	T	229	A	512	loss	Loss of autophosphorylation and kinase;activity."";/evidence=""ECO:0000269|PubMed:15733851""	UniProt
P04629	NTRK1	G577R	G	577	R	207	loss	(in CIPA; loss of function; processed as;wild-type but shows significantly diminished;autophosphorylation in both neuronal and non-neuronal;cells; dbSNP:rs121964866)"";/evidence=""ECO:0000269|PubMed:10567924,;ECO:0000269|PubMed:10982191, ECO:0000269|PubMed:11159935,;ECO:0000269|PubMed:8696348"";/id=""VAR_004103""	UniProt
P04629	NTRK1	D596N	D	596	N	274	loss	(in CIPA; abolishes autophosphorylation)"";/evidence=""ECO:0000269|PubMed:28177573"";/id=""VAR_079404""	UniProt
P04629	NTRK1	R780P	R	780	P	-	loss	(in CIPA; loss of function;;dbSNP:rs35669708)"";/evidence=""ECO:0000269|PubMed:10090906"";/id=""VAR_009635""	UniProt
P04629	NTRK1	K544N	K	544	N	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:1281417,;ECO:0000269|PubMed:8155326""	UniProt
Q16620	NTRK2	Y706C	Y	706	C	461	decrease	(in OBHD; expressed normally on the cell;surface; results in markedly impaired ligand-induced;phosphorylation as well as impaired downstream MAPK1;phosphorylation; dbSNP:rs121434633)"";/evidence=""ECO:0000269|PubMed:15494731"";/id=""VAR_065890""	UniProt
Q16288	NTRK3	K572N	K	572	N	127	loss	Loss of autophosphorylation and loss of NTRK3;signaling."";/evidence=""ECO:0000269|PubMed:25196463""	UniProt
O60285	NUAK1	K84A	K	84	A	127	loss	Abolishes kinase activity and ability to;induce senescence."";/evidence=""ECO:0000269|PubMed:19927127,;ECO:0000269|PubMed:21317932""	UniProt
O60285	NUAK1	T211A	T	211	A	512	loss	Prevents phosphorylation and activation by;STK11/LKB1 complex. Abolishes ability to induce;senescence."";/evidence=""ECO:0000269|PubMed:14976552,;ECO:0000269|PubMed:19927127, ECO:0000269|PubMed:21317932""	UniProt
Q9H093	NUAK2	K81R	K	81	R	127	loss	Loss of autophosphorylation, kinase activity;and of anti-apoptotic activity."";/evidence=""ECO:0000269|PubMed:15345718""	UniProt
O95747	OXSR1	K46A	K	46	A	127	loss	Loss of autophosphorylation and kinase;activity."";/evidence=""ECO:0000269|PubMed:14707132,;ECO:0000269|PubMed:16389068""	UniProt
O95747	OXSR1	K46M	K	46	M	127	loss	Loss of RELT, RELL1 and RELL2 phosphorylation.;Retention of some autophosphorylation activity may be due;to complex formation with other endogenous kinases in the;assay."";/evidence=""ECO:0000269|PubMed:14707132,;ECO:0000269|PubMed:16389068""	UniProt
Q13153	PAK1	D393A	D	393	A	393	loss	Abolishes autophosphorylation at Thr-423."";/evidence=""ECO:0000269|PubMed:22153498""	UniProt
Q13153	PAK1	T423A	T	423	A	512	decrease	Decreases CDC42-stimulated activity and;autophosphorylation."";/evidence=""ECO:0000269|PubMed:10551809""	UniProt
Q13177	PAK2	K278R	K	278	R	127	loss	Abolishes kinase activity and;autophosphorylation."";/evidence=""ECO:0000269|PubMed:9786869""	UniProt
Q13177	PAK2	T402A	T	402	A	512	loss	Abolishes kinase activity and greatly inhibits;autophosphorylation of PAK-2p27 and PAK-2p34."";/evidence=""ECO:0000269|PubMed:9786869""	UniProt
Q96RG2	PASK	K1028R	K	1028	R	127	loss	Loss of autophosphorylating activity."";/evidence=""ECO:0000269|PubMed:11459942,;ECO:0000269|PubMed:20943661""	UniProt
Q96RG2	PASK	R1058A	R	1058	A	181	decrease	Induces lower protein kinase activity."";/evidence=""ECO:0000269|PubMed:20943661""	UniProt
Q96RG2	PASK	A1151K	A	1151	K	448	decrease	Induces lower protein kinase activity and;ability to autophosphorylate."";/evidence=""ECO:0000269|PubMed:20943661""	UniProt
Q96RG2	PASK	Y1152F	Y	1152	F	452	decrease	Induces lower protein kinase activity."";/evidence=""ECO:0000269|PubMed:20943661""	UniProt
Q96RG2	PASK	T1161A	T	1161	A	512	loss	Loss of catalytic activity (PubMed:11459942).;According to another report, does not affect the protein;kinase activity (PubMed:20943661). Does not affect protein;translation."";/evidence=""ECO:0000269|PubMed:11459942,;ECO:0000269|PubMed:17595531, ECO:0000269|PubMed:20943661""	UniProt
Q96RG2	PASK	T1165A	T	1165	A	521	loss	Loss of catalytic activity. Does not affect;protein translation."";/evidence=""ECO:0000269|PubMed:11459942,;ECO:0000269|PubMed:17595531""	UniProt
Q16654	PDK4	Y157F	Y	157	F	-	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:18658136""	UniProt
Q16654	PDK4	R161A	R	161	A	-	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:18658136""	UniProt
O15530	PDPK1	Y9F	Y	9	F	-	decrease	Slight reduction in pervanadate-stimulated;tyrosine phosphorylation."";/evidence=""ECO:0000269|PubMed:11481331""	UniProt
O15530	PDPK1	T354A	T	354	A	-	increase	Abolishes phosphorylation by MELK."";/evidence=""ECO:0000269|PubMed:22544756""	UniProt
P11309	PIM1	P81S	P	81	S	166	decrease	Decreased kinase activity."";/evidence=""ECO:0000269|PubMed:15808862""	UniProt
P11309	PIM1	N82K	N	82	K	167	decrease	Decreased kinase activity."";/evidence=""ECO:0000269|PubMed:15808862""	UniProt
P11309	PIM1	L193F	L	193	F	455	decrease	Decreased kinase activity."";/evidence=""ECO:0000269|PubMed:15808862""	UniProt
Q9BXM7	PINK1	T313M	T	313	M	258	decrease	(in PARK6; decreases PRKN and SNCAIP;ubiquitination and degradation; slightly decreases Drp1;phosphorylation; dbSNP:rs74315359)"";/evidence=""ECO:0000269|PubMed:17030667,;ECO:0000269|PubMed:18785233, ECO:0000269|PubMed:19229105,;ECO:0000269|PubMed:32484300"";/id=""VAR_046589""	UniProt
Q9BXM7	PINK1	G386A	G	386	A	444	loss	(in PARK6; abolishes kinase activity)"";/evidence=""ECO:0000269|PubMed:16401616,;ECO:0000269|PubMed:24784582"";/id=""VAR_062776""	UniProt
Q16512	PKN1	K644E	K	644	E	127	loss	Abolishes Serine/threonine-protein kinase;activity."";/evidence=""ECO:0000269|PubMed:18066052,;ECO:0000269|PubMed:8135837""	UniProt
Q16512	PKN1	K644R	K	644	R	127	decrease	Substantial reduction of autophosphorylation."";/evidence=""ECO:0000269|PubMed:18066052,;ECO:0000269|PubMed:8135837""	UniProt
Q16513	PKN2	T816A	T	816	A	512	decrease	Reduces catalytic activity."";/evidence=""ECO:0000269|PubMed:18835241""	UniProt
Q16513	PKN2	T958A	T	958	A	-	loss	Abolishes catalytic activity."";/evidence=""ECO:0000269|PubMed:18835241""	UniProt
Q16513	PKN2	F977W	F	977	W	-	decrease	Y: Reduces catalytic activity by 50%."";/evidence=""ECO:0000269|PubMed:10226025,;ECO:0000269|PubMed:18835241""	UniProt
Q16513	PKN2	Y979A	Y	979	A	-	decrease	Reduces catalytic activity by 50%."";/evidence=""ECO:0000269|PubMed:10226025,;ECO:0000269|PubMed:18835241""	UniProt
Q16513	PKN2	Y979F	Y	979	F	-	decrease	L,W: Reduces catalytic activity by 25%."";/evidence=""ECO:0000269|PubMed:10226025,;ECO:0000269|PubMed:18835241""	UniProt
Q6P5Z2	PKN3	K588E	K	588	E	127	loss	Abolishes autophosphorylation and catalytic;activity."";/evidence=""ECO:0000269|PubMed:10441506,;ECO:0000269|PubMed:15282551""	UniProt
Q6P5Z2	PKN3	K588R	K	588	R	127	loss	Abolishes catalytic activity."";/evidence=""ECO:0000269|PubMed:10441506,;ECO:0000269|PubMed:15282551""	UniProt
Q6P5Z2	PKN3	T718A	T	718	A	512	loss	Abolishes phosphorylation."";/evidence=""ECO:0000269|PubMed:15282551""	UniProt
P53350	PLK1	D176N	D	176	N	389	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:18615013""	UniProt
P53350	PLK1	T210A	T	210	A	512	loss	Abolishes activity. Abolishes checkpoint;recovery."";/evidence=""ECO:0000269|PubMed:12207013,;ECO:0000269|PubMed:12447691, ECO:0000269|PubMed:17461553,;ECO:0000269|PubMed:18615013, ECO:0000269|PubMed:19160488""	UniProt
Q9NYY3	PLK2	N210A	N	210	A	394	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:19001868""	UniProt
Q9H4B4	PLK3	K91R	K	91	R	127	loss	Kinase defective mutant, abolishes activity."";/evidence=""ECO:0000269|PubMed:11447225,;ECO:0000269|PubMed:14980500, ECO:0000269|PubMed:17804415,;ECO:0000269|PubMed:19103756, ECO:0000269|PubMed:19490146,;ECO:0000269|PubMed:20889502, ECO:0000269|PubMed:20940307""	UniProt
Q9H4B4	PLK3	D203A	D	203	A	442	loss	Kinase defective mutant, abolishes activity."";/evidence=""ECO:0000269|PubMed:11156373""	UniProt
O00444	PLK4	K41M	K	41	M	127	loss	Abolishes ability to phosphorylate CDC25C and;CHEK2."";/evidence=""ECO:0000269|PubMed:18239451,;ECO:0000269|PubMed:19164942""	UniProt
Q99640	PKMYT1	N238A	N	238	A	394	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:10373560""	UniProt
Q99640	PKMYT1	D251A	D	251	A	442	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:10504341""	UniProt
P78527	PRKDC	A3574V	A	3574	V	-	loss	(in IMD26; shows impaired function in;response to irradiation and a less severe defect in V(D)J;end-joining suggesting that the missense mutation retained;some functional capacity; consistent with a loss of;function mutation; dbSNP:rs587777686)"";/evidence=""ECO:0000269|PubMed:23722905"";/id=""VAR_072570""	UniProt
P51817	PRKX	K78R	K	78	R	127	loss	Loss of function."";/evidence=""ECO:0000269|PubMed:12082174""	UniProt
Q13882	PTK6	W44A	W	44	A	-	decrease	Strong decrease in STAP2 phosphorylation.;Markedly decreased interaction between SH3 domain the;linker region."";/evidence=""ECO:0000269|PubMed:10980601,;ECO:0000269|PubMed:17822667""	UniProt
Q13882	PTK6	Y66A	Y	66	A	-	decrease	Decrease in STAP2 phosphorylation."";/evidence=""ECO:0000269|PubMed:10980601""	UniProt
Q13882	PTK6	R105L	R	105	L	-	decrease	Decrease in STAP2 phosphorylation."";/evidence=""ECO:0000269|PubMed:10980601""	UniProt
Q13882	PTK6	K219M	K	219	M	127	loss	Abolishes kinase activity and cell;transformation, and phosphorylation of STAP2."";/evidence=""ECO:0000269|PubMed:10980601,;ECO:0000269|PubMed:15471878, ECO:0000269|PubMed:8940083""	UniProt
Q13882	PTK6	K219R	K	219	R	127	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:27480927""	UniProt
P04049	RAF1	D486N	D	486	N	442	loss	(in NS5; has reduced or absent kinase;activity; dbSNP:rs80338798)"";/evidence=""ECO:0000269|PubMed:17603483"";/id=""VAR_037817""	UniProt
P04049	RAF1	T491I	T	491	I	448	loss	(in NS5; has reduced or absent kinase;activity; dbSNP:rs80338799)"";/evidence=""ECO:0000269|PubMed:17603483"";/id=""VAR_037818""	UniProt
P04049	RAF1	L603P	L	603	P	788	decrease	(in CMD1NN; shows impaired kinase activity;and reduced MAPK3 activation with this mutation;;dbSNP:rs587777586)"";/evidence=""ECO:0000269|PubMed:24777450"";/id=""VAR_071847""	UniProt
P07949	RET	Y1062F	Y	1062	F	-	loss	Abolishes GFRAL-mediated MAPK1/MAPK2;phosphorylation."";/evidence=""ECO:0000269|PubMed:28953886""	UniProt
Q13546	RIPK1	S25D	S	25	D	38	loss	Phophomimetic mutant. Significant loss of;kinase activity."";/evidence=""ECO:0000269|PubMed:30988283""	UniProt
Q13546	RIPK1	K45A	K	45	A	127	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:30988283,;ECO:0000269|PubMed:8612133""	UniProt
Q13546	RIPK1	S161A	S	161	A	448	decrease	Decreases RIPK1 kinase activity."";/evidence=""ECO:0000269|PubMed:18408713""	UniProt
O43353	RIPK2	K47A	K	47	A	127	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:9575181,;ECO:0000269|PubMed:9642260""	UniProt
O43353	RIPK2	D146N	D	146	N	389	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:9705938""	UniProt
O43353	RIPK2	Y381A	Y	381	A	-	decrease	Prevents phosphorylation. Reduces serine and;threonine phosphorylation of ARHGEF2."";/evidence=""ECO:0000269|PubMed:21887730""	UniProt
Q9Y572	RIPK3	K50D	K	50	D	127	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:10339433,;ECO:0000269|PubMed:10358032, ECO:0000269|PubMed:22265414""	UniProt
Q9Y572	RIPK3	D142N	D	142	N	389	loss	Abolishes kinase activity and ability to;mediate necroptosis."";/evidence=""ECO:0000269|PubMed:22265413""	UniProt
P57078	RIPK4	I121N	I	121	N	351	loss	(in BPS; loss of function;;dbSNP:rs387906923)"";/evidence=""ECO:0000269|PubMed:22197489"";/id=""VAR_067332""	UniProt
P57078	RIPK4	T184I	T	184	I	521	loss	(in BPS; loss of function)"";/evidence=""ECO:0000269|PubMed:22197489"";/id=""VAR_067333""	UniProt
Q05823	RNASEL	R462Q	R	462	Q	-	decrease	(risk factor for prostate cancer; reduced;enzymatic activity; dbSNP:rs486907)"";/evidence=""ECO:0000269|PubMed:11799394,;ECO:0000269|PubMed:11941539, ECO:0000269|PubMed:12415269,;ECO:0000269|PubMed:17344846"";/id=""VAR_012056""	UniProt
Q05823	RNASEL	K392R	K	392	R	-	loss	Complete loss of enzymatic activity and enzyme;dimerization. No change in binding to 2-5A and RNA."";/evidence=""ECO:0000269|PubMed:9862963""	UniProt
Q05823	RNASEL	D661A	D	661	A	-	loss	Complete loss of enzymatic activity."";/evidence=""ECO:0000269|PubMed:11333017""	UniProt
Q05823	RNASEL	R667A	R	667	A	-	loss	Complete loss of enzymatic activity. No change;in 2-5A binding and enzyme dimerization."";/evidence=""ECO:0000269|PubMed:11333017""	UniProt
Q05823	RNASEL	H672A	H	672	A	-	loss	Complete loss of enzymatic activity. No change;in 2-5A binding activity and enzyme dimerization."";/evidence=""ECO:0000269|PubMed:11333017""	UniProt
P08922	ROS1	K1980M	K	1980	M	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:12661006""	UniProt
Q52WX2	SBK1	K61R	K	61	R	38	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:16403448""	UniProt
P0C263	SBK2	K73M	K	73	M	41	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:11322885""	UniProt
Q9H5K3	POMK	L137R	L	137	R	-	loss	(in MDDGA12; loss of kinase activity;;dbSNP:rs397509385)"";/evidence=""ECO:0000269|PubMed:23519211,;ECO:0000269|PubMed:23929950"";/id=""VAR_069625""	UniProt
O00141	SGK1	K127M	K	127	M	127	loss	Abolishes enzymatic activity."";/evidence=""ECO:0000269|PubMed:11696533,;ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:15040001""	UniProt
Q96BR1	SGK3	K191M	K	191	M	127	loss	Abolishes activity."";/evidence=""ECO:0000269|PubMed:16790420""	UniProt
P57059	SIK1	K56M	K	56	M	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:18348280,;ECO:0000269|PubMed:19622832""	UniProt
P57059	SIK1	S135A	S	135	A	357	decrease	Decreased kinase activity without affecting;much autophosphorylation status."";/evidence=""ECO:0000269|PubMed:18348280""	UniProt
P57059	SIK1	T182A	T	182	A	512	decrease	Prevents phosphorylation and activation by;STK11/LKB1 complex. Reduced inhibition of CRTC3-mediated;transcriptional activity."";/evidence=""ECO:0000269|PubMed:14976552,;ECO:0000269|PubMed:29211348""	UniProt
P57059	SIK1	S186A	S	186	A	521	loss	D,C,G: Impaired autophosphorylation and kinase;activity."";/evidence=""ECO:0000269|PubMed:18348280""	UniProt
P57059	SIK1	S209A	S	209	A	585	decrease	Decreased kinase activity without affecting;much autophosphorylation status."";/evidence=""ECO:0000269|PubMed:18348280""	UniProt
P57059	SIK1	S248A	S	248	A	751	decrease	Decreased kinase activity without affecting;much autophosphorylation status."";/evidence=""ECO:0000269|PubMed:18348280""	UniProt
P57059	SIK1	S575E	S	575	E	-	decrease	Strongly reduced but still present interaction;with 14-3-3 proteins in response to cAMP signaling and,;thus, still able to inhibit TORC activity."";/evidence=""ECO:0000269|PubMed:29211348""	UniProt
Q9Y2K2	SIK3	T469A	T	469	A	-	loss	Loss of interaction with 14-3-3 proteins in;response to cAMP signaling; inhibits cAMP signaling."";/evidence=""ECO:0000269|PubMed:29211348""	UniProt
Q9Y2K2	SIK3	T469E	T	469	E	-	loss	Loss of interaction with 14-3-3 proteins in;response to cAMP signaling; inhibits cAMP signaling."";/evidence=""ECO:0000269|PubMed:29211348""	UniProt
Q9Y2K2	SIK3	S551A	S	551	A	-	loss	Loss of interaction with 14-3-3 proteins in;response to cAMP signaling; inhibits cAMP signaling."";/evidence=""ECO:0000269|PubMed:29211348""	UniProt
Q9Y2K2	SIK3	S551E	S	551	E	-	loss	Loss of interaction with 14-3-3 proteins in;response to cAMP signaling; inhibits cAMP signaling."";/evidence=""ECO:0000269|PubMed:29211348""	UniProt
Q9H2G2	SLK	K63R	K	63	R	-	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:10699464""	UniProt
Q96Q15	SMG1	D2335A	D	2335	A	-	loss	Loss of function."";/evidence=""ECO:0000269|PubMed:11331269,;ECO:0000269|PubMed:11544179, ECO:0000269|PubMed:15175154""	UniProt
P12931	SRC	K298M	K	298	M	127	loss	Kinase inactive. Abolishes ubiquitination;promoted by CBLC."";/evidence=""ECO:0000269|PubMed:14661060""	UniProt
P12931	SRC	Y419F	Y	419	F	461	loss	Loss of kinase activity. Loss of interaction;with PDLIM4."";/evidence=""ECO:0000269|PubMed:19307596""	UniProt
Q9H3Y6	SRMS	W223A	W	223	A	-	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:23822091""	UniProt
Q96SB4	SRPK1	S51A	S	51	A	-	decrease	Protein phosphorylation impaired at this;position."";/evidence=""ECO:0000269|PubMed:12565829""	UniProt
Q96SB4	SRPK1	S555A	S	555	A	622	decrease	Protein phosphorylation impaired at this;position."";/evidence=""ECO:0000269|PubMed:12565829""	UniProt
Q9UEE5	STK17A	K90A	K	90	A	127	loss	Loss of activity and of apoptotic function."";/evidence=""ECO:0000269|PubMed:9786912""	UniProt
O94768	STK17B	K62A	K	62	A	127	loss	Loss of activity and of apoptotic function."";/evidence=""ECO:0000269|PubMed:9786912""	UniProt
Q9Y2H1	STK38L	T75A	T	75	A	-	decrease	Decreased kinase activity. Reduced binding of;S100B."";/evidence=""ECO:0000269|PubMed:15037617""	UniProt
Q9Y2H1	STK38L	K119A	K	119	A	127	loss	Loss of autophosphorylation and kinase;activity."";/evidence=""ECO:0000269|PubMed:15037617""	UniProt
Q9Y2H1	STK38L	S282A	S	282	A	512	loss	Loss of autophosphorylation and kinase;activity."";/evidence=""ECO:0000269|PubMed:15037617""	UniProt
Q9Y2H1	STK38L	T442A	T	442	A	-	decrease	Decreased kinase activity."";/evidence=""ECO:0000269|PubMed:15037617""	UniProt
O94804	STK10	K65I	K	65	I	-	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:12639966""	UniProt
Q15831	STK11	L67P	L	67	P	72	loss	(in PJS; abolishes kinase activity, leading;to loss of autophosphorylation; dbSNP:rs137853077)"";/evidence=""ECO:0000269|PubMed:9428765,;ECO:0000269|PubMed:9837816"";/id=""VAR_006202""	UniProt
Q15831	STK11	D176N	D	176	N	389	loss	(in PJS; loss of kinase activity, leading to;greatly reduced autophosphorylation; fails to phosphorylate;PTEN in vitro; no significant effect on nucleocytoplasmic;localization; dbSNP:rs730881979)"";/evidence=""ECO:0000269|PubMed:15987703,;ECO:0000269|PubMed:9837816"";/id=""VAR_071058""	UniProt
Q15831	STK11	D176Y	D	176	Y	389	loss	(in sporadic cancer; somatic mutation; Loss;of kinase activity)"";/evidence=""ECO:0000269|PubMed:12805220,;ECO:0000269|PubMed:19892943"";/id=""VAR_065637""	UniProt
Q15831	STK11	E199K	E	199	K	448	loss	(in colorectal cancer; somatic mutation;;impaired kinase activity; dbSNP:rs121913317)"";/evidence=""ECO:0000269|PubMed:9731485"";/id=""VAR_065641""	UniProt
Q15831	STK11	W308C	W	308	C	792	loss	(in PJS; abolishes kinase activity, leading;to loss of autophosphorylation; dbSNP:rs1057520042)"";/evidence=""ECO:0000269|PubMed:9837816"";/id=""VAR_071059""	UniProt
Q15831	STK11	K78I	K	78	I	127	loss	Loss of kinase activity, leading to greatly;reduced autophosphorylation."";/evidence=""ECO:0000269|PubMed:11430832,;ECO:0000269|PubMed:9837816""	UniProt
Q15831	STK11	K78M	K	78	M	127	loss	Loss of kinase activity, leading to reduced;autophosphorylation and acting as a dominant-negative;mutant."";/evidence=""ECO:0000269|PubMed:11430832,;ECO:0000269|PubMed:9837816""	UniProt
Q15831	STK11	T189A	T	189	A	428	decrease	Reduced phosphorylation."";/evidence=""ECO:0000269|PubMed:11430832""	UniProt
Q15831	STK11	D194A	D	194	A	442	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:14517248,;ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:19892943""	UniProt
O75716	STK16	T192A	T	192	A	516	loss	Loss of autophosphorylation."";/evidence=""ECO:0000269|PubMed:8662877""	UniProt
P49842	STK19	K300P	K	300	P	-	decrease	Partial loss of activity."";/evidence=""ECO:0000269|PubMed:9812991""	UniProt
P49842	STK19	K315P	K	315	P	-	decrease	Partial loss of activity."";/evidence=""ECO:0000269|PubMed:9812991""	UniProt
P49842	STK19	K317P	K	317	P	-	loss	Complete loss of activity."";/evidence=""ECO:0000269|PubMed:9812991""	UniProt
Q9Y6E0	STK24	T18A	T	18	A	-	loss	Loss of phosphorylation by PKA."";/evidence=""ECO:0000269|PubMed:10644707""	UniProt
Q9Y6E0	STK24	K65A	K	65	A	127	loss	Loss of activity and autophosphorylation."";/evidence=""ECO:0000269|PubMed:12107159""	UniProt
Q9Y6E0	STK24	T190A	T	190	A	512	loss	Loss of activity and autophosphorylation."";/evidence=""ECO:0000269|PubMed:17046825""	UniProt
O00506	STK25	K49R	K	49	R	127	loss	Loss of kinase activity and;autophosphorylation."";/evidence=""ECO:0000269|PubMed:15037601""	UniProt
O00506	STK25	D158A	D	158	A	442	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:15037601""	UniProt
Q9P289	STK26	K53E	K	53	E	127	loss	Abolished serine/threonine-protein kinase;activity."";/evidence=""ECO:0000269|PubMed:29232556""	UniProt
Q15208	STK38	T74A	T	74	A	-	decrease	Decreases autophosphorylation and kinase;activity. Reduced binding of S100B."";/evidence=""ECO:0000269|PubMed:12493777""	UniProt
Q15208	STK38	K118A	K	118	A	127	loss	Loss of autophosphorylation and kinase;activity."";/evidence=""ECO:0000269|PubMed:12493777,;ECO:0000269|PubMed:7761441""	UniProt
Q15208	STK38	S281A	S	281	A	512	loss	Loss of autophosphorylation and kinase;activity."";/evidence=""ECO:0000269|PubMed:12493777""	UniProt
Q15208	STK38	T444A	T	444	A	-	decrease	Decreases autophosphorylation and kinase;activity."";/evidence=""ECO:0000269|PubMed:12493777""	UniProt
Q13188	STK3	K56R	K	56	R	127	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:16930133""	UniProt
Q13043	STK4	K59R	K	59	R	127	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:15109305,;ECO:0000269|PubMed:16930133""	UniProt
Q13043	STK4	T183A	T	183	A	512	loss	Loss of activity."";/evidence=""ECO:0000269|PubMed:15109305""	UniProt
Q13043	STK4	L444P	L	444	P	-	loss	Loss of homodimerization, activation, and;autophosphorylation."";/evidence=""ECO:0000269|PubMed:15109305""	UniProt
Q7RTN6	STRADA	T329A	T	329	A	731	loss	Loss of STK11/LKB1-mediated phosphorylation."";/evidence=""ECO:0000269|PubMed:12805220""	UniProt
Q7RTN6	STRADA	T419A	T	419	A	-	loss	Loss of STK11/LKB1-mediated phosphorylation."";/evidence=""ECO:0000269|PubMed:12805220""	UniProt
Q7L7X3	TAOK1	K57A	K	57	A	-	loss	Abolishes kinase activity, ability to activate;the MAPK8/JNK cascade and cleavage by caspase-3 (CASP3)."";/evidence=""ECO:0000269|PubMed:16407310""	UniProt
Q7L7X3	TAOK1	D169A	D	169	A	-	loss	Loss of serine/threonine-protein kinase;activity."";/evidence=""ECO:0000269|PubMed:17396146""	UniProt
Q9H2K8	TAOK3	D165A	D	165	A	-	loss	Loss of serine/threonine-protein kinase;activity."";/evidence=""ECO:0000269|PubMed:17396146""	UniProt
Q9UHD2	TBK1	R47H	R	47	H	141	loss	(in FTDALS4; loss of kinase activity)"";/evidence=""ECO:0000269|PubMed:25803835"";/id=""VAR_073938""	UniProt
Q9UHD2	TBK1	G159A	G	159	A	444	loss	(in IIAE8; loss of kinase activity; loss of;autophosphorylation at S-172; loss of IFNB induction;;dbSNP:rs1555202947)"";/evidence=""ECO:0000269|PubMed:22851595,;ECO:0000269|PubMed:32972995"";/id=""VAR_080518""	UniProt
Q9UHD2	TBK1	R308Q	R	308	Q	-	decrease	(in FTDALS4; reduced kinase activity)"";/evidence=""ECO:0000269|PubMed:25803835"";/id=""VAR_073941""	UniProt
Q9UHD2	TBK1	R357Q	R	357	Q	-	decrease	(in FTDALS4; reduced kinase activity;;dbSNP:rs758357594)"";/evidence=""ECO:0000269|PubMed:25803835"";/id=""VAR_073942""	UniProt
Q9UHD2	TBK1	M559R	M	559	R	-	loss	(in FTDALS4; loss of kinase activity)"";/evidence=""ECO:0000269|PubMed:25803835"";/id=""VAR_073944""	UniProt
Q9UHD2	TBK1	E696K	E	696	K	-	loss	(in FTDALS4; loss of kinase activity; impairs;binding to OPTN; dbSNP:rs748112833)"";/evidence=""ECO:0000269|PubMed:25803835,;ECO:0000269|PubMed:25943890"";/id=""VAR_073948""	UniProt
Q9UHD2	TBK1	D33A	D	33	A	109	decrease	Decreases phosphorylation and kinase;activity."";/evidence=""ECO:0000269|PubMed:23453971""	UniProt
Q9UHD2	TBK1	K38A	K	38	A	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:10581243,;ECO:0000269|PubMed:22851595, ECO:0000269|PubMed:23453971,;ECO:0000269|PubMed:23453972, ECO:0000269|PubMed:31709703""	UniProt
Q9UHD2	TBK1	D135N	D	135	N	389	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:21931631,;ECO:0000269|PubMed:23453971, ECO:0000269|PubMed:23453972,;ECO:0000269|PubMed:30842653""	UniProt
Q9UHD2	TBK1	S172E	S	172	E	512	decrease	Decreased kinase activity."";/evidence=""ECO:0000269|PubMed:11839743,;ECO:0000269|PubMed:23453972""	UniProt
Q9UHD2	TBK1	Y325E	Y	325	E	-	loss	Abolishes phosphorylation and kinase;activity."";/evidence=""ECO:0000269|PubMed:23453972""	UniProt
Q9UHD2	TBK1	R547D	R	547	D	-	decrease	Decreases phosphorylation and kinase activity.;Abolishes dimerization."";/evidence=""ECO:0000269|PubMed:23453971""	UniProt
Q9UHD2	TBK1	Y577A	Y	577	A	-	decrease	Decreases kinase activity. Reduced;phosphorylation of STING1."";/evidence=""ECO:0000269|PubMed:23453971,;ECO:0000269|PubMed:30842653""	UniProt
Q9UHD2	TBK1	N578A	N	578	A	-	decrease	Reduced phosphorylation of STING1."";/evidence=""ECO:0000269|PubMed:30842653""	UniProt
Q9UHD2	TBK1	E580A	E	580	A	-	decrease	Decreases kinase activity."";/evidence=""ECO:0000269|PubMed:23453971""	UniProt
Q9UHD2	TBK1	Q581A	Q	581	A	-	decrease	Reduced phosphorylation of STING1."";/evidence=""ECO:0000269|PubMed:30842653""	UniProt
Q9UHD2	TBK1	I582A	I	582	A	-	decrease	Decreases kinase activity."";/evidence=""ECO:0000269|PubMed:23453971""	UniProt
Q9UHD2	TBK1	K589D	K	589	D	-	decrease	Decreases phosphorylation and kinase;activity."";/evidence=""ECO:0000269|PubMed:23453971""	UniProt
P36897	TGFBR1	T200V	T	200	V	-	loss	Loss of phosphorylation. Loss of response to;TGF-beta."";/evidence=""ECO:0000269|PubMed:7774578""	UniProt
P36897	TGFBR1	T204V	T	204	V	-	decrease	Reduced phosphorylation. Reduced response to;TGF-beta."";/evidence=""ECO:0000269|PubMed:7774578""	UniProt
P37173	TGFBR2	K277R	K	277	R	127	loss	Abolishes kinase activity, TGF-beta signaling;and interaction with DAXX."";/evidence=""ECO:0000269|PubMed:11483955""	UniProt
Q02763	TEK	C224S	C	224	S	-	decrease	Reduces protein abundance."";/evidence=""ECO:0000269|PubMed:27270174""	UniProt
Q02763	TEK	K855R	K	855	R	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:12609966,;ECO:0000269|PubMed:15851516""	UniProt
Q9UKI8	TLK1	D607A	D	607	A	442	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:10523312,;ECO:0000269|PubMed:11470414""	UniProt
Q9UKI8	TLK1	S743A	S	743	A	-	loss	Loss of kinase inhibition in response to DNA;damage."";/evidence=""ECO:0000269|PubMed:12660173""	UniProt
Q9UKI8	TLK1	S743D	S	743	D	-	loss	Loss of kinase inhibition in response to DNA;damage."";/evidence=""ECO:0000269|PubMed:12660173""	UniProt
Q9UKI8	TLK1	S743E	S	743	E	-	loss	Loss of kinase inhibition in response to DNA;damage."";/evidence=""ECO:0000269|PubMed:12660173""	UniProt
Q86UE8	TLK2	H493R	H	493	R	129	decrease	(in MRD57; reduced kinase activity;;dbSNP:rs1567974030)"";/evidence=""ECO:0000269|PubMed:29861108,;ECO:0000269|PubMed:29955062"";/id=""VAR_081028""	UniProt
Q86UE8	TLK2	H518R	H	518	R	179	decrease	(in MRD57; severely reduced kinase activity;;dbSNP:rs1567995650)"";/evidence=""ECO:0000269|PubMed:29861108,;ECO:0000269|PubMed:29955062"";/id=""VAR_081029""	UniProt
Q86UE8	TLK2	S617L	S	617	L	447	decrease	(in MRD57; exhibits abnormal perinuclear;localization instead of diffuse nuclear localization;;impairs kinase activity; reduced phosphorylation of ASF1A)"";/evidence=""ECO:0000269|PubMed:21572417,;ECO:0000269|PubMed:33323470"";/id=""VAR_087042""	UniProt
Q86UE8	TLK2	D629N	D	629	N	505	decrease	(in MRD57; reduced phosphorylation of ASF1A;;dbSNP:rs1568006217)"";/evidence=""ECO:0000269|PubMed:29861108,;ECO:0000269|PubMed:29955062"";/id=""VAR_081032""	UniProt
Q86UE8	TLK2	H518N	H	518	N	179	decrease	Reduced kinase activity."";/evidence=""ECO:0000269|PubMed:29955062""	UniProt
Q86UE8	TLK2	D592V	D	592	V	389	loss	Loss of kinase activity. No impact on;interaction with ASF1A."";/evidence=""ECO:0000269|PubMed:33323470,;ECO:0000269|PubMed:35136069""	UniProt
Q86UE8	TLK2	D613A	D	613	A	442	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:10523312,;ECO:0000269|PubMed:11470414, ECO:0000269|PubMed:29955062""	UniProt
Q86UE8	TLK2	S617D	S	617	D	447	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:29955062""	UniProt
Q86UE8	TLK2	S659A	S	659	A	577	decrease	Reduced kinase activity."";/evidence=""ECO:0000269|PubMed:29955062""	UniProt
Q86UE8	TLK2	S686A	S	686	A	623	decrease	Reduced kinase activity."";/evidence=""ECO:0000269|PubMed:29955062""	UniProt
Q86UE8	TLK2	S686D	S	686	D	623	decrease	Reduced kinase activity."";/evidence=""ECO:0000269|PubMed:29955062""	UniProt
Q86UE8	TLK2	T695A	T	695	A	651	decrease	Reduced kinase activity."";/evidence=""ECO:0000269|PubMed:29955062""	UniProt
Q86UE8	TLK2	R720A	R	720	A	762	decrease	Reduced phosphorylation of ASF1A."";/evidence=""ECO:0000269|PubMed:29955062""	UniProt
Q59H18	TNNI3K	G526D	G	526	D	207	decrease	(in CCDD; the mutation results in decreased;protein solubility; causes abnormal aggregation; markedly;reduced protein expression is observed in the sarcoplasm;and nuclei of patient cardiomyocytes; dbSNP:rs606231469)"";/evidence=""ECO:0000269|PubMed:24925317"";/id=""VAR_072650""	UniProt
Q59H18	TNNI3K	K490R	K	490	R	127	loss	Loss of autophosphorylation activity."";/evidence=""ECO:0000269|PubMed:12721663""	UniProt
Q9UKE5	TNIK	K54A	K	54	A	-	loss	Kinase dead. Loss of autophosphorylation and;loss of function in cytoskeleton regulation."";/evidence=""ECO:0000269|PubMed:15342639,;ECO:0000269|PubMed:19816403""	UniProt
O75962	TRIO	E1299K	E	1299	K	-	decrease	(in MRD44; severely decreased activation of;RAC1-mediated signaling; severely decreased neurite;outgrowth)"";/evidence=""ECO:0000269|PubMed:32109419"";/id=""VAR_083920""	UniProt
O75962	TRIO	R1428Q	R	1428	Q	-	decrease	(in MRD44; severely decreased activation of;RAC1-mediated signaling; severely decreased neurite;outgrowth; dbSNP:rs879255626)"";/evidence=""ECO:0000269|PubMed:27418539,;ECO:0000269|PubMed:32109419"";/id=""VAR_077096""	UniProt
O75962	TRIO	H1469R	H	1469	R	-	decrease	(in MRD44; decreased activation of RAC1-;mediated signaling; severely decreased neurite outgrowth;;dbSNP:rs1554070777)"";/evidence=""ECO:0000269|PubMed:32109419"";/id=""VAR_083922""	UniProt
O75962	TRIO	E1299A	E	1299	A	-	decrease	50% decrease in nucleotide exchange activity."";/evidence=""ECO:0000269|PubMed:9790533""	UniProt
O75962	TRIO	T1303A	T	1303	A	-	decrease	40% decrease in nucleotide exchange activity."";/evidence=""ECO:0000269|PubMed:9790533""	UniProt
O75962	TRIO	V1426A	V	1426	A	-	decrease	90% decrease in nucleotide exchange activity."";/evidence=""ECO:0000269|PubMed:9790533""	UniProt
O75962	TRIO	Q1427A	Q	1427	A	-	decrease	80% decrease in nucleotide exchange activity."";/evidence=""ECO:0000269|PubMed:9790533""	UniProt
O75962	TRIO	R1428A	R	1428	A	-	decrease	80% decrease in nucleotide exchange activity."";/evidence=""ECO:0000269|PubMed:9790533""	UniProt
O75962	TRIO	T1430A	T	1430	A	-	decrease	80% decrease in nucleotide exchange activity."";/evidence=""ECO:0000269|PubMed:9790533""	UniProt
O75962	TRIO	K1431A	K	1431	A	-	loss	Loss of nucleotide exchange activity."";/evidence=""ECO:0000269|PubMed:9790533""	UniProt
O75962	TRIO	L1434A	L	1434	A	-	decrease	40% decrease in nucleotide exchange activity."";/evidence=""ECO:0000269|PubMed:9790533""	UniProt
O75962	TRIO	E1438A	E	1438	A	-	decrease	30% decrease in nucleotide exchange activity."";/evidence=""ECO:0000269|PubMed:9790533""	UniProt
P10721	KIT	A829P	A	829	P	516	resistance	-	COSMIC
Q9BX84	TRPM6	K1804R	K	1804	R	-	loss	Abolishes kinase activity but does not affect;expression levels or binding to RACK1."";/evidence=""ECO:0000269|PubMed:18258429""	UniProt
Q9BX84	TRPM6	T1851A	T	1851	A	-	decrease	Significantly decreases autophosphorylation.;Does not alter binding to RACK1 but prevents inhibition by;RACK1."";/evidence=""ECO:0000269|PubMed:18258429""	UniProt
Q96QT4	TRPM7	K1648R	K	1648	R	-	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:12887921""	UniProt
Q96QT4	TRPM7	G1799D	G	1799	D	-	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:12887921""	UniProt
Q9BXA7	TSSK1B	T174A	T	174	A	512	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:15733851""	UniProt
Q6SA08	TSSK4	K54M	K	54	M	127	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:15964553""	UniProt
Q9BXA6	TSSK6	K41M	K	41	M	127	loss	Loss of kinase activity. Loss of binding to;TSACC."";/evidence=""ECO:0000269|PubMed:15870294,;ECO:0000269|PubMed:20829357""	UniProt
Q6IQ55	TTBK2	D163A	D	163	A	442	loss	Abolishes serine/threonine-protein kinase;activity."";/evidence=""ECO:0000269|PubMed:21548880""	UniProt
Q6IQ55	TTBK2	R181E	R	181	E	508	loss	A: Impaired serine/threonine-protein kinase;activity."";/evidence=""ECO:0000269|PubMed:21548880""	UniProt
Q6IQ55	TTBK2	A184E	A	184	E	511	loss	G: Impaired serine/threonine-protein kinase;activity."";/evidence=""ECO:0000269|PubMed:21548880""	UniProt
P33981	TTK	D664A	D	664	A	442	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:18243099,;ECO:0000269|PubMed:18480048""	UniProt
P33981	TTK	T686A	T	686	A	521	loss	Loss of kinase activity."";/evidence=""ECO:0000269|PubMed:18480048""	UniProt
P42681	TXK	K299A	K	299	A	127	loss	Impairs kinase activity."";/evidence=""ECO:0000269|PubMed:9813138""	UniProt
P29597	TYK2	K930R	K	930	R	127	loss	Complete loss of catalytic activity."";/evidence=""ECO:0000269|PubMed:8702790""	UniProt
P29597	TYK2	D1023N	D	1023	N	389	loss	Complete loss of catalytic activity."";/evidence=""ECO:0000269|PubMed:24843152""	UniProt
O75385	ULK1	K46I	K	46	I	127	loss	Abolished serine/threonine-protein kinase;activity."";/evidence=""ECO:0000269|PubMed:20921139,;ECO:0000269|PubMed:28821708""	UniProt
Q8IYT8	ULK2	K39R	K	39	R	127	decrease	Decreased kinase activity and decreased;autophosphorylation."";/evidence=""ECO:0000269|PubMed:18936157""	UniProt
Q6PHR2	ULK3	K44R	K	44	R	127	decrease	Decreased kinase activity."";/evidence=""ECO:0000269|PubMed:19878745""	UniProt
Q6PHR2	ULK3	K139R	K	139	R	391	loss	Loss of kinase activity. Does not promote GLI1;nuclear localization."";/evidence=""ECO:0000269|PubMed:19878745,;ECO:0000269|PubMed:20643644""	UniProt
P17948	FLT1	Y914F	Y	914	F	272	decrease	Reduces phosphorylation at other tyrosine;residues."";/evidence=""ECO:0000269|PubMed:9722576""	UniProt
P17948	FLT1	Y1242F	Y	1242	F	-	loss	Loss of phosphorylation site."";/evidence=""ECO:0000269|PubMed:9722576""	UniProt
P17948	FLT1	Y1327F	Y	1327	F	-	loss	Loss of phosphorylation site."";/evidence=""ECO:0000269|PubMed:9722576""	UniProt
P35968	KDR	V848E	V	848	E	45	decrease	(strongly reduced autophosphorylation and;kinase activity; dbSNP:rs1139776)"";/evidence=""ECO:0000269|PubMed:10037737,;ECO:0000269|PubMed:1656371"";/id=""VAR_046679""	UniProt
P35968	KDR	R726A	R	726	A	-	decrease	Strongly reduced autophosphorylation and;activation of MAP kinases."";/evidence=""ECO:0000269|PubMed:20080685""	UniProt
P35968	KDR	D731A	D	731	A	-	decrease	Strongly reduced autophosphorylation and;activation of MAP kinases."";/evidence=""ECO:0000269|PubMed:20080685""	UniProt
P35968	KDR	K868M	K	868	M	127	loss	Loss of enzyme activity."";/evidence=""ECO:0000269|PubMed:11387210""	UniProt
P35968	KDR	Y996F	Y	996	F	-	decrease	Strongly reduced autophosphorylation. Reduces;phosphorylation of PLCG1."";/evidence=""ECO:0000269|PubMed:10102632""	UniProt
P35968	KDR	Y1175F	Y	1175	F	-	loss	Abolishes phosphorylation of PLCG1 and MAP;kinases in response to VEGFA."";/evidence=""ECO:0000269|PubMed:11387210""	UniProt
P35968	KDR	Y1214F	Y	1214	F	-	loss	Loss of phosphorylation site. Abolishes;reorganization of the actin cytoskeleton in response to;VEGFA."";/evidence=""ECO:0000269|PubMed:16966330""	UniProt
P35916	FLT4	A855T	A	855	T	40	decrease	(in LMPHM1; recessive form; results in;reduced autophosphorylation; results in impaired ligand-;induced receptor internalization and downstream signaling;;dbSNP:rs121909657)"";/evidence=""ECO:0000269|PubMed:19289394"";/id=""VAR_074044""	UniProt
P35916	FLT4	G857R	G	857	R	42	loss	(in LMPHM1; loss of kinase activity;;dbSNP:rs267606818)"";/evidence=""ECO:0000269|PubMed:10835628,;ECO:0000269|PubMed:15102829"";/id=""VAR_018409""	UniProt
P35916	FLT4	H1035R	H	1035	R	387	loss	(in LMPHM1; loss of kinase activity;;dbSNP:rs121909653)"";/evidence=""ECO:0000269|PubMed:10856194"";/id=""VAR_018412""	UniProt
P35916	FLT4	R1041P	R	1041	P	393	loss	(in LMPHM1; loss of kinase activity;;dbSNP:rs121909650)"";/evidence=""ECO:0000269|PubMed:10835628,;ECO:0000269|PubMed:12881528"";/id=""VAR_018413""	UniProt
P35916	FLT4	L1044P	L	1044	P	396	loss	(in LMPHM1; loss of kinase activity;;dbSNP:rs121909651)"";/evidence=""ECO:0000269|PubMed:10835628"";/id=""VAR_018414""	UniProt
P35916	FLT4	P1114L	P	1114	L	616	loss	(in LMPHM1; loss of kinase activity;;dbSNP:rs121909652)"";/evidence=""ECO:0000269|PubMed:10835628,;ECO:0000269|PubMed:9817924"";/id=""VAR_018415""	UniProt
P35916	FLT4	K879G	K	879	G	127	loss	Abolishes enzyme activity."";/evidence=""ECO:0000269|PubMed:12881528""	UniProt
P35916	FLT4	Y1068F	Y	1068	F	462	loss	Global loss of autophosphorylation. Abolishes;stimulation of cell proliferation and cell migration."";/evidence=""ECO:0000269|PubMed:16076871,;ECO:0000269|PubMed:20431062""	UniProt
P35916	FLT4	Y1230F	Y	1230	F	-	decrease	Loss of phosphorylation site. Strongly reduces;stimulation of cell proliferation and cell migration."";/evidence=""ECO:0000269|PubMed:12881528,;ECO:0000269|PubMed:16076871""	UniProt
P35916	FLT4	Y1231F	Y	1231	F	-	decrease	Loss of phosphorylation site. Strongly reduces;stimulation of cell proliferation and cell migration."";/evidence=""ECO:0000269|PubMed:12881528,;ECO:0000269|PubMed:16076871""	UniProt
P35916	FLT4	Y1333F	Y	1333	F	-	decrease	Loss of phosphorylation site. Reduced;autophosphorylation."";/evidence=""ECO:0000269|PubMed:12881528,;ECO:0000269|PubMed:7675451""	UniProt
P35916	FLT4	Y1337F	Y	1337	F	-	decrease	Reduced autophosphorylation. Strongly reduces;stimulation of cell proliferation and cell migration."";/evidence=""ECO:0000269|PubMed:12881528,;ECO:0000269|PubMed:20431062, ECO:0000269|PubMed:7675451""	UniProt
P35916	FLT4	Y1363F	Y	1363	F	-	decrease	Loss of phosphorylation site. Slightly reduced;autophosphorylation."";/evidence=""ECO:0000269|PubMed:12881528,;ECO:0000269|PubMed:7675451""	UniProt
Q99986	VRK1	S342A	S	342	A	-	decrease	Abolishes phosphorylation by PLK3 and;induction of Golgi fragmentation during mitosis. Strongly;reduced autophosphorylation."";/evidence=""ECO:0000269|PubMed:19103756,;ECO:0000269|PubMed:21543316""	UniProt
Q99986	VRK1	T353A	T	353	A	-	decrease	Strongly reduced autophosphorylation."";/evidence=""ECO:0000269|PubMed:21543316""	UniProt
Q86Y07	VRK2	K179E	K	179	E	426	loss	Abolished protein serine/threonine kinase;activity."";/evidence=""ECO:0000269|PubMed:33076429""	UniProt
P30291	WEE1	K328R	K	328	R	127	loss	Abolishes activity."";/evidence=""ECO:0000269|PubMed:8428596""	UniProt
P30291	WEE1	S642A	S	642	A	-	loss	Abolishes phosphorylation by BRSK1 and BRSK2."";/evidence=""ECO:0000269|PubMed:20026642""	UniProt
P0C1S8	WEE2	D234H	D	234	H	99	decrease	(in OOMD5; decreased WEE2 phosphorylation at;serine residues; decreased CDK1/CDC2 phosphorylation at 'Y-;15'; dbSNP:rs1554415096)"";/evidence=""ECO:0000269|PubMed:29606300"";/id=""VAR_080992""	UniProt
P43403	ZAP70	D461N	D	461	N	389	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:17512407""	UniProt
P43403	ZAP70	D479N	D	479	N	442	loss	Abolishes kinase activity."";/evidence=""ECO:0000269|PubMed:15292186""	UniProt
P43403	ZAP70	Y493F	Y	493	F	463	loss	Impairs kinase activity."";/evidence=""ECO:0000269|PubMed:7781602""	UniProt
O00141	SGK1	T256A	T	256	A	512	decrease	T->A: Low activity. ECO:0000269|PubMed:10191262	UniProt
O00141	SGK1	T256D	T	256	D	512	decrease	T->D: Low activity. ECO:0000269|PubMed:10191262	UniProt
O00141	SGK1	T256E	T	256	E	512	decrease	T->E: Low activity. ECO:0000269|PubMed:10191262	UniProt
O00141	SGK1	Y298A	Y	298	A	618	decrease	Y->A: Abolishes interaction with NEDD4 and NEDD4L. ECO:0000269|PubMed:11696533	UniProt
O00141	SGK1	S422A	S	422	A	-	decrease	S->A: Low activity. ECO:0000269|PubMed:10191262, ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:15040001	UniProt
O00238	BMPR1B	R31C	R	31	C	-	decrease	R -> C (in AMD3; unknown pathological significance; mouse BMPR1B construct containing this mutation shows reduced GDF5-dependent receptor activation, mouse BMPR1B construct containing this mutation shows no loss of cell membrane localization; dbSNP:rs745854387) ECO:0000269|PubMed:26105076	UniProt
O00238	BMPR1B	C53R	C	53	R	-	loss	C -> R (in AMD3; mouse BMPR1B construct containing this mutation shows loss of GDF5-dependent receptor activation, chicken BMPR1B construct containing this mutation does not show reduced chondrocyte differentiation, mouse BMPR1B construct containing this mutation shows no loss of cell membrane localization; dbSNP:rs863225041) ECO:0000269|PubMed:24129431	UniProt
O00238	BMPR1B	I200K	I	200	K	-	loss	I -> K (in BDA2; in animal models loss of kinase activity and loss of positive regulation of chondrocyte differentiation; dbSNP:rs121434417) ECO:0000269|PubMed:14523231	UniProt
O00444	PLK4	D154A	D	154	A	442	loss	D->A: Catalytically inactive mutant that causes some centrosome amplification above background levels when overexpressed. ECO:0000269|PubMed:16244668	UniProt
O14730	RIOK3	K290A	K	290	A	-	loss	K->A: Decreases autophosphorylation (in vitro); abolishes inhibition of TNF-alpha-induced NF-kappaB activation; no effect on interaction with IRF3; fails to activate IFN-beta promoter and IRF3 phosphorylation. ECO:0000269|PubMed:19557502, ECO:0000269|PubMed:24807708	UniProt
O14757	CHEK1	K132R	K	132	R	391	decrease	K->R: Strong reduction of chromatin-associated CHK1 ubiquitination. ECO:0000269|PubMed:32357935	UniProt
O14757	CHEK1	S317A	S	317	A	-	decrease	S->A: Abrogates interaction with RAD51; when associated with A-345. Reduces phosphorylation and impairs activation by hydroxyurea and ionizing radiation. Abrogates nuclear retention upon checkpoint activation. Impairs interaction with FBXO6. ECO:0000269|PubMed:11390642, ECO:0000269|PubMed:12588868, ECO:0000269|PubMed:12676583, ECO:0000269|PubMed:12676962, ECO:0000269|PubMed:15665856	UniProt
O14757	CHEK1	S317E	S	317	E	-	increase	S->E: Enhances interaction with RAD51; when associated with E-345. ECO:0000269|PubMed:11390642, ECO:0000269|PubMed:12588868, ECO:0000269|PubMed:12676583, ECO:0000269|PubMed:12676962, ECO:0000269|PubMed:15665856	UniProt
O14757	CHEK1	F344A	F	344	A	-	increase	F->A: Impairs nuclear export. ECO:0000269|PubMed:12676962	UniProt
O14757	CHEK1	S345A	S	345	A	-	decrease	S->A: Abrogates interaction with RAD51; when associated with A-317. Reduces phosphorylation and impairs activation by hydroxyurea and ionizing radiation. Impairs interaction with YWHAZ which is required for nuclear retention after checkpoint activation. ECO:0000269|PubMed:11390642, ECO:0000269|PubMed:12588868, ECO:0000269|PubMed:12676583, ECO:0000269|PubMed:12676962, ECO:0000269|PubMed:15665856, ECO:0000269|PubMed:19716789	UniProt
O14757	CHEK1	S345E	S	345	E	-	increase	S->E: Enhances interaction with RAD51; when associated with E-317. ECO:0000269|PubMed:11390642, ECO:0000269|PubMed:12588868, ECO:0000269|PubMed:12676583, ECO:0000269|PubMed:12676962, ECO:0000269|PubMed:15665856, ECO:0000269|PubMed:19716789	UniProt
O14757	CHEK1	M353A	M	353	A	-	increase	M->A: Impairs nuclear export. ECO:0000269|PubMed:12676962	UniProt
O14920	IKBKB	K44A	K	44	A	127	loss	K->A: Loss of kinase activity and no effect on binding to NIK. ECO:0000269|PubMed:9346484, ECO:0000269|PubMed:9346485	UniProt
O14920	IKBKB	S177E	S	177	E	460	activating	S->E: Full activation. Interaction with TRIM21 is enhanced; when associated with E-181. Monoubiquitinated; when associated with R-163 and E-181. Strongly promoted NF-kappa-B gene expression; when associated with E-181. ECO:0000269|PubMed:19675099, ECO:0000269|PubMed:9346484	UniProt
O14920	IKBKB	S181E	S	181	E	512	activating	S->E: Full activation. Interaction with TRIM21 is enhanced; when associated with E-177. Monoubiquitinated; when associated with R-163 and E-177. Strongly promoted NF-kappa-B gene expression; when associated with E-177. ECO:0000269|PubMed:19675099, ECO:0000269|PubMed:9346484	UniProt
O14965	AURKA	S155R	S	155	R	99	decrease	S -> R (in a colorectal adenocarcinoma sample; somatic mutation; reduces interaction with TPX2) ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19801554	UniProt
O14965	AURKA	G198N	G	198	N	207	decrease	G->N: Reduces interaction with TPX2. Reduces kinase activity tenfold. Promotes interaction with the AURKB binding partners INCENP and BIRC5 that are normally not bound by AURKA. ECO:0000269|PubMed:19357306	UniProt
O14965	AURKA	T287E	T	287	E	511	activating	T->E: Enhances interaction with TPX2. ECO:0000269|PubMed:19668197	UniProt
O14965	AURKA	Y334A	Y	334	A	623	decrease	Y->A: Reduces binding to MYCN. ECO:0000269|PubMed:27837025	UniProt
O14965	AURKA	Q335A	Q	335	A	624	decrease	Q->A: Reduces binding to MYCN. ECO:0000269|PubMed:27837025	UniProt
O15146	MUSK	G584D	G	584	D	39	decrease	G->C,D: Mild decrease in kinase activity. ECO:0000269|PubMed:25029443	UniProt
O15146	MUSK	D743N	D	743	N	442	loss	D->N: Severe loss of kinase activity. ECO:0000269|PubMed:25029443	UniProt
O15530	PDPK1	S241A	S	241	A	512	loss	S->A: No activation. ECO:0000269|PubMed:10455013	UniProt
O15530	PDPK1	Y373F	Y	373	F	-	decrease	Y->F: Reduction in basal activity. ECO:0000269|PubMed:11481331	UniProt
O15530	PDPK1	Y376F	Y	376	F	-	decrease	Y->F: Reduction in basal activity. ECO:0000269|PubMed:11481331	UniProt
O43283	MAP3K13	K195A	K	195	A	127	loss	K->A: Kinase inactive. Fails to activate NF-kappa-B. ECO:0000269|PubMed:12492477	UniProt
O43353	RIPK2	K209R	K	209	R	579	decrease	K->R: Complete loss of polyubiquitination. ECO:0000269|PubMed:18079694	UniProt
O43353	RIPK2	K503R	K	503	R	-	increase	K->R: Abolished ubiquitination by ZNRF4. ECO:0000269|PubMed:28656966	UniProt
O43781	DYRK3	K238M	K	238	M	127	loss	K->M: Kinase dead; Induces formation of stress granules-like in absence of stress. Impaired dissolution of membraneless organelles during mitosis, such as stress granules, nuclear speckles and pericentriolar material. ECO:0000269|PubMed:23415227, ECO:0000269|PubMed:29634919, ECO:0000269|PubMed:29973724	UniProt
O43781	DYRK3	S350A	S	350	A	437	decrease	S->A: Decreased stability of the protein. ECO:0000269|PubMed:29634919	UniProt
O43781	DYRK3	S350D	S	350	D	437	increase	S->E,D: Phosphomimetic mutant; increased stability of the protein. ECO:0000269|PubMed:29634919	UniProt
O60285	NUAK1	S600A	S	600	A	-	loss	S->A: Abrogates phosphorylation by PKB/AKT1. Does not affect ability to induce senescence. ECO:0000269|PubMed:12409306, ECO:0000269|PubMed:19927127	UniProt
O60566	BUB1B	D579E	D	579	E	-	increase	D->E: Abolishes the cleavage by caspase-3. ECO:0000269|PubMed:16227576	UniProt
O60566	BUB1B	D610E	D	610	E	-	increase	D->E: Abolishes the cleavage by caspase-3. ECO:0000269|PubMed:16227576	UniProt
O60566	BUB1B	K795A	K	795	A	-	loss	K->A: Does not abolish the capacity to inhibit APC/CDC20. ECO:0000269|PubMed:11702782, ECO:0000269|PubMed:12925705	UniProt
O60566	BUB1B	K795R	K	795	R	-	loss	K->R: Inhibits kinase activity. ECO:0000269|PubMed:11702782, ECO:0000269|PubMed:12925705	UniProt
O60674	JAK2	V617F	V	617	F	211	activating	V -> F (in PV, THCYT3 and AML; associated with susceptibility to Budd-Chiari syndrome; somatic mutation in a high percentage of patients with essential thrombocythemia or myelofibrosis; leads to constitutive tyrosine phosphorylation activity that promotes cytokine hypersensitivity; dbSNP:rs77375493) ECO:0000269|PubMed:15781101, ECO:0000269|PubMed:15793561, ECO:0000269|PubMed:15858187, ECO:0000269|PubMed:16247455, ECO:0000269|PubMed:16325696, ECO:0000269|PubMed:16603627	UniProt
O75116	ROCK2	D1131A	D	1131	A	-	decrease	D->A: Abolishes cleavage by granzyme B. ECO:0000269|PubMed:15699075	UniProt
O75460	ERN1	Q105E	Q	105	E	-	decrease	Q->E: Impaired ability to homodimerize. ECO:0000269|PubMed:16973740	UniProt
O75460	ERN1	D123P	D	123	P	-	loss	D->P: Abolishes ability to homodimerize. ECO:0000269|PubMed:16973740	UniProt
O75460	ERN1	W125A	W	125	A	-	loss	W->A: Abolishes ability to homodimerize. ECO:0000269|PubMed:16973740	UniProt
O75582	RPS6KA5	S212A	S	212	A	512	loss	S->A: Inactivates the N-terminal kinase domain. ECO:0000269|PubMed:15568999	UniProt
O75582	RPS6KA5	T700D	T	700	D	-	decrease	T->A,D: Strongly reduces phosphorylation of T-581 in response to PMA and UV-C. ECO:0000269|PubMed:17117922	UniProt
O75962	TRIO	T1075I	T	1075	I	-	increase	T -> I (in MRD63; slightly increased occipitofrontal circumference; increased activation of RAC1-mediated signaling; increased lamellipodia formation) ECO:0000269|PubMed:32109419	UniProt
O75962	TRIO	N1080I	N	1080	I	-	increase	N -> I (in MRD63; slightly increased occipitofrontal circumference; increased activation of RAC1-mediated signaling; increased neurite outgrowth; dbSNP:rs879255628) ECO:0000269|PubMed:27418539, ECO:0000269|PubMed:32109419	UniProt
O75962	TRIO	K2917A	K	2917	A	-	decrease	K->A: Expected to disrupt kinase activity. Causes reorganization of the actin cytoskeleton in the absence of NGF. ECO:0000269|PubMed:22155786	UniProt
O76039	CDKL5	A40V	A	40	V	125	decrease	A -> V (in DEE2; causes mislocalization of the protein in the cytoplasm; dbSNP:rs122460159) ECO:0000269|PubMed:17993579, ECO:0000269|PubMed:18790821	UniProt
O76039	CDKL5	C152F	C	152	F	441	decrease	C -> F (in DEE2; affect activity; causes mislocalization of the protein in the cytoplasm; dbSNP:rs122460157) ECO:0000269|PubMed:15499549, ECO:0000269|PubMed:16935860	UniProt
O76039	CDKL5	L220P	L	220	P	646	decrease	L -> P (in DEE2; causes mislocalization of the protein in the cytoplasm; dbSNP:rs267608511) ECO:0000269|PubMed:17993579, ECO:0000269|PubMed:18790821	UniProt
O95835	LATS1	Y559F	Y	559	F	-	decrease	Y->F: Loss of interaction with YAP1. ECO:0000269|PubMed:18158288	UniProt
O96017	CHEK2	R145W	R	145	W	-	decrease	R -> W (in colon cancer and LFS2; does not cause protein abrogation in familial colorectal cancer; loss of the ability to interact with and phosphorylate CDC25A and to promote CDC25A degradation in response to ionizing radiation; dbSNP:rs137853007) ECO:0000269|PubMed:10617473, ECO:0000269|PubMed:11298456, ECO:0000269|PubMed:11719428, ECO:0000269|PubMed:12610780, ECO:0000269|PubMed:15535844, ECO:0000269|PubMed:15818573	UniProt
O96017	CHEK2	I157T	I	157	T	-	decrease	I -> T (might influence susceptibility to different types of cancer; does not cause protein abrogation in familial colorectal cancer; loss of the ability to interact with and phosphorylate CDC25A and to promote CDC25A degradation in response to ionizing radiation; dbSNP:rs17879961) ECO:0000269|PubMed:10617473, ECO:0000269|PubMed:11298456, ECO:0000269|PubMed:11461078, ECO:0000269|PubMed:12533788, ECO:0000269|PubMed:12610780, ECO:0000269|PubMed:14612911, ECO:0000269|PubMed:15087378, ECO:0000269|PubMed:15095295, ECO:0000269|PubMed:15239132, ECO:0000269|PubMed:15492928, ECO:0000269|PubMed:15535844, ECO:0000269|PubMed:15810020, ECO:0000269|PubMed:15818573, ECO:0000269|Ref.10	UniProt
O96017	CHEK2	Y390C	Y	390	C	530	loss	Y -> C (in BC; does not phosphorylate p53/TP53; dbSNP:rs200928781) ECO:0000269|PubMed:25619829	UniProt
O96017	CHEK2	S379A	S	379	A	460	decrease	S->A: Abrogates autophosphorylation at Ser-379 and prevents ubiquitination. ECO:0000269|PubMed:18644861	UniProt
P00533	EGFR	K745M	K	745	M	127	loss	K->A,M: Abolishes kinase activity. ECO:0000269|PubMed:19560417	UniProt
P00533	EGFR	R1068G	R	1068	G	-	increase	R->G: Strongly decreases interaction with CBLC. ECO:0000269|PubMed:22888118	UniProt
P00533	EGFR	Y1069F	Y	1069	F	-	activating	Y->F: Abolishes interaction with CBLC. ECO:0000269|PubMed:22888118	UniProt
P04049	RAF1	K375W	K	375	W	127	loss	K->W: Catalytically inactive. ECO:0000269|PubMed:20956560	UniProt
P04049	RAF1	T491D	T	491	D	448	activating	T->D: Increased kinase activity but can still be inhibited by PPP5C; when associated with D-494. ECO:0000269|PubMed:16892053	UniProt
P04049	RAF1	S494D	S	494	D	451	activating	S->D: Increased kinase activity but can still be inhibited by PPP5C; when associated with D-491. ECO:0000269|PubMed:16892053	UniProt
P04629	NTRK1	L93P	L	93	P	-	decrease	L -> P (in CIPA; aberrantly processed; shows diminished autophosphorylation in neuronal cells) ECO:0000269|PubMed:10982191, ECO:0000269|PubMed:11159935	UniProt
P04629	NTRK1	L213P	L	213	P	-	decrease	L -> P (in CIPA; aberrantly processed; shows diminished autophosphorylation in neuronal cells; dbSNP:rs747711259) ECO:0000269|PubMed:10330344, ECO:0000269|PubMed:11159935	UniProt
P04629	NTRK1	G522E	G	522	E	42	decrease	G -> E (in CIPA; no effect on N-glycosylation, nor on subcellular location; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux) ECO:0000269|PubMed:27676246	UniProt
P04629	NTRK1	G522R	G	522	R	42	decrease	G -> R (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs1571699266) ECO:0000269|PubMed:10982191, ECO:0000269|PubMed:11159935	UniProt
P04629	NTRK1	R649W	R	649	W	388	decrease	R -> W (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs369353892) ECO:0000269|PubMed:10330344, ECO:0000269|PubMed:11159935	UniProt
P04629	NTRK1	R654C	R	654	C	393	decrease	R -> C (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs764992664) ECO:0000269|PubMed:10982191, ECO:0000269|PubMed:11159935, ECO:0000269|PubMed:22302274	UniProt
P04629	NTRK1	L657P	L	657	P	396	decrease	L -> P (in CIPA; following transfection in neuroblastoma cells and NGF treatment, loss of differentiation into neuronal phenotype; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux) ECO:0000269|PubMed:27676246	UniProt
P04629	NTRK1	I699T	I	699	T	536	decrease	I -> T (in CIPA; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux) ECO:0000269|PubMed:27676246	UniProt
P04629	NTRK1	G714S	G	714	S	587	decrease	G -> S (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs770727871) ECO:0000269|PubMed:10330344, ECO:0000269|PubMed:11159935	UniProt
P04629	NTRK1	C763S	C	763	S	763	decrease	C -> S (in CIPA; following transfection in neuroblastoma cells and NGF treatment, decreased percentage of cells differentiated into neuronal phenotype and reduced neurite length compared with wild-type; slightly decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal and NGF-induced autophosphorylation; small reduction in NGF-stimulated calcium flux) ECO:0000269|PubMed:27676246	UniProt
P04629	NTRK1	R771C	R	771	C	773	decrease	R -> C (in CIPA; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux; dbSNP:rs1324983370) ECO:0000269|PubMed:27676246	UniProt
P06213	INSR	I56T	I	56	T	-	decrease	I -> T (in LEPRCH; abolishes post-translational processing; dbSNP:rs1555689937) ECO:0000269|PubMed:24498630	UniProt
P06213	INSR	G58R	G	58	R	-	decrease	G -> R (in LEPRCH; Helmond; inhibits processing and transport; dbSNP:rs52836744) ECO:0000269|PubMed:1730625	UniProt
P06213	INSR	R113P	R	113	P	-	loss	R -> P (in LEPRCH; Atlanta-1; abolishes insulin binding; dbSNP:rs121913153) ECO:0000269|PubMed:12023989, ECO:0000269|PubMed:8419945	UniProt
P06213	INSR	A119V	A	119	V	-	decrease	A -> V (in LEPRCH; markedly impairs insulin binding; dbSNP:rs1347473020) ECO:0000269|PubMed:12023989	UniProt
P06213	INSR	L120Q	L	120	Q	-	decrease	L -> Q (in LEPRCH; inhibits receptor processing) ECO:0000269|PubMed:12970295	UniProt
P06213	INSR	N458D	N	458	D	-	decrease	N -> D (in LEPRCH; partially inhibits receptor processing and autophosphorylation; strongly impairs ERK phosphorylation; induces wild-type levels of IRS-1 phosphorylation; dbSNP:rs121913160) ECO:0000269|PubMed:12970295	UniProt
P06213	INSR	V657F	V	657	F	-	decrease	V -> F (in LEPRCH; impairs post-translational processing; dbSNP:rs1135401737) ECO:0000269|PubMed:28765322	UniProt
P06213	INSR	W659R	W	659	R	-	decrease	W -> R (in LEPRCH; impairs post-translational processing) ECO:0000269|PubMed:28765322	UniProt
P06213	INSR	Y818C	Y	818	C	-	decrease	Y -> C (in LEPRCH; abolishes post-translational processing) ECO:0000269|PubMed:22768670, ECO:0000269|PubMed:28765322	UniProt
P06213	INSR	I925T	I	925	T	-	loss	I -> T (in LEPRCH; abolishes post-translational processing; abolishes insulin binding; dbSNP:rs1599881881) ECO:0000269|PubMed:12023989, ECO:0000269|PubMed:28765322	UniProt
P06213	INSR	R926W	R	926	W	-	decrease	R -> W (in LEPRCH; markedly impairs insulin binding;impairs post-translational processing; dbSNP:rs911929963) ECO:0000269|PubMed:12023989, ECO:0000269|PubMed:28765322	UniProt
P06213	INSR	T937M	T	937	M	-	decrease	T -> M (in LEPRCH; impaired receptor processing; impairs post-translational processing) ECO:0000269|PubMed:28765322, ECO:0000269|PubMed:9299395	UniProt
P06213	INSR	I1143T	I	1143	T	355	decrease	I -> T (in RMS; reduces insulin binding) ECO:0000269|PubMed:10443650, ECO:0000269|PubMed:12023989	UniProt
P06213	INSR	R1158W	R	1158	W	388	loss	R -> W (in RMS; abolishes insulin binding; dbSNP:rs111993466) ECO:0000269|PubMed:10443650, ECO:0000269|PubMed:12023989	UniProt
P06213	INSR	Y999F	Y	999	F	-	loss	Y->F: Has no effect on insulin-stimulated autophosphorylation, but inhibits the biological activity of the receptor. Abolishes interaction with IRS1 and almost completely prevents interaction with SHC1. Has no effect on interaction with PIK3R1. Abolishes interaction with STAT5B. ECO:0000269|PubMed:2842060, ECO:0000269|PubMed:7537849, ECO:0000269|PubMed:7559478, ECO:0000269|PubMed:9428692	UniProt
P06213	INSR	K1057A	K	1057	A	127	loss	K->A: Abolishes the kinase activity and abolishes interaction with IRS1, SHC1, GRB7 and PIK3R1. ECO:0000269|PubMed:10803466, ECO:0000269|PubMed:3101064, ECO:0000269|PubMed:7537849	UniProt
P00533	EGFR	G796R	G	796	R	273	resistance	-	COSMIC
P06213	INSR	K1057R	K	1057	R	127	loss	K->M,R: Abolishes the kinase activity. ECO:0000269|PubMed:10803466, ECO:0000269|PubMed:3101064, ECO:0000269|PubMed:7537849	UniProt
P06493	CDK1	Y4D	Y	4	D	30	decrease	Y->D,E: Constitutive polyubiquitination. ECO:0000269|PubMed:20395957	UniProt
P06493	CDK1	Y4E	Y	4	E	30	decrease	Y->D,E: Constitutive polyubiquitination. ECO:0000269|PubMed:20395957	UniProt
P07332	FES	R483M	R	483	M	-	decrease	R->M: Abolishes pTyr binding. Abolishes association with microtubules. Abolishes autophosphorylation. Reduced kinase activity. ECO:0000269|PubMed:15485904, ECO:0000269|PubMed:18775312	UniProt
P07333	CSF1R	Y708F	Y	708	F	-	increase	Y->F: Impairs degradation of activated CSF1R. ECO:0000269|PubMed:10340379	UniProt
P07333	CSF1R	D802V	D	802	V	452	activating	D->V: Constitutive kinase activity. Loss of inhibition by imatinib. ECO:0000269|PubMed:10340379, ECO:0000269|PubMed:16170366	UniProt
P07947	YES1	Y426F	Y	426	F	461	increase	Y->F: About 50% loss of CSK-mediated inhibition. ECO:0000269|PubMed:9794236	UniProt
P07948	LYN	K275A	K	275	A	127	loss	K->A: Loss of activity and no effect on localization to the cell membrane. Abundant localization in the nucleus; when associated with A-2 and A-3. ECO:0000269|PubMed:11435302, ECO:0000269|PubMed:11517336, ECO:0000269|PubMed:15173188, ECO:0000269|PubMed:18817770	UniProt
P07948	LYN	K275R	K	275	R	127	loss	K->L,R: Loss of kinase activity. ECO:0000269|PubMed:11435302, ECO:0000269|PubMed:11517336, ECO:0000269|PubMed:15173188, ECO:0000269|PubMed:18817770	UniProt
P07949	RET	K758R	K	758	R	127	loss	K->R: Loss of kinase activity. No effect on interaction with and dissociation from CBLC and CD2AP. ECO:0000269|PubMed:18753381, ECO:0000269|PubMed:21357690	UniProt
P08069	IGF1R	Y980F	Y	980	F	-	decrease	Y->F: Reduces tyrosine phosphorylation. Abolishes interaction with IRS1 and SHC1. Does not abolish interaction with PIK3R1, nor with GRB10. ECO:0000269|PubMed:10454568, ECO:0000269|PubMed:7541045	UniProt
P08069	IGF1R	K1033A	K	1033	A	127	loss	K->A: Kinase inactive. Abolishes tyrosine phosphorylation and abolishes interaction with IRS1, SHC1 and PIK3R1. ECO:0000269|PubMed:7541045	UniProt
P08581	MET	N375K	N	375	K	-	decrease	N -> K (found in lung cancer also including cases carrying EGFR mutations; unknown pathological significance; decreased hepatocyte growth factor-activated receptor activity; decreased interaction with HGF; dbSNP:rs776693512) ECO:0000269|PubMed:28294470	UniProt
P08581	MET	P991S	P	991	S	-	increase	P -> S (in gastric cancer; prolonged tyrosine phosphorylation in response to HGF/SF; transforming activity in athymic nude mice; dbSNP:rs768678989) ECO:0000269|PubMed:11042681	UniProt
P08581	MET	Y1234C	Y	1234	C	461	decrease	Y -> C (in DA11; not phosphorylated in reponse to HGF; severely decreased tyrosin kinase activity; dbSNP:rs1554400286) ECO:0000269|PubMed:30777867	UniProt
P08922	ROS1	Y2274F	Y	2274	F	-	decrease	Y->F: Loss of phosphorylation at Y-2274 and loss of interaction with PTPN11. ECO:0000269|PubMed:12538861	UniProt
P08922	ROS1	Y2334F	Y	2334	F	-	decrease	Y->F: Loss of phosphorylation at Y-2334 and loss of interaction with PTPN11. ECO:0000269|PubMed:12538861	UniProt
P09619	PDGFRB	L658P	L	658	P	184	loss	L -> P (in IBGC4; no effect on protein abundance; loss of PDGF beta receptor activity; dbSNP:rs397509381) ECO:0000269|PubMed:23255827, ECO:0000269|PubMed:24065723, ECO:0000269|PubMed:26599395	UniProt
P09619	PDGFRB	Y579F	Y	579	F	-	decrease	Y->F: Loss of kinase activity; when associated with F-581. Strongly reduces interaction with SRC family kinases. No effect on interaction with GRB10. ECO:0000269|PubMed:10454568, ECO:0000269|PubMed:7685273	UniProt
P09619	PDGFRB	Y581F	Y	581	F	-	decrease	Y->F: Loss of kinase activity; when associated with F-579. No effect on interaction with GRB10. ECO:0000269|PubMed:10454568, ECO:0000269|PubMed:7685273	UniProt
P09619	PDGFRB	K634A	K	634	A	127	loss	K->A,R: Loss of kinase activity. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity. ECO:0000269|PubMed:1314164, ECO:0000269|PubMed:1846866, ECO:0000269|PubMed:20494825	UniProt
P09619	PDGFRB	K634R	K	634	R	127	loss	K->A,R: Loss of kinase activity. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity. ECO:0000269|PubMed:1314164, ECO:0000269|PubMed:1846866, ECO:0000269|PubMed:20494825	UniProt
P09619	PDGFRB	Y857F	Y	857	F	462	decrease	Y->F: Reduces kinase activity. No effect on interaction with GRB10. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity. ECO:0000269|PubMed:10454568, ECO:0000269|PubMed:1314164, ECO:0000269|PubMed:1653029, ECO:0000269|PubMed:20494825	UniProt
P10721	KIT	D816V	D	816	V	452	activating	D -> V (in MASTSYS, MASTC and mast cell leukemia; somatic mutation; constitutively activated; loss of interaction with MPDZ; dbSNP:rs121913507) ECO:0000269|PubMed:11018522, ECO:0000269|PubMed:17595334, ECO:0000269|PubMed:19164557, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:19865100, ECO:0000269|PubMed:21640708, ECO:0000269|PubMed:7691885, ECO:0000269|PubMed:9990072	UniProt
P10721	KIT	Y823F	Y	823	F	462	activating	Y->F: No decrease in activity. Leads to autophosphorylation at Tyr-900. ECO:0000269|PubMed:20147452	UniProt
P11362	FGFR1	Y374C	Y	374	C	-	increase	Y -> C (in OGD; elevated basal activity and increased FGF2-mediated activity; dbSNP:rs121909631) ECO:0000269|PubMed:15625620	UniProt
P11362	FGFR1	N546K	N	546	K	203	activating	N -> K (in ECCL; somatic mutation; activating mutation; strongly increased speed of the first autophosphorylation and loss of the normal sequential order of autophosphorylation; dbSNP:rs779707422) ECO:0000269|PubMed:19224897, ECO:0000269|PubMed:26942290	UniProt
P11362	FGFR1	R577E	R	577	E	290	decrease	R->E: Strongly reduced autophosphorylation in response to FGF signaling. No effect on in vitro kinase activity. ECO:0000269|PubMed:20133753	UniProt
P11362	FGFR1	Y654F	Y	654	F	462	decrease	Y->F: Reduced kinase activity. Loss of autophosphorylation and kinase activity; when associated with F-653. ECO:0000269|PubMed:8622701	UniProt
P11362	FGFR1	Y766F	Y	766	F	-	decrease	Y->F: Abolishes interaction with PLCG1 and SHB. Decreases phosphorylation of FRS2, activation of RAS and 	UniProt
P11801	PSKH1	D218A	D	218	A	389	decrease	D->A: Loss of autophosphorylation. ECO:0000269|PubMed:11087665	UniProt
P11802	CDK4	T172A	T	172	A	511	decrease	T->A: Weak enzyme activity towards RB1, but no effect on binding of CCDN1 nor CCDN3. ECO:0000269|PubMed:16782892	UniProt
P11802	CDK4	P173S	P	173	S	512	decrease	P->S: No effect on in vitro phosphorylation by CDK7. Greatly reduced T-172 phosphorylation and enzyme activity. ECO:0000269|PubMed:19487459	UniProt
P22607	FGFR3	Y760F	Y	760	F	-	increase	Y->F: Minor effect on kinase activity. ECO:0000269|PubMed:11294897	UniProt
P15056	BRAF	V600E	V	600	E	449	activating	V -> E (in CRC; also found in sarcoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis; loss of regulation by PMRT5; dbSNP:rs113488022) ECO:0000269|PubMed:12068308, ECO:0000269|PubMed:12198537, ECO:0000269|PubMed:14500344, ECO:0000269|PubMed:16959974, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:21917714, ECO:0000269|PubMed:23263490, ECO:0000269|PubMed:24455489	UniProt
P15056	BRAF	M53D	M	53	D	-	decrease	M->D: Reduces interaction with KSR1 and MAP2K1 and thus phosphorylation of MAP2K1. ECO:0000269|PubMed:29433126	UniProt
P15056	BRAF	K88E	K	88	E	-	decrease	K->E: Reduces interaction with KSR1 and MAP2K1 and thus phosphorylation of MAP2K1. ECO:0000269|PubMed:29433126	UniProt
P15056	BRAF	R509H	R	509	H	185	loss	R->H: Loss of MAP2K1-mediated-BRAF-KSR1 dimerization. ECO:0000269|PubMed:29433126	UniProt
P15056	BRAF	K578R	K	578	R	391	loss	K->R: Blocks EGF-induced ubiquitination and ERK activation. ECO:0000269|PubMed:23907581	UniProt
P15056	BRAF	I666R	I	666	R	632	decrease	I->R: No effect on MAP2K1-mediated-BRAF-KSR1 dimerization, however loss of BRAF-mediated phosphorylation of MAP2K1. ECO:0000269|PubMed:29433126	UniProt
P16234	PDGFRA	Y731F	Y	731	F	-	decrease	Y->F: No effect on autophosphorylation and phosphorylation of PLCG1. Abolishes activation of phosphatidylinositol 3-kinase. ECO:0000269|PubMed:1646396	UniProt
P16234	PDGFRA	Y742F	Y	742	F	-	decrease	Y->F: No effect on autophosphorylation and phosphorylation of PLCG1. Abolishes activation of phosphatidylinositol 3-kinase. ECO:0000269|PubMed:1646396	UniProt
P17612	PRKACA	R195A	R	195	A	509	decrease	R->A: No phosphorylation. ECO:0000269|PubMed:12372837	UniProt
P17612	PRKACA	G201A	G	201	A	518	loss	G->A: No phosphorylation. ECO:0000269|PubMed:12372837	UniProt
P17612	PRKACA	T202A	T	202	A	521	loss	T->A: No phosphorylation. ECO:0000269|PubMed:12372837	UniProt
P17612	PRKACA	Y205A	Y	205	A	530	decrease	Y->A: Loss of allosteric regulation. ECO:0000269|PubMed:18178622	UniProt
P17948	FLT1	K861M	K	861	M	127	loss	K->M: Abolishes enzyme activity. Abolishes interaction with PLCG. ECO:0000269|PubMed:9299537	UniProt
P19525	EIF2AK2	M11L	M	11	L	-	decrease	M -> L (in LEUDEN; unknown pathological significance; reduced phosphorylation of eukaryotic translation initiation factor 2-alpha in patient cells) ECO:0000269|PubMed:32197074	UniProt
P19525	EIF2AK2	Y133F	Y	133	F	-	decrease	Y -> F (in LEUDEN; unknown pathological significance; reduced phosphorylation of eukaryotic translation initiation factor 2-alpha in patient cells) ECO:0000269|PubMed:32197074	UniProt
P19525	EIF2AK2	S461C	S	461	C	565	decrease	S -> C (in LEUDEN; unknown pathological significance; reduced phosphorylation of eukaryotic translation initiation factor 2-alpha in patient cells) ECO:0000269|PubMed:32197074	UniProt
P20594	NPR2	S76P	S	76	P	-	loss	S -> P (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; loss of localization to the plasma membrane; dbSNP:rs796065355) ECO:0000269|PubMed:24001744	UniProt
P20594	NPR2	R110C	R	110	C	-	loss	R -> C (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; retained in the endoplasmic reticulum; dbSNP:rs758478717) ECO:0000269|PubMed:24471569	UniProt
P20594	NPR2	R263P	R	263	P	-	loss	R -> P (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; loss of localization to the plasma membrane; dbSNP:rs139036657) ECO:0000269|PubMed:24001744	UniProt
P20594	NPR2	Q417E	Q	417	E	-	loss	Q -> E (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; no effect on cell surface expression; dbSNP:rs796065356) ECO:0000269|PubMed:24471569	UniProt
P20594	NPR2	L658F	L	658	F	438	decrease	L -> F (in AMD1; no effect on subcellular location; changed glycosylation; no effect on C-type natriuretic peptide binding; decreased guanylate cyclase activity; loss of natriuretic peptide receptor activity; dominant negative effect; dbSNP:rs1314542724) ECO:0000269|PubMed:17652215, ECO:0000269|PubMed:26980729	UniProt
P20594	NPR2	R819C	R	819	C	-	decrease	R -> C (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; no effect on cell surface expression; dbSNP:rs766256429) ECO:0000269|PubMed:24001744	UniProt
P20794	MAK	Y159F	Y	159	F	516	loss	Y->F: Abolishes autophosphorylation and impairs kinase activity. ECO:0000269|PubMed:21986944	UniProt
P21675	TAF1	E721Q	E	721	Q	-	decrease	E->Q: 25% decrease in histone acetylation. ECO:0000269|PubMed:15870300	UniProt
P21860	ERBB3	T873S	T	873	S	521	decrease	T -> S (in VSCN1; unknown pathological significance; some decrease in ERBB2 phosphorylation upon NG1 treatment, compared to wild-type; does not affect the subcellular localization at the cell membrane) ECO:0000269|PubMed:33497358	UniProt
P21860	ERBB3	Q932R	Q	932	R	674	decrease	Q -> R (in VSCN1; unknown pathological significance; some decrease in ERBB2 phosphorylation upon NG1 treatment, compared to wild-type; does not affect the subcellular localization at the cell membrane) ECO:0000269|PubMed:33497358	UniProt
P22455	FGFR4	G388R	G	388	R	-	increase	G -> R (in cancer cells, may be associated with accelerated disease progression and increased tumor cell motility, possibly due to increased stability of the protease MMP14; leads to phosphorylation at residue Y-390, resulting in prolonged FGFR4 activity; increases interaction with STAT3, resulting in STAT3 phosphorylation and signaling activation.; dbSNP:rs351855) ECO:0000269|PubMed:18670643, ECO:0000269|PubMed:18756523, ECO:0000269|PubMed:20876804, ECO:0000269|PubMed:21349172, ECO:0000269|PubMed:21882254, ECO:0000269|PubMed:26675719, ECO:0000269|Ref.7	UniProt
P22455	FGFR4	Y754F	Y	754	F	-	decrease	Y->F: Loss of interaction with PLCG1. ECO:0000269|PubMed:7518429	UniProt
P22607	FGFR3	K650M	K	650	M	509	activating	K -> M (in KERSEB, ACH, TD1 and SADDAN; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs121913105) ECO:0000269|PubMed:10053006, ECO:0000269|PubMed:10671061, ECO:0000269|PubMed:15772091, ECO:0000269|PubMed:17509076, ECO:0000269|PubMed:17561467, ECO:0000269|PubMed:9207791	UniProt
P22607	FGFR3	K650Q	K	650	Q	509	activating	K -> Q (in hypochondroplasia and BLC; in hypochondroplasia the form is milder than that seen in individuals with the K-540 or M-650 mutations; constitutively activated kinase; dbSNP:rs78311289) ECO:0000269|PubMed:11055896, ECO:0000269|PubMed:11314002, ECO:0000269|PubMed:8754806	UniProt
P22607	FGFR3	Y577F	Y	577	F	304	increase	Y->F: Minor effect on kinase activity. ECO:0000269|PubMed:11294897	UniProt
P00533	EGFR	L792R	L	792	R	268	resistance	-	COSMIC
P22607	FGFR3	Y770F	Y	770	F	-	increase	Y->F: Minor effect on kinase activity. Increased mitogen activity. ECO:0000269|PubMed:11294897	UniProt
P22694	PRKACB	H88R	H	88	R	170	increase	H -> R (in CAFD2; increased sensitivity to cAMP activation; dbSNP:rs768056300) ECO:0000269|PubMed:33058759	UniProt
P22694	PRKACB	G235R	G	235	R	602	increase	G -> R (in CAFD2; increased sensitivity to cAMP activation; decreased interaction with regulatory subunits PRKAR1A and PRKAR2B) ECO:0000269|PubMed:33058759	UniProt
P23443	RPS6KB1	T412E	T	412	E	-	increase	T->E: Mimics phosphorylation. Facilitates phosphorylation of T-252 by PDPK1; when associated with E-434; E-441; E-444 and E-447. Mimics phosphorylation. No effect on interaction with PDPK1 and phosphorylation of T-252. Impairs association with the eIF3 complex. ECO:0000269|PubMed:16286006, ECO:0000269|PubMed:19570988, ECO:0000269|PubMed:9445476	UniProt
P23458	JAK1	S703I	S	703	I	363	increase	S -> I (in AIIDE; increased activation of protein kinase activity; constitutive gain of function through the transactivation of associated JAK kinases; increased receptor signaling pathway via JAK-STAT) ECO:0000269|PubMed:32750333	UniProt
P24723	PRKCH	V374I	V	374	I	80	increase	V -> I (associated with susceptibility to ischemic stroke; increases autophosphorylation and kinase activity; dbSNP:rs2230500) ECO:0000269|PubMed:17206144, ECO:0000269|PubMed:17344846	UniProt
P25092	GUCY2C	D387G	D	387	G	-	decrease	D -> G (in MECIL; activation of guanylate cyclase activity is 60% lower than in wild-type; dbSNP:rs587776905) ECO:0000269|PubMed:22521417	UniProt
P25098	GRK2	D3K	D	3	K	-	decrease	D->K: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin. 60% reduction in phosphorylation of beta-2 adrenergic receptor ADRB2. Does not affect binding to ADRB2. Not activated by receptor binding. No effect on phosphorylation of the non-receptor substrate tubulin. ECO:0000269|PubMed:19715378	UniProt
P25098	GRK2	L4A	L	4	A	-	decrease	L->A: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin. 90% reduction in phosphorylation of beta-2 adrenergic receptor ADRB2. Does not affect binding to ADRB2. Not activated by receptor binding. No effect on phosphorylation of the non-receptor substrate tubulin. ECO:0000269|PubMed:19715378	UniProt
P25098	GRK2	D10A	D	10	A	-	decrease	D->A: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin and beta-2 adrenergic receptor ADRB2. Does not affect binding to ADRB2. Not activated by receptor binding. No effect on phosphorylation of the non-receptor substrate tubulin. ECO:0000269|PubMed:19715378	UniProt
P25440	BRD2	Q78A	Q	78	A	-	loss	Q->A: Loss of homodimerization. ECO:0000269|PubMed:17148447	UniProt
P25440	BRD2	Y153K	Y	153	K	-	loss	Y->K: Loss of homodimerization. ECO:0000269|PubMed:17148447	UniProt
P25440	BRD2	E170A	E	170	A	-	loss	E->A: Loss of homodimerization. ECO:0000269|PubMed:17148447	UniProt
P25440	BRD2	L174E	L	174	E	-	loss	L->E: Loss of homodimerization. ECO:0000269|PubMed:17148447	UniProt
P25440	BRD2	V177E	V	177	E	-	loss	V->E: Loss of homodimerization. ECO:0000269|PubMed:17148447	UniProt
P27448	MARK3	T211A	T	211	A	512	loss	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. ECO:0000269|PubMed:14976552	UniProt
P28482	MAPK1	I74N	I	74	N	177	increase	I -> N (in NS13; results in increased MAPK signaling; reduced interaction wth DUSP6; no effect on interaction with MAP2K1) ECO:0000269|PubMed:32721402	UniProt
P28482	MAPK1	H80Y	H	80	Y	194	increase	H -> Y (in NS13; results in increased MAPK signaling; reduced interaction wth DUSP6; no effect on interaction with MAP2K1) ECO:0000269|PubMed:32721402	UniProt
P28482	MAPK1	A174V	A	174	V	455	increase	A -> V (in NS13; results in increased MAPK signaling; increased translocation to the nucleus; reduced interaction wth DUSP6; no effect on interaction with MAP2K1) ECO:0000269|PubMed:32721402	UniProt
P28482	MAPK1	D318G	D	318	G	-	increase	D -> G (in NS13; results in increased MAPK signaling; increased translocation to the nucleus; reduced interaction wth DUSP6; no effect on interaction with MAP2K1) ECO:0000269|PubMed:32721402	UniProt
P28482	MAPK1	P323R	P	323	R	-	increase	P -> R (in NS13; results in increased MAPK signaling; increased translocation to the nucleus; reduced interaction wth DUSP6; no effect on interaction with MAP2K1) ECO:0000269|PubMed:32721402	UniProt
P28482	MAPK1	D318A	D	318	A	-	increase	D->A: Loss of dephosphorylation by PTPRJ. ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:19494114	UniProt
P29317	EPHA2	R103E	R	103	E	-	decrease	R->E: Significantly reduced response to EFNA1. ECO:0000269|PubMed:19525919	UniProt
P29317	EPHA2	D739N	D	739	N	389	increase	D->N: Increases serum-induced chemotaxis. Loss of EFNA1-dependent regulation of cell migration. ECO:0000269|PubMed:19573808	UniProt
P29317	EPHA2	S897D	S	897	D	-	loss	S->A,D: Loss of serum-induced phosphorylation by PKB. Loss of serum-induced chemotaxis. ECO:0000269|PubMed:19573808	UniProt
P29376	LTK	R241A	R	241	A	-	loss	R->A: Abolished homodimerization following interaction with ALKAL1. ECO:0000269|PubMed:34646012	UniProt
P29376	LTK	Y753F	Y	753	F	756	loss	Y->F: Abolishes interaction with PI3-kinase subunit p85, impairs PI3 kinase activity and leads to apoptosis (demonstrated with chimeric EGFR-LTK). ECO:0000269|PubMed:9223670	UniProt
P29597	TYK2	Y1054F	Y	1054	F	462	decrease	Y->F: Reduces basal catalytic activity and abolishes IFN-dependent activation. ECO:0000269|PubMed:8702790	UniProt
P29597	TYK2	Y1055F	Y	1055	F	463	decrease	Y->F: Reduces basal catalytic activity and abolishes IFN-dependent activation. ECO:0000269|PubMed:8702790	UniProt
P30530	AXL	E63R	E	63	R	-	decrease	E->R: Slightly reduced affinity for GAS6. ECO:0000269|PubMed:16362042	UniProt
P30530	AXL	E66R	E	66	R	-	decrease	E->R: Reduced affinity for GAS6. ECO:0000269|PubMed:16362042	UniProt
P30530	AXL	T84R	T	84	R	-	decrease	T->R: Reduced affinity for GAS6. ECO:0000269|PubMed:16362042	UniProt
P30530	AXL	K567M	K	567	M	127	loss	K->M: Catalytically inactive mutant. ECO:0000269|PubMed:28076778	UniProt
P31749	AKT1	R25C	R	25	C	-	decrease	R->A,C: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2. ECO:0000269|PubMed:12176338	UniProt
P31749	AKT1	K14A	K	14	A	-	decrease	K->A: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2. ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:19713527, ECO:0000269|PubMed:21775285	UniProt
P31749	AKT1	K14R	K	14	R	-	decrease	K->R: Substantial reduction of ubiquitination, phosphorylation at T-308 and S-473, AKT activation, loss of binding to PIP3 as well as IGF1-induced membrane recruitment. ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:19713527, ECO:0000269|PubMed:21775285	UniProt
P31749	AKT1	K20R	K	20	R	-	increase	K->R: Slight increase of phosphorylation at T-308 and S-473. ECO:0000269|PubMed:21775285	UniProt
P31749	AKT1	R25A	R	25	A	-	decrease	R->A,C: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2. ECO:0000269|PubMed:12176338	UniProt
P31749	AKT1	R86A	R	86	A	-	decrease	R->A: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2. ECO:0000269|PubMed:12176338	UniProt
P31749	AKT1	Y176F	Y	176	F	122	decrease	Y->F: Significant loss of interaction with TNK2. Loss of membrane localization. Significant reduction in phosphorylation on Ser-473. ECO:0000269|PubMed:20333297	UniProt
P31749	AKT1	T305A	T	305	A	509	increase	T->A: Reduces O-GlcNAc levels; Reduces O-GlcNAc levels even more; when associated with A-312. ECO:0000269|PubMed:22629392	UniProt
P31749	AKT1	T312A	T	312	A	521	increase	T->A: Reduces O-GlcNAc levels; Reduces O-GlcNAc levels even more; when associated with A-305. ECO:0000269|PubMed:22629392	UniProt
P31749	AKT1	Y474F	Y	474	F	-	decrease	Y->F: 55% inhibition of activation. ECO:0000269|PubMed:12149249	UniProt
P31751	AKT2	E17K	E	17	K	-	activating	E -> K (in HIHGHH; exhibits plasma membrane localization in serum-starved cells and produced inappropriate tonic nuclear exclusion of FOXO1 in preadipocytes; dbSNP:rs387906659) ECO:0000269|PubMed:21979934	UniProt
P31751	AKT2	R274H	R	274	H	388	increase	R -> H (in T2D; associated with typical metabolic dyslipidemia with elevated fastin triglyceride, high VLDL triglyceride/cholesterol ratios, low HDL cholesterol levels and high small dense LDL levels; de novo lipogenesis and liver fat are also significantly elevated in this subject; dbSNP:rs121434593) ECO:0000269|PubMed:15166380, ECO:0000269|PubMed:19164855	UniProt
P34925	RYK	N484F	N	484	F	443	increase	N->F: Gain of an autophosphorylation activity. Gain of an autophosphorylation activity; when associated with A-359. Gain of an autophosphorylation activity; when associated with G-334 and G-482. ECO:0000269|PubMed:10454588	UniProt
P34925	RYK	A485G	A	485	G	444	increase	A->G: Gain of an autophosphorylation activity. Gain of an autophosphorylation activity; when associated with G-334 and F-481. ECO:0000269|PubMed:10454588	UniProt
P34947	GRK5	K215R	K	215	R	127	decrease	K->R: Failed to phosphorylate p53/TP53. ECO:0000269|PubMed:20124405	UniProt
P35968	KDR	C482R	C	482	R	-	decrease	C -> R (in HCI; associated with disease susceptibility; expression of FLT1 in hemangioma endothelial cells is markedly reduced and KDR activity is increased compared to controls; low FLT1 expression in hemangioma cells is caused by reduced activity of a pathway involving ITGB1, ANTXR1, KDR and NFATC2IP; the mutation predicts to result in loss-of-function and disruption of the normal association of these molecules; dbSNP:rs34231037) ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:18931684	UniProt
P35968	KDR	Y801F	Y	801	F	-	loss	Y->F: Abolishes stimulation of nitric oxide synthesis. ECO:0000269|PubMed:17303569	UniProt
P35968	KDR	Y951F	Y	951	F	-	loss	Y->F: Abolishes reorganization of the actin cytoskeleton and cell migration in response to VEGFA. ECO:0000269|PubMed:15962004	UniProt
P36888	FLT3	Y589F	Y	589	F	-	decrease	Y->F: Reduced phosphorylation of the wild-type kinase in response to ligand binding. No effect on the phosphorylation of the constitutively activated mutant kinase variants. Abolishes activation of STAT5A. ECO:0000269|PubMed:16627759, ECO:0000269|PubMed:16684964, ECO:0000269|PubMed:9737679	UniProt
P36888	FLT3	Y591F	Y	591	F	-	decrease	Y->F: No significant effect on tyrosine phosphorylation. Abolishes activation of STAT5A. ECO:0000269|PubMed:16627759, ECO:0000269|PubMed:9737679	UniProt
P36888	FLT3	Y599F	Y	599	F	-	decrease	Y->F: Abolishes interaction with PTPN11/SHP2 and phosphorylation of PTPN11/SHP2. ECO:0000269|PubMed:16684964	UniProt
P36896	ACVR1B	I70A	I	70	A	-	decrease	I->A: Decreases binding to activin. ECO:0000269|PubMed:12665502	UniProt
P36896	ACVR1B	L75A	L	75	A	-	decrease	L->A: Decreases binding to activin. ECO:0000269|PubMed:12665502	UniProt
P36896	ACVR1B	P77A	P	77	A	-	decrease	P->A: Decreases binding to activin. ECO:0000269|PubMed:12665502	UniProt
P36897	TGFBR1	L193G	L	193	G	-	decrease	L->G: Loss of interaction with FKBP1A. ECO:0000269|PubMed:9233797	UniProt
P36897	TGFBR1	P194K	P	194	K	-	decrease	P->K: Loss of interaction with FKBP1A. ECO:0000269|PubMed:9233797	UniProt
P36897	TGFBR1	T200D	T	200	D	-	decrease	T->D: Loss of response to TGF-beta. ECO:0000269|PubMed:7774578	UniProt
P37173	TGFBR2	L308P	L	308	P	206	decrease	L -> P (in LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs28934568) ECO:0000269|PubMed:15235604, ECO:0000269|PubMed:20358619	UniProt
P37173	TGFBR2	N435S	N	435	S	563	decrease	N -> S (in a breast tumor; signaling of TGF-beta significantly inhibited) ECO:0000269|PubMed:11212236	UniProt
P37173	TGFBR2	D446N	D	446	N	582	decrease	D -> N (in LDS2; dbSNP:rs886039551) ECO:0000269|PubMed:16251899	UniProt
P37173	TGFBR2	V447A	V	447	A	583	decrease	V -> A (in a breast tumor; signaling of TGF-beta significantly inhibited) ECO:0000269|PubMed:11212236	UniProt
P37173	TGFBR2	S449F	S	449	F	585	decrease	S -> F (in LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs104893807) ECO:0000269|PubMed:15235604, ECO:0000269|PubMed:22113417	UniProt
P37173	TGFBR2	L452M	L	452	M	588	decrease	L -> M (in a breast tumor; signaling of TGF-beta significantly inhibited) ECO:0000269|PubMed:11212236	UniProt
P37173	TGFBR2	R537C	R	537	C	-	decrease	R -> C (in LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs104893809) ECO:0000269|PubMed:15235604	UniProt
P41279	MAP3K8	T290A	T	290	A	521	loss	T->A: Loss of MEK phosphorylation activity and almost abolished autophosphorylation activity. Loss of IL1-stimulated MEK phosphorylation activity but not of IL1-stimulated autophosphorylation activity. No effect on KSR2 binding. ECO:0000269|PubMed:15466476	UniProt
P41279	MAP3K8	T290D	T	290	D	521	decrease	T->D: Impaired MEK phosphorylation and autophosphorylation activities. No effect on KSR2 binding. ECO:0000269|PubMed:15466476	UniProt
P41279	MAP3K8	T290E	T	290	E	521	decrease	T->E: Loss of MEK phosphorylation activity and almost abolished autophosphorylation activity. No effect on KSR2 binding. ECO:0000269|PubMed:15466476	UniProt
P41743	PRKCI	D72A	D	72	A	-	decrease	D->A: Loss of interaction with ECT2, PARD6A and with SQSTM1. ECO:0000269|PubMed:15143057, ECO:0000269|PubMed:15590654, ECO:0000269|PubMed:19617897	UniProt
P43250	GRK6	N9A	N	9	A	-	loss	N->A: 140-fold defects in kinase activity. ECO:0000269|PubMed:20729810	UniProt
P43250	GRK6	L12A	L	12	A	-	loss	L->A: 1100-fold defects in kinase activity. ECO:0000269|PubMed:20729810	UniProt
P36507	MAP2K2	N126D	N	126	D	185	resistance	-	COSMIC
P43403	ZAP70	R192W	R	192	W	-	decrease	R -> W (in ADMIO2; decreases interaction with phosphorylated CD247; decreases ZAP70 phosphorylation; no effect on subcellular localization of CD69 at the cell surface; dbSNP:rs199840952) ECO:0000269|PubMed:26783323	UniProt
P43403	ZAP70	R360P	R	360	P	99	increase	R -> P (in ADMIO2; no effect on interaction with phosphorylated CD247; increases TCR-induced Y-319 and Y-493 phosphorylation of ZAP70 and phosphorylation of LAT and LCP2; increases subcellular localization of CD69 at the cell surface; weakly decreases autoinhibition conformation; dbSNP:rs869025224) ECO:0000269|PubMed:26783323	UniProt
P43405	SYK	S297A	S	297	A	-	decrease	S->A: Abolishes YWHAG binding. ECO:0000269|PubMed:21469132	UniProt
P43405	SYK	Y630F	Y	630	F	-	decrease	Y->F: Loss of interaction with BLNK. ECO:0000269|PubMed:18369315	UniProt
P45983	MAPK8	T183A	T	183	A	511	decrease	T->A: Phosphorylation blocked. ECO:0000269|PubMed:7839144	UniProt
P45983	MAPK8	Y185F	Y	185	F	516	decrease	Y->F: Phosphorylation blocked. ECO:0000269|PubMed:7839144	UniProt
P46734	MAP2K3	S218A	S	218	A	459	loss	S->A: Inactivation. ECO:0000269|PubMed:8622669	UniProt
P46734	MAP2K3	T222A	T	222	A	511	loss	T->A: Inactivation. ECO:0000269|PubMed:8622669	UniProt
P49336	CDK8	D173A	D	173	A	442	loss	D->A: Abrogates kinase activity and TFIIH-dependent transcriptional repression. ECO:0000269|PubMed:10993082, ECO:0000269|PubMed:30905399	UniProt
P49841	GSK3B	R96A	R	96	A	173	loss	R->A: Prevents the phosphorylation of phosphate-primed glycogen synthase. ECO:0000269|PubMed:11430833	UniProt
P49842	STK19	V134Y	V	134	Y	-	decrease	V->Y: Prevents inhibition by ZT-12-037-01 (1a) without affecting much the serine/threonine-protein kinase activity. ECO:0000269|PubMed:30712867	UniProt
P49842	STK19	L139V	L	139	V	-	decrease	L->V: Prevents inhibition by ZT-12-037-01 (1a) without affecting much the serine/threonine-protein kinase activity. ECO:0000269|PubMed:30712867	UniProt
P50750	CDK9	D167N	D	167	N	442	loss	D->N: Abrogates kinase activity. ECO:0000269|PubMed:10958691, ECO:0000269|PubMed:11145967	UniProt
P50750	CDK9	T186A	T	186	A	511	decrease	T->A: Abrogates autophosphorylation; no effect on kinase activity, but impaired CTD phosphorylation. ECO:0000269|PubMed:11145967, ECO:0000269|PubMed:18566585, ECO:0000269|PubMed:21448926	UniProt
P51451	BLK	A71T	A	71	T	-	decrease	A -> T (associated with MODY11; reduces the enhancing effect of BLK on insulin secretion; reduces the inducing effect of BLK on the expression of PDX1 and NKX6-1; found as somatic mutation in a colorectal adenocarcinoma sample; dbSNP:rs55758736) ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19667185	UniProt
P51817	PRKX	R283L	R	283	L	768	increase	R->L: Increases the affinity for PRKAR2A and PRKAR2B. ECO:0000269|PubMed:20819953	UniProt
P52564	MAP2K6	S207A	S	207	A	459	loss	S->A: Inactivation. 	UniProt
P52564	MAP2K6	T211A	T	211	A	511	loss	T->A: Inactivation. 	UniProt
P53350	PLK1	K82M	K	82	M	127	loss	K->M: Loss of kinase activity. No effect on S-phase progression. ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:12447691, ECO:0000269|PubMed:18174154, ECO:0000269|PubMed:24018379	UniProt
P53350	PLK1	K82R	K	82	R	127	loss	K->R: Loss of kinase activity. No effect on RIOK2-binding. ECO:0000269|PubMed:18615013, ECO:0000269|PubMed:19160488, ECO:0000269|PubMed:21880710	UniProt
P53350	PLK1	T210V	T	210	V	512	decrease	T->V: Reduced catalytic activity, but no effect on affinity for ATP. ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:12447691, ECO:0000269|PubMed:17461553, ECO:0000269|PubMed:18615013, ECO:0000269|PubMed:19160488	UniProt
P53355	DAPK1	S289E	S	289	E	-	decrease	S->E: Reduction in proapoptotic activity. 	UniProt
P53355	DAPK1	S308A	S	308	A	-	increase	S->A: Elevated Ca(2+)-calmodulin binding and Ca(2+)-calmodulin-independent kinase activity. Increases apoptotic activity. ECO:0000269|PubMed:11579085	UniProt
P53667	LIMK1	C84S	C	84	S	-	increase	C->S: Enhances actin aggregation. ECO:0000269|PubMed:10196227	UniProt
P53667	LIMK1	D460N	D	460	N	389	loss	D->N,A: Abrogates kinase activity. ECO:0000269|PubMed:10196227, ECO:0000269|PubMed:22328514	UniProt
P53667	LIMK1	D460A	D	460	A	389	loss	D->N,A: Abrogates kinase activity. ECO:0000269|PubMed:10196227, ECO:0000269|PubMed:22328514	UniProt
P53671	LIMK2	D451A	D	451	A	389	loss	D->A: Abrogates kinase activity. ECO:0000269|PubMed:22328514	UniProt
P53779	MAPK10	C462S	C	462	S	-	loss	C->S: Loss of palmitoylation. ECO:0000269|PubMed:21941371	UniProt
P53779	MAPK10	C463S	C	463	S	-	loss	C->S: Loss of palmitoylation. ECO:0000269|PubMed:21941371	UniProt
P54760	EPHB4	F867L	F	867	L	783	decrease	F -> L (in CMAVM2; loss of tyrosine phosphorylation; loss of interaction with RASA1; dbSNP:rs1584652949) ECO:0000269|PubMed:30578106	UniProt
P54760	EPHB4	L95R	L	95	R	-	decrease	L->R: Reduces binding affinity for EFNB2. ECO:0000269|PubMed:16867992	UniProt
P54762	EPHB1	Y594F	Y	594	F	-	decrease	Y->F: Loss of interaction with NCK1. ECO:0000269|PubMed:9430661	UniProt
P54762	EPHB1	Y600F	Y	600	F	-	decrease	Y->F: Loss of interaction with SHC1 and SRC. ECO:0000269|PubMed:12925710	UniProt
P54762	EPHB1	Y778F	Y	778	F	510	decrease	Y->F: Loss of interaction with SHC1. ECO:0000269|PubMed:12925710	UniProt
P54762	EPHB1	Y928F	Y	928	F	-	decrease	Y->F: Disrupts binding with the GRB10 SH2 domain, providing evidence for phosphorylation. Disrupts interaction with GRB7 and ACP1. ECO:0000269|PubMed:12223469, ECO:0000269|PubMed:8798570, ECO:0000269|PubMed:9499402	UniProt
P57059	SIK1	S186T	S	186	T	521	decrease	S->T: Does not autophosphorylation and kinase activity. ECO:0000269|PubMed:18348280	UniProt
P57059	SIK1	T473E	T	473	E	-	decrease	T->E: Reduced but still present interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit TORC activity. ECO:0000269|PubMed:29211348	UniProt
P57059	SIK1	S575A	S	575	A	-	decrease	S->A: Loss of interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit 	UniProt
P78527	PRKDC	L1510P	L	1510	P	-	decrease	L->P: Loss of interaction with C1D. ECO:0000269|PubMed:9679063	UniProt
P80192	MAP3K9	T305A	T	305	A	460	decrease	T->A: Little effect on threonine phosphorylation. Mildly impairs JNK activation. ECO:0000269|PubMed:15610029	UniProt
Q00535	CDK5	S159T	S	159	T	511	decrease	S->T: Impaired p35/p25 (CDK5R1) binding. ECO:0000269|PubMed:11583627	UniProt
Q00536	CDK16	S119A	S	119	A	-	decrease	S->A: Strongly reduces interaction with CCNY. ECO:0000269|PubMed:22184064	UniProt
Q14680	MELK	S171D	S	171	D	521	loss	S->D: Inactive. ECO:0000269|PubMed:16216881	UniProt
Q00536	CDK16	S153A	S	153	A	-	activating	S->A: Constitutively activated, due to loss of an inhibitory phosphorylation site. Increases interaction with CCNY. ECO:0000269|PubMed:22184064, ECO:0000269|PubMed:22798068	UniProt
Q00536	CDK16	S153D	S	153	D	-	decrease	S->D: Abolishes interaction with CCNY. ECO:0000269|PubMed:22184064, ECO:0000269|PubMed:22798068	UniProt
Q02156	PRKCE	S729A	S	729	A	-	decrease	S->A: Enhances T-566 dephosphorylation. ECO:0000269|PubMed:11964154	UniProt
Q02750	MAP2K1	K97R	K	97	R	127	loss	K->R: Loss of catalytic activity. No effect on BRAF-KSR1 or BRAF-KSR2 dimerization. ECO:0000269|PubMed:29433126, ECO:0000269|PubMed:8131746	UniProt
Q02750	MAP2K1	F311S	F	311	S	731	decrease	F->S: Loss of interaction with BRAF and KSR1. Loss of BRAF-KSR1 dimerization. ECO:0000269|PubMed:29433126	UniProt
Q02763	TEK	Y611C	Y	611	C	-	loss	Y -> C (in GLC3E; reduced response to ligand; loss of ligand-induced phosphorylation; no effect on basal membrane location; dbSNP:rs1306527531) ECO:0000269|PubMed:27270174	UniProt
Q02763	TEK	Y1102F	Y	1102	F	-	decrease	Y->F: Abolishes interaction with SHC1. ECO:0000269|PubMed:14665640	UniProt
Q02846	GUCY2D	A710V	A	710	V	532	loss	A -> V (in LCA1; loss of basal and GUCA1A-induced guanylate cyclase activity; does not affect endoplasmic reticulum membrane localization; dbSNP:rs781725943) ECO:0000269|PubMed:27475985, ECO:0000269|PubMed:30319355	UniProt
Q02846	GUCY2D	P873R	P	873	R	-	loss	P -> R (in CORD6; loss basal and GUCA1A-induced guanylate cyclase activity; does not affect endoplasmic reticulum membrane localization; dbSNP:rs1567961680) ECO:0000269|PubMed:30319355	UniProt
Q02846	GUCY2D	V902L	V	902	L	-	increase	V -> L (in LCA1; increases basal and GUCA1A-induced guanylate cyclase activity; inhibition by RD3 is less effective; does not affect endoplasmic reticulum membrane localization; dbSNP:rs1598150793) ECO:0000269|PubMed:30319355	UniProt
Q02846	GUCY2D	R822P	R	822	P	-	decrease	R->P: Fails to become activated by GUCA1A and by GUCA1B. Does not affect the binding to RP3. ECO:0000269|PubMed:26100624	UniProt
Q02846	GUCY2D	M823R	M	823	R	-	decrease	M->R: Fails to become activated by GUCA1A and by GUCA1B. Does not affect the binding to RP3. ECO:0000269|PubMed:26100624	UniProt
Q04759	PRKCQ	K409E	K	409	E	127	loss	K->A,E: Loss of kinase activity. ECO:0000269|PubMed:10652356	UniProt
Q04771	ACVR1	Q207D	Q	207	D	-	increase	Q->D: Strong induction of SMAD1 phosphorylation. ECO:0000269|PubMed:9748228	UniProt
Q05397	PTK2	Y397F	Y	397	F	-	decrease	Y->F: Abolishes autophosphorylation. Abolishes interaction with SRC and activation of BMX. Reduces phosphorylation of NEDD9. ECO:0000269|PubMed:11331870, ECO:0000269|PubMed:9360983	UniProt
Q05397	PTK2	V928G	V	928	G	-	decrease	V->G: Loss of interaction with TGFB1I1. ECO:0000269|PubMed:9756887	UniProt
Q05397	PTK2	L1034S	L	1034	S	-	decrease	L->S: Loss of interaction with TGFB1I1. ECO:0000269|PubMed:9756887	UniProt
Q05513	PRKCZ	D62A	D	62	A	-	decrease	D->A: Loss of interaction with SQSTM1 and PARD6B. ECO:0000269|PubMed:12887891	UniProt
Q05513	PRKCZ	D66A	D	66	A	-	decrease	D->A: Loss of interaction with SQSTM1 and PARD6B. ECO:0000269|PubMed:12887891	UniProt
Q06187	BTK	R520Q	R	520	Q	388	loss	R -> Q (in XLA; severe; prevents activation due to absence of contact between the catalytic loop and the regulatory phosphorylated residue; dbSNP:rs128621202) ECO:0000269|PubMed:7633429, ECO:0000269|PubMed:7809124, ECO:0000269|PubMed:7849697, ECO:0000269|PubMed:7880320	UniProt
Q06187	BTK	R525Q	R	525	Q	393	decrease	R -> Q (in XLA; severe; disturbs ATP-binding; dbSNP:rs128620183) ECO:0000269|PubMed:7809124, ECO:0000269|PubMed:9445504	UniProt
Q06187	BTK	E589G	E	589	G	592	decrease	E -> G (in XLA; moderate; interferes with substrate binding; dbSNP:rs128621206) ECO:0000269|PubMed:7809124, ECO:0000269|PubMed:7849721	UniProt
Q06187	BTK	G594E	G	594	E	602	decrease	G -> E (in XLA; mild; interferes with substrate binding) ECO:0000269|PubMed:7809124, ECO:0000269|PubMed:9445504	UniProt
Q06187	BTK	G613D	G	613	D	667	decrease	G -> D (in XLA; mild; interferes with substrate binding and/or domain interactions; dbSNP:rs128621209) ECO:0000269|PubMed:7809124, ECO:0000269|PubMed:7849721	UniProt
Q06187	BTK	Y617E	Y	617	E	672	decrease	Y->E: Defective in mediating calcium response. ECO:0000269|PubMed:15375214	UniProt
Q06418	TYRO3	I99R	I	99	R	-	loss	I->R: Abolishes dimerization. ECO:0000269|PubMed:14623883	UniProt
Q07912	TNK2	R34L	R	34	L	-	increase	R -> L (in a lung adenocarcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates; no effect on subcellular localization to perinuclear region) ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:20110370	UniProt
Q07912	TNK2	R99Q	R	99	Q	-	increase	R -> Q (in an ovarian mucinous carcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on subcellular localization to perinuclear region; dbSNP:rs113498671) ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:20110370	UniProt
Q07912	TNK2	E346K	E	346	K	666	increase	E -> K (in an ovarian endometrioid cancer sample; somatic mutation; undergoes autoactivation and causes phosphorylation on Y-284 leading to activation of AKT1; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on catalytic activity itself as the purified kinase domain has activity in vitro comparable to wild-type protein; no effect on subcellular localization to perinuclear region; dbSNP:rs970946035) ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:20110370, ECO:0000269|PubMed:20333297	UniProt
Q07912	TNK2	M409I	M	409	I	-	increase	M -> I (in a gastric adenocarcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on subcellular localization to perinuclear region) ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:20110370	UniProt
Q07912	TNK2	V638M	V	638	M	-	increase	V -> M (found in patients with childhood-onset epilepsy; unknown pathological significance; loss of interaction with NEDD4 and NEDD4L; increased protein abundance; dbSNP:rs201407161) ECO:0000269|PubMed:23686771	UniProt
Q08345	DDR1	R105A	R	105	A	-	decrease	R->A: Inhibits collagen-induced phosphorylation. ECO:0000269|PubMed:24509848	UniProt
Q08345	DDR1	N260Q	N	260	Q	-	decrease	N->Q: Phosphorylates in response to collagen, but at lower levels compared to wild-type. No activation in the absence of collagen. ECO:0000269|PubMed:24509848	UniProt
Q08345	DDR1	N371Q	N	371	Q	-	decrease	N->Q: Phosphorylates in response to collagen, but at lower levels compared to wild-type. No activation in the absence of collagen. ECO:0000269|PubMed:24509848	UniProt
Q08345	DDR1	N394Q	N	394	Q	-	decrease	N->Q: Phosphorylates in response to collagen, but at lower levels compared to wild-type. No activation in the absence of collagen. ECO:0000269|PubMed:24509848	UniProt
Q08345	DDR1	G707A	G	707	A	273	increase	G->A: Confers over 20-fold resistance to the ability of an inhibitor to inhibit autophosphorylation. ECO:0000269|PubMed:23899692	UniProt
Q08345	DDR1	Y740F	Y	740	F	342	decrease	Y->F: Abolishes interaction with PTPN11. ECO:0000269|PubMed:16337946	UniProt
Q08881	ITK	P288G	P	288	G	-	decrease	P->G: Complete loss of interaction with PPIA/CYPA. ECO:0000269|PubMed:15308100	UniProt
Q12979	ABR	V859A	V	859	A	-	decrease	V->A: Abolishes interaction with DLG4. No effect on synaptic localization. ECO:0000269|PubMed:20962234	UniProt
Q13131	PRKAA1	V307Q	V	307	Q	-	increase	V->G,Q: Activates the kinase activity. ECO:0000269|PubMed:17088252	UniProt
Q13153	PAK1	Y131C	Y	131	C	-	increase	Y -> C (in IDDMSSD; gain of function; enhanced PAK1 kinase activity and significantly reduced homodimerization; dbSNP:rs1565638316) ECO:0000269|PubMed:30290153	UniProt
Q13153	PAK1	Y429C	Y	429	C	529	increase	Y -> C (in IDDMSSD; gain-of-function; enhanced PAK1 kinase activity and significantly reduced homodimerization; dbSNP:rs1565583382) ECO:0000269|PubMed:30290153	UniProt
Q13163	MAP2K5	K195M	K	195	M	127	loss	K->M: Inactivation. ECO:0000269|PubMed:7759517	UniProt
Q13163	MAP2K5	S311A	S	311	A	459	loss	S->A: Inactivation. ECO:0000269|PubMed:7759517	UniProt
Q13163	MAP2K5	T315A	T	315	A	512	loss	T->A: Inactivation. ECO:0000269|PubMed:7759517	UniProt
Q13177	PAK2	E435K	E	435	K	592	loss	E -> K (in KNO2; loss of protein serine/threonine kinase activity) ECO:0000269|PubMed:33693784	UniProt
Q13315	ATM	H2554D	H	2554	D	-	loss	H -> D (in AT; lack of phosphorylation of target proteins) ECO:0000269|PubMed:19431188, ECO:0000269|PubMed:9463314	UniProt
Q13315	ATM	G2765S	G	2765	S	-	loss	G -> S (may contribute to breast cancer; lack of phosphorylation of target proteins; dbSNP:rs748634900) ECO:0000269|PubMed:10534763, ECO:0000269|PubMed:19431188	UniProt
Q13315	ATM	R3008C	R	3008	C	-	loss	R -> C (in AT; also found in T-prolymphocytic leukemia and mantle cell lymphoma; lack of phosphorylation of target proteins; dbSNP:rs587782292) ECO:0000269|PubMed:10706620, ECO:0000269|PubMed:10817650, ECO:0000269|PubMed:19431188, ECO:0000269|PubMed:9334731, ECO:0000269|PubMed:9488043, ECO:0000269|PubMed:9872980	UniProt
Q13315	ATM	S367A	S	367	A	-	loss	S->A: Loss of IR-induced S-367 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-1893 nor S-1981 autophosphorylation. ECO:0000269|PubMed:16858402	UniProt
Q13315	ATM	S1893A	S	1893	A	-	loss	S->A: Loss of IR-induced S-1893 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-367 nor S-1981 autophosphorylation. ECO:0000269|PubMed:16858402	UniProt
Q13315	ATM	S1981A	S	1981	A	-	loss	S->A: Loss of IR-induced S-1981 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-367 nor S-1893 autophosphorylation. No dimer disruption. ECO:0000269|PubMed:12556884, ECO:0000269|PubMed:16858402	UniProt
Q13315	ATM	S1981D	S	1981	D	-	activating	S->D,E: Disrupts the dimer. ECO:0000269|PubMed:12556884, ECO:0000269|PubMed:16858402	UniProt
Q13315	ATM	S1981E	S	1981	E	-	activating	S->D,E: Disrupts the dimer. ECO:0000269|PubMed:12556884, ECO:0000269|PubMed:16858402	UniProt
Q13315	ATM	K3016Q	K	3016	Q	-	activating	K->Q: Mimics acetylation, preventing dephosphorylation and subsequent ATM deactivation during the late stage of DNA damage response. ECO:0000269|PubMed:30944854	UniProt
Q13418	ILK	E359K	E	359	K	534	loss	E->K: Inactivation of ILK. ECO:0000269|PubMed:9736715	UniProt
Q13554	CAMK2B	E110K	E	110	K	323	increase	E -> K (in MRD54; decreased protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554402092) ECO:0000269|PubMed:29100089	UniProt
Q13554	CAMK2B	P139L	P	139	L	392	increase	P -> L (in MRD54; decreased protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554389088) ECO:0000269|PubMed:29100089	UniProt
Q13554	CAMK2B	E237K	E	237	K	674	increase	E -> K (in MRD54; no effect on protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554386687) ECO:0000269|PubMed:29100089	UniProt
Q13554	CAMK2B	K301E	K	301	E	-	loss	K -> E (in MRD54; no effect on protein abundance; loss of autophosphorylation; changed function in neuronal migration; dbSNP:rs1554385111) ECO:0000269|PubMed:29100089	UniProt
Q13882	PTK6	Y342A	Y	342	A	461	decrease	Y->A: 3-fold lower specific kinase activity. Decreased, but still significant, autophosphorylation. Decreased, but still significant, autophosphorylation; when associated with A-447. ECO:0000269|PubMed:12121988	UniProt
Q13882	PTK6	Y447F	Y	447	F	-	increase	Y->F: Decrease in transforming potential and increase in the kinase activity level. Decreased, but still significant, autophosphorylation; when associated with A-342. ECO:0000269|PubMed:12121988, ECO:0000269|PubMed:15471878, ECO:0000269|PubMed:8940083	UniProt
Q14012	CAMK1	K49A	K	49	A	127	loss	K->A: Catalytically inactive form; prevents CDK4 activation. ECO:0000269|PubMed:14754892, ECO:0000269|PubMed:7641687	UniProt
Q14012	CAMK1	T177D	T	177	D	512	increase	T->D: Partial activation in absence of CaMKK1. ECO:0000269|PubMed:7641687	UniProt
Q14164	IKBKE	K30A	K	30	A	92	decrease	K->A: Loss of ubiquitination and decreased kinase activity. No effect on homodimerization. ECO:0000269|PubMed:23453969	UniProt
Q14164	IKBKE	K30R	K	30	R	92	decrease	K->R: Loss of ubiquitination and decreased kinase activity. Decreases interaction with IKBKB, IKBKG and MYD88. No effect on homodimerization. ECO:0000269|PubMed:23453969	UniProt
Q14164	IKBKE	K401A	K	401	A	-	decrease	K->A: Loss of ubiquitination and decreased kinase activity. No effect on homodimerization. ECO:0000269|PubMed:23453969	UniProt
Q14164	IKBKE	K401R	K	401	R	-	decrease	K->R: Loss of ubiquitination and decreased kinase activity. Decreases interaction with IKBKB, IKBKG and MYD88. No effect on homodimerization. ECO:0000269|PubMed:23453969	UniProt
Q14289	PTK2B	Y402F	Y	402	F	-	loss	Y->F: Abolishes autophosphorylation. Abolishes interaction with SRC. ECO:0000269|PubMed:8849729	UniProt
Q14680	MELK	Y163F	Y	163	F	508	decrease	Y->F: Abolishes autophosphorylation on tyrosine but still active on exogenous substrates. ECO:0000269|PubMed:16216881	UniProt
Q14680	MELK	T167E	T	167	E	512	activating	T->D,E: Phosphomimetic mutant that has similar kinase activity as wild-type. ECO:0000269|PubMed:14976552	UniProt
Q15120	PDK3	R158H	R	158	H	-	activating	R -> H (in CMTX6; gain of function; results in a 5-fold increase in kinase activity, decreased sensitivity to pyruvate inhibition, reduced affinity for nucleotides and increased affinity for pyruvate dehydrogenase complex component E2 (PDC-E2), leading to PDC hyperphosphorylation and increased inactivation; dbSNP:rs397515323) ECO:0000269|PubMed:23297365	UniProt
Q15139	PRKD1	Y463F	Y	463	F	-	decrease	Y->F: Decreased phosphorylation level when coexpressed with either SRC or ABL in HeLa cells. Decreased kinase activity. ECO:0000269|PubMed:12637538	UniProt
Q15303	ERBB4	Y1056A	Y	1056	A	-	loss	Y->A: Abolishes interaction with NEDD4 and impairs ubiquitination. Promotes nuclear translocation of ERBB4 intracellular domain E4ICD1. ECO:0000269|PubMed:19561640	UniProt
Q15759	MAPK11	T180A	T	180	A	511	loss	T->A: Inactivation. ECO:0000269|PubMed:15356147	UniProt
Q15759	MAPK11	Y182F	Y	182	F	516	loss	Y->F: Inactivation. ECO:0000269|PubMed:15356147	UniProt
Q15831	STK11	G163D	G	163	D	358	decrease	G -> D (in TGCT; a tumor with seminoma and teratoma components; associated with severely impaired but detectable kinase activity; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; predominantly nuclear localization; dbSNP:rs137853078) ECO:0000269|PubMed:19892943, ECO:0000269|PubMed:9605748, ECO:0000269|PubMed:9887330	UniProt
Q15831	STK11	Q170P	Q	170	P	371	loss	Q -> P (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39) ECO:0000269|PubMed:19892943	UniProt
Q15831	STK11	G171S	G	171	S	372	loss	G -> S (in colorectal cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs1599926499) ECO:0000269|PubMed:19892943, ECO:0000269|PubMed:9731485	UniProt
Q15831	STK11	H174R	H	174	R	387	loss	H -> R (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39) ECO:0000269|PubMed:19892943	UniProt
Q15831	STK11	I177N	I	177	N	390	loss	I -> N (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs1057520041) ECO:0000269|PubMed:19892943	UniProt
Q15831	STK11	N181E	N	181	E	394	loss	N -> E (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; requires 2 nucleotide substitutions; dbSNP:rs1568707668) ECO:0000269|PubMed:19892943	UniProt
Q15831	STK11	S216F	S	216	F	521	loss	S -> F (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs1057520017) ECO:0000269|PubMed:19892943	UniProt
Q15831	STK11	E223V	E	223	V	534	loss	E -> V (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39) ECO:0000269|PubMed:19892943	UniProt
Q16288	NTRK3	T93M	T	93	M	-	decrease	T -> M (probable disease-associated variant found in patients with CHD; associated with CHD susceptibility; significantly reduced autophosphorylation; decreased NTRK3 signaling associated with decreased apoptosis in absence of NTF3; dbSNP:rs147992979) ECO:0000269|PubMed:25196463	UniProt
Q16512	PKN1	D451A	D	451	A	-	loss	D->A: Abolishes cleavage by caspase-3 and formation of 70 kDa fragment. ECO:0000269|PubMed:9751706	UniProt
Q16512	PKN1	D454A	D	454	A	-	loss	D->A: Abolishes cleavage by caspase-3 and formation of 70 kDa fragment. ECO:0000269|PubMed:9751706	UniProt
Q16512	PKN1	D558A	D	558	A	-	loss	D->A: Abolishes cleavage by caspase-3 and formation of AF3 fragment. ECO:0000269|PubMed:9751706	UniProt
Q16512	PKN1	D560A	D	560	A	-	loss	D->A: Abolishes cleavage by caspase-3 and formation of AF3 fragment. ECO:0000269|PubMed:9751706	UniProt
Q16513	PKN2	F977A	F	977	A	-	decrease	F->A,L: Abolishes interaction with PDPK1 and prevents the phosphorylation of AKT1 at 'Ser-473'. Reduces catalytic activity by 90%. ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:18835241	UniProt
Q16513	PKN2	F977L	F	977	L	-	decrease	F->A,L: Abolishes interaction with PDPK1 and prevents the phosphorylation of AKT1 at 'Ser-473'. Reduces catalytic activity by 90%. ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:18835241	UniProt
Q16513	PKN2	F977Y	F	977	Y	-	decrease	F->W,Y: Reduces catalytic activity by 50%. ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:18835241	UniProt
Q16513	PKN2	Y979L	Y	979	L	-	decrease	Y->F,L,W: Reduces catalytic activity by 25%. ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:18835241	UniProt
Q16513	PKN2	Y979W	Y	979	W	-	decrease	Y->F,L,W: Reduces catalytic activity by 25%. ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:18835241	UniProt
Q16539	MAPK14	D176A	D	176	A	456	increase	D->A: Emulation of the active state. Increase in activity; when associated with S-327 or L-327. ECO:0000269|PubMed:15284239	UniProt
Q16539	MAPK14	F327L	F	327	L	-	increase	F->L: Emulation of the active state. Increase in activity; when associated with A-176. ECO:0000269|PubMed:15284239	UniProt
Q16539	MAPK14	F327S	F	327	S	-	increase	F->S: Emulation of the active state. Increase in activity; when associated with A-176. ECO:0000269|PubMed:15284239	UniProt
Q16566	CAMK4	S189A	S	189	A	447	increase	S->A: Increases phosphorylation of CREB1 2-fold. Decreases total O-linked glycosylation 2-fold. Increases ATP-binding affinity. ECO:0000269|PubMed:19506079	UniProt
Q16832	DDR2	Y736F	Y	736	F	456	decrease	Y->F: Reduces autophosphorylation. Abolishes phosphorylation by SRC; when associated with F-740 and F-741. ECO:0000269|PubMed:16186108	UniProt
Q16832	DDR2	Y740F	Y	740	F	461	increase	Y->F: Promotes autophosphorylation. Abolishes phosphorylation by SRC; when associated with F-736 and F-741. ECO:0000269|PubMed:16186108	UniProt
Q16832	DDR2	Y741F	Y	741	F	462	decrease	Y->F: Reduces autophosphorylation. Abolishes phosphorylation by SRC; when associated with F-736 and F-740. ECO:0000269|PubMed:16186108	UniProt
Q2M2I8	AAK1	K74A	K	74	A	127	loss	K->A: Inhibits autophosphorylation and phosphorylation of AP2M1. Does not affect NUMB localization. Does not interact with monoubiquitinated NOTCH1. ECO:0000269|PubMed:12952931, ECO:0000269|PubMed:18657069, ECO:0000269|PubMed:21464124	UniProt
Q2M2I8	AAK1	D176A	D	176	A	389	loss	D->A: Inhibits autophosphorylation and phosphorylation of AP2M1. Does not affect NUMB localization. ECO:0000269|PubMed:12952931, ECO:0000269|PubMed:18657069	UniProt
Q38SD2	LRRK1	K746G	K	746	G	-	decrease	K->G: No effect on GTP-binding but reduction in subsequent stimulation of kinase activity. ECO:0000269|PubMed:16243488	UniProt
Q38SD2	LRRK1	F1022C	F	1022	C	-	loss	F->C: No effect on GTP-binding but loss of subsequent stimulation of kinase activity. ECO:0000269|PubMed:16243488	UniProt
Q38SD2	LRRK1	I1412T	I	1412	T	445	decrease	I->T: No effect on GTP-binding but reduction in subsequent stimulation of kinase activity. ECO:0000269|PubMed:16243488	UniProt
Q5S007	LRRK2	R1441C	R	1441	C	-	increase	R -> C (in PARK8; shows an increase in activity in both autophosphorylation and phosphorylation of a generic substrate; loss of interaction with SEC16A; shows an increase in activity in phosphorylation of RAB10; decreases phosphorylation-dependent binding to YWHAG; dbSNP:rs33939927) ECO:0000269|PubMed:15541309, ECO:0000269|PubMed:16157909, ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:16269541, ECO:0000269|PubMed:16333314, ECO:0000269|PubMed:16533964, ECO:0000269|PubMed:25201882, ECO:0000269|PubMed:26824392, ECO:0000269|PubMed:28202711, ECO:0000269|PubMed:29212815	UniProt
Q5S007	LRRK2	R1441H	R	1441	H	-	increase	R -> H (in PARK8; shows an increase in activity in phosphorylation of RAB8A and RAB10; decreases phosphorylation-dependent binding to YWHAG; dbSNP:rs34995376) ECO:0000269|PubMed:16157909, ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:26824392, ECO:0000269|PubMed:29212815	UniProt
Q5S007	LRRK2	C727D	C	727	D	-	decrease	C->D: Decreased kinase activity. Loss of RAB29-mediated activation and autophosphorylation of S-910, S-935, S-955, S-973 and S-1292. Decreased membrane association; when associated with G-1441, C-1699 and S-2019. ECO:0000269|PubMed:29212815	UniProt
Q5S007	LRRK2	L728D	L	728	D	-	decrease	L->D: Decreased kinase activity. Loss of RAB29-mediated activation and autophosphorylation of S-910, S-935, S-955, S-973 and S-1292. Decreased membrane association; when associated with G-1441, C-1699 and S-2019. ECO:0000269|PubMed:29212815	UniProt
Q5S007	LRRK2	L729D	L	729	D	-	decrease	L->D: Decreased kinase activity. Loss of RAB29-mediated activation and autophosphorylation of S-910, S-935, S-955, S-973 and S-1292. Decreased membrane association; when associated with G-1441, C-1699 and S-2019. ECO:0000269|PubMed:29212815	UniProt
Q5S007	LRRK2	K1347A	K	1347	A	-	loss	K->A: GTPase-dead mutant. Loss of interaction with SEC16A and impaired ability to recruit SEC16A to endoplasmic reticulum exit sites. ECO:0000269|PubMed:25201882	UniProt
Q5S007	LRRK2	K1906A	K	1906	A	127	loss	K->A: Loss of kinase activity. Decreases proteosomal degradation of MAPT; when associated with N-1994 and A-2017. ECO:0000269|PubMed:26014385	UniProt
Q5S007	LRRK2	D1994N	D	1994	N	389	loss	D->N: Loss of kinase activity. No loss of interaction with SEC16A and no loss of ability to recruit SEC16A to endoplasmic reticulum exit sites. Decreases proteosomal degradation of MAPT; when associated with A-1906 and A-2017. ECO:0000269|PubMed:25201882, ECO:0000269|PubMed:26014385, ECO:0000269|PubMed:26824392	UniProt
Q5S007	LRRK2	D2017A	D	2017	A	442	loss	D->A: Loss of kinase activity. Decreases proteosomal degradation of MAPT; when associated with A-1906 and N-1994. Loss of phosphorylation of RAB10; when associated with G-1441, C-1699, or S-2019. ECO:0000269|PubMed:26014385, ECO:0000269|PubMed:29125462, ECO:0000269|PubMed:29212815, ECO:0000269|PubMed:30635421	UniProt
Q6IQ55	TTBK2	K50E	K	50	E	127	loss	K->E,A: Leads to inactivation/destabilization of the protein. ECO:0000269|PubMed:21548880	UniProt
Q6IQ55	TTBK2	K50A	K	50	A	127	loss	K->E,A: Leads to inactivation/destabilization of the protein. ECO:0000269|PubMed:21548880	UniProt
Q6IQ55	TTBK2	K143E	K	143	E	391	loss	K->E,A: Leads to inactivation/destabilization of the protein. ECO:0000269|PubMed:21548880	UniProt
Q6IQ55	TTBK2	K143A	K	143	A	391	loss	K->E,A: Leads to inactivation/destabilization of the protein. ECO:0000269|PubMed:21548880	UniProt
Q6IQ55	TTBK2	R181A	R	181	A	508	loss	R->E,A: Impaired serine/threonine-protein kinase activity. ECO:0000269|PubMed:21548880	UniProt
Q6IQ55	TTBK2	A184G	A	184	G	511	loss	A->E,G: Impaired serine/threonine-protein kinase activity. ECO:0000269|PubMed:21548880	UniProt
Q7KZI7	MARK2	T208A	T	208	A	512	loss	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. ECO:0000269|PubMed:14976552	UniProt
Q86UE8	TLK2	D551G	D	551	G	274	decrease	D -> G (in MRD57; unknown pathological significance; exhibits abnormal perinuclear localization instead of diffuse nuclear localization; mildly impairs kinase activity; reduced phosphorylation of ASF1A; dbSNP:rs2082811958) ECO:0000269|PubMed:33323470	UniProt
Q8IU85	CAMK1D	K52A	K	52	A	127	loss	K->A: Catalytically inactive form. ECO:0000269|PubMed:16324104	UniProt
Q8IVH8	MAP4K3	K45E	K	45	E	127	loss	K->E: Loss of kinase activity and ability to activate JNK family. ECO:0000269|PubMed:9275185	UniProt
Q8IWQ3	BRSK2	T174A	T	174	A	512	loss	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:18339622, ECO:0000269|PubMed:22798068	UniProt
Q8IY84	NIM1K	T229E	T	229	E	512	activating	T->E: Constitutively active. ECO:0000269|PubMed:15733851	UniProt
Q8NB16	MLKL	K230M	K	230	M	127	loss	K->M: Abolishes ATP-binding. ECO:0000269|PubMed:24219132	UniProt
Q8NB16	MLKL	K331N	K	331	N	389	loss	K->N: Impairs ATP-binding. ECO:0000269|PubMed:24219132	UniProt
Q8NB16	MLKL	E351K	E	351	K	444	increase	E->K: Binds ATP with an enhanced affinity. ECO:0000269|PubMed:24219132	UniProt
Q8NG66	NEK11	K61R	K	61	R	127	loss	K->R: Loss of kinase activity. ECO:0000269|PubMed:12154088	UniProt
Q8TAS1	UHMK1	K54A	K	54	A	127	loss	K->A: Loss of kinase activity. ECO:0000269|PubMed:12093740	UniProt
Q8TD08	MAPK15	D155A	D	155	A	442	loss	D->A: Unable to induce the formation of autophagosomal structures. Is able to bind to MAP1LC3B and to colocalize with this protein to autophagosomal structures. Does not induce phosphorylation by methyl methanesulfonate. Loas of phosphorylation. Dominant negative mutant. Not phosphorylated at Thr-175 and Tyr-177. ECO:0000269|PubMed:16336213, ECO:0000269|PubMed:19166846, ECO:0000269|PubMed:22948227	UniProt
Q8TD08	MAPK15	T175A	T	175	A	511	loss	T->A: Loss of autophosphorylation and activity. Still heavily phosphorylated at Tyr-177. Does not rescues inhibition of O-glycosylation in MAPK15-depleted cells; when associated with F-177. ECO:0000269|PubMed:11875070, ECO:0000269|PubMed:16336213, ECO:0000269|PubMed:24618899	UniProt
Q8TDC3	BRSK1	T189A	T	189	A	512	loss	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. ECO:0000269|PubMed:14976552	UniProt
Q8TDR2	STK35	K231M	K	231	M	127	loss	K->M: No autophosphorylation. ECO:0000269|PubMed:11973348	UniProt
Q8TDX7	NEK7	Y28A	Y	28	A	-	decrease	Y->A: Significant decrease in catalytic activity; when associated with A-31. ECO:0000269|PubMed:19941817	UniProt
Q8TDX7	NEK7	L31A	L	31	A	-	decrease	L->A: Significant decrease in catalytic activity; when associated with A-28. ECO:0000269|PubMed:19941817	UniProt
Q8TDX7	NEK7	N90A	N	90	A	185	decrease	N->A: Reduced protein kinase activity. ECO:0000269|PubMed:26522158	UniProt
Q8TDX7	NEK7	N90R	N	90	R	185	decrease	N->R,K: Strongly reduced protein kinase activity. ECO:0000269|PubMed:26522158	UniProt
P00533	EGFR	C797G	C	797	G	274	resistance	-	COSMIC
Q8TDX7	NEK7	N90K	N	90	K	185	decrease	N->R,K: Strongly reduced protein kinase activity. ECO:0000269|PubMed:26522158	UniProt
Q8TDX7	NEK7	K96E	K	96	E	203	increase	K->E: Strongly increased protein kinase activity. ECO:0000269|PubMed:26522158	UniProt
Q8TDX7	NEK7	Y97L	Y	97	L	205	increase	Y->F,L: Moderate increase in catalytic activity. ECO:0000269|PubMed:19941817	UniProt
Q8TDX7	NEK7	M122A	M	122	A	285	decrease	M->A,R: Decreased interaction with NEK9 and subsequent activation of NEK7 kinase activity. ECO:0000269|PubMed:26522158	UniProt
Q8TDX7	NEK7	M122R	M	122	R	285	decrease	M->A,R: Decreased interaction with NEK9 and subsequent activation of NEK7 kinase activity. ECO:0000269|PubMed:26522158	UniProt
Q8TDX7	NEK7	R131A	R	131	A	314	loss	R->A,D: Abolished interaction with NEK9 and subsequent activation of NEK7 kinase activity. ECO:0000269|PubMed:26522158	UniProt
Q8TDX7	NEK7	R131D	R	131	D	314	loss	R->A,D: Abolished interaction with NEK9 and subsequent activation of NEK7 kinase activity. ECO:0000269|PubMed:26522158	UniProt
Q8TDX7	NEK7	L132D	L	132	D	315	loss	L->D: Abolished interaction with NEK9 and subsequent activation of NEK7 kinase activity. ECO:0000269|PubMed:26522158	UniProt
Q8TDX7	NEK7	R155E	R	155	E	371	decrease	R->E: Strongly reduced protein kinase activity. ECO:0000269|PubMed:26522158	UniProt
Q8TDX7	NEK7	S195A	S	195	A	512	loss	S->A: Abolished phosphorylation with NEK9 and protein kinase activity. ECO:0000269|PubMed:26522158	UniProt
Q8WZ42	TTN	K32207A	K	32207	A	-	loss	K->A: Disrupts catalytic activity. ECO:0000269|PubMed:9804419	UniProt
Q96GD4	AURKB	K215Q	K	215	Q	439	activating	K->Q: Mimics acetylation, promoting accurate chromosome segregation. ECO:0000269|PubMed:26829474	UniProt
Q96GD4	AURKB	K215R	K	215	R	439	loss	K->R: Abolished acetylation by KAT5, leading to impaired chromosome segregation. ECO:0000269|PubMed:26829474	UniProt
Q96L34	MARK4	T214A	T	214	A	512	loss	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. ECO:0000269|PubMed:14976552	UniProt
Q99683	MAP3K5	S966A	S	966	A	-	increase	S->A: Enhanced induction of apoptosis, increased kinase activity, and loss of YWHAG binding. ECO:0000269|PubMed:10411906, ECO:0000269|PubMed:15094778	UniProt
Q9BQI3	EIF2AK1	I448V	I	448	V	395	decrease	I -> V (in LEMSPAD; unknown pathological significance; mildly reduced phosphorylation of eukaryotic translation initiation factor 2-alpha; dbSNP:rs1583476115) ECO:0000269|PubMed:32197074	UniProt
Q9BRS2	RIOK1	D324A	D	324	A	-	loss	D->A: Abolishes autophosphorylation activity; enhances association with pre-40S ribosomal subunits; inhibits processing of 18S-E pre-rRNA to the mature 18S rRNA. ECO:0000269|PubMed:22072790	UniProt
Q9BVS4	RIOK2	K123A	K	123	A	-	loss	K->A: Abolishes autophosphorylation; impairs release of pre-40S trans-acting factors and rRNA processing; when associated with A-246. ECO:0000269|PubMed:19564402	UniProt
Q9BVS4	RIOK2	D246A	D	246	A	-	loss	D->A: Abolishes autophosphorylation; impairs release of pre-40S trans-acting factors and rRNA processing; when associated with A-123. ECO:0000269|PubMed:19564402	UniProt
Q9BX84	TRPM6	S141L	S	141	L	-	decrease	S -> L (in HOMG1; impairs heterodimer formation resulting in intracellular retention; dbSNP:rs121912625) ECO:0000269|PubMed:12032568, ECO:0000269|PubMed:14976260	UniProt
Q9BX84	TRPM6	L708P	L	708	P	-	loss	L -> P (in HOMG1; loss of function; no effect on cell membrane localization) ECO:0000269|PubMed:23942199	UniProt
Q9BX84	TRPM6	E872G	E	872	G	-	loss	E -> G (in HOMG1; loss of function; no effect on cell membrane localization) ECO:0000269|PubMed:23942199	UniProt
Q9BX84	TRPM6	Y1053C	Y	1053	C	-	loss	Y -> C (in HOMG1; loss of function; no effect on cell membrane localization) ECO:0000269|PubMed:23942199	UniProt
Q9BX84	TRPM6	L1143P	L	1143	P	-	loss	L -> P (in HOMG1; loss of function; no effect on cell membrane localization) ECO:0000269|PubMed:23942199	UniProt
Q9BX84	TRPM6	S1754N	S	1754	N	-	loss	S -> N (in HOMG1; loss of function; no effect on cell membrane localization) ECO:0000269|PubMed:23942199	UniProt
Q9BX84	TRPM6	T1851D	T	1851	D	-	loss	T->D: Significantly decreases autophosphorylation. Does not alter binding to RACK1 or inhibition by RACK1. ECO:0000269|PubMed:18258429	UniProt
Q9BXA6	TSSK6	D135N	D	135	N	389	loss	D->N: Loss of kinase activity. No effect of binding to TSACC. ECO:0000269|PubMed:15870294, ECO:0000269|PubMed:20829357	UniProt
Q9BXM7	PINK1	G309D	G	309	D	253	decrease	G -> D (in PARK6; fails to maintain mitochondrial membrane potential; full-length mutant has no effect on autophosphorylation; strongly reduces interaction with PRKN; decreases PRKN and SNCAIP ubiquitination and degradation; decreases Drp1 phosphorylation; dbSNP:rs74315355) ECO:0000269|PubMed:15087508, ECO:0000269|PubMed:16207731, ECO:0000269|PubMed:19229105, ECO:0000269|PubMed:20798600, ECO:0000269|PubMed:32484300	UniProt
Q9BXM7	PINK1	L347P	L	347	P	356	decrease	L -> P (in PARK6; strongly reduces interaction with PRKN; reduced ubiquitination of MIRO1; dbSNP:rs28940285) ECO:0000269|PubMed:15349870, ECO:0000269|PubMed:15596610, ECO:0000269|PubMed:20798600, ECO:0000269|PubMed:22396657, ECO:0000269|PubMed:22956510	UniProt
Q9BXM7	PINK1	P399L	P	399	L	505	decrease	P -> L (probable disease-associated variant found in early-onset Parkinson disease with digenic inheritance; found in a patient also carrying mutation S-39 in PARK7; decreases PRKN and SNCAIP ubiquitination and degradation; dbSNP:rs119451946) ECO:0000269|PubMed:16632486, ECO:0000269|PubMed:19229105	UniProt
Q9BXM7	PINK1	D384N	D	384	N	442	loss	D->N: Loss of activity. Abolishes Drp1 phosphorylation. No effect on localization to mitochondria. ECO:0000269|PubMed:32484300	UniProt
Q9BYP7	WNK3	D294A	D	294	A	442	loss	D->A: Catalytically inactive form. Inhibits sodium-coupled chloride cotransporters and activates potassium-coupled chloride cotransporters. ECO:0000269|PubMed:16275913, ECO:0000269|PubMed:21613606	UniProt
Q9BZL6	PRKD2	Y438D	Y	438	D	-	increase	Y->D: Slight increase in Tyr-717 phosphorylation. No effect on Ser-706 or/and Ser-710 phosphorylation. Increase in Tyr-717 phosphorylation; when associated with E-706 and E-710. ECO:0000269|PubMed:28428613	UniProt
Q9BZL6	PRKD2	Y438F	Y	438	F	-	decrease	Y->F: Loss of phosphorylation. No effect on phosphorylation of Tyr-717 and on Ser-706 or/and Ser-710 phosphorylation. ECO:0000269|PubMed:15604256, ECO:0000269|PubMed:28428613	UniProt
Q9H093	NUAK2	T208A	T	208	A	512	loss	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. ECO:0000269|PubMed:14976552	UniProt
Q9H0K1	SIK2	T175A	T	175	A	512	loss	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. ECO:0000269|PubMed:14976552	UniProt
P00533	EGFR	L792F	L	792	F	268	resistance	-	COSMIC
Q06187	BTK	C481R	C	481	R	274	resistance	-	COSMIC
Q9H2X6	HIPK2	K228A	K	228	A	127	loss	K->A: Locates in the nucleoplasm, no effect on interaction with RANBP9, but loss of kinase activity toward PML, RUNX1, EP300 and DAZAP2. ECO:0000269|PubMed:11267674, ECO:0000269|PubMed:11740489, ECO:0000269|PubMed:11925430, ECO:0000269|PubMed:12220523, ECO:0000269|PubMed:12874272, ECO:0000269|PubMed:12907596, ECO:0000269|PubMed:14678985, ECO:0000269|PubMed:18695000, ECO:0000269|PubMed:19015637, ECO:0000269|PubMed:33591310	UniProt
Q9H2X6	HIPK2	K228R	K	228	R	127	loss	K->R: Abolishes enzymatic activity, no effect on interaction with TP53 and TP73 or on BMP-induced transcriptional activation. Enhances BMP-induced transcriptional activation; when associated with 359-AAF-361. ECO:0000269|PubMed:11267674, ECO:0000269|PubMed:11740489, ECO:0000269|PubMed:11925430, ECO:0000269|PubMed:12220523, ECO:0000269|PubMed:12874272, ECO:0000269|PubMed:12907596, ECO:0000269|PubMed:14678985, ECO:0000269|PubMed:18695000, ECO:0000269|PubMed:19015637	UniProt
Q9H3Y6	SRMS	K258M	K	258	M	127	loss	K->M: Loss of kinase activity. Exhibits a diffused cytoplasmic localization. No effect on interaction with KHDRBS1 or VIM but abolishes tyrosine phosphorylation of both substrates. ECO:0000269|PubMed:23822091, ECO:0000269|PubMed:29496907	UniProt
Q9H3Y6	SRMS	Y380F	Y	380	F	461	decrease	Y->F: Significant reduction in phosphorylation. ECO:0000269|PubMed:23822091	UniProt
Q9H4B4	PLK3	T219E	T	219	E	512	loss	T->E: Kinase-defective mutant. ECO:0000269|PubMed:16478733	UniProt
Q9NRH2	SNRK	T173A	T	173	A	512	loss	T->A,E: Prevents phosphorylation and activation by STK11/LKB1 complex. ECO:0000269|PubMed:15733851	UniProt
Q9NRH2	SNRK	T173E	T	173	E	512	loss	T->A,E: Prevents phosphorylation and activation by STK11/LKB1 complex. ECO:0000269|PubMed:15733851	UniProt
Q9NWZ3	IRAK4	G298D	G	298	D	358	decrease	G -> D (in IMD67; decreases inhibition of NF-kappa-B complex activation; impairs neutrophil migration and phagocytosis; dbSNP:rs568782766) ECO:0000269|PubMed:19663824, ECO:0000269|PubMed:21057262, ECO:0000269|PubMed:24316379	UniProt
Q9P0L2	MARK1	T215A	T	215	A	512	loss	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. ECO:0000269|PubMed:14976552	UniProt
Q9UBE8	NLK	K167N	K	167	N	127	loss	K->N: Abrogates kinase activity. ECO:0000269|PubMed:20061393	UniProt
Q9UHD2	TBK1	S172A	S	172	A	512	loss	S->A: Loss of kinase activity. No effect on dimerization. Loss of localization to cytoplasmic spherical structures. ECO:0000269|PubMed:11839743, ECO:0000269|PubMed:23453972, ECO:0000269|PubMed:36640307	UniProt
Q9UHD2	TBK1	L316E	L	316	E	-	decrease	L->E: Decreases kinase activity. No effect on phosphorylation. ECO:0000269|PubMed:23453972	UniProt
Q9UL54	TAOK2	K57A	K	57	A	-	loss	K->A: Loss of kinase activity. In isoform 1, excluded from the nucleus. No effect on microtubule-binding. ECO:0000269|PubMed:10660600, ECO:0000269|PubMed:12639963, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:17158878	UniProt
Q9UL54	TAOK2	D169A	D	169	A	-	loss	D->A: Loss of kinase activity; No effect on MAP3K7-mediated activation of NF-kappa-B. ECO:0000269|PubMed:16893890	UniProt
Q9UPZ9	CILK1	T157A	T	157	A	511	decrease	T->A: Reduction of activity and loss of autophosphorylation. Loss of activity and autophosphorylation; when associated with F-159. ECO:0000269|PubMed:10699974	UniProt
Q9UPZ9	CILK1	Y159F	Y	159	F	516	decrease	Y->F: Reduction of activity and loss of autophosphorylation. Loss of activity and autophosphorylation; when associated with A-157. ECO:0000269|PubMed:10699974	UniProt
Q9UQM7	CAMK2A	F98S	F	98	S	283	decrease	F -> S (in MRD53; no effect on protein abundance; decreased autophosphorylation; decreased neuronal migration; dbSNP:rs1554122526) ECO:0000269|PubMed:29100089	UniProt
Q9UQM7	CAMK2A	E109D	E	109	D	323	increase	E -> D (in MRD53; no effect on protein abundance; increased autophosphorylation; decreased neuronal migration) ECO:0000269|PubMed:29100089	UniProt
Q9UQM7	CAMK2A	E183V	E	183	V	534	decrease	E -> V (in MRD53; increased ubiquitin-mediated proteasomal degradation with a dominant negative effect on wild-type protein; decreased localization to dendritic spines; no effect on holoenzyme assembly; loss of interaction with SHANK3; loss of interaction with GRIN2B; loss of interaction with CACNB2; loss of interaction with LRRC7; loss of interaction with GRM5; decreased protein serine/threonine kinase activity with a dominant negative effect on wild-type protein; decreased autophosphorylation; changed dendritic spine development; decreased neuronal migration; dbSNP:rs1554122129) ECO:0000269|PubMed:28130356, ECO:0000269|PubMed:29100089	UniProt
Q9UQM7	CAMK2A	H282R	H	282	R	-	increase	H -> R (in MRD53; decreased protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554121875) ECO:0000269|PubMed:29100089	UniProt
Q9Y243	AKT3	T305D	T	305	D	512	increase	T->D: 2-fold increase of phosphorylation steady state level, no activation after pervanadate treatment. ECO:0000269|PubMed:11387345	UniProt
Q9Y243	AKT3	S472D	S	472	D	-	increase	S->D: 1.4-fold increase of phosphorylation steady state level, 50% decrease of activity after pervanadate treatment. ECO:0000269|PubMed:10092583	UniProt
Q9Y2K2	SIK3	R187C	R	187	C	388	decrease	R -> C (in SEMDK; decreased protein expression; decreased kinase activity; no effect on the interaction with DEPTOR, MLST8/GbetaL, RICTOR and RPTOR; dbSNP:rs1565460853) ECO:0000269|PubMed:30232230	UniProt
Q9Y2K2	SIK3	T221A	T	221	A	512	loss	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. ECO:0000269|PubMed:14976552	UniProt
Q9Y463	DYRK1B	R102C	R	102	C	-	decrease	R -> C (in AOMS3; accumulation of intracellular lipid is significantly greater than with wild-type protein; cells expressing the variant are able to transform into mature adipocytes without requiring adipogenic medium; expression levels of CEBPA, PPARG forms 1 and 2 and PPARGC1A are higher and those of GLI1 and CDKN1B are lower in cells transfected with the mutant protein compared to wild-type; WNT1 signaling activity is lower in mutant cells compared to wild-type; dbSNP:rs367643250) ECO:0000269|PubMed:24827035	UniProt
Q9Y572	RIPK3	K50A	K	50	A	127	loss	K->A: Abolishes kinase activity. Loss of PGAM5- and MLKL-binding. No effect on RIPK1-binding. Loss of interaction with PELI1 and PELI1-mediated ubiquitination. No loss of STUB1-mediated ubiquitination. ECO:0000269|PubMed:10339433, ECO:0000269|PubMed:10358032, ECO:0000269|PubMed:22265414, ECO:0000269|PubMed:29883609	UniProt
Q9Y572	RIPK3	T182A	T	182	A	521	loss	T->A: Abolishes kinase activity. Loss of interaction with PELI1 and PELI1-mediated ubiquitination. No loss of interaction with STUB1 and STUB1-mediated ubiquitination. No loss of interaction with RIPK1. Loss of ability to mediate TNF-induced necroptosis. Loss of autophosphorylation at Ser-227. ECO:0000269|PubMed:29883609	UniProt
Q9Y572	RIPK3	S227A	S	227	A	623	decrease	S->A: Abolishes ability to mediate necroptosis. Partial loss of kinase activity. No loss of PELI1-mediated degradation. ECO:0000269|PubMed:22265413, ECO:0000269|PubMed:29883609	UniProt
Q04771	ACVR1	R206H	R	206	H	-	activating	35442931,29128351,25722188,23861958,24705252,24852373,20463014,22408652,22579779,16642017; constitutively-active	UniProt
Q06187	BTK	E41K	E	41	K	-	activating	32272741,20623551,9333013,9736610,10196129,10352268,11751885,12835482,16585544; constitutively-active	UniProt
P31749	AKT1	S473D	S	473	D	-	activating	35115496,34178653,32371868,20489726; constitutively-active	UniProt
P06239	LCK	Y505F	Y	505	F	-	activating	20826747,1292628,8397196,15199125; constitutively-active	UniProt
O60674	JAK2	R683G	R	683	G	402	activating	26216197,23748007,23452118,20585391; constitutively-active	UniProt
P29597	TYK2	V678F	V	678	F	211	activating	16239216,17011030,18456658; constitutively-active	UniProt
P11362	FGFR1	K656E	K	656	E	509	activating	32187553,29683947,26942290; constitutively-active	UniProt
Q13418	ILK	S343D	S	343	D	447	activating	24260102,17088456; constitutively-active	UniProt
Q02750	MAP2K1	K57E	K	57	E	-	activating	32387835,31827134; constitutively-active	UniProt
Q02750	MAP2K1	Q56P	Q	56	P	-	activating	32387835,31827134; constitutively-active	UniProt
P22607	FGFR3	G382D	G	382	D	-	activating	11429702,16467200; constitutively-active	UniProt
P22607	FGFR3	G375C	G	375	C	-	activating	31804721,12009017; constitutively-active	UniProt
P06241	FYN	Y531F	Y	531	F	-	activating	24860422,15713745; constitutively-active	UniProt
P04626	ERBB2	V659E	V	659	E	-	activating	31431454,16489002; constitutively-active	UniProt
O00141	SGK1	S429D	S	429	D	-	activating	15845389,16036218; constitutively-active	UniProt
P31749	AKT1	T308D	T	308	D	512	activating	15845389,16036218; constitutively-active	UniProt
Q8TDC3	BRSK1	T189E	T	189	E	512	activating	22020259; constitutively-active	UniProt
Q04771	ACVR1	Q207E	Q	207	E	-	activating	24852373; constitutively-active	UniProt
P23458	JAK1	S646F	S	646	F	185	activating	23791841; constitutively-active	UniProt
P16234	PDGFRA	V536E	V	536	E	-	activating	30253204; constitutively-active	UniProt
P16234	PDGFRA	I537D	I	537	D	-	activating	30253204; constitutively-active	UniProt
P15056	BRAF	V600F	V	600	F	449	activating	25348715; constitutively-active	UniProt
P12931	SRC	Y530F	Y	530	F	-	activating	16909109; constitutively-active	UniProt
P06493	CDK1	Y15F	Y	15	F	41	activating	23741412; constitutively-active	UniProt
P04626	ERBB2	Q646C	Q	646	C	-	activating	24791013; constitutively-active	UniProt
P00533	EGFR	G652R	G	652	R	-	activating	36148499; constitutively-active	UniProt
O60674	JAK2	K539A	K	539	A	-	activating	22584586; constitutively-active	UniProt
O60674	JAK2	H574R	H	574	R	114	activating	26216197; constitutively-active	UniProt
O60674	JAK2	H345L	H	345	L	-	activating	30259120; constitutively-active	UniProt
Q5S007	LRRK2	G2019S	G	2019	S	444	activating	34419621,32550012,32926469,29038245,29311810,30150626,26931464,24916379,25009464,22952710,21454543,21698001,21806997,22110348; constitutively-active	UniProt
P52333	JAK3	A572V	A	572	V	174	activating	29986854,24928228,22705984,18829468; constitutively-active	UniProt
P10721	KIT	N822K	N	822	K	461	activating	31217744,14695343,15621809,15911092; constitutively-active	UniProt
P10721	KIT	L576P	L	576	P	-	activating	19723893,19802003,21595858; constitutively-active	UniProt
P22607	FGFR3	A391E	A	391	E	-	activating	26244699,19165726; constitutively-active	UniProt
P21802	FGFR2	C342Y	C	342	Y	-	activating	35651944,15781477; constitutively-active	UniProt
P09619	PDGFRB	N666H	N	666	H	203	activating	28726812; constitutively-active	UniProt
P07949	RET	Y606C	Y	606	C	-	activating	18248647; constitutively-active	UniProt
O60674	JAK2	S523L	S	523	L	-	activating	32956452; constitutively-active	UniProt
P10721	KIT	T670I	T	670	I	266	resistance	-	COSMIC
P00533	EGFR	T790M	T	790	M	266	resistance	-	COSMIC
P10721	KIT	V654A	V	654	A	202	resistance	-	COSMIC
P00519	ABL1	T315I	T	315	I	266	resistance	-	COSMIC
P00519	ABL1	G250E	G	250	E	38	resistance	-	COSMIC
P00519	ABL1	Y253H	Y	253	H	41	resistance	-	COSMIC
P00519	ABL1	E255K	E	255	K	43	resistance	-	COSMIC
Q9UM73	ALK	L1196M	L	1196	M	266	resistance	-	COSMIC
P16234	PDGFRA	D842V	D	842	V	452	resistance	-	COSMIC
P10721	KIT	N822K	N	822	K	461	resistance	-	COSMIC
P10721	KIT	Y823D	Y	823	D	462	resistance	-	COSMIC
Q06187	BTK	C481S	C	481	S	274	resistance	-	COSMIC
P00533	EGFR	L718Q	L	718	Q	36	resistance	-	COSMIC
P00533	EGFR	C797S	C	797	S	274	resistance	-	COSMIC
P21802	FGFR2	N549K	N	549	K	203	resistance	-	COSMIC
P21802	FGFR2	V395D	V	395	D	-	resistance	-	COSMIC
P21802	FGFR2	L617M	L	617	M	365	resistance	-	COSMIC
Q9UM73	ALK	G1202R	G	1202	R	273	resistance	-	COSMIC
P10721	KIT	D816H	D	816	H	452	resistance	-	COSMIC
P10721	KIT	D820Y	D	820	Y	459	resistance	-	COSMIC
P00519	ABL1	F317L	F	317	L	268	resistance	-	COSMIC
P21802	FGFR2	V564F	V	564	F	266	resistance	-	COSMIC
Q06187	BTK	C481Y	C	481	Y	274	resistance	-	COSMIC
P11362	FGFR1	N546K	N	546	K	203	resistance	-	COSMIC
P10721	KIT	N822Y	N	822	Y	461	resistance	-	COSMIC
Q9UM73	ALK	I1171N	I	1171	N	179	resistance	-	COSMIC
P36507	MAP2K2	C125S	C	125	S	184	resistance	-	COSMIC
P10721	KIT	D820G	D	820	G	459	resistance	-	COSMIC
P15056	BRAF	V600E	V	600	E	449	resistance	-	COSMIC
P00533	EGFR	G796D	G	796	D	273	resistance	-	COSMIC
P00533	EGFR	L718V	L	718	V	36	resistance	-	COSMIC
P21802	FGFR2	E565A	E	565	A	267	resistance	-	COSMIC
P21802	FGFR2	N549H	N	549	H	203	resistance	-	COSMIC
P36888	FLT3	F691L	F	691	L	266	resistance	-	COSMIC
P36888	FLT3	D835H	D	835	H	452	resistance	-	COSMIC
P08581	MET	Y1230H	Y	1230	H	456	resistance	-	COSMIC
P00533	EGFR	G719A	G	719	A	37	resistance	-	COSMIC
P10721	KIT	D820E	D	820	E	459	resistance	-	COSMIC
P00519	ABL1	D276G	D	276	G	135	resistance	-	COSMIC
Q9UM73	ALK	F1174L	F	1174	L	184	resistance	-	COSMIC
P10721	KIT	K642E	K	642	E	176	resistance	-	COSMIC
P36507	MAP2K2	F57C	F	57	C	-	resistance	-	COSMIC
P00533	EGFR	L747P	L	747	P	129	resistance	-	COSMIC
P10721	KIT	C809G	C	809	G	441	resistance	-	COSMIC
P22455	FGFR4	V550L	V	550	L	266	resistance	-	COSMIC
P08581	MET	D1228N	D	1228	N	452	resistance	-	COSMIC
Q02750	MAP2K1	P124L	P	124	L	195	resistance	-	COSMIC
P36507	MAP2K2	V35M	V	35	M	-	resistance	-	COSMIC
P22455	FGFR4	V550M	V	550	M	266	resistance	-	COSMIC
P42345	MTOR	F2108L	F	2108	L	-	resistance	-	COSMIC
P21802	FGFR2	K659M	K	659	M	509	resistance	-	COSMIC
Q9UM73	ALK	C1156Y	C	1156	Y	136	resistance	-	COSMIC
Q02750	MAP2K1	V60E	V	60	E	-	resistance	-	COSMIC
P36888	FLT3	D835Y	D	835	Y	452	resistance	-	COSMIC
Q9UM73	ALK	F1174V	F	1174	V	184	resistance	-	COSMIC
P15056	BRAF	L505H	L	505	H	179	resistance	-	COSMIC
P08581	MET	Y1230C	Y	1230	C	456	resistance	-	COSMIC
P00519	ABL1	F311I	F	311	I	259	resistance	-	COSMIC
Q9UM73	ALK	S1206F	S	1206	F	284	resistance	-	COSMIC
Q02750	MAP2K1	G128V	G	128	V	203	resistance	-	COSMIC
Q02750	MAP2K1	C121S	C	121	S	184	resistance	-	COSMIC
P08581	MET	D1228V	D	1228	V	452	resistance	-	COSMIC
P08581	MET	Y1230S	Y	1230	S	456	resistance	-	COSMIC
P04626	ERBB2	S310Y	S	310	Y	-	resistance	-	COSMIC
P00533	EGFR	L792V	L	792	V	268	resistance	-	COSMIC
P21802	FGFR2	N549T	N	549	T	203	resistance	-	COSMIC
P00533	EGFR	G796S	G	796	S	273	resistance	-	COSMIC
P00533	EGFR	L792P	L	792	P	268	resistance	-	COSMIC
P10721	KIT	N655T	N	655	T	203	resistance	-	COSMIC
P21802	FGFR2	K641R	K	641	R	439	resistance	-	COSMIC
P00533	EGFR	D761Y	D	761	Y	173	resistance	-	COSMIC
P21802	FGFR2	L617V	L	617	V	365	resistance	-	COSMIC
Q02750	MAP2K1	G128D	G	128	D	203	resistance	-	COSMIC
Q02750	MAP2K1	P124S	P	124	S	195	resistance	-	COSMIC
Q02750	MAP2K1	E203K	E	203	K	428	resistance	-	COSMIC
P36507	MAP2K2	E207K	E	207	K	428	resistance	-	COSMIC
P36507	MAP2K2	L46F	L	46	F	-	resistance	-	COSMIC
P10721	KIT	D716N	D	716	N	-	resistance	-	COSMIC
Q02750	MAP2K1	K57E	K	57	E	-	resistance	-	COSMIC
P08581	MET	D1228H	D	1228	H	452	resistance	-	COSMIC
P21802	FGFR2	M537I	M	537	I	177	resistance	-	COSMIC
P10721	KIT	D816G	D	816	G	452	resistance	-	COSMIC
Q02750	MAP2K1	K57N	K	57	N	-	resistance	-	COSMIC
P36507	MAP2K2	Q60P	Q	60	P	-	resistance	-	COSMIC
P36888	FLT3	D835I	D	835	I	452	resistance	-	COSMIC
Q02750	MAP2K1	K57T	K	57	T	-	resistance	-	COSMIC
P29322	EPHA8	S457P	S	457	P	-	neutral	AC/AN:0.88932 ; Hom/AC:0.20792	gnomAD
P29322	EPHA8	L492F	L	492	F	-	neutral	AC/AN:0.18058 ; Hom/AC:0.05123	gnomAD
P29322	EPHA8	E612Q	E	612	Q	-	neutral	AC/AN:0.21325 ; Hom/AC:0.05150	gnomAD
Q15418	RPS6KA1	K243T	K	243	T	580	neutral	AC/AN:0.50458 ; Hom/AC:0.12063	gnomAD
Q15418	RPS6KA1	K324T	K	324	T	-	neutral	AC/AN:0.50458 ; Hom/AC:0.12063	gnomAD
Q15418	RPS6KA1	K335T	K	335	T	-	neutral	AC/AN:0.50458 ; Hom/AC:0.12063	gnomAD
Q15418	RPS6KA1	K243T	K	243	T	580	neutral	AC/AN:0.50458 ; Hom/AC:0.12063	gnomAD
Q15418	RPS6KA1	K319T	K	319	T	791	neutral	AC/AN:0.50458 ; Hom/AC:0.12063	gnomAD
Q15418	RPS6KA1	K344T	K	344	T	-	neutral	AC/AN:0.50458 ; Hom/AC:0.12063	gnomAD
Q15418	RPS6KA1	N112Y	N	112	Y	174	neutral	AC/AN:0.21583 ; Hom/AC:0.06027	gnomAD
O95382	MAP3K6	G1233A	G	1233	A	-	neutral	AC/AN:0.10044 ; Hom/AC:0.05152	gnomAD
O95382	MAP3K6	G1225A	G	1225	A	-	neutral	AC/AN:0.10044 ; Hom/AC:0.05152	gnomAD
O95382	MAP3K6	G49A	G	49	A	-	neutral	AC/AN:0.10044 ; Hom/AC:0.05152	gnomAD
O95382	MAP3K6	G1233A	G	1233	A	-	neutral	AC/AN:0.10044 ; Hom/AC:0.05152	gnomAD
O95382	MAP3K6	N622K	N	622	K	-	neutral	AC/AN:0.51193 ; Hom/AC:0.13321	gnomAD
O95382	MAP3K6	N614K	N	614	K	-	neutral	AC/AN:0.51193 ; Hom/AC:0.13321	gnomAD
O95382	MAP3K6	N346K	N	346	K	-	neutral	AC/AN:0.51193 ; Hom/AC:0.13321	gnomAD
O95382	MAP3K6	N622K	N	622	K	-	neutral	AC/AN:0.51193 ; Hom/AC:0.13321	gnomAD
O95382	MAP3K6	T455I	T	455	I	-	neutral	AC/AN:0.74595 ; Hom/AC:0.17898	gnomAD
O95382	MAP3K6	T447I	T	447	I	-	neutral	AC/AN:0.74595 ; Hom/AC:0.17898	gnomAD
O95382	MAP3K6	T179I	T	179	I	-	neutral	AC/AN:0.74595 ; Hom/AC:0.17898	gnomAD
O95382	MAP3K6	T455I	T	455	I	-	neutral	AC/AN:0.74595 ; Hom/AC:0.17898	gnomAD
O95382	MAP3K6	V207G	V	207	G	-	neutral	AC/AN:0.03254 ; Hom/AC:0.05581	gnomAD
O95382	MAP3K6	V199G	V	199	G	-	neutral	AC/AN:0.03254 ; Hom/AC:0.05581	gnomAD
O95382	MAP3K6	V207G	V	207	G	-	neutral	AC/AN:0.03254 ; Hom/AC:0.05581	gnomAD
Q32MK0	MYLK3	R45Q	R	45	Q	-	neutral	AC/AN:0.03575 ; Hom/AC:0.06229	gnomAD
Q32MK0	MYLK3	R89Q	R	89	Q	-	neutral	AC/AN:0.03575 ; Hom/AC:0.06229	gnomAD
Q32MK0	MYLK3	R45Q	R	45	Q	-	neutral	AC/AN:0.03575 ; Hom/AC:0.06229	gnomAD
Q32MK0	MYLK3	R89Q	R	89	Q	-	neutral	AC/AN:0.03575 ; Hom/AC:0.06229	gnomAD
Q32MK0	MYLK3	R45Q	R	45	Q	-	neutral	AC/AN:0.03575 ; Hom/AC:0.06229	gnomAD
Q8N2I9	STK40	A395T	A	395	T	-	neutral	AC/AN:0.47319 ; Hom/AC:0.11256	gnomAD
Q8N2I9	STK40	A400T	A	400	T	-	neutral	AC/AN:0.47319 ; Hom/AC:0.11256	gnomAD
Q8N2I9	STK40	A395T	A	395	T	-	neutral	AC/AN:0.47319 ; Hom/AC:0.11256	gnomAD
Q5JZY3	EPHA10	G244E	G	244	E	-	neutral	AC/AN:0.32070 ; Hom/AC:0.08330	gnomAD
Q5JZY3	EPHA10	G749E	G	749	E	350	neutral	AC/AN:0.32070 ; Hom/AC:0.08330	gnomAD
Q5JZY3	EPHA10	F281I	F	281	I	-	neutral	AC/AN:0.72042 ; Hom/AC:0.16031	gnomAD
Q5JZY3	EPHA10	T220K	T	220	K	-	neutral	AC/AN:0.09279 ; Hom/AC:0.08134	gnomAD
Q6P0Q8	MAST2	G1468A	G	1468	A	-	neutral	AC/AN:0.11771 ; Hom/AC:0.05223	gnomAD
Q6P0Q8	MAST2	G1278A	G	1278	A	-	neutral	AC/AN:0.11771 ; Hom/AC:0.05223	gnomAD
Q6P0Q8	MAST2	D1551G	D	1551	G	-	neutral	AC/AN:0.17180 ; Hom/AC:0.05170	gnomAD
Q6P0Q8	MAST2	D1361G	D	1361	G	-	neutral	AC/AN:0.17180 ; Hom/AC:0.05170	gnomAD
Q01973	ROR1	T518M	T	518	M	169	neutral	AC/AN:0.71010 ; Hom/AC:0.16383	gnomAD
O96013	PAK4	C22S	C	22	S	-	neutral	AC/AN:0.18396 ; Hom/AC:0.11271	gnomAD
Q58F21	BRDT	K238N	K	238	N	-	neutral	AC/AN:0.24883 ; Hom/AC:0.09343	gnomAD
Q58F21	BRDT	K165N	K	165	N	-	neutral	AC/AN:0.24883 ; Hom/AC:0.09343	gnomAD
Q58F21	BRDT	K192N	K	192	N	-	neutral	AC/AN:0.24883 ; Hom/AC:0.09343	gnomAD
Q58F21	BRDT	K238N	K	238	N	-	neutral	AC/AN:0.24883 ; Hom/AC:0.09343	gnomAD
Q58F21	BRDT	N410K	N	410	K	-	neutral	AC/AN:0.48628 ; Hom/AC:0.12083	gnomAD
Q58F21	BRDT	N337K	N	337	K	-	neutral	AC/AN:0.48628 ; Hom/AC:0.12083	gnomAD
Q58F21	BRDT	N364K	N	364	K	-	neutral	AC/AN:0.48628 ; Hom/AC:0.12083	gnomAD
Q58F21	BRDT	N410K	N	410	K	-	neutral	AC/AN:0.48628 ; Hom/AC:0.12083	gnomAD
P16066	NPR1	R939Q	R	939	Q	-	neutral	AC/AN:0.18491 ; Hom/AC:0.05437	gnomAD
P14616	INSRR	P928L	P	928	L	-	neutral	AC/AN:0.37614 ; Hom/AC:0.08625	gnomAD
Q07002	CDK18	G67R	G	67	R	-	neutral	AC/AN:0.17997 ; Hom/AC:0.05679	gnomAD
Q07002	CDK18	G46R	G	46	R	-	neutral	AC/AN:0.17997 ; Hom/AC:0.05679	gnomAD
Q07002	CDK18	G67R	G	67	R	-	neutral	AC/AN:0.17997 ; Hom/AC:0.05679	gnomAD
Q14164	IKBKE	A602V	A	602	V	-	neutral	AC/AN:0.23145 ; Hom/AC:0.14858	gnomAD
Q14164	IKBKE	A517V	A	517	V	-	neutral	AC/AN:0.23145 ; Hom/AC:0.14858	gnomAD
Q14164	IKBKE	P713L	P	713	L	-	neutral	AC/AN:0.45776 ; Hom/AC:0.11190	gnomAD
Q14164	IKBKE	P628L	P	628	L	-	neutral	AC/AN:0.45776 ; Hom/AC:0.11190	gnomAD
P49137	MAPKAPK2	G51V	G	51	V	-	neutral	AC/AN:0.02575 ; Hom/AC:0.06265	gnomAD
Q96NX5	CAMK1G	V329I	V	329	I	-	neutral	AC/AN:0.42860 ; Hom/AC:0.10153	gnomAD
P51955	NEK2	N354S	N	354	S	168	neutral	AC/AN:0.35664 ; Hom/AC:0.08258	gnomAD
P51955	NEK2	N311S	N	311	S	-	neutral	AC/AN:0.35664 ; Hom/AC:0.08258	gnomAD
Q5VT25	CDC42BPA	V1304I	V	1304	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V1276I	V	1276	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V1317I	V	1317	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V1339I	V	1339	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V1223I	V	1223	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V1304I	V	1304	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V202I	V	202	I	390	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V529I	V	529	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V633I	V	633	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V507I	V	507	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V1284I	V	1284	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VST9	OBSCN	A908T	A	908	T	-	neutral	AC/AN:0.80204 ; Hom/AC:0.18220	gnomAD
Q5VST9	OBSCN	A1000T	A	1000	T	-	neutral	AC/AN:0.80204 ; Hom/AC:0.18220	gnomAD
Q5VST9	OBSCN	C170G	C	170	G	-	neutral	AC/AN:0.02710 ; Hom/AC:0.07446	gnomAD
Q5VST9	OBSCN	C1698G	C	1698	G	-	neutral	AC/AN:0.02710 ; Hom/AC:0.07446	gnomAD
Q5VST9	OBSCN	A1532V	A	1532	V	-	neutral	AC/AN:0.67259 ; Hom/AC:0.15117	gnomAD
Q5VST9	OBSCN	A188V	A	188	V	-	neutral	AC/AN:0.67259 ; Hom/AC:0.15117	gnomAD
Q5VST9	OBSCN	A1532V	A	1532	V	-	neutral	AC/AN:0.67259 ; Hom/AC:0.15117	gnomAD
Q5VST9	OBSCN	A1716V	A	1716	V	-	neutral	AC/AN:0.67259 ; Hom/AC:0.15117	gnomAD
Q5VST9	OBSCN	A1601T	A	1601	T	-	neutral	AC/AN:0.05925 ; Hom/AC:0.07780	gnomAD
Q5VST9	OBSCN	A257T	A	257	T	-	neutral	AC/AN:0.05925 ; Hom/AC:0.07780	gnomAD
Q5VST9	OBSCN	A1601T	A	1601	T	-	neutral	AC/AN:0.05925 ; Hom/AC:0.07780	gnomAD
Q5VST9	OBSCN	A1785T	A	1785	T	-	neutral	AC/AN:0.05925 ; Hom/AC:0.07780	gnomAD
Q5VST9	OBSCN	N93D	N	93	D	-	neutral	AC/AN:0.84674 ; Hom/AC:0.18630	gnomAD
Q5VST9	OBSCN	N2674D	N	2674	D	-	neutral	AC/AN:0.84674 ; Hom/AC:0.18630	gnomAD
Q5VST9	OBSCN	R2529Q	R	2529	Q	-	neutral	AC/AN:0.10895 ; Hom/AC:0.09175	gnomAD
Q5VST9	OBSCN	R1376Q	R	1376	Q	-	neutral	AC/AN:0.10895 ; Hom/AC:0.09175	gnomAD
Q5VST9	OBSCN	R377Q	R	377	Q	-	neutral	AC/AN:0.10895 ; Hom/AC:0.09175	gnomAD
Q5VST9	OBSCN	R2529Q	R	2529	Q	-	neutral	AC/AN:0.10895 ; Hom/AC:0.09175	gnomAD
Q5VST9	OBSCN	R2958Q	R	2958	Q	-	neutral	AC/AN:0.10895 ; Hom/AC:0.09175	gnomAD
Q5VST9	OBSCN	V2720M	V	2720	M	-	neutral	AC/AN:0.66269 ; Hom/AC:0.15329	gnomAD
Q5VST9	OBSCN	V1567M	V	1567	M	-	neutral	AC/AN:0.66269 ; Hom/AC:0.15329	gnomAD
Q5VST9	OBSCN	V568M	V	568	M	-	neutral	AC/AN:0.66269 ; Hom/AC:0.15329	gnomAD
Q5VST9	OBSCN	V2720M	V	2720	M	-	neutral	AC/AN:0.66269 ; Hom/AC:0.15329	gnomAD
Q5VST9	OBSCN	V3149M	V	3149	M	-	neutral	AC/AN:0.66269 ; Hom/AC:0.15329	gnomAD
Q5VST9	OBSCN	R2812W	R	2812	W	-	neutral	AC/AN:0.10741 ; Hom/AC:0.07645	gnomAD
Q5VST9	OBSCN	R1659W	R	1659	W	-	neutral	AC/AN:0.10741 ; Hom/AC:0.07645	gnomAD
Q5VST9	OBSCN	R660W	R	660	W	-	neutral	AC/AN:0.10741 ; Hom/AC:0.07645	gnomAD
Q5VST9	OBSCN	R2812W	R	2812	W	-	neutral	AC/AN:0.10741 ; Hom/AC:0.07645	gnomAD
Q5VST9	OBSCN	R88W	R	88	W	-	neutral	AC/AN:0.10741 ; Hom/AC:0.07645	gnomAD
Q5VST9	OBSCN	R3241W	R	3241	W	-	neutral	AC/AN:0.10741 ; Hom/AC:0.07645	gnomAD
Q5VST9	OBSCN	A3300T	A	3300	T	-	neutral	AC/AN:0.66563 ; Hom/AC:0.15151	gnomAD
Q5VST9	OBSCN	A2147T	A	2147	T	-	neutral	AC/AN:0.66563 ; Hom/AC:0.15151	gnomAD
Q5VST9	OBSCN	A419T	A	419	T	-	neutral	AC/AN:0.66563 ; Hom/AC:0.15151	gnomAD
Q5VST9	OBSCN	A3300T	A	3300	T	-	neutral	AC/AN:0.66563 ; Hom/AC:0.15151	gnomAD
Q5VST9	OBSCN	A576T	A	576	T	-	neutral	AC/AN:0.66563 ; Hom/AC:0.15151	gnomAD
Q5VST9	OBSCN	A3729T	A	3729	T	-	neutral	AC/AN:0.66563 ; Hom/AC:0.15151	gnomAD
Q5VST9	OBSCN	E3372D	E	3372	D	-	neutral	AC/AN:0.11689 ; Hom/AC:0.09493	gnomAD
Q5VST9	OBSCN	E2219D	E	2219	D	-	neutral	AC/AN:0.11689 ; Hom/AC:0.09493	gnomAD
Q5VST9	OBSCN	E491D	E	491	D	-	neutral	AC/AN:0.11689 ; Hom/AC:0.09493	gnomAD
Q5VST9	OBSCN	E3372D	E	3372	D	-	neutral	AC/AN:0.11689 ; Hom/AC:0.09493	gnomAD
Q5VST9	OBSCN	E648D	E	648	D	-	neutral	AC/AN:0.11689 ; Hom/AC:0.09493	gnomAD
Q5VST9	OBSCN	E3801D	E	3801	D	-	neutral	AC/AN:0.11689 ; Hom/AC:0.09493	gnomAD
Q5VST9	OBSCN	S3373C	S	3373	C	-	neutral	AC/AN:0.11774 ; Hom/AC:0.09494	gnomAD
Q5VST9	OBSCN	S2220C	S	2220	C	-	neutral	AC/AN:0.11774 ; Hom/AC:0.09494	gnomAD
Q5VST9	OBSCN	S492C	S	492	C	-	neutral	AC/AN:0.11774 ; Hom/AC:0.09494	gnomAD
Q5VST9	OBSCN	S3373C	S	3373	C	-	neutral	AC/AN:0.11774 ; Hom/AC:0.09494	gnomAD
Q5VST9	OBSCN	S649C	S	649	C	-	neutral	AC/AN:0.11774 ; Hom/AC:0.09494	gnomAD
Q5VST9	OBSCN	S3802C	S	3802	C	-	neutral	AC/AN:0.11774 ; Hom/AC:0.09494	gnomAD
Q5VST9	OBSCN	T3726P	T	3726	P	-	neutral	AC/AN:0.03822 ; Hom/AC:0.05159	gnomAD
Q5VST9	OBSCN	T2573P	T	2573	P	-	neutral	AC/AN:0.03822 ; Hom/AC:0.05159	gnomAD
Q5VST9	OBSCN	T845P	T	845	P	-	neutral	AC/AN:0.03822 ; Hom/AC:0.05159	gnomAD
Q5VST9	OBSCN	T3726P	T	3726	P	-	neutral	AC/AN:0.03822 ; Hom/AC:0.05159	gnomAD
Q5VST9	OBSCN	T1002P	T	1002	P	-	neutral	AC/AN:0.03822 ; Hom/AC:0.05159	gnomAD
Q5VST9	OBSCN	T4155P	T	4155	P	-	neutral	AC/AN:0.03822 ; Hom/AC:0.05159	gnomAD
Q5VST9	OBSCN	T1089M	T	1089	M	-	neutral	AC/AN:0.42870 ; Hom/AC:0.10311	gnomAD
Q5VST9	OBSCN	T1246M	T	1246	M	-	neutral	AC/AN:0.42870 ; Hom/AC:0.10311	gnomAD
Q5VST9	OBSCN	T4399M	T	4399	M	-	neutral	AC/AN:0.42870 ; Hom/AC:0.10311	gnomAD
Q5VST9	OBSCN	G4039R	G	4039	R	-	neutral	AC/AN:0.94104 ; Hom/AC:0.22601	gnomAD
Q5VST9	OBSCN	G1673R	G	1673	R	-	neutral	AC/AN:0.94104 ; Hom/AC:0.22601	gnomAD
Q5VST9	OBSCN	G1158R	G	1158	R	-	neutral	AC/AN:0.94104 ; Hom/AC:0.22601	gnomAD
Q5VST9	OBSCN	G4039R	G	4039	R	-	neutral	AC/AN:0.94104 ; Hom/AC:0.22601	gnomAD
Q5VST9	OBSCN	G4996R	G	4996	R	-	neutral	AC/AN:0.94104 ; Hom/AC:0.22601	gnomAD
Q5VST9	OBSCN	H4489Q	H	4489	Q	-	neutral	AC/AN:0.44226 ; Hom/AC:0.10041	gnomAD
Q5VST9	OBSCN	H2123Q	H	2123	Q	-	neutral	AC/AN:0.44226 ; Hom/AC:0.10041	gnomAD
Q5VST9	OBSCN	H1608Q	H	1608	Q	-	neutral	AC/AN:0.44226 ; Hom/AC:0.10041	gnomAD
Q5VST9	OBSCN	H4489Q	H	4489	Q	-	neutral	AC/AN:0.44226 ; Hom/AC:0.10041	gnomAD
Q5VST9	OBSCN	H5446Q	H	5446	Q	-	neutral	AC/AN:0.44226 ; Hom/AC:0.10041	gnomAD
Q5VST9	OBSCN	R4534H	R	4534	H	-	neutral	AC/AN:0.60081 ; Hom/AC:0.15512	gnomAD
Q5VST9	OBSCN	R2168H	R	2168	H	-	neutral	AC/AN:0.60081 ; Hom/AC:0.15512	gnomAD
Q5VST9	OBSCN	R1653H	R	1653	H	-	neutral	AC/AN:0.60081 ; Hom/AC:0.15512	gnomAD
Q5VST9	OBSCN	R4534H	R	4534	H	-	neutral	AC/AN:0.60081 ; Hom/AC:0.15512	gnomAD
Q5VST9	OBSCN	R5491H	R	5491	H	-	neutral	AC/AN:0.60081 ; Hom/AC:0.15512	gnomAD
Q5VST9	OBSCN	R4662C	R	4662	C	-	neutral	AC/AN:0.11184 ; Hom/AC:0.09937	gnomAD
Q5VST9	OBSCN	R2296C	R	2296	C	-	neutral	AC/AN:0.11184 ; Hom/AC:0.09937	gnomAD
Q5VST9	OBSCN	R1781C	R	1781	C	-	neutral	AC/AN:0.11184 ; Hom/AC:0.09937	gnomAD
Q5VST9	OBSCN	R4662C	R	4662	C	-	neutral	AC/AN:0.11184 ; Hom/AC:0.09937	gnomAD
Q5VST9	OBSCN	R5619C	R	5619	C	-	neutral	AC/AN:0.11184 ; Hom/AC:0.09937	gnomAD
Q5VST9	OBSCN	G4666S	G	4666	S	-	neutral	AC/AN:0.43487 ; Hom/AC:0.10504	gnomAD
Q5VST9	OBSCN	G2300S	G	2300	S	-	neutral	AC/AN:0.43487 ; Hom/AC:0.10504	gnomAD
Q5VST9	OBSCN	G1785S	G	1785	S	-	neutral	AC/AN:0.43487 ; Hom/AC:0.10504	gnomAD
Q5VST9	OBSCN	G4666S	G	4666	S	-	neutral	AC/AN:0.43487 ; Hom/AC:0.10504	gnomAD
Q5VST9	OBSCN	G5623S	G	5623	S	-	neutral	AC/AN:0.43487 ; Hom/AC:0.10504	gnomAD
Q5VST9	OBSCN	L5269V	L	5269	V	-	neutral	AC/AN:0.85074 ; Hom/AC:0.19160	gnomAD
Q5VST9	OBSCN	L2903V	L	2903	V	-	neutral	AC/AN:0.85074 ; Hom/AC:0.19160	gnomAD
Q5VST9	OBSCN	L2388V	L	2388	V	-	neutral	AC/AN:0.85074 ; Hom/AC:0.19160	gnomAD
Q5VST9	OBSCN	L5269V	L	5269	V	-	neutral	AC/AN:0.85074 ; Hom/AC:0.19160	gnomAD
Q5VST9	OBSCN	L6226V	L	6226	V	-	neutral	AC/AN:0.85074 ; Hom/AC:0.19160	gnomAD
Q5VST9	OBSCN	R5575H	R	5575	H	-	neutral	AC/AN:0.30265 ; Hom/AC:0.07811	gnomAD
Q5VST9	OBSCN	R3209H	R	3209	H	-	neutral	AC/AN:0.30265 ; Hom/AC:0.07811	gnomAD
Q5VST9	OBSCN	R2694H	R	2694	H	-	neutral	AC/AN:0.30265 ; Hom/AC:0.07811	gnomAD
Q5VST9	OBSCN	R5575H	R	5575	H	-	neutral	AC/AN:0.30265 ; Hom/AC:0.07811	gnomAD
Q5VST9	OBSCN	R191H	R	191	H	-	neutral	AC/AN:0.30265 ; Hom/AC:0.07811	gnomAD
Q5VST9	OBSCN	R6532H	R	6532	H	211	neutral	AC/AN:0.30265 ; Hom/AC:0.07811	gnomAD
Q5VST9	OBSCN	R6535H	R	6535	H	256	neutral	AC/AN:0.28423 ; Hom/AC:0.08382	gnomAD
Q5VST9	OBSCN	R3654H	R	3654	H	-	neutral	AC/AN:0.28423 ; Hom/AC:0.08382	gnomAD
Q5VST9	OBSCN	P3905S	P	3905	S	-	neutral	AC/AN:0.28400 ; Hom/AC:0.08446	gnomAD
Q5VST9	OBSCN	P6271S	P	6271	S	-	neutral	AC/AN:0.28400 ; Hom/AC:0.08446	gnomAD
Q5VST9	OBSCN	P888S	P	888	S	-	neutral	AC/AN:0.28400 ; Hom/AC:0.08446	gnomAD
Q5VST9	OBSCN	P7228S	P	7228	S	-	neutral	AC/AN:0.28400 ; Hom/AC:0.08446	gnomAD
Q5VST9	OBSCN	R5358H	R	5358	H	-	neutral	AC/AN:0.28187 ; Hom/AC:0.08216	gnomAD
Q5VST9	OBSCN	R7724H	R	7724	H	185	neutral	AC/AN:0.28187 ; Hom/AC:0.08216	gnomAD
Q5VST9	OBSCN	R2341H	R	2341	H	-	neutral	AC/AN:0.28187 ; Hom/AC:0.08216	gnomAD
Q5VST9	OBSCN	R8681H	R	8681	H	-	neutral	AC/AN:0.28187 ; Hom/AC:0.08216	gnomAD
Q5TCX8	MAP3K21	R4P	R	4	P	-	neutral	AC/AN:0.33969 ; Hom/AC:0.07865	gnomAD
Q5TCX8	MAP3K21	V174I	V	174	I	177	neutral	AC/AN:0.52460 ; Hom/AC:0.13173	gnomAD
Q5TCX8	MAP3K21	V728I	V	728	I	-	neutral	AC/AN:0.52460 ; Hom/AC:0.13173	gnomAD
Q5TCX8	MAP3K21	E187D	E	187	D	206	neutral	AC/AN:0.53157 ; Hom/AC:0.13261	gnomAD
Q5TCX8	MAP3K21	E741D	E	741	D	-	neutral	AC/AN:0.53157 ; Hom/AC:0.13261	gnomAD
Q5TCX8	MAP3K21	C230G	C	230	G	314	neutral	AC/AN:0.53060 ; Hom/AC:0.13246	gnomAD
Q5TCX8	MAP3K21	C784G	C	784	G	-	neutral	AC/AN:0.53060 ; Hom/AC:0.13246	gnomAD
Q92519	TRIB2	P192L	P	192	L	439	neutral	AC/AN:0.58348 ; Hom/AC:0.16331	gnomAD
Q86Y07	VRK2	I167V	I	167	V	390	neutral	AC/AN:0.82320 ; Hom/AC:0.19039	gnomAD
Q86Y07	VRK2	I144V	I	144	V	346	neutral	AC/AN:0.82320 ; Hom/AC:0.19039	gnomAD
O96017	CHEK2	Q142H	Q	142	H	-	neutral	AC/AN:0.41254 ; Hom/AC:0.09122	gnomAD
O96017	CHEK2	Q114H	Q	114	H	-	neutral	AC/AN:0.41254 ; Hom/AC:0.09122	gnomAD
O96017	CHEK2	R844K	R	844	K	-	neutral	AC/AN:0.13897 ; Hom/AC:0.17763	gnomAD
O96017	CHEK2	R816K	R	816	K	-	neutral	AC/AN:0.13897 ; Hom/AC:0.17763	gnomAD
Q9NZJ5	EIF2AK3	S136C	S	136	C	-	neutral	AC/AN:0.69543 ; Hom/AC:0.16740	gnomAD
Q04912	MST1R	P6S	P	6	S	-	neutral	AC/AN:0.53927 ; Hom/AC:0.12401	gnomAD
Q12866	MERTK	S118N	S	118	N	-	neutral	AC/AN:0.53107 ; Hom/AC:0.12978	gnomAD
Q56UN5	MAP3K19	Q1104H	Q	1104	H	-	neutral	AC/AN:0.09665 ; Hom/AC:0.12886	gnomAD
Q56UN5	MAP3K19	I1100T	I	1100	T	-	neutral	AC/AN:0.53365 ; Hom/AC:0.13918	gnomAD
Q56UN5	MAP3K19	E699G	E	699	G	-	neutral	AC/AN:0.09872 ; Hom/AC:0.12888	gnomAD
Q56UN5	MAP3K19	E812G	E	812	G	-	neutral	AC/AN:0.09872 ; Hom/AC:0.12888	gnomAD
Q56UN5	MAP3K19	E829G	E	829	G	-	neutral	AC/AN:0.09872 ; Hom/AC:0.12888	gnomAD
Q56UN5	MAP3K19	E202G	E	202	G	-	neutral	AC/AN:0.09872 ; Hom/AC:0.12888	gnomAD
Q56UN5	MAP3K19	E563Q	E	563	Q	-	neutral	AC/AN:0.12096 ; Hom/AC:0.11969	gnomAD
Q56UN5	MAP3K19	E676Q	E	676	Q	-	neutral	AC/AN:0.12096 ; Hom/AC:0.11969	gnomAD
Q56UN5	MAP3K19	E693Q	E	693	Q	-	neutral	AC/AN:0.12096 ; Hom/AC:0.11969	gnomAD
Q56UN5	MAP3K19	E66Q	E	66	Q	-	neutral	AC/AN:0.12096 ; Hom/AC:0.11969	gnomAD
Q56UN5	MAP3K19	T325I	T	325	I	-	neutral	AC/AN:0.36705 ; Hom/AC:0.09217	gnomAD
Q56UN5	MAP3K19	T438I	T	438	I	-	neutral	AC/AN:0.36705 ; Hom/AC:0.09217	gnomAD
Q56UN5	MAP3K19	T455I	T	455	I	-	neutral	AC/AN:0.36705 ; Hom/AC:0.09217	gnomAD
Q56UN5	MAP3K19	R22Q	R	22	Q	-	neutral	AC/AN:0.31725 ; Hom/AC:0.10032	gnomAD
Q8NER5	ACVR1C	I482V	I	482	V	-	neutral	AC/AN:0.18845 ; Hom/AC:0.08766	gnomAD
Q8NER5	ACVR1C	I402V	I	402	V	597	neutral	AC/AN:0.18845 ; Hom/AC:0.08766	gnomAD
Q8NER5	ACVR1C	I325V	I	325	V	391	neutral	AC/AN:0.18845 ; Hom/AC:0.08766	gnomAD
Q8NER5	ACVR1C	I432V	I	432	V	650	neutral	AC/AN:0.18845 ; Hom/AC:0.08766	gnomAD
Q8WXR4	MYO3B	K318E	K	318	E	-	neutral	AC/AN:0.86863 ; Hom/AC:0.19954	gnomAD
Q8WXR4	MYO3B	K309E	K	309	E	-	neutral	AC/AN:0.86863 ; Hom/AC:0.19954	gnomAD
Q8WXR4	MYO3B	K318E	K	318	E	-	neutral	AC/AN:0.86863 ; Hom/AC:0.19954	gnomAD
Q8WXR4	MYO3B	E782G	E	782	G	-	neutral	AC/AN:0.78665 ; Hom/AC:0.18424	gnomAD
Q8WXR4	MYO3B	E773G	E	773	G	-	neutral	AC/AN:0.78665 ; Hom/AC:0.18424	gnomAD
Q8WXR4	MYO3B	E782G	E	782	G	-	neutral	AC/AN:0.78665 ; Hom/AC:0.18424	gnomAD
Q9NYL2	MAP3K20	S531L	S	531	L	-	neutral	AC/AN:0.88270 ; Hom/AC:0.21935	gnomAD
Q9NYL2	MAP3K20	Y773H	Y	773	H	-	neutral	AC/AN:0.27452 ; Hom/AC:0.08167	gnomAD
Q9NRP7	STK36	K295R	K	295	R	-	neutral	AC/AN:0.17886 ; Hom/AC:0.07738	gnomAD
Q9NRP7	STK36	D415E	D	415	E	-	neutral	AC/AN:0.02774 ; Hom/AC:0.05272	gnomAD
Q9NRP7	STK36	R583Q	R	583	Q	-	neutral	AC/AN:0.94937 ; Hom/AC:0.22110	gnomAD
Q9NRP7	STK36	G1003D	G	1003	D	-	neutral	AC/AN:0.73373 ; Hom/AC:0.17971	gnomAD
Q9NRP7	STK36	G982D	G	982	D	-	neutral	AC/AN:0.73373 ; Hom/AC:0.17971	gnomAD
Q9NRP7	STK36	G1003D	G	1003	D	-	neutral	AC/AN:0.73373 ; Hom/AC:0.17971	gnomAD
Q9NRP7	STK36	V1004I	V	1004	I	-	neutral	AC/AN:0.03684 ; Hom/AC:0.10022	gnomAD
Q9NRP7	STK36	V983I	V	983	I	-	neutral	AC/AN:0.03684 ; Hom/AC:0.10022	gnomAD
Q9NRP7	STK36	V1004I	V	1004	I	-	neutral	AC/AN:0.03684 ; Hom/AC:0.10022	gnomAD
Q9NRP7	STK36	C1231G	C	1231	G	-	neutral	AC/AN:0.03571 ; Hom/AC:0.09701	gnomAD
Q9NRP7	STK36	C1210G	C	1210	G	-	neutral	AC/AN:0.03571 ; Hom/AC:0.09701	gnomAD
Q9NRP7	STK36	C1231G	C	1231	G	-	neutral	AC/AN:0.03571 ; Hom/AC:0.09701	gnomAD
Q96RG2	PASK	F1266C	F	1266	C	-	neutral	AC/AN:0.43830 ; Hom/AC:0.14673	gnomAD
Q96RG2	PASK	F1273C	F	1273	C	-	neutral	AC/AN:0.43830 ; Hom/AC:0.14673	gnomAD
Q96RG2	PASK	F1266C	F	1266	C	-	neutral	AC/AN:0.43830 ; Hom/AC:0.14673	gnomAD
Q96RG2	PASK	F1050C	F	1050	C	172	neutral	AC/AN:0.43830 ; Hom/AC:0.14673	gnomAD
Q96RG2	PASK	F1080C	F	1080	C	265	neutral	AC/AN:0.43830 ; Hom/AC:0.14673	gnomAD
Q96RG2	PASK	V1210M	V	1210	M	631	neutral	AC/AN:0.02414 ; Hom/AC:0.05497	gnomAD
Q96RG2	PASK	V1217M	V	1217	M	676	neutral	AC/AN:0.02414 ; Hom/AC:0.05497	gnomAD
Q96RG2	PASK	V1210M	V	1210	M	631	neutral	AC/AN:0.02414 ; Hom/AC:0.05497	gnomAD
Q96RG2	PASK	V994M	V	994	M	-	neutral	AC/AN:0.02414 ; Hom/AC:0.05497	gnomAD
Q96RG2	PASK	V1024M	V	1024	M	117	neutral	AC/AN:0.02414 ; Hom/AC:0.05497	gnomAD
Q96RG2	PASK	R1130W	R	1130	W	391	neutral	AC/AN:0.38520 ; Hom/AC:0.12259	gnomAD
Q96RG2	PASK	P844Q	P	844	Q	-	neutral	AC/AN:0.02089 ; Hom/AC:0.05821	gnomAD
Q96RG2	PASK	P628Q	P	628	Q	-	neutral	AC/AN:0.02089 ; Hom/AC:0.05821	gnomAD
Q96RG2	PASK	P658Q	P	658	Q	-	neutral	AC/AN:0.02089 ; Hom/AC:0.05821	gnomAD
Q96RG2	PASK	G725D	G	725	D	-	neutral	AC/AN:0.12743 ; Hom/AC:0.10935	gnomAD
Q96RG2	PASK	G509D	G	509	D	-	neutral	AC/AN:0.12743 ; Hom/AC:0.10935	gnomAD
Q96RG2	PASK	G539D	G	539	D	-	neutral	AC/AN:0.12743 ; Hom/AC:0.10935	gnomAD
Q96RG2	PASK	L514S	L	514	S	-	neutral	AC/AN:0.12782 ; Hom/AC:0.11020	gnomAD
Q96RG2	PASK	L298S	L	298	S	-	neutral	AC/AN:0.12782 ; Hom/AC:0.11020	gnomAD
Q96RG2	PASK	L328S	L	328	S	-	neutral	AC/AN:0.12782 ; Hom/AC:0.11020	gnomAD
Q96RG2	PASK	V250I	V	250	I	-	neutral	AC/AN:0.72801 ; Hom/AC:0.16954	gnomAD
Q96RG2	PASK	V34I	V	34	I	-	neutral	AC/AN:0.72801 ; Hom/AC:0.16954	gnomAD
Q96RG2	PASK	V65I	V	65	I	-	neutral	AC/AN:0.72801 ; Hom/AC:0.16954	gnomAD
Q96RG2	PASK	V34I	V	34	I	-	neutral	AC/AN:0.72801 ; Hom/AC:0.16954	gnomAD
Q96RG2	PASK	V64I	V	64	I	-	neutral	AC/AN:0.72801 ; Hom/AC:0.16954	gnomAD
Q96RG2	PASK	M2T	M	2	T	-	neutral	AC/AN:0.67814 ; Hom/AC:0.16549	gnomAD
O43187	IRAK2	L392V	L	392	V	572	neutral	AC/AN:0.84552 ; Hom/AC:0.19761	gnomAD
Q6ZWH5	NEK10	R190K	R	190	K	-	neutral	AC/AN:0.05080 ; Hom/AC:0.13407	gnomAD
Q6ZWH5	NEK10	R275K	R	275	K	-	neutral	AC/AN:0.05080 ; Hom/AC:0.13407	gnomAD
Q6ZWH5	NEK10	R190K	R	190	K	-	neutral	AC/AN:0.05080 ; Hom/AC:0.13407	gnomAD
Q6ZWH5	NEK10	R878K	R	878	K	-	neutral	AC/AN:0.05080 ; Hom/AC:0.13407	gnomAD
Q6ZWH5	NEK10	L513S	L	513	S	-	neutral	AC/AN:0.61446 ; Hom/AC:0.14507	gnomAD
Q6ZWH5	NEK10	L46S	L	46	S	-	neutral	AC/AN:0.61446 ; Hom/AC:0.14507	gnomAD
Q6ZWH5	NEK10	L513S	L	513	S	-	neutral	AC/AN:0.61446 ; Hom/AC:0.14507	gnomAD
O95747	OXSR1	T304I	T	304	I	-	neutral	AC/AN:0.28958 ; Hom/AC:0.08938	gnomAD
Q96C45	ULK4	V851I	V	851	I	-	neutral	AC/AN:0.44023 ; Hom/AC:0.11698	gnomAD
Q96C45	ULK4	L844M	L	844	M	-	neutral	AC/AN:0.44025 ; Hom/AC:0.11695	gnomAD
Q96C45	ULK4	A715T	A	715	T	-	neutral	AC/AN:0.28332 ; Hom/AC:0.07451	gnomAD
Q96C45	ULK4	L603S	L	603	S	-	neutral	AC/AN:0.04579 ; Hom/AC:0.08910	gnomAD
Q96C45	ULK4	K569R	K	569	R	-	neutral	AC/AN:0.38652 ; Hom/AC:0.09233	gnomAD
Q96C45	ULK4	S417P	S	417	P	-	neutral	AC/AN:0.03465 ; Hom/AC:0.05185	gnomAD
Q96C45	ULK4	S348G	S	348	G	-	neutral	AC/AN:0.28457 ; Hom/AC:0.07394	gnomAD
P17948	FLT1	E579D	E	579	D	-	neutral	AC/AN:0.74825 ; Hom/AC:0.17024	gnomAD
P17948	FLT1	E577D	E	577	D	-	neutral	AC/AN:0.74825 ; Hom/AC:0.17024	gnomAD
P17948	FLT1	E535D	E	535	D	-	neutral	AC/AN:0.74825 ; Hom/AC:0.17024	gnomAD
P17948	FLT1	E566D	E	566	D	-	neutral	AC/AN:0.74825 ; Hom/AC:0.17024	gnomAD
P17948	FLT1	A193V	A	193	V	-	neutral	AC/AN:0.03080 ; Hom/AC:0.08487	gnomAD
P17948	FLT1	A149V	A	149	V	-	neutral	AC/AN:0.03080 ; Hom/AC:0.08487	gnomAD
P17948	FLT1	A180V	A	180	V	-	neutral	AC/AN:0.03080 ; Hom/AC:0.08487	gnomAD
P17948	FLT1	K47R	K	47	R	-	neutral	AC/AN:0.94348 ; Hom/AC:0.23473	gnomAD
P17948	FLT1	K3R	K	3	R	-	neutral	AC/AN:0.94348 ; Hom/AC:0.23473	gnomAD
P17948	FLT1	K47R	K	47	R	-	neutral	AC/AN:0.94348 ; Hom/AC:0.23473	gnomAD
P17948	FLT1	K3R	K	3	R	-	neutral	AC/AN:0.94348 ; Hom/AC:0.23473	gnomAD
P17948	FLT1	K58R	K	58	R	-	neutral	AC/AN:0.94348 ; Hom/AC:0.23473	gnomAD
P17948	FLT1	K34R	K	34	R	-	neutral	AC/AN:0.94348 ; Hom/AC:0.23473	gnomAD
P17948	FLT1	A29T	A	29	T	-	neutral	AC/AN:0.77747 ; Hom/AC:0.17612	gnomAD
P17948	FLT1	A40T	A	40	T	-	neutral	AC/AN:0.77747 ; Hom/AC:0.17612	gnomAD
P17948	FLT1	A16T	A	16	T	-	neutral	AC/AN:0.77747 ; Hom/AC:0.17612	gnomAD
Q04912	MST1R	R1335G	R	1335	G	784	neutral	AC/AN:0.93778 ; Hom/AC:0.22976	gnomAD
Q04912	MST1R	R1286G	R	1286	G	614	neutral	AC/AN:0.93778 ; Hom/AC:0.22976	gnomAD
Q04912	MST1R	T957M	T	957	M	-	neutral	AC/AN:0.03918 ; Hom/AC:0.07053	gnomAD
Q04912	MST1R	T908M	T	908	M	-	neutral	AC/AN:0.03918 ; Hom/AC:0.07053	gnomAD
Q04912	MST1R	T4M	T	4	M	-	neutral	AC/AN:0.03918 ; Hom/AC:0.07053	gnomAD
Q04912	MST1R	Q523R	Q	523	R	-	neutral	AC/AN:0.93542 ; Hom/AC:0.22897	gnomAD
P51957	NEK4	P225A	P	225	A	672	neutral	AC/AN:0.86579 ; Hom/AC:0.20498	gnomAD
P51957	NEK4	P136A	P	136	A	394	neutral	AC/AN:0.86579 ; Hom/AC:0.20498	gnomAD
Q7Z7A4	PXK	K464R	K	464	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K481R	K	481	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K464R	K	464	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K448R	K	448	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K174R	K	174	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K448R	K	448	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K236R	K	236	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K464R	K	464	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K481R	K	481	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K17R	K	17	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K53R	K	53	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K344R	K	344	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	A518V	A	518	V	-	neutral	AC/AN:0.66327 ; Hom/AC:0.16779	gnomAD
Q7Z7A4	PXK	A535V	A	535	V	-	neutral	AC/AN:0.66327 ; Hom/AC:0.16779	gnomAD
Q7Z7A4	PXK	A502V	A	502	V	-	neutral	AC/AN:0.66327 ; Hom/AC:0.16779	gnomAD
Q7Z7A4	PXK	A269V	A	269	V	-	neutral	AC/AN:0.66327 ; Hom/AC:0.16779	gnomAD
Q7Z7A4	PXK	A398V	A	398	V	-	neutral	AC/AN:0.66327 ; Hom/AC:0.16779	gnomAD
P29320	EPHA3	W924R	W	924	R	-	neutral	AC/AN:0.85065 ; Hom/AC:0.20128	gnomAD
Q9UF33	EPHA6	A805V	A	805	V	396	neutral	AC/AN:0.06660 ; Hom/AC:0.07642	gnomAD
Q9UF33	EPHA6	A171V	A	171	V	-	neutral	AC/AN:0.06660 ; Hom/AC:0.07642	gnomAD
Q9UF33	EPHA6	A197V	A	197	V	-	neutral	AC/AN:0.06660 ; Hom/AC:0.07642	gnomAD
Q32MK0	MYLK3	T1016A	T	1016	A	-	neutral	AC/AN:0.03485 ; Hom/AC:0.09074	gnomAD
Q32MK0	MYLK3	T1085A	T	1085	A	-	neutral	AC/AN:0.03485 ; Hom/AC:0.09074	gnomAD
Q32MK0	MYLK3	D845E	D	845	E	-	neutral	AC/AN:0.23416 ; Hom/AC:0.16471	gnomAD
Q32MK0	MYLK3	D914E	D	914	E	-	neutral	AC/AN:0.23416 ; Hom/AC:0.16471	gnomAD
Q32MK0	MYLK3	L792P	L	792	P	-	neutral	AC/AN:0.26460 ; Hom/AC:0.16671	gnomAD
Q32MK0	MYLK3	L861P	L	861	P	-	neutral	AC/AN:0.26460 ; Hom/AC:0.16671	gnomAD
Q32MK0	MYLK3	V261A	V	261	A	-	neutral	AC/AN:0.27866 ; Hom/AC:0.18212	gnomAD
Q32MK0	MYLK3	A128V	A	128	V	-	neutral	AC/AN:0.03933 ; Hom/AC:0.06602	gnomAD
Q32MK0	MYLK3	P21H	P	21	H	-	neutral	AC/AN:0.27173 ; Hom/AC:0.09004	gnomAD
Q8NG66	NEK11	V562A	V	562	A	-	neutral	AC/AN:0.24293 ; Hom/AC:0.09014	gnomAD
Q8NG66	NEK11	V378A	V	378	A	-	neutral	AC/AN:0.24293 ; Hom/AC:0.09014	gnomAD
Q8NG66	NEK11	V562A	V	562	A	-	neutral	AC/AN:0.24293 ; Hom/AC:0.09014	gnomAD
Q8NG66	NEK11	V457A	V	457	A	-	neutral	AC/AN:0.24293 ; Hom/AC:0.09014	gnomAD
P34925	RYK	S97N	S	97	N	-	neutral	AC/AN:0.37431 ; Hom/AC:0.10848	gnomAD
P34925	RYK	S79N	S	79	N	-	neutral	AC/AN:0.37431 ; Hom/AC:0.10848	gnomAD
Q8WTQ7	GRK7	P460T	P	460	T	-	neutral	AC/AN:0.21528 ; Hom/AC:0.05844	gnomAD
P32298	GRK4	R33L	R	33	L	-	neutral	AC/AN:0.74135 ; Hom/AC:0.17757	gnomAD
P32298	GRK4	R65L	R	65	L	-	neutral	AC/AN:0.74135 ; Hom/AC:0.17757	gnomAD
P32298	GRK4	A110V	A	110	V	-	neutral	AC/AN:0.83615 ; Hom/AC:0.19953	gnomAD
P32298	GRK4	A142V	A	142	V	-	neutral	AC/AN:0.83615 ; Hom/AC:0.19953	gnomAD
Q9NY57	STK32B	R198G	R	198	G	565	neutral	AC/AN:0.42116 ; Hom/AC:0.13069	gnomAD
Q9NY57	STK32B	R151G	R	151	G	394	neutral	AC/AN:0.42116 ; Hom/AC:0.13069	gnomAD
Q9NY57	STK32B	R121G	R	121	G	324	neutral	AC/AN:0.42116 ; Hom/AC:0.13069	gnomAD
P16234	PDGFRA	S478P	S	478	P	-	neutral	AC/AN:0.35425 ; Hom/AC:0.09483	gnomAD
Q9NSY1	BMP2K	G405S	G	405	S	-	neutral	AC/AN:0.13986 ; Hom/AC:0.05445	gnomAD
Q9NSY1	BMP2K	G98S	G	98	S	177	neutral	AC/AN:0.13986 ; Hom/AC:0.05445	gnomAD
Q9NSY1	BMP2K	G405S	G	405	S	-	neutral	AC/AN:0.13986 ; Hom/AC:0.05445	gnomAD
Q9NSY1	BMP2K	T1002S	T	1002	S	-	neutral	AC/AN:0.24667 ; Hom/AC:0.06889	gnomAD
Q9NSY1	BMP2K	T695S	T	695	S	-	neutral	AC/AN:0.24667 ; Hom/AC:0.06889	gnomAD
Q8TEA7	TBCK	M471I	M	471	I	-	neutral	AC/AN:0.36736 ; Hom/AC:0.08991	gnomAD
Q8TEA7	TBCK	M408I	M	408	I	-	neutral	AC/AN:0.36736 ; Hom/AC:0.08991	gnomAD
Q8TEA7	TBCK	M432I	M	432	I	-	neutral	AC/AN:0.36736 ; Hom/AC:0.08991	gnomAD
Q8TEA7	TBCK	M471I	M	471	I	-	neutral	AC/AN:0.36736 ; Hom/AC:0.08991	gnomAD
P17948	FLT1	R431K	R	431	K	-	neutral	AC/AN:0.22562 ; Hom/AC:0.06369	gnomAD
P17948	FLT1	R389K	R	389	K	-	neutral	AC/AN:0.22562 ; Hom/AC:0.06369	gnomAD
Q96QP1	ALPK1	N175D	N	175	D	-	neutral	AC/AN:0.17690 ; Hom/AC:0.05013	gnomAD
Q96QP1	ALPK1	N97D	N	97	D	-	neutral	AC/AN:0.17690 ; Hom/AC:0.05013	gnomAD
Q8NG66	NEK11	E724G	E	724	G	-	neutral	AC/AN:0.23062 ; Hom/AC:0.05435	gnomAD
Q8NG66	NEK11	E752G	E	752	G	-	neutral	AC/AN:0.23062 ; Hom/AC:0.05435	gnomAD
Q8NG66	NEK11	E680G	E	680	G	-	neutral	AC/AN:0.23062 ; Hom/AC:0.05435	gnomAD
Q8NG66	NEK11	E708G	E	708	G	-	neutral	AC/AN:0.23062 ; Hom/AC:0.05435	gnomAD
Q8NG66	NEK11	E655G	E	655	G	-	neutral	AC/AN:0.23062 ; Hom/AC:0.05435	gnomAD
Q9BVS4	RIOK2	S96C	S	96	C	-	neutral	AC/AN:0.93360 ; Hom/AC:0.21306	gnomAD
P09619	PDGFRB	I29F	I	29	F	-	neutral	AC/AN:0.08611 ; Hom/AC:0.07243	gnomAD
P22455	FGFR4	V10I	V	10	I	-	neutral	AC/AN:0.56547 ; Hom/AC:0.14421	gnomAD
P22455	FGFR4	G388R	G	388	R	-	neutral	AC/AN:0.74806 ; Hom/AC:0.17306	gnomAD
P22455	FGFR4	G24R	G	24	R	-	neutral	AC/AN:0.74806 ; Hom/AC:0.17306	gnomAD
P35916	FLT4	R1146H	R	1146	H	758	neutral	AC/AN:0.17164 ; Hom/AC:0.05167	gnomAD
P35916	FLT4	T494A	T	494	A	-	neutral	AC/AN:0.20288 ; Hom/AC:0.05594	gnomAD
Q86YV6	MYLK4	T242M	T	242	M	437	neutral	AC/AN:0.48346 ; Hom/AC:0.12862	gnomAD
Q86YV6	MYLK4	T126M	T	126	M	86	neutral	AC/AN:0.21370 ; Hom/AC:0.06049	gnomAD
Q86YV6	MYLK4	G50R	G	50	R	-	neutral	AC/AN:0.37657 ; Hom/AC:0.10323	gnomAD
Q08345	DDR1	P200L	P	200	L	-	neutral	AC/AN:0.37402 ; Hom/AC:0.08951	gnomAD
Q08345	DDR1	P265L	P	265	L	-	neutral	AC/AN:0.37402 ; Hom/AC:0.08951	gnomAD
P49842	STK19	S307G	S	307	G	-	neutral	AC/AN:0.22949 ; Hom/AC:0.09947	gnomAD
P49842	STK19	S311G	S	311	G	-	neutral	AC/AN:0.22949 ; Hom/AC:0.09947	gnomAD
P25440	BRD2	D647N	D	647	N	-	neutral	AC/AN:0.49802 ; Hom/AC:0.11905	gnomAD
Q13308	PTK7	Y455C	Y	455	C	-	neutral	AC/AN:0.09810 ; Hom/AC:0.11354	gnomAD
Q5TCY1	TTBK1	G623A	G	623	A	-	neutral	AC/AN:0.74211 ; Hom/AC:0.16051	gnomAD
Q5TCY1	TTBK1	G572A	G	572	A	-	neutral	AC/AN:0.74211 ; Hom/AC:0.16051	gnomAD
Q5TCY1	TTBK1	K1145R	K	1145	R	-	neutral	AC/AN:0.55516 ; Hom/AC:0.12768	gnomAD
Q5TCY1	TTBK1	L1184S	L	1184	S	-	neutral	AC/AN:0.60008 ; Hom/AC:0.13796	gnomAD
Q96GD4	AURKB	Q293P	Q	293	P	676	neutral	AC/AN:0.54833 ; Hom/AC:0.12910	gnomAD
Q96GD4	AURKB	C491R	C	491	R	-	neutral	AC/AN:0.45967 ; Hom/AC:0.11020	gnomAD
Q96GD4	AURKB	C1395Y	C	1395	Y	-	neutral	AC/AN:0.60798 ; Hom/AC:0.14704	gnomAD
Q96GD4	AURKB	C214Y	C	214	Y	438	neutral	AC/AN:0.60798 ; Hom/AC:0.14704	gnomAD
Q96GD4	AURKB	T1445S	T	1445	S	-	neutral	AC/AN:0.03661 ; Hom/AC:0.07669	gnomAD
Q96GD4	AURKB	T264S	T	264	S	591	neutral	AC/AN:0.03661 ; Hom/AC:0.07669	gnomAD
O95835	LATS1	S8L	S	8	L	-	neutral	AC/AN:0.90877 ; Hom/AC:0.21350	gnomAD
Q9BQI3	EIF2AK1	K558R	K	558	R	758	neutral	AC/AN:0.20765 ; Hom/AC:0.08619	gnomAD
Q9BQI3	EIF2AK1	K434R	K	434	R	367	neutral	AC/AN:0.20765 ; Hom/AC:0.08619	gnomAD
Q9BXU1	STK31	Q48H	Q	48	H	-	neutral	AC/AN:0.64700 ; Hom/AC:0.15118	gnomAD
Q9BXU1	STK31	Q71H	Q	71	H	-	neutral	AC/AN:0.64700 ; Hom/AC:0.15118	gnomAD
Q9BXU1	STK31	Q48H	Q	48	H	-	neutral	AC/AN:0.64700 ; Hom/AC:0.15118	gnomAD
Q9BXU1	STK31	Q71H	Q	71	H	-	neutral	AC/AN:0.64700 ; Hom/AC:0.15118	gnomAD
Q9BXU1	STK31	Q48H	Q	48	H	-	neutral	AC/AN:0.64700 ; Hom/AC:0.15118	gnomAD
Q9BXU1	STK31	E238K	E	238	K	-	neutral	AC/AN:0.30369 ; Hom/AC:0.08036	gnomAD
Q9BXU1	STK31	E261K	E	261	K	-	neutral	AC/AN:0.30369 ; Hom/AC:0.08036	gnomAD
Q9BXU1	STK31	E238K	E	238	K	-	neutral	AC/AN:0.30369 ; Hom/AC:0.08036	gnomAD
Q9BXU1	STK31	E261K	E	261	K	-	neutral	AC/AN:0.30369 ; Hom/AC:0.08036	gnomAD
Q9BXU1	STK31	K245N	K	245	N	-	neutral	AC/AN:0.30488 ; Hom/AC:0.07959	gnomAD
Q9BXU1	STK31	K268N	K	268	N	-	neutral	AC/AN:0.30488 ; Hom/AC:0.07959	gnomAD
Q9BXU1	STK31	K245N	K	245	N	-	neutral	AC/AN:0.30488 ; Hom/AC:0.07959	gnomAD
Q9BXU1	STK31	K268N	K	268	N	-	neutral	AC/AN:0.30488 ; Hom/AC:0.07959	gnomAD
Q9BXU1	STK31	G387E	G	387	E	-	neutral	AC/AN:0.45230 ; Hom/AC:0.12705	gnomAD
Q9BXU1	STK31	G410E	G	410	E	-	neutral	AC/AN:0.45230 ; Hom/AC:0.12705	gnomAD
Q9BXU1	STK31	G387E	G	387	E	-	neutral	AC/AN:0.45230 ; Hom/AC:0.12705	gnomAD
Q9BXU1	STK31	G410E	G	410	E	-	neutral	AC/AN:0.45230 ; Hom/AC:0.12705	gnomAD
Q9BXU1	STK31	N598K	N	598	K	-	neutral	AC/AN:0.34834 ; Hom/AC:0.08943	gnomAD
Q9BXU1	STK31	N621K	N	621	K	-	neutral	AC/AN:0.34834 ; Hom/AC:0.08943	gnomAD
Q9BXU1	STK31	N598K	N	598	K	-	neutral	AC/AN:0.34834 ; Hom/AC:0.08943	gnomAD
Q9BXU1	STK31	N621K	N	621	K	-	neutral	AC/AN:0.34834 ; Hom/AC:0.08943	gnomAD
Q9BXU1	STK31	S600I	S	600	I	-	neutral	AC/AN:0.26899 ; Hom/AC:0.06871	gnomAD
Q9BXU1	STK31	S623I	S	623	I	-	neutral	AC/AN:0.26899 ; Hom/AC:0.06871	gnomAD
Q9BXU1	STK31	S600I	S	600	I	-	neutral	AC/AN:0.26899 ; Hom/AC:0.06871	gnomAD
Q9BXU1	STK31	S623I	S	623	I	-	neutral	AC/AN:0.26899 ; Hom/AC:0.06871	gnomAD
Q14004	CDK13	T500A	T	500	A	-	neutral	AC/AN:0.30609 ; Hom/AC:0.09793	gnomAD
Q13554	CAMK2B	E510K	E	510	K	-	neutral	AC/AN:0.15426 ; Hom/AC:0.05213	gnomAD
P17948	FLT1	R521K	R	521	K	-	neutral	AC/AN:0.67141 ; Hom/AC:0.16124	gnomAD
P17948	FLT1	R468K	R	468	K	-	neutral	AC/AN:0.67141 ; Hom/AC:0.16124	gnomAD
P17948	FLT1	R476K	R	476	K	-	neutral	AC/AN:0.67141 ; Hom/AC:0.16124	gnomAD
P17948	FLT1	S703F	S	703	F	-	neutral	AC/AN:0.02038 ; Hom/AC:0.05628	gnomAD
Q8IWU2	LMTK2	P30A	P	30	A	-	neutral	AC/AN:0.18442 ; Hom/AC:0.05710	gnomAD
Q8IWU2	LMTK2	I693T	I	693	T	-	neutral	AC/AN:0.21838 ; Hom/AC:0.12574	gnomAD
Q8IWU2	LMTK2	L780M	L	780	M	-	neutral	AC/AN:0.92301 ; Hom/AC:0.24054	gnomAD
Q7Z695	ADCK2	S66G	S	66	G	-	neutral	AC/AN:0.39950 ; Hom/AC:0.14159	gnomAD
Q7Z695	ADCK2	S307P	S	307	P	-	neutral	AC/AN:0.39557 ; Hom/AC:0.14298	gnomAD
Q7Z695	ADCK2	S145P	S	145	P	-	neutral	AC/AN:0.39557 ; Hom/AC:0.14298	gnomAD
Q7Z695	ADCK2	P622L	P	622	L	-	neutral	AC/AN:0.23721 ; Hom/AC:0.06555	gnomAD
Q7Z695	ADCK2	P219L	P	219	L	-	neutral	AC/AN:0.23721 ; Hom/AC:0.06555	gnomAD
Q86YV5	PRAG1	A1111T	A	1111	T	335	neutral	AC/AN:0.74111 ; Hom/AC:0.18421	gnomAD
Q86YV5	PRAG1	S576C	S	576	C	-	neutral	AC/AN:0.88740 ; Hom/AC:0.21616	gnomAD
Q86YV5	PRAG1	P567L	P	567	L	-	neutral	AC/AN:0.88968 ; Hom/AC:0.21494	gnomAD
Q86YV5	PRAG1	R402Q	R	402	Q	-	neutral	AC/AN:0.90168 ; Hom/AC:0.21785	gnomAD
Q96KB5	PBK	N107S	N	107	S	214	neutral	AC/AN:0.32802 ; Hom/AC:0.09946	gnomAD
P78527	PRKDC	I3433T	I	3433	T	-	neutral	AC/AN:0.27397 ; Hom/AC:0.11109	gnomAD
Q96QS6	PSKH2	I336V	I	336	V	-	neutral	AC/AN:0.04316 ; Hom/AC:0.05421	gnomAD
Q96QS6	PSKH2	A176S	A	176	S	370	neutral	AC/AN:0.79559 ; Hom/AC:0.18327	gnomAD
Q96QS6	PSKH2	Q132R	Q	132	R	258	neutral	AC/AN:0.05584 ; Hom/AC:0.12670	gnomAD
Q14289	PTK2B	T84A	T	84	A	-	neutral	AC/AN:0.50714 ; Hom/AC:0.13434	gnomAD
Q8TD08	MAPK15	R247T	R	247	T	724	neutral	AC/AN:0.57367 ; Hom/AC:0.14986	gnomAD
Q9Y6S9	RPS6KL1	L86F	L	86	F	-	neutral	AC/AN:0.23735 ; Hom/AC:0.06319	gnomAD
P22612	PRKACG	H268D	H	268	D	758	neutral	AC/AN:0.61603 ; Hom/AC:0.14507	gnomAD
Q9BX84	TRPM6	K1584E	K	1584	E	-	neutral	AC/AN:0.46122 ; Hom/AC:0.12331	gnomAD
Q9BX84	TRPM6	K1579E	K	1579	E	-	neutral	AC/AN:0.46122 ; Hom/AC:0.12331	gnomAD
Q9BX84	TRPM6	K1584E	K	1584	E	-	neutral	AC/AN:0.46122 ; Hom/AC:0.12331	gnomAD
Q9BX84	TRPM6	K1579E	K	1579	E	-	neutral	AC/AN:0.46122 ; Hom/AC:0.12331	gnomAD
Q9BX84	TRPM6	K1584E	K	1584	E	-	neutral	AC/AN:0.46122 ; Hom/AC:0.12331	gnomAD
Q9BX84	TRPM6	V1393I	V	1393	I	-	neutral	AC/AN:0.27206 ; Hom/AC:0.07692	gnomAD
Q9BX84	TRPM6	V1388I	V	1388	I	-	neutral	AC/AN:0.27206 ; Hom/AC:0.07692	gnomAD
Q9BX84	TRPM6	V1393I	V	1393	I	-	neutral	AC/AN:0.27206 ; Hom/AC:0.07692	gnomAD
Q9BX84	TRPM6	V1388I	V	1388	I	-	neutral	AC/AN:0.27206 ; Hom/AC:0.07692	gnomAD
Q9BX84	TRPM6	V1393I	V	1393	I	-	neutral	AC/AN:0.27206 ; Hom/AC:0.07692	gnomAD
P53355	DAPK1	V416I	V	416	I	-	neutral	AC/AN:0.05390 ; Hom/AC:0.14139	gnomAD
Q9Y3S1	WNK2	P865S	P	865	S	-	neutral	AC/AN:0.11936 ; Hom/AC:0.09781	gnomAD
Q9Y3S1	WNK2	P477S	P	477	S	-	neutral	AC/AN:0.11936 ; Hom/AC:0.09781	gnomAD
Q9Y3S1	WNK2	P865S	P	865	S	-	neutral	AC/AN:0.11936 ; Hom/AC:0.09781	gnomAD
Q9Y3S1	WNK2	P469S	P	469	S	-	neutral	AC/AN:0.11936 ; Hom/AC:0.09781	gnomAD
Q9Y3S1	WNK2	P477S	P	477	S	-	neutral	AC/AN:0.11936 ; Hom/AC:0.09781	gnomAD
Q9Y3S1	WNK2	P861S	P	861	S	-	neutral	AC/AN:0.11936 ; Hom/AC:0.09781	gnomAD
Q9Y3S1	WNK2	Q1112H	Q	1112	H	-	neutral	AC/AN:0.02257 ; Hom/AC:0.05931	gnomAD
Q9Y3S1	WNK2	Q724H	Q	724	H	-	neutral	AC/AN:0.02257 ; Hom/AC:0.05931	gnomAD
Q9Y3S1	WNK2	Q1112H	Q	1112	H	-	neutral	AC/AN:0.02257 ; Hom/AC:0.05931	gnomAD
Q9Y3S1	WNK2	Q716H	Q	716	H	-	neutral	AC/AN:0.02257 ; Hom/AC:0.05931	gnomAD
Q9Y3S1	WNK2	Q724H	Q	724	H	-	neutral	AC/AN:0.02257 ; Hom/AC:0.05931	gnomAD
Q9Y3S1	WNK2	Q1108H	Q	1108	H	-	neutral	AC/AN:0.02257 ; Hom/AC:0.05931	gnomAD
O15146	MUSK	S159G	S	159	G	-	neutral	AC/AN:0.35365 ; Hom/AC:0.08511	gnomAD
O15146	MUSK	S41G	S	41	G	-	neutral	AC/AN:0.35365 ; Hom/AC:0.08511	gnomAD
O15146	MUSK	S159G	S	159	G	-	neutral	AC/AN:0.35365 ; Hom/AC:0.08511	gnomAD
O15146	MUSK	M413I	M	413	I	-	neutral	AC/AN:0.27468 ; Hom/AC:0.07129	gnomAD
O15146	MUSK	G5R	G	5	R	-	neutral	AC/AN:0.27468 ; Hom/AC:0.07129	gnomAD
O15146	MUSK	M413I	M	413	I	-	neutral	AC/AN:0.27468 ; Hom/AC:0.07129	gnomAD
O15146	MUSK	V829L	V	829	L	752	neutral	AC/AN:0.09976 ; Hom/AC:0.06078	gnomAD
O15146	MUSK	V821L	V	821	L	653	neutral	AC/AN:0.09976 ; Hom/AC:0.06078	gnomAD
Q8NE28	STKLD1	L212R	L	212	R	577	neutral	AC/AN:0.18577 ; Hom/AC:0.05128	gnomAD
Q8NE28	STKLD1	L679R	L	679	R	-	neutral	AC/AN:0.18577 ; Hom/AC:0.05128	gnomAD
Q04759	PRKCQ	P330L	P	330	L	-	neutral	AC/AN:0.70198 ; Hom/AC:0.16660	gnomAD
Q04759	PRKCQ	P205L	P	205	L	-	neutral	AC/AN:0.70198 ; Hom/AC:0.16660	gnomAD
Q8NEV4	MYO3A	T1284S	T	1284	S	-	neutral	AC/AN:0.94533 ; Hom/AC:0.20955	gnomAD
Q96GX5	MASTL	P620A	P	620	A	-	neutral	AC/AN:0.18856 ; Hom/AC:0.05252	gnomAD
P36894	BMPR1A	P2T	P	2	T	-	neutral	AC/AN:0.82175 ; Hom/AC:0.21004	gnomAD
P34947	GRK5	Q41L	Q	41	L	-	neutral	AC/AN:0.08627 ; Hom/AC:0.07515	gnomAD
P34947	GRK5	R199H	R	199	H	43	neutral	AC/AN:0.24990 ; Hom/AC:0.06885	gnomAD
P34947	GRK5	R304H	R	304	H	370	neutral	AC/AN:0.24990 ; Hom/AC:0.06885	gnomAD
P21802	FGFR2	M97T	M	97	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M186T	M	186	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M71T	M	71	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M97T	M	97	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M186T	M	186	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M97T	M	97	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M186T	M	186	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M71T	M	71	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M186T	M	186	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
Q86UX6	STK32C	S136R	S	136	R	169	neutral	AC/AN:0.77222 ; Hom/AC:0.18168	gnomAD
Q86UX6	STK32C	S136N	S	136	N	169	neutral	AC/AN:0.77195 ; Hom/AC:0.18174	gnomAD
Q86UX6	STK32C	G67R	G	67	R	-	neutral	AC/AN:0.75404 ; Hom/AC:0.17771	gnomAD
Q86UX6	STK32C	G72R	G	72	R	-	neutral	AC/AN:0.75404 ; Hom/AC:0.17771	gnomAD
Q86UX6	STK32C	G35R	G	35	R	-	neutral	AC/AN:0.75404 ; Hom/AC:0.17771	gnomAD
Q86UX6	STK32C	G69R	G	69	R	-	neutral	AC/AN:0.75404 ; Hom/AC:0.17771	gnomAD
Q86UX6	STK32C	H62Y	H	62	Y	-	neutral	AC/AN:0.47884 ; Hom/AC:0.12558	gnomAD
Q86UX6	STK32C	H67Y	H	67	Y	-	neutral	AC/AN:0.47884 ; Hom/AC:0.12558	gnomAD
Q86UX6	STK32C	H30Y	H	30	Y	-	neutral	AC/AN:0.47884 ; Hom/AC:0.12558	gnomAD
Q86UX6	STK32C	H64Y	H	64	Y	-	neutral	AC/AN:0.47884 ; Hom/AC:0.12558	gnomAD
Q86UX6	STK32C	V17F	V	17	F	-	neutral	AC/AN:0.34311 ; Hom/AC:0.09835	gnomAD
Q86UX6	STK32C	V22F	V	22	F	-	neutral	AC/AN:0.34311 ; Hom/AC:0.09835	gnomAD
Q86UX6	STK32C	V19F	V	19	F	-	neutral	AC/AN:0.34311 ; Hom/AC:0.09835	gnomAD
Q86UX6	STK32C	A15E	A	15	E	-	neutral	AC/AN:0.77365 ; Hom/AC:0.17863	gnomAD
Q86UX6	STK32C	A20E	A	20	E	-	neutral	AC/AN:0.77365 ; Hom/AC:0.17863	gnomAD
Q86UX6	STK32C	A17E	A	17	E	-	neutral	AC/AN:0.77365 ; Hom/AC:0.17863	gnomAD
Q86UX6	STK32C	R6S	R	6	S	-	neutral	AC/AN:0.77775 ; Hom/AC:0.17652	gnomAD
Q86UX6	STK32C	R3S	R	3	S	-	neutral	AC/AN:0.77775 ; Hom/AC:0.17652	gnomAD
Q9BYT3	STK33	A437T	A	437	T	-	neutral	AC/AN:0.59503 ; Hom/AC:0.13817	gnomAD
Q9BYT3	STK33	A250T	A	250	T	418	neutral	AC/AN:0.59503 ; Hom/AC:0.13817	gnomAD
Q9BYT3	STK33	A437T	A	437	T	-	neutral	AC/AN:0.59503 ; Hom/AC:0.13817	gnomAD
Q9BYT3	STK33	A396T	A	396	T	-	neutral	AC/AN:0.59503 ; Hom/AC:0.13817	gnomAD
Q9BYT3	STK33	D436E	D	436	E	-	neutral	AC/AN:0.59502 ; Hom/AC:0.13816	gnomAD
Q9BYT3	STK33	D249E	D	249	E	417	neutral	AC/AN:0.59502 ; Hom/AC:0.13816	gnomAD
Q9BYT3	STK33	D436E	D	436	E	-	neutral	AC/AN:0.59502 ; Hom/AC:0.13816	gnomAD
Q9BYT3	STK33	D395E	D	395	E	-	neutral	AC/AN:0.59502 ; Hom/AC:0.13816	gnomAD
O75676	RPS6KA4	S510A	S	510	A	352	neutral	AC/AN:0.74826 ; Hom/AC:0.17949	gnomAD
O75676	RPS6KA4	S758A	S	758	A	-	neutral	AC/AN:0.74826 ; Hom/AC:0.17949	gnomAD
O75676	RPS6KA4	S751A	S	751	A	-	neutral	AC/AN:0.74826 ; Hom/AC:0.17949	gnomAD
Q9UBS0	RPS6KB2	A420V	A	420	V	-	neutral	AC/AN:0.95100 ; Hom/AC:0.22665	gnomAD
P54764	EPHA4	S192Y	S	192	Y	-	neutral	AC/AN:0.58429 ; Hom/AC:0.16931	gnomAD
P54764	EPHA4	R402Q	R	402	Q	-	neutral	AC/AN:0.40442 ; Hom/AC:0.11958	gnomAD
Q8NFD2	ANKK1	A239T	A	239	T	646	neutral	AC/AN:0.58205 ; Hom/AC:0.15204	gnomAD
Q8NFD2	ANKK1	G318R	G	318	R	-	neutral	AC/AN:0.89394 ; Hom/AC:0.22618	gnomAD
Q8NFD2	ANKK1	H490R	H	490	R	-	neutral	AC/AN:0.90232 ; Hom/AC:0.22154	gnomAD
Q8NFD2	ANKK1	E713K	E	713	K	-	neutral	AC/AN:0.60637 ; Hom/AC:0.15287	gnomAD
Q9Y2K2	SIK3	P1078R	P	1078	R	-	neutral	AC/AN:0.43115 ; Hom/AC:0.09983	gnomAD
Q9Y2K2	SIK3	P413R	P	413	R	-	neutral	AC/AN:0.43115 ; Hom/AC:0.09983	gnomAD
Q9Y2K2	SIK3	P1136R	P	1136	R	-	neutral	AC/AN:0.43115 ; Hom/AC:0.09983	gnomAD
Q9Y2K2	SIK3	P917R	P	917	R	-	neutral	AC/AN:0.43115 ; Hom/AC:0.09983	gnomAD
Q9Y2K2	SIK3	P1178R	P	1178	R	-	neutral	AC/AN:0.43115 ; Hom/AC:0.09983	gnomAD
Q9Y2K2	SIK3	P1076R	P	1076	R	-	neutral	AC/AN:0.43115 ; Hom/AC:0.09983	gnomAD
Q9Y2K2	SIK3	P1018R	P	1018	R	-	neutral	AC/AN:0.43115 ; Hom/AC:0.09983	gnomAD
Q9H4A3	WNK1	A141T	A	141	T	-	neutral	AC/AN:0.27368 ; Hom/AC:0.07445	gnomAD
Q9H4A3	WNK1	L730F	L	730	F	-	neutral	AC/AN:0.29124 ; Hom/AC:0.06622	gnomAD
Q9H4A3	WNK1	M1808I	M	1808	I	-	neutral	AC/AN:0.84972 ; Hom/AC:0.19390	gnomAD
Q9H4A3	WNK1	M1401I	M	1401	I	-	neutral	AC/AN:0.84972 ; Hom/AC:0.19390	gnomAD
Q9H4A3	WNK1	M2306I	M	2306	I	-	neutral	AC/AN:0.84972 ; Hom/AC:0.19390	gnomAD
Q9H4A3	WNK1	M1561I	M	1561	I	-	neutral	AC/AN:0.84972 ; Hom/AC:0.19390	gnomAD
Q9H4A3	WNK1	M2068I	M	2068	I	-	neutral	AC/AN:0.84972 ; Hom/AC:0.19390	gnomAD
Q5S007	LRRK2	N551K	N	551	K	-	neutral	AC/AN:0.19930 ; Hom/AC:0.05437	gnomAD
Q5S007	LRRK2	N299K	N	299	K	-	neutral	AC/AN:0.19930 ; Hom/AC:0.05437	gnomAD
Q5S007	LRRK2	R1398H	R	1398	H	-	neutral	AC/AN:0.19462 ; Hom/AC:0.05171	gnomAD
Q5S007	LRRK2	S1647T	S	1647	T	-	neutral	AC/AN:0.68107 ; Hom/AC:0.15828	gnomAD
Q9NWZ3	IRAK4	A304T	A	304	T	370	neutral	AC/AN:0.26103 ; Hom/AC:0.06736	gnomAD
Q9NWZ3	IRAK4	A428T	A	428	T	753	neutral	AC/AN:0.26103 ; Hom/AC:0.06736	gnomAD
P37023	ACVRL1	Q150R	Q	150	R	-	neutral	AC/AN:0.60526 ; Hom/AC:0.13994	gnomAD
P36896	ACVR1B	R478H	R	478	H	765	neutral	AC/AN:0.02010 ; Hom/AC:0.06593	gnomAD
P21860	ERBB3	S1119C	S	1119	C	-	neutral	AC/AN:0.20410 ; Hom/AC:0.05165	gnomAD
P21860	ERBB3	S1060C	S	1060	C	-	neutral	AC/AN:0.20410 ; Hom/AC:0.05165	gnomAD
P21860	ERBB3	S476C	S	476	C	-	neutral	AC/AN:0.20410 ; Hom/AC:0.05165	gnomAD
P21860	ERBB3	S239C	S	239	C	-	neutral	AC/AN:0.20410 ; Hom/AC:0.05165	gnomAD
P21860	ERBB3	S426C	S	426	C	-	neutral	AC/AN:0.20410 ; Hom/AC:0.05165	gnomAD
P21860	ERBB3	S360C	S	360	C	-	neutral	AC/AN:0.20410 ; Hom/AC:0.05165	gnomAD
Q9Y616	IRAK3	Y69C	Y	69	C	-	neutral	AC/AN:0.03741 ; Hom/AC:0.10727	gnomAD
Q92630	DYRK2	G33S	G	33	S	-	neutral	AC/AN:0.82403 ; Hom/AC:0.18641	gnomAD
Q6P3W7	SCYL2	P357L	P	357	L	-	neutral	AC/AN:0.18882 ; Hom/AC:0.05526	gnomAD
O60285	NUAK1	P543R	P	543	R	-	neutral	AC/AN:0.52323 ; Hom/AC:0.12530	gnomAD
Q96RR4	CAMKK2	R363C	R	363	C	566	neutral	AC/AN:0.43407 ; Hom/AC:0.11813	gnomAD
Q96RR4	CAMKK2	R150C	R	150	C	-	neutral	AC/AN:0.43407 ; Hom/AC:0.11813	gnomAD
Q96RR4	CAMKK2	T85S	T	85	S	-	neutral	AC/AN:0.85910 ; Hom/AC:0.19908	gnomAD
O75385	ULK1	P714L	P	714	L	-	neutral	AC/AN:0.58519 ; Hom/AC:0.15904	gnomAD
O75385	ULK1	P62L	P	62	L	173	neutral	AC/AN:0.58519 ; Hom/AC:0.15904	gnomAD
P36888	FLT3	V557I	V	557	I	-	neutral	AC/AN:0.02931 ; Hom/AC:0.06737	gnomAD
Q6P3R8	NEK5	K255Q	K	255	Q	789	neutral	AC/AN:0.24489 ; Hom/AC:0.05968	gnomAD
P51956	NEK3	E305D	E	305	D	-	neutral	AC/AN:0.06119 ; Hom/AC:0.06370	gnomAD
Q6SA08	TSSK4	Q196R	Q	196	R	511	neutral	AC/AN:0.02466 ; Hom/AC:0.06081	gnomAD
Q6SA08	TSSK4	Q206R	Q	206	R	532	neutral	AC/AN:0.02466 ; Hom/AC:0.06081	gnomAD
Q6SA08	TSSK4	Q13R	Q	13	R	-	neutral	AC/AN:0.02466 ; Hom/AC:0.06081	gnomAD
Q6SA08	TSSK4	Q120R	Q	120	R	319	neutral	AC/AN:0.02466 ; Hom/AC:0.06081	gnomAD
Q9Y572	RIPK3	P492Q	P	492	Q	-	neutral	AC/AN:0.16834 ; Hom/AC:0.05392	gnomAD
Q9Y4K4	MAP4K5	T633M	T	633	M	-	neutral	AC/AN:0.16070 ; Hom/AC:0.05731	gnomAD
Q9Y6S9	RPS6KL1	P121L	P	121	L	-	neutral	AC/AN:0.81677 ; Hom/AC:0.19701	gnomAD
Q9Y6S9	RPS6KL1	R21Q	R	21	Q	-	neutral	AC/AN:0.86426 ; Hom/AC:0.20025	gnomAD
P27448	MARK3	S427G	S	427	G	-	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
P27448	MARK3	S443G	S	443	G	-	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
P27448	MARK3	S466G	S	466	G	-	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
P27448	MARK3	S443G	S	443	G	-	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
P27448	MARK3	S364G	S	364	G	-	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
P27448	MARK3	S443G	S	443	G	-	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
P27448	MARK3	S195G	S	195	G	441	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
P27448	MARK3	S22G	S	22	G	-	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
Q9P2K8	EIF2AK4	I441L	I	441	L	440	neutral	AC/AN:0.34468 ; Hom/AC:0.12393	gnomAD
Q9P2K8	EIF2AK4	I247L	I	247	L	-	neutral	AC/AN:0.34468 ; Hom/AC:0.12393	gnomAD
Q9P2K8	EIF2AK4	G1306C	G	1306	C	-	neutral	AC/AN:0.29725 ; Hom/AC:0.08067	gnomAD
Q9P2K8	EIF2AK4	G1278C	G	1278	C	-	neutral	AC/AN:0.29725 ; Hom/AC:0.08067	gnomAD
Q9P2K8	EIF2AK4	G1084C	G	1084	C	-	neutral	AC/AN:0.29725 ; Hom/AC:0.08067	gnomAD
O60566	BUB1B	E390D	E	390	D	-	neutral	AC/AN:0.02027 ; Hom/AC:0.05230	gnomAD
O60566	BUB1B	E404D	E	404	D	-	neutral	AC/AN:0.02027 ; Hom/AC:0.05230	gnomAD
O60566	BUB1B	V618A	V	618	A	-	neutral	AC/AN:0.04698 ; Hom/AC:0.11829	gnomAD
O60566	BUB1B	V632A	V	632	A	-	neutral	AC/AN:0.04698 ; Hom/AC:0.11829	gnomAD
Q9NQU5	PAK6	M76V	M	76	V	-	neutral	AC/AN:0.23993 ; Hom/AC:0.07146	gnomAD
Q9NQU5	PAK6	H215R	H	215	R	-	neutral	AC/AN:0.24160 ; Hom/AC:0.07235	gnomAD
Q9NQU5	PAK6	P337L	P	337	L	-	neutral	AC/AN:0.25976 ; Hom/AC:0.06671	gnomAD
Q9NYL2	MAP3K20	R42Q	R	42	Q	122	neutral	AC/AN:0.29857 ; Hom/AC:0.08764	gnomAD
Q06418	TYRO3	I346N	I	346	N	-	neutral	AC/AN:0.51627 ; Hom/AC:0.09405	gnomAD
Q06418	TYRO3	I301N	I	301	N	-	neutral	AC/AN:0.51627 ; Hom/AC:0.09405	gnomAD
Q6IQ55	TTBK2	L8P	L	8	P	-	neutral	AC/AN:0.84471 ; Hom/AC:0.21104	gnomAD
Q96QT4	TRPM7	T1482I	T	1482	I	-	neutral	AC/AN:0.19439 ; Hom/AC:0.05027	gnomAD
Q9UIK4	DAPK2	L483V	L	483	V	-	neutral	AC/AN:0.98972 ; Hom/AC:0.21626	gnomAD
Q9UIK4	DAPK2	L470V	L	470	V	-	neutral	AC/AN:0.33979 ; Hom/AC:0.08438	gnomAD
Q9C098	DCLK3	A113T	A	113	T	-	neutral	AC/AN:0.70345 ; Hom/AC:0.21569	gnomAD
Q9C098	DCLK3	R78H	R	78	H	-	neutral	AC/AN:0.25273 ; Hom/AC:0.13254	gnomAD
Q9H792	PEAK1	S1542T	S	1542	T	462	neutral	AC/AN:0.58122 ; Hom/AC:0.13301	gnomAD
Q9H792	PEAK1	R1071K	R	1071	K	-	neutral	AC/AN:0.67941 ; Hom/AC:0.16475	gnomAD
Q96L96	ALPK3	T414S	T	414	S	-	neutral	AC/AN:0.50062 ; Hom/AC:0.12335	gnomAD
Q96L96	ALPK3	G579E	G	579	E	-	neutral	AC/AN:0.50076 ; Hom/AC:0.12352	gnomAD
Q96L96	ALPK3	L1622P	L	1622	P	-	neutral	AC/AN:0.52730 ; Hom/AC:0.12506	gnomAD
Q38SD2	LRRK1	G1935D	G	1935	D	-	neutral	AC/AN:0.70979 ; Hom/AC:0.15950	gnomAD
Q38SD2	LRRK1	G1938D	G	1938	D	-	neutral	AC/AN:0.70979 ; Hom/AC:0.15950	gnomAD
Q99640	PKMYT1	A566V	A	566	V	-	neutral	AC/AN:0.09027 ; Hom/AC:0.09120	gnomAD
Q76MJ5	ERN2	S535T	S	535	T	45	neutral	AC/AN:0.71508 ; Hom/AC:0.17247	gnomAD
Q76MJ5	ERN2	S435T	S	435	T	-	neutral	AC/AN:0.71508 ; Hom/AC:0.17247	gnomAD
P05771	PRKCB	M82V	M	82	V	-	neutral	AC/AN:0.89462 ; Hom/AC:0.20452	gnomAD
Q96Q40	CDK15	P33A	P	33	A	-	neutral	AC/AN:0.17578 ; Hom/AC:0.07086	gnomAD
Q96Q40	CDK15	K30R	K	30	R	-	neutral	AC/AN:0.45365 ; Hom/AC:0.13638	gnomAD
Q8TF76	HASPIN	G204D	G	204	D	-	neutral	AC/AN:0.69072 ; Hom/AC:0.17293	gnomAD
Q8TF76	HASPIN	I328T	I	328	T	-	neutral	AC/AN:0.68735 ; Hom/AC:0.17268	gnomAD
Q8N4C8	MINK1	V834I	V	834	I	-	neutral	AC/AN:0.34540 ; Hom/AC:0.13589	gnomAD
Q8N4C8	MINK1	V863I	V	863	I	-	neutral	AC/AN:0.34540 ; Hom/AC:0.13589	gnomAD
Q8N4C8	MINK1	V843I	V	843	I	-	neutral	AC/AN:0.34540 ; Hom/AC:0.13589	gnomAD
Q02846	GUCY2D	A52S	A	52	S	-	neutral	AC/AN:0.96906 ; Hom/AC:0.23334	gnomAD
Q02846	GUCY2D	P701S	P	701	S	516	neutral	AC/AN:0.12048 ; Hom/AC:0.05212	gnomAD
Q02846	GUCY2D	L782H	L	782	H	758	neutral	AC/AN:0.28235 ; Hom/AC:0.09072	gnomAD
Q96J92	WNK4	A601S	A	601	S	-	neutral	AC/AN:0.08132 ; Hom/AC:0.07725	gnomAD
Q96J92	WNK4	P961S	P	961	S	-	neutral	AC/AN:0.08241 ; Hom/AC:0.07801	gnomAD
Q8IWB6	TEX14	N786D	N	786	D	-	neutral	AC/AN:0.35321 ; Hom/AC:0.09336	gnomAD
Q8IWB6	TEX14	N780D	N	780	D	-	neutral	AC/AN:0.35321 ; Hom/AC:0.09336	gnomAD
O75460	ERN1	L914M	L	914	M	-	neutral	AC/AN:0.03925 ; Hom/AC:0.07383	gnomAD
Q6ZMQ8	AATK	A1314T	A	1314	T	-	neutral	AC/AN:0.03898 ; Hom/AC:0.06171	gnomAD
Q6ZMQ8	AATK	A1211T	A	1211	T	-	neutral	AC/AN:0.03898 ; Hom/AC:0.06171	gnomAD
Q6ZMQ8	AATK	F1266S	F	1266	S	-	neutral	AC/AN:0.81421 ; Hom/AC:0.20424	gnomAD
Q6ZMQ8	AATK	F1163S	F	1163	S	-	neutral	AC/AN:0.81421 ; Hom/AC:0.20424	gnomAD
Q6ZMQ8	AATK	A541T	A	541	T	-	neutral	AC/AN:0.30812 ; Hom/AC:0.07814	gnomAD
Q6ZMQ8	AATK	A438T	A	438	T	-	neutral	AC/AN:0.30812 ; Hom/AC:0.07814	gnomAD
P31152	MAPK4	V38M	V	38	M	72	neutral	AC/AN:0.84038 ; Hom/AC:0.19592	gnomAD
Q86TB3	ALPK2	H1767Y	H	1767	Y	-	neutral	AC/AN:0.23825 ; Hom/AC:0.06351	gnomAD
Q86TB3	ALPK2	Q1579R	Q	1579	R	-	neutral	AC/AN:0.23212 ; Hom/AC:0.06395	gnomAD
Q86TB3	ALPK2	A1551S	A	1551	S	-	neutral	AC/AN:0.97477 ; Hom/AC:0.22698	gnomAD
Q86TB3	ALPK2	P1449S	P	1449	S	-	neutral	AC/AN:0.97253 ; Hom/AC:0.22663	gnomAD
Q86TB3	ALPK2	S977T	S	977	T	-	neutral	AC/AN:0.12755 ; Hom/AC:0.06292	gnomAD
Q9HBH9	MKNK2	Q10K	Q	10	K	-	neutral	AC/AN:0.22442 ; Hom/AC:0.05934	gnomAD
O43293	DAPK3	A79T	A	79	T	205	neutral	AC/AN:0.40134 ; Hom/AC:0.09191	gnomAD
P29597	TYK2	V362F	V	362	F	-	neutral	AC/AN:0.63083 ; Hom/AC:0.15243	gnomAD
P29597	TYK2	V177F	V	177	F	-	neutral	AC/AN:0.63083 ; Hom/AC:0.15243	gnomAD
P29597	TYK2	V362F	V	362	F	-	neutral	AC/AN:0.63083 ; Hom/AC:0.15243	gnomAD
Q16512	PKN1	A102T	A	102	T	-	neutral	AC/AN:0.06236 ; Hom/AC:0.09828	gnomAD
Q16512	PKN1	V901I	V	901	I	-	neutral	AC/AN:0.39210 ; Hom/AC:0.19421	gnomAD
Q16512	PKN1	V907I	V	907	I	-	neutral	AC/AN:0.39210 ; Hom/AC:0.19421	gnomAD
Q16512	PKN1	R109H	R	109	H	-	neutral	AC/AN:0.39210 ; Hom/AC:0.19421	gnomAD
Q16512	PKN1	R158H	R	158	H	-	neutral	AC/AN:0.39210 ; Hom/AC:0.19421	gnomAD
Q16512	PKN1	H133Y	H	133	Y	-	neutral	AC/AN:0.46321 ; Hom/AC:0.12211	gnomAD
Q16512	PKN1	H182Y	H	182	Y	-	neutral	AC/AN:0.46321 ; Hom/AC:0.12211	gnomAD
Q8NE63	HIPK4	A386T	A	386	T	-	neutral	AC/AN:0.07849 ; Hom/AC:0.10832	gnomAD
Q8NE63	HIPK4	R302Q	R	302	Q	736	neutral	AC/AN:0.20750 ; Hom/AC:0.05811	gnomAD
Q6DT37	CDC42BPG	I154T	I	154	T	273	neutral	AC/AN:0.03085 ; Hom/AC:0.06897	gnomAD
Q6DT37	CDC42BPG	L423V	L	423	V	-	neutral	AC/AN:0.29802 ; Hom/AC:0.07912	gnomAD
Q6DT37	CDC42BPG	L433V	L	433	V	-	neutral	AC/AN:0.29802 ; Hom/AC:0.07912	gnomAD
Q6DT37	CDC42BPG	L418V	L	418	V	-	neutral	AC/AN:0.29802 ; Hom/AC:0.07912	gnomAD
Q6DT37	CDC42BPG	L82V	L	82	V	41	neutral	AC/AN:0.29802 ; Hom/AC:0.07912	gnomAD
Q6DT37	CDC42BPG	L428V	L	428	V	-	neutral	AC/AN:0.29802 ; Hom/AC:0.07912	gnomAD
Q96Q04	LMTK3	V938A	V	938	A	-	neutral	AC/AN:0.14343 ; Hom/AC:0.05289	gnomAD
Q96Q04	LMTK3	V909A	V	909	A	-	neutral	AC/AN:0.14343 ; Hom/AC:0.05289	gnomAD
Q8IV63	VRK3	S371G	S	371	G	580	neutral	AC/AN:0.03227 ; Hom/AC:0.08482	gnomAD
Q8IV63	VRK3	S321G	S	321	G	437	neutral	AC/AN:0.03227 ; Hom/AC:0.08482	gnomAD
Q8IV63	VRK3	S140G	S	140	G	-	neutral	AC/AN:0.03227 ; Hom/AC:0.08482	gnomAD
Q8IV63	VRK3	S67G	S	67	G	-	neutral	AC/AN:0.03227 ; Hom/AC:0.08482	gnomAD
Q8IV63	VRK3	S371G	S	371	G	580	neutral	AC/AN:0.03227 ; Hom/AC:0.08482	gnomAD
Q8IV63	VRK3	S321G	S	321	G	437	neutral	AC/AN:0.03227 ; Hom/AC:0.08482	gnomAD
Q8IV63	VRK3	C288Y	C	288	Y	353	neutral	AC/AN:0.03219 ; Hom/AC:0.08519	gnomAD
Q8IV63	VRK3	C238Y	C	238	Y	-	neutral	AC/AN:0.03219 ; Hom/AC:0.08519	gnomAD
Q8IV63	VRK3	C57Y	C	57	Y	-	neutral	AC/AN:0.03219 ; Hom/AC:0.08519	gnomAD
Q8IV63	VRK3	C288Y	C	288	Y	353	neutral	AC/AN:0.03219 ; Hom/AC:0.08519	gnomAD
Q8IV63	VRK3	C238Y	C	238	Y	-	neutral	AC/AN:0.03219 ; Hom/AC:0.08519	gnomAD
Q8IV63	VRK3	S268L	S	268	L	284	neutral	AC/AN:0.03221 ; Hom/AC:0.08549	gnomAD
Q8IV63	VRK3	S218L	S	218	L	-	neutral	AC/AN:0.03221 ; Hom/AC:0.08549	gnomAD
Q8IV63	VRK3	S37L	S	37	L	-	neutral	AC/AN:0.03221 ; Hom/AC:0.08549	gnomAD
Q8IV63	VRK3	S268L	S	268	L	284	neutral	AC/AN:0.03221 ; Hom/AC:0.08549	gnomAD
Q8IV63	VRK3	S218L	S	218	L	-	neutral	AC/AN:0.03221 ; Hom/AC:0.08549	gnomAD
Q8IV63	VRK3	H21R	H	21	R	-	neutral	AC/AN:0.03164 ; Hom/AC:0.08464	gnomAD
Q8IV63	VRK3	T188A	T	188	A	-	neutral	AC/AN:0.03176 ; Hom/AC:0.08398	gnomAD
Q8IV63	VRK3	T138A	T	138	A	-	neutral	AC/AN:0.03176 ; Hom/AC:0.08398	gnomAD
Q8IV63	VRK3	T188A	T	188	A	-	neutral	AC/AN:0.03176 ; Hom/AC:0.08398	gnomAD
Q8IV63	VRK3	T138A	T	138	A	-	neutral	AC/AN:0.03176 ; Hom/AC:0.08398	gnomAD
Q8IV63	VRK3	F171L	F	171	L	-	neutral	AC/AN:0.03234 ; Hom/AC:0.08649	gnomAD
Q8IV63	VRK3	F121L	F	121	L	-	neutral	AC/AN:0.03234 ; Hom/AC:0.08649	gnomAD
Q8IV63	VRK3	F171L	F	171	L	-	neutral	AC/AN:0.03234 ; Hom/AC:0.08649	gnomAD
Q8IV63	VRK3	F121L	F	121	L	-	neutral	AC/AN:0.03234 ; Hom/AC:0.08649	gnomAD
Q8IV63	VRK3	F139L	F	139	L	-	neutral	AC/AN:0.03234 ; Hom/AC:0.08649	gnomAD
Q8IV63	VRK3	F121L	F	121	L	-	neutral	AC/AN:0.03234 ; Hom/AC:0.08649	gnomAD
Q8IV63	VRK3	P105T	P	105	T	-	neutral	AC/AN:0.03229 ; Hom/AC:0.08635	gnomAD
Q8IV63	VRK3	P55T	P	55	T	-	neutral	AC/AN:0.03229 ; Hom/AC:0.08635	gnomAD
Q8IV63	VRK3	P105T	P	105	T	-	neutral	AC/AN:0.03229 ; Hom/AC:0.08635	gnomAD
Q8IV63	VRK3	P55T	P	55	T	-	neutral	AC/AN:0.03229 ; Hom/AC:0.08635	gnomAD
Q8IV63	VRK3	P73T	P	73	T	-	neutral	AC/AN:0.03229 ; Hom/AC:0.08635	gnomAD
Q8IV63	VRK3	P105T	P	105	T	-	neutral	AC/AN:0.03229 ; Hom/AC:0.08635	gnomAD
Q8IV63	VRK3	P55T	P	55	T	-	neutral	AC/AN:0.03229 ; Hom/AC:0.08635	gnomAD
Q8IV63	VRK3	S59F	S	59	F	-	neutral	AC/AN:0.03217 ; Hom/AC:0.08610	gnomAD
Q8TDC3	BRSK1	G749S	G	749	S	-	neutral	AC/AN:0.17501 ; Hom/AC:0.05098	gnomAD
Q8TDC3	BRSK1	G444S	G	444	S	-	neutral	AC/AN:0.17501 ; Hom/AC:0.05098	gnomAD
Q8TDC3	BRSK1	G765S	G	765	S	-	neutral	AC/AN:0.17501 ; Hom/AC:0.05098	gnomAD
Q96RU7	TRIB3	Q84R	Q	84	R	-	neutral	AC/AN:0.40659 ; Hom/AC:0.11093	gnomAD
Q96RU7	TRIB3	Q111R	Q	111	R	-	neutral	AC/AN:0.40659 ; Hom/AC:0.11093	gnomAD
Q96RU7	TRIB3	Q84R	Q	84	R	-	neutral	AC/AN:0.40659 ; Hom/AC:0.11093	gnomAD
Q8TDR2	STK35	R69G	R	69	G	-	neutral	AC/AN:0.81385 ; Hom/AC:0.17843	gnomAD
Q9P286	PAK5	S511N	S	511	N	207	neutral	AC/AN:0.85408 ; Hom/AC:0.21473	gnomAD
Q9P286	PAK5	R335P	R	335	P	-	neutral	AC/AN:0.28536 ; Hom/AC:0.08907	gnomAD
Q9P286	PAK5	G118D	G	118	D	-	neutral	AC/AN:0.05270 ; Hom/AC:0.07614	gnomAD
Q8N2I9	STK40	V312M	V	312	M	765	neutral	AC/AN:0.60435 ; Hom/AC:0.15429	gnomAD
Q8N2I9	STK40	V257M	V	257	M	583	neutral	AC/AN:0.60435 ; Hom/AC:0.15429	gnomAD
Q9H3Y6	SRMS	V457L	V	457	L	758	neutral	AC/AN:0.16202 ; Hom/AC:0.09787	gnomAD
Q9H3Y6	SRMS	A453T	A	453	T	752	neutral	AC/AN:0.23072 ; Hom/AC:0.11041	gnomAD
Q9H3Y6	SRMS	P452L	P	452	L	751	neutral	AC/AN:0.06895 ; Hom/AC:0.14812	gnomAD
Q9H3Y6	SRMS	A397V	A	397	V	535	neutral	AC/AN:0.06557 ; Hom/AC:0.13550	gnomAD
Q9H3Y6	SRMS	V301L	V	301	L	265	neutral	AC/AN:0.09508 ; Hom/AC:0.08783	gnomAD
Q9H3Y6	SRMS	P218L	P	218	L	-	neutral	AC/AN:0.15206 ; Hom/AC:0.08715	gnomAD
Q9H3Y6	SRMS	I88V	I	88	V	-	neutral	AC/AN:0.05253 ; Hom/AC:0.12599	gnomAD
P57058	HUNK	R591C	R	591	C	-	neutral	AC/AN:0.52329 ; Hom/AC:0.12303	gnomAD
P57078	RIPK4	A12G	A	12	G	-	neutral	AC/AN:0.29974 ; Hom/AC:0.07703	gnomAD
P57059	SIK1	G15S	G	15	S	-	neutral	AC/AN:0.52904 ; Hom/AC:0.12422	gnomAD
Q07002	CDK18	S278R	S	278	R	428	neutral	AC/AN:0.32490 ; Hom/AC:0.09690	gnomAD
O60566	BUB1B	H310R	H	310	R	-	neutral	AC/AN:0.31318 ; Hom/AC:0.07271	gnomAD
O60566	BUB1B	H230R	H	230	R	-	neutral	AC/AN:0.31318 ; Hom/AC:0.07271	gnomAD
O60566	BUB1B	H299R	H	299	R	-	neutral	AC/AN:0.31318 ; Hom/AC:0.07271	gnomAD
O60566	BUB1B	R175Q	R	175	Q	-	neutral	AC/AN:0.31225 ; Hom/AC:0.07246	gnomAD
O60566	BUB1B	R176Q	R	176	Q	-	neutral	AC/AN:0.31225 ; Hom/AC:0.07246	gnomAD
O60566	BUB1B	R95Q	R	95	Q	-	neutral	AC/AN:0.31225 ; Hom/AC:0.07246	gnomAD
O60566	BUB1B	R164Q	R	164	Q	-	neutral	AC/AN:0.31225 ; Hom/AC:0.07246	gnomAD
Q96PF2	TSSK2	T280M	T	280	M	-	neutral	AC/AN:0.50665 ; Hom/AC:0.11998	gnomAD
P53671	LIMK2	G35S	G	35	S	-	neutral	AC/AN:0.35065 ; Hom/AC:0.11460	gnomAD
P53671	LIMK2	Q684R	Q	684	R	-	neutral	AC/AN:0.13604 ; Hom/AC:0.11803	gnomAD
P53671	LIMK2	Q627R	Q	627	R	-	neutral	AC/AN:0.13604 ; Hom/AC:0.11803	gnomAD
O15075	DCLK1	S648G	S	648	G	-	neutral	AC/AN:0.86883 ; Hom/AC:0.23017	gnomAD
O15075	DCLK1	S598G	S	598	G	637	neutral	AC/AN:0.86883 ; Hom/AC:0.23017	gnomAD
O15075	DCLK1	S648G	S	648	G	-	neutral	AC/AN:0.86883 ; Hom/AC:0.23017	gnomAD
P53778	MAPK12	T103M	T	103	M	256	neutral	AC/AN:0.14636 ; Hom/AC:0.05496	gnomAD
P53778	MAPK12	T23M	T	23	M	-	neutral	AC/AN:0.14636 ; Hom/AC:0.05496	gnomAD
